<SEC-DOCUMENT>0001213900-22-070181.txt : 20221108
<SEC-HEADER>0001213900-22-070181.hdr.sgml : 20221108
<ACCEPTANCE-DATETIME>20221108170048
ACCESSION NUMBER:		0001213900-22-070181
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		50
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221108
DATE AS OF CHANGE:		20221108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VS Trust
		CENTRAL INDEX KEY:			0001793497
		STANDARD INDUSTRIAL CLASSIFICATION:	 [6221]
		IRS NUMBER:				846704517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41280
		FILM NUMBER:		221369751

	BUSINESS ADDRESS:	
		STREET 1:		100 SOUTH BEDFORD ROAD, SUITE 340
		CITY:			MOUNT KISCO
		STATE:			NY
		ZIP:			10549
		BUSINESS PHONE:		2039986005

	MAIL ADDRESS:	
		STREET 1:		100 SOUTH BEDFORD ROAD, SUITE 340
		CITY:			MOUNT KISCO
		STATE:			NY
		ZIP:			10549
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>f10q0922_vstrust.htm
<DESCRIPTION>QUARTERLY REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Nov 08 21:24:36 UTC 2022 -->
<html xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:cik0001793497="http://www.vts.com/20220930" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><b>UNITED
STATES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D.C. 20549</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><b>FORM
<ix:nonNumeric contextRef="c0" name="dei:DocumentType">10-Q</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-size: 6pt">&#160;</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric>&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quarterly
report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate">September 30, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric></ix:nonNumeric>.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric>&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transition
report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from<span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>to&#160;<span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
file number: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-34200</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; font-variant: small-caps"><b>VS
Trust</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></ix:nonNumeric></td> <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>84-6704517</b></span></ix:nonNumeric></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State or other jurisdiction of <br/> incorporation or organization)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(I.R.S. Employer <br/> Identification No.)</b></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c/o
Volatility Shares LLC</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">2000
PGA Boulevard</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2">Suite 4440</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Palm
Beach Gardens</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric>. <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode">33408</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
of principal executive offices) (Zip Code)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">(866)</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">261-0273</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Registrant&#8217;s
telephone number, including area code)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="padding: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:Security12bTitle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-1x Short VIX Futures ETF</b></span></ix:nonNumeric></td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:TradingSymbol"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SVIX</b></span></ix:nonNumeric></td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><ix:nonNumeric contextRef="c2" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cboe BZX Exchange</b></span></ix:nonNumeric></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; "> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><ix:nonNumeric contextRef="c2" name="dei:Security12bTitle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2x Long VIX Futures ETF</b></span></ix:nonNumeric></td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><ix:nonNumeric contextRef="c2" name="dei:TradingSymbol"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UVIX</b></span></ix:nonNumeric></td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center"><ix:nonNumeric contextRef="c1" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cboe BZX Exchange</b></span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
registered pursuant to Section 12(g) of the Act: None</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.&#160;&#160;&#9746;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>&#160;&#9744;&#160; No</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).&#160;&#9746;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>&#160;&#9744;&#160;No</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller
reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large Accelerated Filer</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated Filer</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 31%">&#9744;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Accelerated Filer</span></ix:nonNumeric></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller Reporting Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></ix:nonNumeric></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging Growth Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.). &#9744;&#160;Yes&#160;<ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric>&#160;No</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.&#160;&#160;&#9746;&#160;Yes&#160;&#9744;&#160; No</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2022, the registrant had <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">12,140,000</ix:nonFraction> shares of common stock, $0 par value per share, outstanding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VS
Trust</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table
of Contents</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0 0 1.5pt; width: 91%; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; padding-left: 0; width: 9%; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part I. FINANCIAL INFORMATION</b></span></a></td>
    <td style="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1. Financial Statements</span></a></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_004">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4. Controls and Procedures</span></a></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#160;</td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part II. OTHER INFORMATION</b></span></a></td>
    <td style="text-align: center; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1. Legal Proceedings</span></a></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1A. Risk Factors</span></a></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></a></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3. Defaults Upon Senior Securities</span></a></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4. Mine Safety Disclosures</span></a></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 5. Other Information</span></a></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
    <td style="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><a href="#k_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 6. Exhibits</span></a></td>
    <td style="vertical-align: bottom; padding: 0; font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="k_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part
I. FINANCIAL INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="k_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1. Financial Statements.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Index</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Documents</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 13.5pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
    of Financial Condition, Schedule of Investments, Statements of Operations, Statements of Changes in Shareholders&#8217; Equity, and
    Statements of Cash Flows:</span></td>
    <td>&#160;</td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; ">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 13.5pt; text-indent: -12pt"><a href="#k_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF</span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 13.5pt; text-indent: -12pt"><a href="#k_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></a></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; ">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 13.5pt; text-indent: -12pt"><a href="#k_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VS Trust</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 13.5pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_018">Notes to Financial Statements</a></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>VS Trust</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Statements of Assets and Liabilities</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">September 30, 2022 (Unaudited)</p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">-1x Short <br/>
VIX Futures ETF</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2x Long <br/>
VIX Futures ETF</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Investments in securities, at value *</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtFairValue" scale="0" unitRef="usd">16,492,725</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtFairValue" scale="0" unitRef="usd">31,236,527</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestReceivable" scale="0" unitRef="usd">22,965</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestReceivable" scale="0" unitRef="usd">69,844</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Receivable for shares sold</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ReceivableForSharesSold" scale="0" unitRef="usd">4,444,910</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-0">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deposit at Broker for Futures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommodityContractAssetCurrent" scale="0" unitRef="usd">36,207,427</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommodityContractAssetCurrent" scale="0" unitRef="usd">56,663,638</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Variation margin receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:VariationMarginReceivable" scale="0" unitRef="usd">2,708,079</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivablesNetCurrent" scale="0" unitRef="usd">1,333</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-2">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Due from Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DueFromRelatedPartiesCurrent" scale="0" unitRef="usd">3,727,069</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; padding-left: 0.125in; font-weight: normal; text-align: left; padding-bottom: 1.5pt"><span style="font-style: normal; font-weight: normal">Total
    Assets</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">57,169,361</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">94,405,157</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Variation margin payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" unitRef="usd">774,721</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Due to Custodian</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DueToOtherRelatedPartiesClassifiedCurrent" scale="0" unitRef="usd">575,655</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DueToOtherRelatedPartiesClassifiedCurrent" scale="0" unitRef="usd">264,682</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Management fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeePayable" scale="0" unitRef="usd">44,372</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeePayable" scale="0" unitRef="usd">177,469</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Administrative, accounting and custodian fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableOtherCurrent" scale="0" unitRef="usd">38,976</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableOtherCurrent" scale="0" unitRef="usd">49,916</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Professional fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="0" unitRef="usd">70,547</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="0" unitRef="usd">71,973</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Licensing and registration fees payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:LicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">50,564</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:LicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">58,460</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-style: normal; font-weight: normal">Total
    Liabilities</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">1,554,835</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">622,499</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">NET ASSETS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">55,614,526</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">93,782,658</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">NET ASSETS CONSIST OF:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" sign="-" unitRef="usd">58,167,050</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" sign="-" unitRef="usd">89,025,195</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total distributable earnings (accumulated deficit)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" unitRef="usd">2,552,524</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">4,757,463</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Net Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">55,614,526</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">93,782,658</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net Asset Value (unlimited shares authorized):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Class I (unlimited shares authorized):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net Assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">55,614,526</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">93,782,658</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Shares Outstanding&#8224;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,380,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,760,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Net Asset Value, Offering and Redemption Price per Share</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:NetAssetValuePerShare" scale="0" unitRef="usdPershares">10.34</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:NetAssetValuePerShare" scale="0" unitRef="usdPershares">13.87</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">*Investments in securities, at cost</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtFairValue" scale="0" unitRef="usd">16,492,725</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtFairValue" scale="0" unitRef="usd">31,236,527</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0">&#8224; No Par Value</p><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>VS Trust</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Statements of Operations</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">For the Quarter Ended September 30, 2022 (Unaudited)</p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short <br/>
VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long <br/>
VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">INVESTMENT INCOME</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Income:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Interest income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="0" unitRef="usd">43,411</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="0" unitRef="usd">126,917</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="0" unitRef="usd">7</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">Total
    Income</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="0" unitRef="usd">43,411</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeNet" scale="0" unitRef="usd">126,924</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Management fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeeExpense" scale="0" unitRef="usd">146,457</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ManagementFeeExpense" scale="0" unitRef="usd">464,768</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Administrative, accounting and custodian fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">15,331</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd">25,723</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="0" unitRef="usd">80,462</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="0" unitRef="usd">81,792</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Licensing and registration fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd">27,963</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LegalFees" scale="0" unitRef="usd">34,070</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Broker interest expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FloorBrokerageExchangeAndClearanceFees" scale="0" unitRef="usd">4,038</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FloorBrokerageExchangeAndClearanceFees" scale="0" unitRef="usd">16,295</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt">Total Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">274,252</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd">622,647</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net Investment Loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff" scale="0" unitRef="usd">230,841</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff" scale="0" unitRef="usd">495,724</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: left"><b>REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES
    CONTRACTS</b></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net realized gain (loss) on:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Short Term Investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Futures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContracts" scale="0" sign="-" unitRef="usd">8,077,788</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContracts" scale="0" unitRef="usd">22,686,414</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net change in unrealized appreciation (depreciation) of:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Short Term Investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-9">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Futures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContractsUnrealizedAppreciation" scale="0" unitRef="usd">6,278,300</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FuturesContractsUnrealizedAppreciation" scale="0" sign="-" unitRef="usd">20,574,735</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net realized and unrealized gain (loss) on investments and futures contracts</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnEnergyContracts" scale="0" unitRef="usd">1,799,488</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnEnergyContracts" scale="0" sign="-" unitRef="usd">2,111,678</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" scale="0" unitRef="usd">1,568,647</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" scale="0" sign="-" unitRef="usd">2,607,402</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><div>



</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>VS Trust</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Statements of Changes in Net Assets</b></p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">-1x Short<br/>
VIX&#160;Futures<br/>
ETF</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2x Long<br/>
VIX&#160;Futures<br/>
ETF</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September&#160;30, <br/>
2022<br/>
(Unaudited)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September&#160;30, <br/>
2022<br/>
(Unaudited)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">INCREASE (DECREASE) IN NET ASSETS:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">OPERATIONS</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: left">Net investment loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="0" sign="-" unitRef="usd">230,841</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="0" sign="-" unitRef="usd">495,724</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left">Net realized gain (loss) on investments and futures contracts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RealizedInvestmentGainsLosses" scale="0" unitRef="usd">8,077,788</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RealizedInvestmentGainsLosses" scale="0" sign="-" unitRef="usd">22,686,414</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net change in unrealized appreciation (depreciation) of investments and futures contracts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="0" sign="-" unitRef="usd">6,278,300</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="0" unitRef="usd">20,574,735</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net increase (decrease) in net assets resulting from operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" scale="0" unitRef="usd">1,568,647</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" scale="0" sign="-" unitRef="usd">2,607,402</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">CAPITAL SHARE TRANSACTIONS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Shares sold</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldinShares" scale="0" sign="-" unitRef="usd">37,128,501</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldinShares" scale="0" sign="-" unitRef="usd">148,158,278</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Shares redeemed</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare" scale="0" unitRef="usd">29,971,993</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare" scale="0" unitRef="usd">112,204,673</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt"><b>Net increase in net assets from capital share
transactions</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions" scale="0" unitRef="usd">7,156,508</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions" scale="0" unitRef="usd">35,953,605</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total increase in net assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetsPeriodIncreaseDecrease" scale="0" unitRef="usd">8,725,155</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetsPeriodIncreaseDecrease" scale="0" unitRef="usd">33,346,203</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">NET ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Beginning of Period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">46,889,371</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">60,436,455</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">End of Period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">55,614,526</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsNet" scale="0" unitRef="usd">93,782,658</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>





</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>VS Trust</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Statements of Cash Flows</b></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short<br/> VIX&#160;Futures<br/> ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long<br/> VIX&#160;Futures<br/> ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September&#160;30, <br/> 2022<br/> (Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September&#160;30, <br/> 2022<br/> (Unaudited)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">CASH FLOW FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.125in">Net increase (decrease) in net assets resulting from operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" unitRef="usd">1,568,647</ix:nonFraction></td><td style="width: 1%; text-align: left"></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">2,607,402</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Purchase of investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:PurchasesOfInvestments" scale="0" unitRef="usd">73,580,457</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:PurchasesOfInvestments" scale="0" unitRef="usd">189,402,007</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in">Proceeds from sales or maturities of investments held</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments" scale="0" unitRef="usd">65,379,064</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments" scale="0" unitRef="usd">175,315,240</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Decrease (Increase) in Deposits at broker for futures contracts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding" scale="0" sign="-" unitRef="usd">3,665,556</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding" scale="0" unitRef="usd">16,108,875</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in">Decrease (Increase) in Variation margin receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:DecreaseIncreaseInVariationMarginReceivable" scale="0" unitRef="usd">1,274,983</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Decrease (Increase) in interest receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="0" unitRef="usd">13,363</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="0" unitRef="usd">57,469</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in">Decrease (Increase) in other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="0" unitRef="usd">1,333</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Decrease (Increase) in Due from Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseDueFromOtherRelatedParties" scale="0" unitRef="usd">4,743,330</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in">Increase (Decrease) in Variation margin payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInVariationMarginPayable" scale="0" unitRef="usd">191,690</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Increase (Decrease) in Due to Custodian</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInDueToCustodian" scale="0" unitRef="usd">575,655</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInDueToCustodian" scale="0" unitRef="usd">264,682</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in">Increase (Decrease) in Payable to Sponsor</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInPayableToSponsor" scale="0" unitRef="usd">17,753</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseDecreaseInPayableToSponsor" scale="0" sign="-" unitRef="usd">107,134</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in">Increase (Decrease) in Administrative, accounting and custodian fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">16,555</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">27,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in">Increase (Decrease) in Professional fees payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInProfessionalFeesPayable" scale="0" unitRef="usd">55,336</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInProfessionalFeesPayable" scale="0" unitRef="usd">56,798</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Increase (Decrease) in Licensing and registration fees payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">14,922</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable" scale="0" unitRef="usd">21,029</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.25in">Net cash provided by (used in) operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">2,145,481</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">38,401,864</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CASH FLOW FROM FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.125in">Proceeds from shares sold, net of cost from shares purchased</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSaleOfUnits" scale="0" unitRef="usd">32,683,591</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ProceedsFromSaleOfUnits" scale="0" unitRef="usd">150,498,756</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in">Cost of shares redeemed</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd">34,077,640</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="0" unitRef="usd">112,204,673</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" sign="-" unitRef="usd">1,394,049</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">38,294,083</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">NET DECREASE IN CASH</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">3,539,530</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">107,781</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Beginning of Period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">3,539,530</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd">107,781</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>




</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><div><a id="k_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: center"><b>-1x Short VIX Futures ETF</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Schedule of Investments (Unaudited)</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>September 30, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold">SHORT TERM INVESTMENT - 29.7%</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold">Money Market Fund - 29.7%</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; width: 11%; text-align: right">16,492,725</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="padding-bottom: 1.5pt; width: 76%; text-align: left">First American Government Obligations Fund, <ix:nonFraction contextRef="c11" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:MoneyMarketFundPercentage" scale="-2" unitRef="pure">2.77</ix:nonFraction>% (a)</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:OtherShortTermInvestments" scale="0" unitRef="usd">16,492,725</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">TOTAL SHORT TERM INVESTMENT (Cost $<ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="0" unitRef="usd">16,492,725</ix:nonFraction>)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherShortTermInvestments" scale="0" unitRef="usd">16,492,725</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">TOTAL INVESTMENTS (Cost $16,492,725) - <ix:nonFraction contextRef="c13" decimals="3" format="ixt:num-dot-decimal" name="cik0001793497:MoneyMarketFundPercentage" scale="-2" unitRef="pure">29.7</ix:nonFraction>%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherInvestments" scale="0" unitRef="usd">16,492,725</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Other Assets in Excess of Liabilities - <ix:nonFraction contextRef="c12" decimals="3" format="ixt:num-dot-decimal" name="cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage" scale="-2" unitRef="pure">70.3</ix:nonFraction>% (b)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" id="ix_0_fact" name="cik0001793497:OtherAssetsInExcessOfLiabilitiesAmount" scale="0" unitRef="usd">39,121,801</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt"><b>TOTAL NET ASSETS - <ix:nonFraction contextRef="c12" decimals="3" format="ixt:num-dot-decimal" name="cik0001793497:TotalNetAssetsPercentage" scale="-2" unitRef="pure">100.0</ix:nonFraction>%</b></td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherAssets" scale="0" unitRef="usd">55,614,526</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Percentages are stated as a percent of net assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in">(a)</td><td>Represents annualized seven-day yield at September 30, 2022.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in">(b)</td><td>$35,432,706 of cash is pledged as collateral for futures contracts.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>-1x Short VIX Futures ETF</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Short Futures Contracts (Unaudited)</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>September 30, 2022</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Contracts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Unrealized<br/> Appreciation/<br/> (Depreciation)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 11%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">(1,069)</div></td><td style="width: 1%">&#160;</td>
    <td style="width: 76%; text-align: left">CBOE VIX Futures</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ContractsOblication" scale="0" sign="-" unitRef="usd">4,642,568</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left; padding-left: 9pt">Expiring October 2022 (Underlying Face Amount at Market Value $33,566,600)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1.5pt"><div style="-sec-ix-hidden: hidden-fact-17">(713)</div></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">CBOE VIX Futures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ContractsOblication" scale="0" sign="-" unitRef="usd">935,201</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: right; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Expiring November 2022 (Underlying Face Amount at Market Value $22,053,090)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:TotalContractsObligations" scale="0" sign="-" unitRef="usd">5,577,769</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">See accompanying notes to financial statements</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="k_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2x Long VIX Futures ETF</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Schedule of Investments (Unaudited)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>September 30, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold">SHORT TERM INVESTMENT - 33.3%</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="font-weight: bold">Money Market Fund - 33.3%</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 11%; text-align: right; padding-bottom: 1.5pt">31,236,527</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">First American Government Obligations Fund, <ix:nonFraction contextRef="c17" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:MoneyMarketFundPercentage" scale="-2" unitRef="pure">2.77</ix:nonFraction>% (a)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:OtherShortTermInvestments" scale="0" unitRef="usd">31,236,527</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 4pt">TOTAL SHORT TERM INVESTMENT (Cost $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="0" unitRef="usd">31,236,527</ix:nonFraction>)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherShortTermInvestments" scale="0" unitRef="usd">31,236,527</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>TOTAL INVESTMENTS (Cost $31,236,527) - <ix:nonFraction contextRef="c7" decimals="3" format="ixt:num-dot-decimal" name="cik0001793497:MoneyMarketFundPercentage" scale="-2" unitRef="pure">33.3</ix:nonFraction>%</b></td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><b><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherInvestments" scale="0" unitRef="usd">31,236,527</ix:nonFraction></b></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt"><b>Other Assets in Excess of Liabilities - <ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage" scale="-2" unitRef="pure">66.7</ix:nonFraction>% (b)</b></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" id="ix_3_fact" name="cik0001793497:OtherAssetsInExcessOfLiabilitiesAmount" scale="0" unitRef="usd">62,546,131</ix:nonFraction></b></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: right; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 4pt"><b>TOTAL NET ASSETS - <ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="cik0001793497:TotalNetAssetsPercentage" scale="-2" unitRef="pure">100.0</ix:nonFraction>%</b></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; text-align: right"><b><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherAssets" scale="0" unitRef="usd">93,782,658</ix:nonFraction></b></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Percentages are stated as a percent of net assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents annualized
    seven-day yield at September 30, 2022.</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$59,371,717 of cash is pledged as collateral for futures contracts. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2x Long VIX Futures ETF</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Long Futures Contracts (Unaudited)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>September 30, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Contracts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Unrealized<br/> Appreciation/<br/> (Depreciation)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 11%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">3,606</div></td><td style="width: 1%">&#160;</td>
    <td style="width: 76%; text-align: left">CBOE VIX Futures</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ContractsOblication" scale="0" unitRef="usd">16,904,759</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left; padding-left: 9pt">Expiring October 2022 (Underlying Face Amount at Market Value $113,228,400)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-bottom: 1.5pt"><div style="-sec-ix-hidden: hidden-fact-19">2,404</div></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">CBOE VIX Futures</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ContractsOblication" scale="0" unitRef="usd">3,689,234</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: right; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Expiring November 2022 (Underlying Face Amount at Market Value $74,355,720)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:TotalContractsObligations" scale="0" unitRef="usd">20,593,993</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">See accompanying notes to financial statements</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="k_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VS
Trust</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO FINANCIAL STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
30, 2022</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(unaudited)</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8211; ORGANIZATION</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VS
Trust (the &#8220;Trust&#8221;) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series
(each, a &#8220;Fund&#8221; and collectively, the &#8220;Funds&#8221;). As of September 30, 2022, the following two series of the Trust
have commenced investment operations: -1x Short VIX Futures ETF (&#8220;SVIX&#8221;) and 2x Long VIX Futures ETF (&#8220;UVIX&#8221;).
Each of the Funds listed above issues common units of beneficial interest (&#8220;Shares&#8221;), which represent units of fractional
undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (&#8220;Cboe
BZX&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_3" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Funds&#8217; inception of operation was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other
than matters relating to its organization and the registration of each series under the Securities Act of 1933.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_4" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Fund&#8217;s investment exposure to&#160;VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each
Fund to regulation under the Commodity Exchange&#160;Act&#160;of&#160;1934 (&#8220;CEA&#8221;) and Commodity Futures Trading Commission
(&#8220;CFTC&#8221;) rules. The Sponsor is registered as a Commodity Pool Operator (&#8220;CPO&#8221;) and the Fund will be operated
in accordance with applicable CFTC rules. Registration as a CPO imposes additional compliance obligations on the Sponsor and the Funds
related to additional laws, regulations and enforcement policies, which could increase compliance costs and may affect the operations
and financial performance of the Funds.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility
Shares LLC (the &#8220;Sponsor&#8221;) is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust&#8217;s commodity
pool operator. The Funds are commodity pools, as defined under the Commodity Exchange&#160;Act (the &#8220;CEA&#8221;), and the applicable
regulations of the CFTC and are operated by the Sponsor, which is registered as a commodity pool operator with the CFTC.&#160;The Trust
is not an investment company registered under the Investment Company Act&#160;of&#160;1940.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8211; SIGNIFICANT ACCOUNTING POLICIES</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_2" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Fund is an investment company, as defined by Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 946 &#8220;Financial Services &#8212; Investment Companies.&#8221; As such, the Funds follow the investment
company accounting and reporting guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable,
in preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United
States of America (&#8220;GAAP&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_3" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited financial statements were prepared in accordance with GAAP for interim financial information and with the instructions
for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). In the opinion of management,
all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period
financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_4" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_EmergingGrowthCompanyPolicyTextBlock-c0_cont_1" escape="true" name="cik0001793497:EmergingGrowthCompanyPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
growth company</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_5" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:continuation continuedAt="_EmergingGrowthCompanyPolicyTextBlock-c0_cont_2" id="_EmergingGrowthCompanyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act&#160;of&#160;2012. It will remain
an emerging growth company until the earlier of (1)&#160;the beginning of the first fiscal year following the fifth anniversary of its
initial public offering, (2)&#160;the beginning of the first fiscal year after annual gross revenue is $<ix:nonFraction contextRef="c0" decimals="-7" format="ixt:num-dot-decimal" name="cik0001793497:GrossRevenue" scale="9" unitRef="usd">1.07</ix:nonFraction>&#160;billion (subject to
adjustment for inflation) or more, (3)&#160;the date on which the Fund has, during the previous three-year&#160;period, issued more than
$<ix:nonFraction contextRef="c0" decimals="-8" format="ixt:num-dot-decimal" name="cik0001793497:NonconvertibleDebtSecurities" scale="9" unitRef="usd">1.0</ix:nonFraction>&#160;billion in non-convertible&#160;debt securities and (4)&#160;as of the end of any fiscal year in which the market value of
common equity held by non-affiliates&#160;exceeded $<ix:nonFraction contextRef="c0" decimals="-6" format="ixt:num-dot-decimal" name="cik0001793497:NonaffiliatesExceeded" scale="6" unitRef="usd">700</ix:nonFraction>&#160;million as of the end of the second quarter of that fiscal year.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_6" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:continuation id="_EmergingGrowthCompanyPolicyTextBlock-c0_cont_2">For
as long as the Trust remains an &#8220;emerging growth company,&#8221; it may take advantage of certain exemptions from the various reporting
requirements that are applicable to public companies that are not &#8220;emerging growth companies&#8221; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley&#160;Act, reduced
disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions
from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden
parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an &#8220;emerging
growth company.</ix:continuation>&#8221;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_7" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Estimates &amp; Indemnifications</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_8" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:continuation continuedAt="_UseOfEstimates-c0_cont_2" id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_9" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:continuation id="_UseOfEstimates-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications.
The Trust&#8217;s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_10" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_9"><ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Presentation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_11" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_10"><ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for
each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect
to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any
other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or
distributed to the Trust for the purchase of Shares in that Fund.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_12" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_11"><ix:nonNumeric contextRef="c0" continuedAt="_StatementsOfCashFlowsPolicyTextBlock-c0_cont_1" escape="true" name="cik0001793497:StatementsOfCashFlowsPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements
of Cash Flows</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_13" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_12"><ix:continuation id="_StatementsOfCashFlowsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated September
30, 2022, and represents cash, segregated cash balances with brokers for futures contracts, segregated cash with brokers for swap agreements
but does not include short-term investments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_14" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_13"><ix:nonNumeric contextRef="c0" continuedAt="_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_1" escape="true" name="cik0001793497:FinalNetAssetValueForFiscalPeriodPolcyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Final
Net Asset Value for Fiscal Period</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_15" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_14"><ix:continuation continuedAt="_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_2" id="_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cut-off times and the times of the calculation of the Funds&#8217; final net asset value for creation and redemption of fund Shares for
the three months ended September 30, 2022 were typically as follows. All times are Eastern Standard Time:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "></p><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_16" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_15"><ix:nonNumeric contextRef="c0" escape="true" name="cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock"><ix:continuation continuedAt="_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_3" id="_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Create/Redeem</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV Calculation</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; width: 52%; font-weight: bold">Fund</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Cut-off*(EST)</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Time (EST)</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Calculation Date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; text-align: left">-1x Short VIX Futures ETF and</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center"><ix:nonNumeric contextRef="c6" id="ix_4_fact" name="cik0001793497:CreateRedeemCutoffDescription">2:00 p.m.</ix:nonNumeric></td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center"><ix:nonNumeric contextRef="c6" name="cik0001793497:NAVCalculationTimeESTDescription">4:00 p.m.</ix:nonNumeric></td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center"><ix:nonNumeric contextRef="c6" format="ixt:date-monthname-day-year-en" name="cik0001793497:NAVCalculationDate">September 30, 2022</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="white-space: nowrap; text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c7" id="ix_5_fact" name="cik0001793497:CreateRedeemCutoffDescription">2:00 p.m.</ix:nonNumeric></td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c7" name="cik0001793497:NAVCalculationTimeESTDescription">4:00 p.m.</ix:nonNumeric></td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c7" format="ixt:date-monthname-day-year-en" name="cik0001793497:NAVCalculationDate">September 30, 2022</ix:nonNumeric></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:nonNumeric></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_17" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_16"><ix:continuation continuedAt="_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_4" id="_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
                                            the Funds&#8217; shares may continue to trade on secondary markets subsequent to the calculation
                                            of the final NAV, these times represent the final opportunity to transact in creation or
                                            redemption units for the three months ended September 30, 2022.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_18" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_17"><ix:continuation continuedAt="_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_5" id="_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
value per Share is determined at the close of Cboe BZX and may be later than when the Funds&#8217; NAV per Share is calculated.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_19" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_18"><ix:continuation id="_FinalNetAssetValueForFiscalPeriodPolcyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly,
the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds&#8217;
final creation/redemption NAV for the three months ended September 30, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_20" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_19"><ix:nonNumeric contextRef="c0" continuedAt="_InvestmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Valuation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_21" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_20"><ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_2" id="_InvestmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term
investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each
of these situations, valuations are typically categorized as Level I in the fair value hierarchy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_22" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_21"><ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_3" id="_InvestmentPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivatives
(e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties
or other procedures as determined by the Sponsor. Futures contracts are generally valued at the last settled price on the applicable
exchange on which that future trades. For financial reporting purposes, all futures contracts are generally valued at the last settled
price. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically
categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as
the basis for determining the market value of such position. Such fair value prices would generally be determined based on available
inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor
deems fair and equitable so long as such principles are consistent with industry standards. The Sponsor may fair value an asset of a
Fund pursuant to the policies the Sponsor has adopted. Depending on the source and relevant significance of valuation inputs, these instruments
may be classified as Level II or Level III in the fair value hierarchy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_23" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_22"><ix:continuation id="_InvestmentPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value pricing may require subjective determinations about the value of an investment. While the Funds&#8217; policies are intended to
result in a calculation of its respective Fund&#8217;s NAV that fairly reflects investment values as of the time of pricing, such Fund
cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that
a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or
distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the
differences could be material to the financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_24" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_23"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
Value of Financial Instruments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_25" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_24"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure
fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions
developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds&#8217; own assumptions
about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs).
The three levels defined by the disclosure requirements hierarchy are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_26" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_25"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
I &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability
to access at the measurement date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_27" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_26"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
II &#8211; Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or
indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for
identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the
asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means
(market-corroborated inputs).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_28" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_27"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
III &#8211; Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure
fair value to the extent that observable inputs are not available.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_29" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_28"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair
value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant
to the fair value measurement in its entirety.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_30" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_29"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly
decreased, as well as when circumstances indicate that a transaction is not orderly.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_31" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_30"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_8" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the valuation of investments at September 30, 2022 using the fair value hierarchy:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "></p><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_32" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_31"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_9" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_8"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level I - Quoted Prices</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level II - Other Significant<br/> Observable Inputs</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Money Market Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Futures Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Foreign</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Currency</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Forward</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contracts</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Swap</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Agreements</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">-1x Short VIX Futures ETF </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">16,492,725</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" id="ix_6_fact" name="cik0001793497:AmountOfTotalTrust" scale="0" sign="-" unitRef="usd">55,619,690</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">&#160;&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" sign="-" unitRef="usd">39,126,965</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">31,236,527</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" id="ix_7_fact" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">187,584,120</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">218,820,647</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Total Trust </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">47,729,252</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" id="ix_8_fact" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">131,964,430</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-24"></div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-25"></div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountOfTotalTrust" scale="0" unitRef="usd">179,693,682</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_33" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_32"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_10" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_9"><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of
                                            Investments. Only current day&#8217;s variation margin is reported within the Statements
                                            of Financial Condition in receivable/payable on open futures.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_34" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_33"><ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_35" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_34"><ix:nonNumeric contextRef="c0" continuedAt="_UnremittedEarningsInForeignInvestmentPolicy-c0_cont_1" escape="true" name="us-gaap:UnremittedEarningsInForeignInvestmentPolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Transactions and Related Income</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_36" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_35"><ix:continuation continuedAt="_UnremittedEarningsInForeignInvestmentPolicy-c0_cont_2" id="_UnremittedEarningsInForeignInvestmentPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily.
Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized
appreciation (depreciation) between periods are reflected in the Statements of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_37" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_36"><ix:continuation id="_UnremittedEarningsInForeignInvestmentPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as
Interest Income in the Statement of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_38" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_37"><ix:nonNumeric contextRef="c0" continuedAt="_FloorBrokeragePolicy-c0_cont_1" escape="true" name="us-gaap:FloorBrokeragePolicy"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Brokerage
Commissions and Futures Account Fees</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_39" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_38"><ix:continuation id="_FloorBrokeragePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (&#8220;NFA&#8221;)
fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities
for each Fund&#8217;s investment in U.S. Commodity Futures Trading Commission (&#8220;CFTC&#8221;) regulated investments. The effects
of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities
or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are
recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized
when the transaction is closed). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed
variable create/redeem fees collected by more than <ix:nonFraction contextRef="c20" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:FundsAverageNetAssetsAnnually" scale="-2" unitRef="pure">0.04</ix:nonFraction>% and <ix:nonFraction contextRef="c21" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:FundsAverageNetAssetsAnnually" scale="-2" unitRef="pure">0.09</ix:nonFraction>%, for SVIX and UVIX, respectively, of each Fund&#8217;s average net assets annually.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_40" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_39"><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Federal
Income Tax</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_41" id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_40"><ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly,
no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund&#8217;s Shares is required to take
into account its allocable share of its Fund&#8217;s income, gain, loss, deductions and other items for its Fund&#8217;s taxable year
ending with or within the beneficial owner&#8217;s taxable year.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation id="_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock-c0_cont_41"><ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since
then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income
tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is
reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing
basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary
based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_InvestmentTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; INVESTMENTS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_2" id="_InvestmentTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Short-Term
Investments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_3" id="_InvestmentTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Funds may purchase U.S. Treasury Bills, agency securities, and other high-credit quality short-term fixed income or similar securities
with original maturities of one year or less. A portion of these investments may be posted as collateral in connection with swap agreements,
futures, and/or forward contracts.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_4" id="_InvestmentTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting
for Derivative Instruments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_5" id="_InvestmentTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
seeking to achieve each Fund&#8217;s investment objective, the Sponsor uses a mathematical approach to investing. Using this approach,
the Sponsor determines the type, quantity and mix of investment positions, including derivative positions, which the Sponsor believes
in combination, should produce returns consistent with a Fund&#8217;s objective.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_6" id="_InvestmentTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
open derivative positions at period end are reflected on each respective Fund&#8217;s Schedule of Investments. Certain Funds utilized
a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objectives during
the period. While the volume of open positions may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve
the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective
Fund at the date of this report is generally representative of open positions throughout the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_7" id="_InvestmentTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
is a description of the derivative instruments used by the Funds during the reporting period, including the primary underlying risk exposures
related to each instrument type.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_8" id="_InvestmentTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Futures
Contracts</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_9" id="_InvestmentTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Funds may enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or
shorting), an underlying benchmark. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery
of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally
be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase
of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration
of contract.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_10" id="_InvestmentTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
entering into a futures contract, each Fund is required to deposit and maintain as collateral at least such initial margin as required
by the exchange on which the transaction is affected. The initial margin is segregated as cash and/or securities balances with brokers
for futures contracts, as disclosed in the Statements of Financial Condition, and is restricted as to its use. The Funds that enter into
futures contracts maintain collateral at the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund
generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract.
Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize
a gain or loss upon closing of a futures transaction.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_11" id="_InvestmentTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">Futures contracts involve,
to varying degrees, elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility
risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure
each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation
between movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility
of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures
contracts are exchange-traded and the credit risk resides with the Funds&#8217; clearing broker or clearinghouse itself. Many futures
exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the
daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended
for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with
little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses.
If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund
will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will
be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_12" id="_InvestmentTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Option Contracts</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_13" id="_InvestmentTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">An option is a contract
that gives the buyer the right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific
(or strike) price within a specified period of time, regardless of the market price of that instrument. There are two types of options:
calls and puts. A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any
time during the life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated
price at any time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds
an offsetting position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor&#8217;s entire investment
(i.e., the premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the
option expires. Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin,
and the risk of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price
which may, upon exercise of the option, be significantly different from the market value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_14" id="_InvestmentTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">When a Fund writes a call
or put, an amount equal to the premium received is recorded and subsequently marked to market to reflect the current value of the option
written. Premiums received from writing options which expire are treated as realized gains. Premiums received from writing options which
are exercised or closed are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction
to determine the realized gain (loss).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_15" id="_InvestmentTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">When a Fund purchases an
option, the Fund pays a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market
to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk
associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised
or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized
gain (loss) when the underlying transaction is executed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_16" id="_InvestmentTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">Certain options transactions
may subject the writer (seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or
delivered. The value of a Fund&#8217;s options transactions, if any, will be affected by, among other things, changes in the value of
a Fund&#8217;s underlying benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility
of the Fund&#8217;s underlying benchmark, and the remaining time until the options expire, or any combination thereof. The value of the
options should not be expected to increase or decrease at the same rate as the level of the Fund&#8217;s underlying benchmark, which may
contribute to tracking error. Options may be less liquid than certain other securities. A Fund&#8217;s ability to trade options will be
dependent on the willingness of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have
difficulty closing out certain option positions at desired times and prices. A Fund may experience substantial downside from specific
option positions and certain option positions may expire worthless. Over-the-counter options generally are not assignable except by agreement
between the parties concerned, and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for
options is relatively illiquid, particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity
risk and counterparty credit risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell
options on futures contracts, which may present even greater volatility and risk of loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_17" id="_InvestmentTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Swap Agreements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_18" id="_InvestmentTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">The Funds may enter into
swap agreements for purposes of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying
Index or to create an economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered
into primarily with institutional investors in over-the-counter (&#8220;OTC&#8221;) markets for a specified period, ranging from a day
to more than one year. However, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#8220;Dodd-Frank Act&#8221;) provides
for significant reforms of the OTC derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated
market and/or to clear such transactions through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties
agree to exchange the returns earned or realized on a particular predetermined investment, instrument or Index in exchange for a fixed
or floating rate of return in respect of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark
level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to a notional amount and
the benchmark returns to which the swap is linked. Swap agreements do not involve the delivery of underlying instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_19" id="_InvestmentTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">Generally, swap agreements
entered into by the Funds calculate and settle the obligations of the parties to the agreement on a &#8220;net basis&#8221; with a single
payment. Consequently, each Fund&#8217;s current obligations (or rights) under a swap agreement will generally be equal only to the net
amount to be paid or received under the agreement based on the relative values of such obligations (or rights) (the &#8220;net amount&#8221;).
In a typical swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark
increases and would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted
for any transaction costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX,
the Fund would be required to make payments to the swap counterparties in the event the level of the benchmark increases and would be
entitled to settlement payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads
on the notional amount the Funds may pay.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_20" id="_InvestmentTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">The net amount of the excess,
if any, of each Fund&#8217;s obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and
an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the
counterparty in a segregated account by the Funds&#8217; Custodian. The net amount of the excess, if any, of each Fund&#8217;s entitlements
over its obligations with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having
an aggregate value at least equal to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third
party custodian. Until a swap agreement is settled in cash, the gain or loss on the notional amount less any transaction costs or trading
spreads payable by each Fund on the notional amount are recorded as &#8220;unrealized appreciation or depreciation on swap agreements&#8221;
and, when cash is exchanged, the gain or loss realized is recorded as &#8220;realized gains or losses on swap agreements.&#8221; Swap
agreements are generally valued at the last settled price of the benchmark referenced asset.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_21" id="_InvestmentTextBlock-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">Swap agreements contain
various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default
on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in
an amount equal to the net positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction
with the same counterparty, enter into a transaction with a different counterparty or seek to achieve its investment objective through
any number of different investments or investment techniques.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_22" id="_InvestmentTextBlock-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">Swap agreements involve,
to varying degrees, elements of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts
reflect the extent of the total investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional
risks associated with the use of swap agreements are imperfect correlations between movements in the notional amount and the price of
the underlying reference Index and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected
to be received under a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically
enter into swap agreements only with major global financial institutions. The creditworthiness of each of the firms that is a party to
a swap agreement is monitored by the Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination
and payment, using different counterparties, limiting the net amount due from any individual counterparty and generally requiring collateral
to be posted by the counterparty in an amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually
terminate within one month but may be terminated without penalty by either party at any time. Upon termination, the Fund is obligated
to pay or receive the &#8220;unrealized appreciation or depreciation&#8221; amount.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_23" id="_InvestmentTextBlock-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">The Funds, as applicable,
collateralize swap agreements by segregating or designating cash and/or certain securities as indicated on the Statements of Financial
Condition or Schedules of Investments. As noted above, collateral posted in connection with OTC derivative transactions is held for the
benefit of the counterparty in a segregated tri-party account at the Custodian to protect the counterparty against non-payment by the
Funds. The collateral held in this account is restricted as to its use. In the event of a default by the counterparty, the Funds will
seek withdrawal of this collateral from the segregated account and may incur certain costs in exercising its right with respect to the
collateral. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, the Funds
may experience significant delays in obtaining any recovery in a bankruptcy or other reorganizational proceeding. The Funds may obtain
only limited recovery or may obtain no recovery in such circumstances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_24" id="_InvestmentTextBlock-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">The Funds remain subject
to credit risk with respect to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these
risks in connection with OTC swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit
of the Fund, marked to market daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum
thresholds. In the event of a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty,
generally as of the day prior to the bankruptcy, because there is a one day time lag between the Fund&#8217;s request for collateral and
the delivery of such collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as
described above, including the possible delays in recovering amounts as a result of bankruptcy proceedings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_25" id="_InvestmentTextBlock-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">The counterparty/credit
risk for cleared derivative transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted
for each counterparty to a cleared derivative contract and, in effect, guarantees the parties&#8217; performance under the contract as
each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative
transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_26" id="_InvestmentTextBlock-c0_cont_25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>Fair Value of Derivative
Instruments as of September 30, 2022</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_27" id="_InvestmentTextBlock-c0_cont_26"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="5" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset
    Derivatives</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability
    Derivatives</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives
    Not Accounted<br/> for as Hedging Instruments</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements
    of <br/>
Financial Condition<br/> Location</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized<br/>
Appreciation</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements
of <br/>
Financial Condition<br/>
Location &#160;&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized<br/>
Depreciation</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables on open futures contracts, unrealized appreciation
    on swap agreements</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payable on open futures contracts, unrealized depreciation
    on swap agreements</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 20%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX
    Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 20%; text-align: right"></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" id="ix_9_fact" name="cik0001793497:TotalTrust" scale="0" sign="-" unitRef="usd">5,577,769</ix:nonFraction></span></td><td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)*</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 25%; text-align: right"></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-26"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td style="width: 1%; text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; ">
    <td></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:TotalTrust" scale="0" unitRef="usd">20,593,993</ix:nonFraction></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-27; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 13.5pt"></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Trust</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" id="ix_10_fact" name="cik0001793497:TotalTrust" scale="0" unitRef="usd">14,296,435</ix:nonFraction></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-28"></div></td><td style="font-weight: bold; text-align: left">*</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b>&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_28" id="_InvestmentTextBlock-c0_cont_27"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_29" id="_InvestmentTextBlock-c0_cont_28"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>The Effect of Derivative
Instruments on the Statement of Operations</b></p></ix:continuation><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_30" id="_InvestmentTextBlock-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>For the three months
ended September 30, 2022</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_31" id="_InvestmentTextBlock-c0_cont_30"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; padding: 0; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Derivatives Not Accounted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>for as Hedging Instruments</b></p></td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Location of Gain</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Loss) on Derivatives</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Recognized in Income</b></p></td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; text-indent: 0">Fund</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="3" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Realized
Gain<br/>
(Loss) on<br/>
Derivatives<br/>
Recognized in<br/>
Income</b></p></td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="3" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in<br/> Unrealized<br/>
                                                                                 Appreciation<br/> (Depreciation)<br/>
on</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Derivatives<br/>
Recognized in<br/>
Income</b></p></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">VIX Futures Contracts</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">Net realized gain (loss) on futures contracts and/or swap agreements/ changes in unrealized appreciation (depreciation) on futures contracts and/or swap agreements</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; width: 16%; text-indent: 0"></td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 38%; text-indent: 0"></td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 20%; text-align: left; text-indent: 0">-1x Short VIX Futures ETF</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c40" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesRealizedGainLoss" scale="0" unitRef="usd">8,077,788</ix:nonFraction></td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">(<ix:nonFraction contextRef="c40" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" scale="0" sign="-" unitRef="usd">6,278,300</ix:nonFraction></td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0"></td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-indent: 0"></td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">2x Long VIX Futures ETF</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">(<ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesRealizedGainLoss" scale="0" sign="-" unitRef="usd">22,686,414</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0"><ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">20,574,735</ix:nonFraction></td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><b>&#160;</b></td><td style="padding: 0; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; text-indent: 0"><b>&#160;</b></td><td style="padding: 0; font-weight: bold; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; font-weight: bold; text-align: left; text-indent: 0"><b>Total Trust</b></td><td style="padding: 0; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; text-align: left; text-indent: 0"><b>$</b></td><td style="padding: 0; text-align: right; text-indent: 0"><b>(<ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesRealizedGainLoss" scale="0" sign="-" unitRef="usd">14,608,626</ix:nonFraction></b></td><td style="padding: 0; text-align: left; text-indent: 0"><b>)</b></td><td style="padding: 0; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; text-align: left; text-indent: 0"><b>$</b></td><td style="padding: 0; text-align: right; text-indent: 0"><b><ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" scale="0" unitRef="usd">14,296,435</ix:nonFraction></b></td><td style="padding: 0; text-align: left; text-indent: 0"><b>&#160;</b></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_32" id="_InvestmentTextBlock-c0_cont_31"><ix:continuation id="_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>The Effect of Derivative
Instruments on the Statement of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>For the three months
ended September 30, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; ">&#160;</p><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_33" id="_InvestmentTextBlock-c0_cont_32"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Offsetting Assets and Liabilities</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_34" id="_InvestmentTextBlock-c0_cont_33"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund is subject to master netting agreements
or similar arrangements that allow for amounts owed between each Fund and the counterparty to be netted upon an early termination. The
party that has the larger payable pays the excess of the larger amount over the smaller amount to the other party. The master netting
agreements or similar arrangements do not apply to amounts owed to/from different counterparties. As described above, the Funds utilize
derivative instruments to achieve their investment objective during the year. The amounts shown in the Statements of Financial Condition
do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_35" id="_InvestmentTextBlock-c0_cont_34"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">For financial reporting purposes, the Funds
do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition.
The following table presents each Fund&#8217;s derivatives by investment type and by counterparty net of amounts available for offset
under a master netting agreement and the related collateral received or pledged by the Funds as of September 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_36" id="_InvestmentTextBlock-c0_cont_35"><ix:nonNumeric contextRef="c0" escape="true" name="cik0001793497:ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="19" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Values of Derivative Instruments as of September 30, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts<br/> of Recognized<br/> Assets presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts<br/> Offset in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net Amounts of Assets presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross Amounts<br/> of Recognized<br/> Liabilities<br/> presented <br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts<br/> Offset in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts of<br/> Liabilities<br/> presented <br/> in the<br/> Statements of<br/> Financial<br/> Condition</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">-1x Short VIX Futures ETF </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29"></div></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"><div style="-sec-ix-hidden: hidden-fact-30"></div></td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">774,721</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left"></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">774,721</ix:nonFraction></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">2,708,079</ix:nonFraction></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" scale="0" unitRef="usd">2,708,079</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">&#160;</div></td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">&#160;</div></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_37" id="_InvestmentTextBlock-c0_cont_36"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Asset (Liability) amounts shown in the table
below represent amounts owed to (by) the Funds for the derivative-related investments at September 30, 2022. These amounts may be collateralized
by cash or financial instruments, segregated for the benefit of the Funds or the counterparties, depending on whether the related contracts
are in an appreciated or depreciated position at period end. Amounts shown in the column labeled &#8220;Net Amount&#8221; represent the
uncollateralized portions of these amounts at period end. These amounts may be un-collateralized due to timing differences related to
market movements or due to minimum thresholds for collateral movement, as further described above under the caption &#8220;Accounting
for Derivative Instruments&#8221;.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><ix:continuation id="_InvestmentTextBlock-c0_cont_37"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross Amounts Not Offset in the Statements of Financial Condition as of September 30, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments<br/> for the<br/> Benefit of <br/> (the Funds) /<br/> the<br/> Counterparties</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>Cash Collateral<br/> for the Benefit<br/> of (the Funds) /<br/> the<br/> Counterparties</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net<br/> Amount</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" scale="0" sign="-" unitRef="usd">774,721</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: left">$</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: left">$</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" scale="0" sign="-" unitRef="usd">774,721</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" scale="0" unitRef="usd">2,708,079</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="cik0001793497:FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" scale="0" unitRef="usd">2,708,079</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AgreementsDisclosureTextBlock-c0_cont_1" escape="true" name="cik0001793497:AgreementsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 4 &#8211; AGREEMENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_2" id="_AgreementsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Management Fee</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_3" id="_AgreementsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">SVIX pays the Sponsor a management fee (the &#8220;Management Fee&#8221;),
monthly in arrears, in an amount equal to <b><ix:nonFraction contextRef="c47" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:AverageDailyNetAssetsRate" scale="-2" unitRef="pure">1.35</ix:nonFraction></b>% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee,
monthly in arrears, in an amount equal to <b><ix:nonFraction contextRef="c48" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:AverageDailyNetAssetsRate" scale="-2" unitRef="pure">1.65</ix:nonFraction></b>% per annum of its average daily net assets. &#8220;Average daily net assets&#8221;
is calculated by dividing the month-end net assets of each Fund by the number of calendar&#160;days in such month.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_4" id="_AgreementsDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">No other Management Fee is paid by the Funds. The Management Fee is
paid in consideration of the Sponsor&#8217;s trading advisory services and the other services provided to the Fund that the Sponsor pays
directly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_5" id="_AgreementsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Pursuant to the Sponsor Agreement between Sponsor and the Trust, on
behalf of the Funds, the Sponsor oversees and pays Milliman FRM (&#8220;Commodity Sub-Adviser&#8221;) for its services as Commodity Sub-Adviser.
The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory fee of <ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:SubadvisoryFeeRate" scale="-2" unitRef="pure">0.25</ix:nonFraction>% based on each Fund&#8217;s average daily net assets
(total assets of the Fund, minus the sum of its accrued liabilities). The commodity sub-advisory fee is waived for the first 6&#160;months
of each Fund&#8217;s operations or until a Fund reaches $<ix:nonFraction contextRef="c3" decimals="-6" format="ixt:num-dot-decimal" name="cik0001793497:AverageDailyNetAssets" scale="6" unitRef="usd">35</ix:nonFraction>&#160;million in average daily net assets. The Funds do not directly pay the
Commodity Sub-Adviser.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_6" id="_AgreementsDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Non-Recurring Fees and Expenses</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_7" id="_AgreementsDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund pays all its non-recurring and unusual
fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses that are unexpected
or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material expenses which are not
currently anticipated obligations of the Funds.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_8" id="_AgreementsDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>The Administrator, Transfer Agent and Custodian</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_9" id="_AgreementsDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">U.S.&#160;Bancorp Fund Services, LLC, doing business as U.S.&#160;Bank
Global Fund Services (&#8220;Fund Services&#8221;), an indirect subsidiary of U.S.&#160;Bancorp, serves as the Fund&#8217;s fund accountant,
administrator and transfer agent pursuant to certain fund accounting servicing, fund administration servicing and transfer agent servicing
agreements. U.S.&#160;Bank National Association, a subsidiary of U.S.&#160;Bancorp and parent company of Fund Services, intends to serve
as the Fund&#8217;s custodian pursuant to a custody agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_10" id="_AgreementsDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>The Marketing Agent</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_11" id="_AgreementsDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Foreside Fund Services, LLC (the &#8220;Marketing Agent&#8221;) serves
as the Marketing Agent of the Funds. Its principal duties are: (i)&#160;to work with the Transfer Agent to review and approve orders placed
by Authorized Participants and transmitted to the Transfer Agent; (ii)&#160;maintain copies of confirmations of Creation Unit creation
and redemption order acceptances; (iii)&#160;maintain telephonic, facsimile and/or access to direct computer communications links with
the Transfer Agent; and (iv)&#160;review and approve, prior to use, all Trust marketing materials for compliance with applicable SEC and
FINRA advertising rules.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_AgreementsDisclosureTextBlock-c0_cont_12" id="_AgreementsDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Marketing Agent retains all marketing materials separately for
the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_AgreementsDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As compensation for the services it provides, the Marketing Agent receives
a fee from the Funds.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_OfferingCostsTextBlock-c0_cont_1" escape="true" name="cik0001793497:OfferingCostsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 5 &#8211; OFFERING COSTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_OfferingCostsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Offering costs will be amortized by the Funds
over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge its Management
Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred in connection
with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 6 &#8211; CREATION AND REDEMPTION
OF CREATION UNITS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_2" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund issues and redeems shares from time
to time, but only in one or more Creation Units. A Creation Unit is a block of at least <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">10,000</ix:nonFraction> Shares of a Fund. Creation Units may be
created or redeemed only by Authorized Participants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_3" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Except when aggregated in Creation Units,
the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares directly
from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of a broker.
Thus, some of the information contained in these Notes to Financial Statements&#8212;such as references to the Transaction Fees imposed
on purchases and redemptions is not relevant to retail investors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_4" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Transaction Fees on Creation and Redemption
Transactions</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_5" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The manner by which Creation Units are purchased
or redeemed is governed by the terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing
a purchase order, an Authorized Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its
sole discretion, enter into or arrange for an exchange of futures contract for related position or block trade with the relevant fund
whereby the Authorized Participant would also transfer to such Fund a number and type of exchange-traded futures contracts at or near
the closing settlement price for such contracts on the purchase order date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_6" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Authorized Participants may pay a fee up to
<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="cik0001793497:AuthorizedParticipantsPercentage" scale="-2" unitRef="pure">0.20</ix:nonFraction>% of the value of each order they place with each order to create or redeem a Creation Unit in order to compensate the Administrator,
the Custodian and the Transfer Agent of each Fund and its Shares, for services in processing the creation and redemption of Creation Units
and to offset the costs of increasing or decreasing derivative positions, unless the transaction fee is waived or otherwise adjusted by
the Sponsor. The Sponsor provides such Authorized Participant with prompt notice in advance of any such waiver or adjustment of the transaction
fee. Authorized Participants may sell the Shares included in the Creation Units they purchase from the Funds to other investors in the
secondary market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_7" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Transaction fees for the three months ended
September 30, 2022 were as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="cik0001793497:ScheduleOfTransactionFeesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> September&#160;30, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd">20,124</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd">78,086</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsHeldInTrustNoncurrent" scale="0" unitRef="usd">98,210</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>


</div><ix:nonNumeric contextRef="c0" continuedAt="_QuarterlyFinancialInformationTextBlock-c0_cont_1" escape="true" name="us-gaap:QuarterlyFinancialInformationTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 7 &#8211; FINANCIAL HIGHLIGHTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_QuarterlyFinancialInformationTextBlock-c0_cont_2" id="_QuarterlyFinancialInformationTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Selected data is for a Share outstanding throughout
the three months ended September 30, 2022</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.6pt; text-indent: -21.6pt">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>VS Trust</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Financial Highlights</b></p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><ix:continuation continuedAt="_QuarterlyFinancialInformationTextBlock-c0_cont_3" id="_QuarterlyFinancialInformationTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareOutstandingTableTextBlock-c0_cont_1" escape="true" name="cik0001793497:ScheduleOfShareOutstandingTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">-1x Short VIX<br/>
Futures<br/>
ETF</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2x Long VIX<br/>
Futures<br/>
ETF</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September&#160;30, 2022<br/> (Unaudited)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September&#160;30, 2022<br/> (Unaudited)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Net Asset Value, Beginning of Period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:NetAssetValuePerShare" scale="0" unitRef="usdPershares">10.40</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c9" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:NetAssetValuePerShare" scale="0" unitRef="usdPershares">17.12</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" id="ix_17_fact" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" sign="-" unitRef="usdPershares">0.06</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" id="ix_18_fact" name="us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare" scale="0" sign="-" unitRef="usdPershares">0.05</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" id="ix_23_fact" name="cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" scale="0" unitRef="usdPershares">0.00</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" id="ix_24_fact" name="cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" scale="0" sign="-" unitRef="usdPershares">3.20</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" sign="-" unitRef="usdPershares">0.06</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" scale="0" sign="-" unitRef="usdPershares">3.25</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:NetAssetValuePerShare" scale="0" unitRef="usdPershares">10.34</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:NetAssetValuePerShare" scale="0" unitRef="usdPershares">13.87</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-size: 10pt">Market Value Per Share, at September 30, 2022 <sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" id="ix_21_fact" name="cik0001793497:MarketValuePerShare" scale="0" unitRef="usdPershares">10.52</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" id="ix_22_fact" name="cik0001793497:MarketValuePerShare" scale="0" unitRef="usdPershares">13.40</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c6" decimals="4" format="ixt:num-dot-decimal" id="ix_11_fact" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" sign="-" unitRef="pure">0.58</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" id="ix_12_fact" name="us-gaap:InvestmentCompanyTotalReturn" scale="-2" sign="-" unitRef="pure">18.97</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c6" decimals="4" format="ixt:num-dot-decimal" id="ix_13_fact" name="cik0001793497:InvestmentCompanyTotalReturnMarketValue" scale="-2" sign="-" unitRef="pure">0.87</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-<ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" id="ix_14_fact" name="cik0001793497:InvestmentCompanyTotalReturnMarketValue" scale="-2" sign="-" unitRef="pure">18.21</ix:nonFraction></td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="4" format="ixt:num-dot-decimal" id="ix_19_fact" name="us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation" scale="-2" unitRef="pure">2.34</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" id="ix_20_fact" name="us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation" scale="-2" unitRef="pure">2.35</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net Investment Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<ix:nonFraction contextRef="c6" decimals="4" format="ixt:num-dot-decimal" id="ix_15_fact" name="us-gaap:InvestmentCompanyInvestmentIncomeLossRatio" scale="-2" sign="-" unitRef="pure">2.06</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-<ix:nonFraction contextRef="c7" decimals="4" format="ixt:num-dot-decimal" id="ix_16_fact" name="us-gaap:InvestmentCompanyInvestmentIncomeLossRatio" scale="-2" sign="-" unitRef="pure">1.93</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table><p style="margin: 0">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_QuarterlyFinancialInformationTextBlock-c0_cont_3"><ix:continuation id="_ScheduleOfShareOutstandingTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: left"><ix:footnote id="ix_7_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</span></ix:footnote></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: left"><ix:footnote id="ix_10_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</span></ix:footnote></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="text-align: left"><ix:footnote id="ix_9_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds&#8217; net asset value is calculated.</span></ix:footnote></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="ix_5_footnote" xml:lang="en-US">Percentages are not annualized for the period ended September 30, 2022.</ix:footnote> <b>&#160;</b></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td> <td style="text-align: left"><ix:footnote id="ix_8_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages are annualized.</span></ix:footnote></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td> <td style="text-align: left"><ix:footnote id="ix_6_footnote" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expense ratio would be 2.23% and 2.27% respectively, if brokerage commissions and futures and futures account fees were excluded.</span></ix:footnote></td></tr> </table></ix:continuation></ix:continuation><div>

</div><p style="margin: 0">&#160;<b>&#160;</b></p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 8 &#8211; RISK</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_2" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Correlation and Compounding Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_3" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Funds do not seek to achieve their stated
investment objective over a period of time greater than a single day (as measured from NAV calculation time to NAV calculation time).
The return of a Fund for a period longer than a single day is the result of its return for each day compounded over the period and usually
will differ in amount and possibly even direction from the inverse (-1x) or two times (2x) the return of the Fund&#8217;s benchmark for
the period. A Fund will lose money if its benchmark performance is flat over time, and it is possible for a Fund to lose money over time
even if the performance of its benchmark increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing,
the benchmark&#8217;s volatility, compounding, and other factors. Compounding is the cumulative effect of applying investment gains and
losses and income to the principal amount invested over time. Gains or losses experienced over a given period will increase or reduce
the principal amount invested from which the subsequent period&#8217;s returns are calculated. The effects of compounding will likely
cause the performance of a Fund to differ from the Fund&#8217;s stated multiple times the return of its benchmark for the same period.
The effect of compounding becomes more pronounced as benchmark volatility and holding period increase. The impact of compounding will
impact each shareholder differently depending on the period of time an investment in a Fund is held and the volatility of the benchmark
during the holding period of an investment in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater
leverage each affect the impact of compounding on a Fund&#8217;s returns. Daily compounding of a Fund&#8217;s investment returns can dramatically
and adversely affect its longer-term performance during periods of high volatility. Volatility may be at least as important to a Fund&#8217;s
return for a period as the return of the Fund&#8217;s underlying benchmark.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_4" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund uses leverage and should produce
daily returns that are more volatile than that of its benchmark. For example, the daily return of UVIX should be approximately two times
as volatile on a daily basis as is the return of a fund with an objective of matching the same benchmark. The daily return of SVIX is
designed to return the inverse (-1x) of the return that would be expected of a fund with an objective of matching the same benchmark.
<b><i>The Funds are not appropriate for all investors and present significant risks not applicable to other types of funds. </i></b>The
Funds use leverage and are riskier than similarly benchmarked exchange-traded funds that do not use leverage. An investor should only
consider an investment in a Fund if he or she understands the consequences of seeking daily leveraged or daily inverse investment results.
Shareholders who invest in the Funds should actively manage and monitor their investments, as frequently as daily.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_5" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">While the Funds seek to meet their investment
objectives, there is no guarantee they will do so. Factors that may affect a Fund&#8217;s ability to meet its investment objective include:
(1) the Sponsor&#8217;s ability to purchase and sell Financial Instruments in a manner that correlates to a Fund&#8217;s objective; (2)
an imperfect correlation between the performance of Financial Instruments held by a Fund and the performance of the applicable benchmark;
(3) bid-ask spreads on such Financial Instruments; (4) fees, expenses, transaction costs, financing costs associated with the use of Financial
Instruments and commission costs; (5) holding or trading instruments in a market that has become illiquid or disrupted; (6) a Fund&#8217;s
Share prices being rounded to the nearest cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated
in advance; (8) the need to conform a Fund&#8217;s portfolio holdings to comply with investment restrictions or policies or regulatory
or tax law requirements; (9) early and unanticipated closings of the markets on which the holdings of a Fund trade, resulting in the inability
of the Fund to execute intended portfolio transactions; (10) accounting standards; and (11) differences caused by a Fund obtaining exposure
to only a representative sample of the components of a benchmark, over weighting or under weighting certain components of a benchmark
or obtaining exposure to assets that are not included in a benchmark.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_6" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">A number of factors may affect a Fund&#8217;s
ability to achieve a high degree of correlation with its benchmark, and there can be no guarantee that a Fund will achieve a high degree
of correlation. Failure to achieve a high degree of correlation may prevent a Fund from achieving its investment objective. In order to
achieve a high degree of correlation with their underlying benchmarks, the Funds seek to rebalance their portfolios daily to keep exposure
consistent with their investment objectives. Being materially under- or over-exposed to the benchmark may prevent such Funds from achieving
a high degree of correlation with such benchmark. Market disruptions or closure, large amounts of assets into or out of the Funds, regulatory
restrictions, extreme market volatility, and other factors will adversely affect such Funds&#8217; ability to adjust exposure to requisite
levels. The target amount of portfolio exposure is impacted dynamically by the benchmarks&#8217; movements during each day. Other things
being equal, more significant movement in the value of its benchmark up or down will require more significant adjustments to a Fund&#8217;s
portfolio. Because of this, it is unlikely that the Funds will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark
at the end of each day, and the likelihood of being materially under- or over-exposed is higher on days when the benchmark levels are
volatile near the close of the trading day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_7" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund seeks to rebalance its portfolio
on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending upon market conditions
and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios as frequently, each
Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate exposure to
the underlying benchmarks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_8" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Counterparty Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_9" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund may use derivatives such as swap
agreements and forward contracts (collectively referred to herein as &#8220;derivatives&#8221;) in the manner described herein as a means
to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_10" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><span style="text-decoration:underline">Regulatory Treatment</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_11" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Derivatives are generally traded in OTC markets
and have only recently become subject to comprehensive regulation in the United States. Cash-settled forwards are generally regulated
as &#8220;swaps&#8221;, whereas physically settled forwards are generally not subject to regulation (in the case of commodities other
than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (&#8220;Title
VII&#8221;) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible
for the regulation of &#8220;security-based swaps.&#8221; The SEC requirements have largely yet to be made effective, but the CFTC requirements
are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage,
including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated
market participants, such as &#8220;swap dealers,&#8221; &#8220;security-based swap dealers,&#8221; &#8220;major swap participants,&#8221;
and &#8220;major security-based swap participants&#8221; who are, or will be, subject to significant new capital, registration, recordkeeping,
reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be
developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades
and the counterparties with which the Fund engages in transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_12" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">As noted, the CFTC rules may not apply to
all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection of CFTC
regulation or the statutory scheme of the Commodity Exchange Act (the &#8220;CEA&#8221;) in connection with each Fund&#8217;s swap agreements
or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain circumstances,
including in the event of trading abuses or financial failure by participants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_13" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><span style="text-decoration:underline">Counterparty Credit Risk</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_14" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Funds will be subject to the credit risk
of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing corporation
in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to the credit
risk of the counterparty to the transaction &#8211; typically a single bank or financial institution. As a result, a Fund is subject to
increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into as part of
that Fund&#8217;s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due
to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor&#8217;s investment in
a Fund may decline.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_15" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Funds have sought to mitigate these risks
by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily,
subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest in swap agreements
or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are delays in accessing
the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering amounts as
a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_16" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">OTC derivatives of the type that may be utilized
by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have uniform terms and
conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit support, such
as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various conditions,
events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms
of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to
the net positions owed to the party under the agreement. For example, if the level of the Fund&#8217;s benchmark has a dramatic intraday
move that would cause a material decline in the Fund&#8217;s NAV, the terms of the swap may permit the counterparty to immediately close
out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other
Financial Instruments necessary to achieve the desired exposure consistent with the Fund&#8217;s objective. This, in turn, may prevent
the Fund from achieving its investment objective, particularly if the level of the Fund&#8217;s benchmark reverses all or part of its
intraday move by the end of the day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_17" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">In addition, cleared derivatives benefit from
daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To the extent the
Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts, which are
required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap customer
collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions
but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default.
For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted
to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer
of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the
commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do
not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a &#8220;swap dealer&#8221;
with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions
because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing
the Funds to suffer a loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_18" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Sponsor regularly reviews the performance
of its counterparties for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers
the addition of new counterparties and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio
holdings as of the prior Business Day. Each Fund&#8217;s portfolio holdings identifies its counterparties, as applicable. This portfolio
holdings information may be accessed through the web on the Sponsor&#8217;s website at www.volatilityshares.com.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_19" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each counterparty and/or any of its affiliates
may be an Authorized Participant or shareholder of a Fund, subject to applicable law.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_20" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The counterparty risk for cleared derivatives
transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and
is a Fund&#8217;s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative.
Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations
to a Fund.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_21" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Leverage Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_22" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Funds may utilize leverage in seeking
to achieve their respective investment objectives and will lose more money in market environments adverse to their respective daily investment
objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged positions increases the risk of total
loss of an investor&#8217;s investment, even over periods as short as a single day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_23" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">For example, because UVIX includes a two times
(2x) multiplier, a single-day movement in the relevant benchmark approaching <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="cik0001793497:RelevantBenchmark" scale="-2" unitRef="pure">50</ix:nonFraction>% at any point in the day could result in the total loss
or almost total loss of an investor&#8217;s investment if that movement is contrary to the investment objective of the Fund in which an
investor has invested, even if such Fund&#8217;s benchmark subsequently moves in an opposite direction, eliminating all or a portion of
the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund or upward single-day
or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than zero at all times.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_24" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Liquidity Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_25" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Financial Instruments cannot always be liquidated
at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of buy and sell orders
in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract counterparty at
a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds may acquire increases
the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred while trying to
do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically invest in Financial
Instruments related to one benchmark, which in many cases is highly concentrated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_26" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#8220;Contango&#8221; and &#8220;Backwardation&#8221;
Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_27" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_26"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Funds typically hold futures contracts.
As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for example, a
contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may be replaced
by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as &#8220;rolling.&#8221;
Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts
have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred
to as &#8220;backwardation.&#8221; In these circumstances, absent other factors, the sale of the January 2020 contract would take place
at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling.
While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not
exist in these markets at all times.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_28" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Since the introduction of VIX futures contracts,
there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in time. This can result
in a loss from &#8220;rolling&#8221; the VIX futures to maintain the constant weighted average maturity of the applicable Fund benchmark.
Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely affect
the value of a Fund and, accordingly, decrease the return of a Fund.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_29" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_28"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Natural Disaster/Epidemic Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_30" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Natural or environmental disasters, such as
earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease, including
pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and markets
and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster and
health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays,
shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding
results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of
infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment
opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy
of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely
impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual
companies (including, but not limited to, the Funds&#8217; Sponsor and third party service providers), sectors, industries, markets, securities
and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the
value of the Funds&#8217; investments. These factors can cause substantial market volatility, exchange trading suspensions and closures
and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary
market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long
such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact
on a Fund&#8217;s performance, resulting in losses to your investment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_31" id="_ConcentrationRiskDisclosureTextBlock-c0_cont_30"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Risk that Current Assumptions and Expectations
Could Become Outdated As a Result of Global Economic Shocks</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_ConcentrationRiskDisclosureTextBlock-c0_cont_31"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The onset of the novel coronavirus (COVID-19)
has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow and contain
the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies as economic
activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at least equal
to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market in the fastest
such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US, oil experienced
shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as of the date hereof
may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting in significant
losses.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 9 &#8211; SUBSEQUENT EVENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_SubsequentEventsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Management has evaluated the possibility of
subsequent events existing in the Trust&#8217;s and the Funds&#8217; financial statements through the date the financial statements were
issued. Management has determined that there are no material events that would require disclosure in the Trust&#8217;s or the Funds&#8217;
financial statements through this date.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><div><a id="k_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Item 2. Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><i>This information should be read in conjunction
with the financial statements and notes to the financial statements included with this Quarterly Report on Form 10-Q. The discussion and
analysis that follows may contain statements that relate to future events or future performance. In some cases, such forward-looking statements
can be identified by terminology such as &#8220;will,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221;
&#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;intend,&#8221;
&#8220;project,&#8221; &#8220;seek&#8221; or the negative of these terms or other comparable terminology. None of the Trust, the Sponsor,
the Trustee, or the Administrator assumes responsibility for the accuracy or completeness of any forward-looking statements. Except as
expressly required by federal securities laws, none of the Trust, the Sponsor, the Trustee, or the Administrator is under a duty to update
any of the forward-looking statements to conform such statements to actual results or to a change in expectations or predictions.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><i>Because forward-looking statements relate
to the future, they are subject to inherent uncertainties, risk and changes in circumstances that are difficult to predict and many of
which are outside of the Funds&#8217; control. The Funds&#8217; forward-looking statements are not guarantees of future results and conditions
and important factors, risks and uncertainties in the markets for financial instruments that the Funds trade, in the markets for related
physical commodities, in the legal and regulatory regimes applicable to the Sponsor, the Funds, and the Funds&#8217; service providers,
and in the broader economy may cause the Funds&#8217; actual results to differ materially from those expressed in forward-looking statements.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Introduction</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">VS Trust (the &#8220;Trust&#8221;) is a Delaware
statutory trust formed on October 24, 2019 and is currently organized into two separate series (each, a &#8220;Fund&#8221; and collectively,
the &#8220;Funds&#8221;). As of September 30, 2022, the following two series of the Trust have commenced investment operations: -1x Short
VIX Futures ETF and 2x Long VIX Futures ETF. Each of the Funds listed above issues common units of beneficial interest (&#8220;Shares&#8221;),
which represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed
on the Cboe BZX Exchange (&#8220;Cboe BZX&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The Trust had no operations prior to March
28, 2022, other than matters relating to its organization, the registration of each series under the Securities Act of 1933, as amended.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The Sponsor also serves as the Trust&#8217;s
commodity pool operator. Wilmington Trust Company serves as the Trustee of the Trust (the &#8220;Trustee&#8221;). The Funds are commodity
pools, as defined under the Commodity Exchange Act (the &#8220;CEA&#8221;), and the applicable regulations of the Commodity Futures Trading
Commission (the &#8220;CFTC&#8221;) and are operated by the Sponsor, a commodity pool operator registered with the CFTC. The Trust is
not an investment company registered under the Investment Company Act of 1940, as amended.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">SVIX seeks daily investment results, before
fees and expenses, that correspond to the performance of the Short&#160;VIX Futures Index (the &#8220;Short Index&#8221;) for a single&#160;day,
not for any other period. UVIX seeks daily investment results, before fees and expenses, that correspond to twice the performance of the
Long&#160;VIX Futures Index (the &#8220;Long Index&#8221;). A &#8220;single&#160;day&#8221; is measured from the time a Fund calculates
its net asset value (&#8220;NAV&#8221;) to the time of the Fund&#8217;s next NAV calculation. The NAV calculation time for a Fund typically
is 4:00&#160;p.m. (Eastern Time).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The Funds seek to achieve their investment objective
through the appropriate amount of exposure to the&#160;VIX&#160;futures contracts included in their respective index. The Funds also have
the ability to engage in options transactions, swaps, forward contracts and other instruments in order to achieve their investment objective,
in the manner and to the extent described herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">SVIX is not benchmarked to the inverse of, and UVIX
is not benchmarked to twice, the widely referenced&#160;VIX.&#160;The Short Index and the inverse of the&#160;VIX are separate measurements
and can be expected to perform very differently. The Long Index and twice the&#160;VIX also are separate measurements and can be expected
to perform very differently. As such, SVIX can be expected to perform very differently from the inverse (-1x) of the performance of the&#160;VIX
over any period, and UVIX can be expected to perform very differently from twice (2x) of the performance of the&#160;VIX over any period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 25; Options: NewSection; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The Funds continuously offer and redeem Shares
in blocks of at least 10,000&#160;Shares (each such block, a &#8220;Creation Unit&#8221;). Only Authorized Participants (as defined herein)
may purchase and redeem Shares from a Fund and then only in Creation Units. An Authorized Participant is an entity that has entered into
an Authorized Participant Agreement with the Trust and Volatility Shares LLC (the &#8220;Sponsor&#8221;). Shares are offered on a continuous
basis to Authorized Participants in Creation Units&#160;at NAV.&#160;Authorized Participants may then offer to the public, from time to
time, Shares from any Creation Unit they create at a per-Share market price. The form of Authorized Participant Agreement and the related
Authorized Participant Procedures Handbook set forth the terms and conditions under which an Authorized Participant may purchase or redeem
a Creation Unit. Authorized Participants will not receive from a Fund, the Sponsor, or any of their affiliates, any fee or other compensation
in connection with their sale of Shares to the public. An Authorized Participant may receive commissions or fees from investors who purchase
Shares through their commission or fee-based brokerage accounts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The form of Authorized Participant
Agreement and related Authorized Participant Handbook set forth the terms and conditions under which an Authorized Participant may
purchase or redeem a Creation Unit. Authorized Participants do not receive from any Fund, the Sponsor, or any of their affiliates,
any underwriting fees or compensation in connection with their sale of Shares to the public. The Sponsor maintains a website at
www.volatilityshares.com, through which monthly account statements and the Trust&#8217;s Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange
Act of 1934, as amended (the &#8220;1934 Act&#8221;), can be accessed free of charge, as soon as reasonably practicable after such
material is electronically filed with, or furnished to, the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).
Additional information regarding the Trust may also be found on the SEC&#8217;s EDGAR database at www.sec.gov.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Liquidity and Capital Resources</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">In order to collateralize derivatives positions
in indices, commodities or currencies, a portion of the NAV of each Fund is held in cash and/or U.S. Treasury securities, agency securities,
or other high credit quality short term fixed-income or similar securities (such as shares of money market funds, bank deposits, bank
money market accounts, certain variable rate-demand notes and repurchase agreements collateralized by government securities. A portion
of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts. The percentage
that U.S. Treasury bills and other short-term fixed-income securities bear to the shareholders&#8217; equity of each Fund varies from
period to period as the market values of the underlying swaps, futures contracts and forward contracts change. During the three months
ended September 31, 2022, each of the Funds earned interest income as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Interest Income <br/> Three Months Ended<br/> September&#160;30,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">43,411</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">126,917</td><td style="text-align: left">&#160;</td></tr>
  </table><div>





</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Futures Contracts</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">A futures contract is a standardized contract traded
on, or subject to the rules of, an exchange that calls for the future delivery of a specified quantity and type of a particular underlying
asset at a specified time and place or alternatively may call for cash settlement. Futures contracts are traded on a wide variety of underlying
assets, including bonds, interest rates, agricultural products, stock indexes, currencies, energy, metals, economic indicators and statistical
measures. The notional size and calendar term futures contracts on a particular underlying asset are identical and are not subject to
any negotiation, other than with respect to price and the number of contracts traded between the buyer and seller. A Fund generally deposits
cash and/or securities with an FCM for its open positions in futures contracts, which may, in turn, transfer such deposits to the clearinghouse
to protect the clearing house against non-payment by the Fund. The clearing house becomes substituted for each counterparty to a futures
contract, and, in effect, guarantees performance. In addition, the FCM may require a Fund to deposit collateral in excess of the clearing
house&#8217;s margin requirements for the FCM&#8217;s own protection.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Certain futures contracts, including stock index
contracts,&#160;VIX futures contracts and certain commodity futures contracts settle in cash. The cash settlement amount reflects the
difference between the contract purchase/sale price and the contract settlement price. The cash settlement mechanism avoids the potential
for either side to have to deliver the underlying asset. For other futures contracts, the contractual obligations of a buyer or seller
may generally be satisfied by taking or making physical delivery of the underlying asset or by making an offsetting sale or purchase of
an identical futures contract on the same or linked exchange before the designated date of delivery. The difference between the price
at which the futures contract is purchased or sold and the price paid for the offsetting sale or purchase, after allowance for brokerage
commissions and exchange fees, constitutes the profit or loss to the trader.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Futures contracts involve, to varying degrees, elements
of market risk and exposure to loss in excess of the amounts of variation margin, which are the amounts of cash that a Fund agrees to
pay to or receive from FCMs equal to the daily fluctuation in the value of a futures contract. Additional risks associated with the use
of futures contracts are imperfect correlation between movements in the price of the futures contracts and the level of the underlying
benchmark and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty
risk to a Fund since futures contracts are exchange traded and the exchange&#8217;s clearing house, as counterparty to all exchange-traded
futures contracts, effectively guarantees futures contracts against default. Many futures exchanges and boards of trade limit the amount
of fluctuation permitted in futures contract prices during a single&#160;trading day. Once the daily limit has been reached in a particular
contract, no trades may be made that&#160;day at a price beyond that limit or trading may be suspended for specified times during the&#160;trading
day. Futures contracts prices could move to the limit for several consecutive&#160;trading days with little or no trading, thereby preventing
prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible or if a Fund
determines not to close a futures position in anticipation of adverse price movements, the Fund may be required to make daily cash payments
of variation margin.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Futures Account Agreements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Each Fund has entered into a written agreement (each,
a &#8220;Futures Account Agreement&#8221;) with one or more FCMs governing the terms of futures transactions of a Fund cleared by such
FCM.&#160;Each FCM has its own agreement and other documentation used for establishing customer relationships. As such, the terms of the
Futures Account Agreement and other documentation that a Fund has with a particular FCM may differ in material respects from that with
another FCM.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Most Futures Account Agreements do not require the
FCM to enter into new transactions or maintain existing transactions with a Fund. In general, each FCM is permitted to terminate its agreement
with a Fund at any time in its sole discretion. In addition, an FCM generally will have the discretion to set margin requirements and/or
position limits that would be in addition to any margin requirements and/or position limits required by applicable law, set by the exchange,
or set by the clearing house that clears the futures contracts in which a Fund transacts. As a result, a Fund&#8217;s ability to engage
in futures transactions or maintain open positions in such contracts will be dependent on the willingness of its FCMs to continue to accept
or maintain such transactions on terms that are economically appropriate for a Fund&#8217;s investment strategy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">When a Fund has an open futures contract position,
it is subject to at least daily variation margin calls by an FCM that could be substantial in the event of adverse price movements. Because
futures contracts may require only a small initial investment in the form of a deposit or margin, they may involve a high degree of leverage.
A Fund with open positions is subject to maintenance or variance margin on its open positions. If a Fund has insufficient cash to meet
daily variation margin requirements, it may need to sell Financial Instruments at a time when such sales are disadvantageous. Futures
markets are highly volatile and the use of or exposure to futures contracts may increase volatility of a Fund&#8217;s NAV.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Margin posted by a Fund to an FCM typically will
be held by relevant exchange&#8217;s clearing house (in the case of clearing house-required margin) or the FCM (in the case of &#8220;house&#8221;
margin requirements of the FCM). In the event that market movements favorable to a Fund result in the Fund having posted more margin than
is required, the Fund typically would have a right to return of margin from the FCM.&#160;However, the timing of such return may be uncertain.
As a result, it is possible that a Fund may face liquidity constraints including potential delays in its ability to pay redemption proceeds,
where margin is not immediately returned by an FCM.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">In the event that a Fund fails to comply with its
obligations under a Futures Account Agreement (including, for example, failing to deliver the margin required by an FCM on a timely basis),
the Futures Account Agreement typically will provide the FCM with broad discretion to take remedial action against the Fund. Among other
things, the FCM typically will have the right, upon the occurrence of such a failure by a Fund, to terminate any or all futures contracts
in the Fund&#8217;s account with that FCM, to sell the collateral posted as margin by the Fund, to close out any open positions of the
Fund in whole or in part, and to cancel any or all pending transactions with the Fund. Futures Account Agreements typically provide that
the Fund will remain liable for paying to the relevant FCM, on demand, the amount of any deficiency in a Fund&#8217;s account with that
FCM.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The Futures Account Agreement between the Fund and
an FCM generally requires the Fund to indemnify and hold harmless the FCM, its directors, officers, employees, agents and affiliates (collectively,
&#8220;indemnified persons&#8221;) from and against all claims, damages, losses and costs (including reasonable attorneys&#8217; fees)
incurred by the indemnified persons, in connection with: (1)&#160;any failure by the Fund to perform its obligations under the Futures
Account Agreement and the FCM&#8217;s exercise of its rights and remedies thereunder; (2)&#160;any failure by the Fund to comply with
applicable law; (3)&#160;any action reasonably taken by the indemnified persons pursuant to the Futures Account Agreement to comply with
applicable law; and (4)&#160;any actions taken by the FCM in reliance on instructions, notices and other communications that the FCM and
its relevant personnel, as applicable, reasonably believes to originate from a person authorized to act on behalf of the Fund.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">To the extent that the Fund trades in futures contracts
on U.S.&#160;exchanges, the assets deposited by the Fund with the FCMs (or another eligible financial institution, as applicable) as margin
must be segregated pursuant to the regulations of the CFTC.&#160;Such segregated funds may be invested only in a limited range of instruments&#160;&#8212;&#160;principally
U.S.&#160;government obligations to margin futures and forward contract positions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Options</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">An option is a contract that gives the purchaser
of the option, in return for the premium paid, the right to buy an underlying reference instrument, such as a specified security index,
or other instrument, from the writer of the option (in the case of a call option), or to sell a specified reference instrument to the
writer of the option (in the case of a put option) at a designated price during the term of the option. The premium paid by the buyer
of an option will reflect, among other things, the relationship of the exercise price to the market price and the volatility of the underlying
reference instrument, the remaining term of the option, supply, demand or interest rates. An American style put or call option may be
exercised at any time during the option period while a European style put or call option may be exercised only upon expiration or during
a fixed period prior thereto. Put and call options are traded on national securities exchanges and in the OTC market. Options traded on
national securities exchanges are within the jurisdiction of the SEC or other appropriate national securities regulator, as are securities
traded on such exchanges. As a result, many of the protections provided to traders on organized exchanges will be available with respect
to such transactions. In particular, all option positions entered into on a national securities exchange in the United&#160;States are
cleared and guaranteed by the Options Clearing Corporation, thereby reducing the risk of counterparty default. Furthermore, a liquid secondary
market in options traded on a national securities exchange may be more readily available than in the OTC market, potentially permitting
a Fund to liquidate open positions at a profit prior to exercise or expiration, or to limit losses in the event of adverse market movements.
There is no assurance, however, that higher than anticipated trading activity or other unforeseen events might not temporarily render
the capabilities of the Options Clearing Corporation inadequate, and thereby result in the exchange instituting special procedures which
may interfere with the timely execution of a Fund&#8217;s orders to close out open options positions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Swap Agreements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Swaps are contracts that have traditionally been
entered into primarily by institutional investors in OTC markets for a specified period ranging from a&#160;day to many&#160;years. Certain
types of swaps may be cleared, and certain types are, in fact, required to be cleared. The types of swaps that may be cleared are generally
limited to only swaps where the most liquidity exists and a clearing organization is willing to clear the trade on standardized terms.
Swaps with customized terms or those for which significant market liquidity does not exist are generally not able to be cleared.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">In a standard swap transaction, the parties agree
to exchange the returns on, among other things, a particular predetermined security, commodity, interest rate, or index for a fixed or
floating rate of return (the &#8220;interest rate leg,&#8221; which will also include the cost of borrowing for short swaps) in respect
of a predetermined notional amount. The notional amount of the swap reflects the extent of a Fund&#8217;s total investment exposure under
the swap.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">In the case of futures contracts-based indexes,
such as those used by a Fund, the reference interest rate typically is zero, although a financing spread or fee is generally still applied.
Transaction or commission costs are reflected in the benchmark level at which the transaction is entered into. The gross returns to be
exchanged are calculated with respect to the notional amount and the benchmark returns to which the swap is linked. Swaps are usually
closed out on a net basis, <i>i.e.</i>, the two payment streams are netted out in a cash settlement on the payment date specified in the
agreement, with the parties receiving or paying, as the case may be, only the net amount of the two payments. Thus, while the notional
amount reflects a Fund&#8217;s total investment exposure under the swap (<i>i.e.</i>, the entire face amount or principal of a swap),
the net amount is the Fund&#8217;s current obligations (or rights) under the swap. That is the amount to be paid or received under the
agreement based on the relative values of the positions held by each party to the agreement on any given termination date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Swaps may also expose a Fund to liquidity risk.
Although a Fund may have the ability to terminate a swap at any time, doing so may subject the Fund to certain early termination charges.
In addition, there may not be a liquid market within which to dispose of an outstanding swap even if a permitted disposal might avoid
an early termination charge. Uncleared swaps generally are not assignable except by agreement between the parties to the swap, and generally
no party or purchaser has any obligation to permit such assignments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Swaps involve, to varying degrees, elements of market
risk and exposure to loss in excess of the amount which would be reflected on a Fund&#8217;s Statement of Financial Condition. In addition
to market risk and other risks, the use of swaps also comes with counterparty credit risk&#160;&#8212;&#160;<i>i.e.</i>, the inability
of a counterparty to a swap to perform its obligations. A Fund that invests in swaps bears the risk of loss of the net amount, if any,
expected to be received under a swap agreement in the event of the default or bankruptcy of a swap counterparty. A Fund enters or intends
to enter into swaps only with major, global financial institutions. However, there are no limitations on the percentage of its assets
a Fund may invest in swaps with a particular counterparty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">A Fund that invests in swaps may use various techniques
to minimize counterparty credit risk. A Fund that invests in swaps generally enters into arrangements with its counterparties whereby
both sides exchange collateral on a mark-to-market basis. In addition, the Fund may post &#8220;initial margin&#8221; or &#8220;independent
amount&#8221; to counterparties in swaps. Such collateral serves as protection for the counterparty in the event of a failure by the Fund
and is in addition to any mark-to-market collateral that (<i>i.e.</i>, the Fund may post initial margin to the counterparty even where
the counterparty would owe money to the Fund if the swap were to be terminated). The amount of initial margin posted by the Fund may vary
depending on the risk profile of the swap. The collateral, whether for mark-to-market or for initial margin, generally consists of cash
and/or securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Collateral posted by a Fund to a counterparty in
connection with uncleared derivatives transactions is generally held for the benefit of the counterparty in a segregated tri-party account
at a third-party custodian to protect the counterparty against non-payment by the Fund. In the event of a default by a Fund where the
counterparty is owed money in the uncleared swap transaction, such counterparty will seek withdrawal of this collateral from the segregated
account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Collateral posted by the counterparty to a Fund
is typically held for the benefit of the Fund in a segregated tri-party account at a third-party custodian. In the event of a default
by the counterparty where the Fund is owed money in the uncleared swap transaction, the Fund will seek withdrawal of this collateral from
the segregated account. The Fund may incur certain costs exercising its right with respect to the collateral.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Notwithstanding the use of collateral arrangements,
to the extent any collateral provided to a Fund is insufficient or there are delays in accessing the collateral, a Fund will be exposed
to counterparty risk as described above, including possible delays in recovering amounts as a result of bankruptcy proceedings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Off-Balance Sheet Arrangements and Contractual
Obligations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">As of September 30, 2022, the Funds have not
used, nor do they expect to use in the future, special purpose entities to facilitate off-balance sheet financing arrangements and have
no loan guarantee arrangements or off-balance sheet arrangements of any kind other than agreements entered into in the normal course of
business, which may include indemnification provisions related to certain risks service providers undertake in performing services which
are in the best interests of the Funds. While each Fund&#8217;s exposure under such indemnification provisions cannot be estimated, these
general business indemnifications are not expected to have a material impact on a Fund&#8217;s financial position.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Management fee payments made to the Sponsor
are calculated as a fixed percentage of each Fund&#8217;s NAV. As such, the Sponsor cannot anticipate the payment amounts that will be
required under these arrangements for future periods as NAVs are not known until a future date. The agreement with the Sponsor may be
terminated by either party upon 30 days written notice to the other party.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Critical Accounting Policies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Preparation of the financial statements and
related disclosures in compliance with accounting principles generally accepted in the United States of America requires the application
of appropriate accounting rules and guidance, as well as the use of estimates. The Trust&#8217;s and the Funds&#8217; application of these
policies involves judgments and actual results may differ from the estimates used.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Each Fund has significant exposure to Financial
Instruments. The Funds hold a significant portion of their assets in futures, all of which are recorded on a trade date basis and at fair
value in the financial statements, with changes in fair value reported in the Statements of Operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The use of fair value to measure Financial
Instruments, with related unrealized gains or losses recognized in earnings in each period, is fundamental to the Trust&#8217;s and the
Funds&#8217; financial statements. The fair value of a Financial Instrument is the amount that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">For financial reporting purposes, the Funds
value investments based upon the closing price in their primary markets. Accordingly, the investment valuations in these financial statements
may differ from those used in the calculation of certain Funds&#8217; final creation/redemption NAV for the period ended September 30,
2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Short-term investments are valued at amortized
cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their
market price using information provided by a third-party pricing service or market quotations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Derivatives (e.g., futures contracts, options,
swap agreements) are generally valued using independent sources and/or agreements with counterparties or other procedures as determined
by the Sponsor. Futures contracts, are generally valued at the last settled price on the applicable exchange on which that future trades.
Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically
categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as
the basis for determining the market value of such position. Such fair value prices would be generally determined based on available inputs
about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor deems fair
and equitable so long as such principles are consistent with normal industry standards. The Sponsor may fair value an asset of a Fund
pursuant to the policies the Sponsor has adopted, which are consistent with normal industry standards. Depending on the source and relevant
significance of valuation inputs, these instruments may be classified as Level II or Level III in the fair value hierarchy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Fair value pricing may require subjective
determinations about the value of an investment. While each Fund&#8217;s policy is intended to result in a calculation of the Fund&#8217;s
NAV that fairly reflects investment values as of the time of pricing, the Funds cannot ensure that fair values determined by the Sponsor
or persons acting at their direction would accurately reflect the price that the Fund could obtain for an investment if it were to dispose
of that investment as of the time of pricing (for instance, in a forced or distressed sale).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The prices used by a Fund may differ from
the value that would be realized if the investments were sold and the differences could be material to the financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The Funds disclose the fair value of their
investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Discounts on short-term securities purchased
are amortized and reflected as Interest Income in the Statements of Operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Realized gains (losses) and changes in unrealized
gain (loss) on open investments are determined on a specific identification basis and recognized in the Statements of Operations in the
period in which the contract is closed or the changes occur, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Each Fund pays its respective brokerage commissions,
including applicable exchange fees, NFA fees, give up fees, pit futures account fees and other transaction related fees and expenses charged
in connection with trading activities for each Fund&#8217;s investment in U.S. Commodity Futures Trading Commission regulated investments.
Brokerage commissions on futures contracts are recognized on a half-turn basis. The Sponsor is currently paying brokerage commissions
in VIX futures contracts exceed variable create/redeem fees collected by more than 0.02% of the Fund&#8217;s average net assets annually.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><div><a id="k_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Item 3. Quantitative and Qualitative Disclosures
About Market Risk.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Quantitative Disclosure</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><i>Equity Market Volatility Sensitivity</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Each of the Funds is exposed to certain risks
pertaining to the use of Financial Instruments. Each Fund is exposed to equity market volatility risk through its holdings of Financial
Instruments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The tables below provide information about
each Fund&#8217;s Financial Instruments. As of September 30, 2022, each of the Fund&#8217;s positions were as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="text-decoration:underline">-1x Short VIX Futures ETF</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">As of September 30, 2022, SVIX was exposed
to inverse equity market volatility risk through its holding of VIX futures contracts. The following table provides information about
the Fund&#8217;s positions in VIX futures contracts as of September 30, 2022, which were sensitive to equity market volatility risk.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>Futures Positions as
of September 30, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; ">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Contract</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Long or Short</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiration</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Contracts</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Valuation<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Contract<br/> Multiplier</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notional&#160;<br/>
Amount <br/> at Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">VIX Futures (Cboe)</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">Short</td><td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: center">October 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,069</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">31.40</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(33,566,600</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">VIX Futures (Cboe)</td><td>&#160;</td>
    <td style="text-align: center">Short</td><td>&#160;</td>
    <td style="text-align: center">November 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">713</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(22,053,090</td><td style="text-align: left">)</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The short futures notional values are calculated
by multiplying the number of contracts held times the valuation price times the contract multiplier. The short notional values will increase
(decrease) proportionally with decreases (increases) in the price of the futures contract. Additional gains (losses) associated with these
contracts will be equal to any such subsequent decreases (increases) in short notional values, before accounting for spreads or transaction
or financing costs. The Fund will generally attempt to adjust its position in Financial Instruments each day to have -$1.00 of short exposure
to the Index for every $1.00 of net assets. Future period returns, before fees and expenses, cannot be estimated simply by estimating
the return of the Index and multiplying by negative one-half. See &#8220;Item 1A. Risk Factors&#8221; in the Annual Report on Form 10-K
for additional information regarding performance for periods longer than a single day.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 2 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="text-decoration:underline">2x Long VIX Futures ETF</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">As of September 30, 2022, UVIX was exposed
to equity market volatility risk through its holding of VIX futures contracts. The following tables provide information about the Fund&#8217;s
positions in these Financial Instruments as of September 30, 2022, which were sensitive to equity market volatility risk.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>Futures Positions as
of September 30, 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; "><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Contract</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Long or Short</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Expiration</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Contracts</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Valuation<br/>
 Price</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contract<br/>
 Multiplier</b>
</span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Notional Amount <br/>
at Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">VIX Futures (Cboe)</td><td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 10%">Long</td><td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 14%">October 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,606</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">31.40</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">113,228,400</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">VIX Futures (Cboe)</td><td>&#160;</td>
    <td style="text-align: center">Long</td><td>&#160;</td>
    <td style="text-align: center">November 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,404</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30.93</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,355,720</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The futures notional values are
calculated by multiplying the number of contracts held times the valuation price times the contract multiplier. The swap notional
values are calculated by multiplying the number of units times the closing level of the Index. These notional values will increase
(decrease) proportionally with increases (decreases) in the price of the futures contract or the level of the Index, as applicable.
Additional gains (losses) associated with these contracts will be equal to any such subsequent increases (decreases) in notional
values, before accounting for spreads or transaction or financing costs. The Fund will generally attempt to adjust its positions in
Financial Instruments each day to have $2.00 of exposure to the Index for every $1.00 of net assets. Future period returns, before
fees and expenses, cannot be estimated simply by estimating the return of the Index and multiplying by one and one-half. See
&#8220;Item 1A. Risk Factors&#8221; in the Annual Report on Form 10-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><div><a id="k_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Item 4. Controls and Procedures.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Disclosure Controls and Procedures</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Under the supervision and with the participation
of the principal executive officer and principal financial officer of the Trust, Trust management has evaluated the effectiveness of the
Trust&#8217;s and the Funds&#8217; disclosure controls and procedures, and have concluded that the disclosure controls and procedures
of the Trust and the Funds (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;1934
Act&#8221;)) were effective, as of March 31, 2022, including providing reasonable assurance that information required to be disclosed
in the reports that the Trust files or submits under the 1934 Act on behalf of the Trust and the Funds is recorded, processed, summarized
and reported, within the time periods specified in the applicable rules and forms, and that such information is accumulated and communicated
to management, including the principal executive officer and principal financial officer, of the Trust as appropriate to allow timely
decisions regarding required disclosure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Changes in Internal Control over Financial
Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">There were no changes in the Trust&#8217;s
or the Funds&#8217; internal control over financial reporting that occurred during the quarter ended September 30, 2022 that have materially
affected, or are reasonably likely to materially affect, the Trust&#8217;s or the Funds&#8217; internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Certifications</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">The certifications by the Principal
Executive Officer and Principal Financial Officer of the Trust required by Section 302 and Section 906 of the Sarbanes-Oxley Act of
2002, which are filed or furnished as exhibits to this Quarterly Report on Form 10-Q, apply both to the Trust taken as a whole and
each Fund, and the Principal Executive Officer and Principal Financial Officer of the Trust are certifying both as to the Trust
taken as a whole and each Fund.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><div><a id="k_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Part II. OTHER INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><div><a id="k_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Item 1. Legal Proceedings.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><div><a id="k_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Item 1A. Risk Factors.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Investments in futures contracts are subject
to current position limits and accountability levels established by the exchanges. Accordingly, the Sponsor and the Funds may be required
to reduce the size of outstanding positions or be restricted from entering into new positions that would otherwise be taken for a Fund
or not trade in certain markets on behalf of the Fund in order to comply with those limits or any future limits. These restrictions, if
implemented, could limit the ability of each Fund to invest in additional futures contracts, add to existing positions in the desired
amount, or create additional Creation Units and could otherwise have a significant negative impact on Fund operations and performance,
decreasing a Fund&#8217;s correlation to the performance of its benchmark, and otherwise preventing a Fund from achieving its investment
objective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><div><a id="k_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">a) None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: left">Title of Securities Registered</td><td style="padding-bottom: 1.5pt; text-align: center; white-space: nowrap; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Amount <br/>
Registered as of<br/>
September 30, <br/>
2022</td><td style="padding-bottom: 1.5pt; text-align: center; white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Shares Sold<br/>
 For the<br/>
Three Months <br/>
Ended<br/>
 September 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; text-align: center; white-space: nowrap; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Sale Price&#160;of<br/>
 Shares<br/>
Sold For the<br/>
Three Months<br/>
Ended<br/>
 September 30,<br/>
2022</td><td style="padding-bottom: 1.5pt; text-align: center; white-space: nowrap; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">-1x Short VIX Futures ETF </td><td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 11%">unlimited</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,290,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">37,128,501</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futres ETF </td><td>&#160;</td>
    <td style="text-align: center">unlimited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,610,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">148,158,278</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Total Trust:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">15,900,000</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">185,286,779</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><div><a id="k_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Item 3. Defaults Upon Senior Securities.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><div><a id="k_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Item 4. Mine Safety Disclosures.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><div><a id="k_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Item 5. Other Information.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><div><a id="k_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Item 6. Exhibits.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left; width: 90%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: left"><a href="f10q0922ex31-1_vstrust.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description of Document Certification by Principal Executive Officer of the Trust Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934</b></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</span></td>
    <td>&#160;</td>
    <td style="text-align: left"><a href="f10q0922ex31-2_vstrust.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description of Document Certification by Principal Financial Officer of the Trust Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934</b></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: left"><a href="f10q0922ex32-1_vstrust.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description of Document Certification by Principal Executive Officer of the Trust Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 under the Securities Exchange Act of 1934</b></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2*</span></td>
    <td>&#160;</td>
    <td style="text-align: left"><a href="f10q0922ex32-2_vstrust.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description of Document Certification by Principal Financial Officer of the Trust Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 under the Securities Exchange Act of 1934</b></span></a></td></tr>

<tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EX-101.INS</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Instance
    Document (1)</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EX-101.SCH</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document (1)</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EX-101.CAL</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Calculation Linkbase Document (1)</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EX-101.DEF</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Definition Linkbase
    Document (1)</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EX-101.LAB</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Label Linkbase Document (1)</span></td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EX-101.PRE</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Presentation Linkbase Document (1)</span></td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="width: 100%">Cover Page Interactive Data File - The
cover page interactive data file does not appear in the interactive data file because its XBRL</td></tr>
</table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104.1</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tags are embedded
    within the inline XBRL document.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">Filed herewith.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">These certifications
are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><span style="font-size: 10pt"><b>Signatures</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><span style="font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>VS Trust</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Justin Young</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin Young</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">Date: November 8, 2022
    </td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Justin Young</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    </tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin Young</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Financial and Accounting Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">Date: November 8, 2022
    </td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">13</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c5" id="hidden-fact-0" name="cik0001793497:ReceivableForSharesSold" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-1" name="cik0001793497:VariationMarginReceivable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-2" name="us-gaap:OtherReceivablesNetCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-3" name="us-gaap:DueFromRelatedPartiesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-4" name="us-gaap:AccountsPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-5" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-6" name="cik0001793497:ShortTermInvestmentsRealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-7" name="cik0001793497:ShortTermInvestmentsRealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-8" name="cik0001793497:ShortTermInvestmentsUnrealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-9" name="cik0001793497:ShortTermInvestmentsUnrealized" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-10" name="cik0001793497:DecreaseIncreaseInVariationMarginReceivable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-11" name="us-gaap:IncreaseDecreaseInOtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-12" name="us-gaap:IncreaseDecreaseDueFromOtherRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-13" name="cik0001793497:IncreaseDecreaseInVariationMarginPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-14" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-15" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" decimals="0" id="hidden-fact-16" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="usdPershares">33566600</ix:nonFraction>
<ix:nonFraction contextRef="c15" decimals="0" id="hidden-fact-17" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="usdPershares">22053090</ix:nonFraction>
<ix:nonFraction contextRef="c18" decimals="0" id="hidden-fact-18" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="usdPershares">113228400</ix:nonFraction>
<ix:nonFraction contextRef="c19" decimals="0" id="hidden-fact-19" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="usdPershares">74355720</ix:nonFraction>
<ix:footnote id="ix_0_footnote" xml:lang="en-US">$35,432,706 of cash is pledged as collateral for futures contracts.</ix:footnote><!--Text not found in sections after Schedule of Investments (Unaudited)-->
<ix:footnote id="ix_1_footnote" xml:lang="en-US">Represents annualized seven-day yield at September 30, 2022.</ix:footnote><!--Text not found in sections after Schedule of Investments (Unaudited)-->
<ix:footnote id="ix_2_footnote" xml:lang="en-US">$59,371,717 of cash is pledged as collateral for futures contracts.</ix:footnote><!--Text not found in sections after Schedule of Investments (Unaudited)-->
<ix:footnote id="ix_3_footnote" xml:lang="en-US">Although the Funds&#8217; shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended September 30, 2022.</ix:footnote><!--Text not found in footnote sections assigned to Schedule of cut-off times and times of calculation-->
<ix:nonFraction contextRef="c24" id="hidden-fact-20" name="cik0001793497:AmountOfTotalTrust" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-21" name="cik0001793497:AmountOfTotalTrust" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-22" name="cik0001793497:AmountOfTotalTrust" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-23" name="cik0001793497:AmountOfTotalTrust" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-24" name="cik0001793497:AmountOfTotalTrust" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c33" id="hidden-fact-25" name="cik0001793497:AmountOfTotalTrust" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:footnote id="ix_4_footnote" xml:lang="en-US">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</ix:footnote><!--Text not found in footnote sections assigned to Schedule of valuation of investments at using the fair value hierarchy-->
<ix:nonFraction contextRef="c35" id="hidden-fact-26" name="cik0001793497:TotalTrust" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c37" id="hidden-fact-27" name="cik0001793497:TotalTrust" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-28" name="cik0001793497:TotalTrust" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-29" name="cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-30" name="cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-31" name="cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c46" id="hidden-fact-32" name="cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">Q3</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001793497</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="cik0001793497-20220930.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><ix:relationship fromRefs="ix_0_fact" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_1_fact ix_2_fact" toRefs="ix_1_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_3_fact" toRefs="ix_2_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_4_fact ix_5_fact" toRefs="ix_3_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_6_fact ix_7_fact ix_8_fact ix_9_fact hidden-fact-26 ix_10_fact hidden-fact-28" toRefs="ix_4_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_11_fact ix_12_fact ix_13_fact ix_14_fact" toRefs="ix_5_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_15_fact ix_16_fact" toRefs="ix_6_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_17_fact ix_18_fact" toRefs="ix_7_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_19_fact ix_20_fact" toRefs="ix_8_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_21_fact ix_22_fact" toRefs="ix_9_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_23_fact ix_24_fact" toRefs="ix_10_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:FirstAmericanFundsIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:FirstAmericanFundsIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cik0001793497:ExpiringJulyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cik0001793497:ExpiringAugustTwoThousandTwentyTwoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:FirstAmericanFundsIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:FirstAmericanFundsIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cik0001793497:ExpiringJulyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cik0001793497:ExpiringAugustTwoThousandTwentyTwoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cik0001793497:SVIXMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cik0001793497:UVIXMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zePyEEX8UMXPGRT6jVEkkUQgWgaqqF9GQL9wFW7E0MzwxrclS2X/RqDmyKWx+zgnoR6LqD+eUXGVN9YGKC9bMazjBUuNr0QoSkd7zLFjAbz7lZBG9ZtNq+kmTZTVFgqZ2Y] CSR-->
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:ForeignCurrencyForwardContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:SwapAgreementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:ForeignCurrencyForwardContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:SwapAgreementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:ForeignCurrencyForwardContractsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:SwapAgreementsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedAppreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedDepreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedAppreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedDepreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedAppreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedDepreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoXLongVIXFuturesETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cik0001793497:SVIXMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001793497</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cik0001793497:UVIXMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>f10q0922ex31-1_vstrust.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;302 of the Sarbanes-Oxley
Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Justin Young, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">I have reviewed this Quarterly
Report on Form&nbsp;10-Q&nbsp;of VS Trust and each of its Funds;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Based on my knowledge, this
report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Based on my knowledge, the
financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other
certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules&nbsp;13a-15(e)&nbsp;and&nbsp;15d-15(e))&nbsp;and internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f)&nbsp;and&nbsp;15d-15(f))&nbsp;for
the registrant and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Designed such internal control
over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Disclosed in this report any
change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal
quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other
certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">All significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material,
that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Date: November 8, 2022</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-size: 10pt">/s/ Justin Young</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Justin Young</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Principal Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">VS Trust</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>f10q0922ex31-2_vstrust.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Financial Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;302 of the Sarbanes-Oxley
Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Justin Young, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">I have reviewed this Quarterly
Report on Form&nbsp;10-Q&nbsp;of VS Trust and each of its Funds;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Based on my knowledge, this
report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Based on my knowledge, the
financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other
certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules&nbsp;13a-15(e)&nbsp;and&nbsp;15d-15(e))&nbsp;and internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f)&nbsp;and&nbsp;15d-15(f))&nbsp;for
the registrant and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Designed such internal control
over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Disclosed in this report any
change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal
quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other
certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(a)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">All significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material,
that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Date: November 8, 2022</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-size: 10pt">/s/ Justin Young</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Justin Young</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Principal Financial and Accounting Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">VS Trust</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>f10q0922ex32-1_vstrust.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;906 of the Sarbanes-Oxley
Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">In connection with this Quarterly Report on
Form&nbsp;10-Q&nbsp;for the quarter ended September 30, 2022 (the &ldquo;Report&rdquo;) of VS Trust (the &ldquo;Registrant&rdquo;) and
each of its Funds, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Justin Young, the Principal
Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The Report fully complies with
the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;&nbsp;<U>and</U></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The information contained in
the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Date: November 8, 2022</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-size: 10pt">/s/ Justin Young</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Justin Young</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Principal Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">VS Trust</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>f10q0922ex32-2_vstrust.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Certification of Principal Financial Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;906 of the Sarbanes-Oxley
Act of 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">In connection with this Quarterly Report on
Form&nbsp;10-Q&nbsp;for the quarter ended September 30, 2022 (the &ldquo;Report&rdquo;) of VS Trust (the &ldquo;Registrant&rdquo;) and
each of its Funds, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Justin Young, the Principal
Financial and Accounting Officer of the Registrant, hereby certify, to the best of my knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The Report fully complies with
the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;&nbsp;<U>and</U></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The information contained in
the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Date: November 8, 2022</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By: &nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-size: 10pt">/s/ Justin Young</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Justin Young</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Principal Financial and Accounting Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">VS Trust</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cik0001793497-20220930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Nov 08 21:24:36 UTC 2022 -->
<xs:schema elementFormDefault="qualified" xmlns:cik0001793497="http://www.vts.com/20220930" xmlns:srt-types="http://fasb.org/srt-types/2022" targetNamespace="http://www.vts.com/20220930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cik0001793497-20220930_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cik0001793497-20220930_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cik0001793497-20220930_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cik0001793497-20220930_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedBalanceSheet" id="cik0001793497_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Statements of Assets and Liabilities (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedBalanceSheetAlt0" id="cik0001793497_r_ConsolidatedBalanceSheetAlt0">
        <link:definition>001 - Statement - Statements of Assets and Liabilities (Unaudited) Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedBalanceSheetAlt1" id="cik0001793497_r_ConsolidatedBalanceSheetAlt1">
        <link:definition>001 - Statement - Statements of Assets and Liabilities (Unaudited) Alternate 1</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement" id="cik0001793497_r_ConsolidatedIncomeStatement">
        <link:definition>002 - Statement - Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement0" id="cik0001793497_r_ConsolidatedIncomeStatement0">
        <link:definition>003 - Statement - Statements of Changes in Net Assets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ConsolidatedCashFlow" id="cik0001793497_r_ConsolidatedCashFlow">
        <link:definition>004 - Statement - Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable" id="cik0001793497_r_ScheduleofInvestmentsUnauditedTable">
        <link:definition>005 - Statement - Schedule of Investments (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals" id="cik0001793497_r_ScheduleofInvestmentsUnauditedTable_Parentheticals">
        <link:definition>006 - Statement - Schedule of Investments (Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/Organization" id="cik0001793497_r_Organization">
        <link:definition>007 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/SignificantAccountingPolicies" id="cik0001793497_r_SignificantAccountingPolicies">
        <link:definition>008 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/Investments" id="cik0001793497_r_Investments">
        <link:definition>009 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/Agreements" id="cik0001793497_r_Agreements">
        <link:definition>010 - Disclosure - Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/OfferingCosts" id="cik0001793497_r_OfferingCosts">
        <link:definition>011 - Disclosure - Offering Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnits" id="cik0001793497_r_CreationandRedemptionofCreationUnits">
        <link:definition>012 - Disclosure - Creation and Redemption of Creation Units</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/FinancialHighlights" id="cik0001793497_r_FinancialHighlights">
        <link:definition>013 - Disclosure - Financial Highlights</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/Risk" id="cik0001793497_r_Risk">
        <link:definition>014 - Disclosure - Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/SubsequentEvents" id="cik0001793497_r_SubsequentEvents">
        <link:definition>015 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/AccountingPoliciesByPolicy" id="cik0001793497_r_AccountingPoliciesByPolicy">
        <link:definition>016 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/SignificantAccountingPoliciesTables" id="cik0001793497_r_SignificantAccountingPoliciesTables">
        <link:definition>017 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/InvestmentsTables" id="cik0001793497_r_InvestmentsTables">
        <link:definition>018 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables" id="cik0001793497_r_CreationandRedemptionofCreationUnitsTables">
        <link:definition>019 - Disclosure - Creation and Redemption of Creation Units (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/FinancialHighlightsTables" id="cik0001793497_r_FinancialHighlightsTables">
        <link:definition>020 - Disclosure - Financial Highlights (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/SignificantAccountingPoliciesDetails" id="cik0001793497_r_SignificantAccountingPoliciesDetails">
        <link:definition>021 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable" id="cik0001793497_r_ScheduleofcutofftimesandtimesofcalculationTable">
        <link:definition>022 - Disclosure - Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" id="cik0001793497_r_ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable">
        <link:definition>023 - Disclosure - Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable" id="cik0001793497_r_ScheduleoffairvalueofderivativeinstrumentsTable">
        <link:definition>024 - Disclosure - Investments (Details) - Schedule of fair value of derivative instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" id="cik0001793497_r_ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable">
        <link:definition>025 - Disclosure - Investments (Details) - Schedule of effect of derivative instruments on the statement of operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" id="cik0001793497_r_ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable">
        <link:definition>026 - Disclosure - Investments (Details) - Schedule of pledged by funds fair values of derivative instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zePyEEX8UMXPGRT6jVEkkUQgWgaqqF9GQL9wFW7E0MzwxrclS2X/RqDmyKWx+zgnoR6LqD+eUXGVN9YGKC9bMazjBUuNr0QoSk5OC5n25Q7JW/dCTyiHQzT+EIJWaEby4b] CSR-->
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" id="cik0001793497_r_ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable">
        <link:definition>027 - Disclosure - Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/AgreementsDetails" id="cik0001793497_r_AgreementsDetails">
        <link:definition>028 - Disclosure - Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails" id="cik0001793497_r_CreationandRedemptionofCreationUnitsDetails">
        <link:definition>029 - Disclosure - Creation and Redemption of Creation Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleoftransactionfeesTable" id="cik0001793497_r_ScheduleoftransactionfeesTable">
        <link:definition>030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of transaction fees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/ScheduleofshareoutstandingTable" id="cik0001793497_r_ScheduleofshareoutstandingTable">
        <link:definition>031 - Disclosure - Financial Highlights (Details) - Schedule of share outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/RiskDetails" id="cik0001793497_r_RiskDetails">
        <link:definition>032 - Disclosure - Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.vts.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <xs:element name="ScheduleOfInvestmentsUnauditedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfInvestmentsUnauditedAbstract"/>
  <xs:element name="ScheduleOfCutOffTimesAndTimesOfCalculationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfCutOffTimesAndTimesOfCalculationAbstract"/>
  <xs:element name="ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract"/>
  <xs:element name="ScheduleOfFairValueOfDerivativeInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract"/>
  <xs:element name="ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract"/>
  <xs:element name="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract"/>
  <xs:element name="ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract"/>
  <xs:element name="AgreementsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AgreementsDisclosureAbstract"/>
  <xs:element name="OfferingCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OfferingCostsAbstract"/>
  <xs:element name="ScheduleOfTransactionFeesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfTransactionFeesAbstract"/>
  <xs:element name="ScheduleOfShareOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfShareOutstandingAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract"/>
  <xs:element name="PayablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_PayablesAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract0"/>
  <xs:element name="NetAssetsConsistOfAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetAssetsConsistOfAbstract"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract1"/>
  <xs:element name="NetAssetValueUnlimitedSharesAuthorizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract"/>
  <xs:element name="ClassIUnlimitedSharesAuthorizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract2"/>
  <xs:element name="InvestmentIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentIncomeAbstract"/>
  <xs:element name="IncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncomeAbstract"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract3"/>
  <xs:element name="ExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ExpensesAbstract"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract4"/>
  <xs:element name="RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract"/>
  <xs:element name="NetRealizedGainLossOnAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetRealizedGainLossOnAbstract"/>
  <xs:element name="NetChangeInUnrealizedAppreciationDepreciationOfAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract"/>
  <xs:element name="IncreaseDecreaseInNetAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseDecreaseInNetAssetsAbstract"/>
  <xs:element name="OperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OperationsAbstract"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract5"/>
  <xs:element name="CapitalShareTransactionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CapitalShareTransactionsAbstract"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract6"/>
  <xs:element name="NetAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract7"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract8"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract9"/>
  <xs:element name="VixFuturesContractsNetRealizedGainLossOnFuturesContractsAndOrSwapAgreementsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAndOrSwapAgreementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsAndOrSwapAgreementsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAndOrSwapAgreementsAbstract"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnlabeledAbstract10"/>
  <xs:element name="RatiosToAverageNetAssets5Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RatiosToAverageNetAssets5Abstract"/>
  <xs:element name="ReceivableForSharesSold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ReceivableForSharesSold"/>
  <xs:element name="VariationMarginReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_VariationMarginReceivable"/>
  <xs:element name="LicensingAndRegistrationFeesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_LicensingAndRegistrationFeesPayable"/>
  <xs:element name="ShortTermInvestmentsRealized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ShortTermInvestmentsRealized"/>
  <xs:element name="FuturesContracts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FuturesContracts"/>
  <xs:element name="ShortTermInvestmentsUnrealized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ShortTermInvestmentsUnrealized"/>
  <xs:element name="FuturesContractsUnrealizedAppreciation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FuturesContractsUnrealizedAppreciation"/>
  <xs:element name="SharesSoldinShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SharesSoldinShares"/>
  <xs:element name="SharesSoldNetOfSharesRedeemedinDollarsPerShare" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare"/>
  <xs:element name="NetIncreaseInNetAssetsFromCapitalShareTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions"/>
  <xs:element name="PurchasesOfInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_PurchasesOfInvestments"/>
  <xs:element name="ProceedsFromSalesOrMaturitiesOfInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments"/>
  <xs:element name="DecreaseIncreaseInVariationMarginReceivable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_DecreaseIncreaseInVariationMarginReceivable"/>
  <xs:element name="IncreaseDecreaseInVariationMarginPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseDecreaseInVariationMarginPayable"/>
  <xs:element name="IncreaseDecreaseInDueToCustodian" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseDecreaseInDueToCustodian"/>
  <xs:element name="IncreaseDecreaseInPayableToSponsor" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseDecreaseInPayableToSponsor"/>
  <xs:element name="IncreaseInProfessionalFeesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseInProfessionalFeesPayable"/>
  <xs:element name="IncreaseInLicensingAndRegistrationFeesPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable"/>
  <xs:element name="ProceedsFromSaleOfUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ProceedsFromSaleOfUnits"/>
  <xs:element name="OtherAssetsInExcessOfLiabilitiesAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount"/>
  <xs:element name="ContractsOblication" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ContractsOblication"/>
  <xs:element name="TotalContractsObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_TotalContractsObligations"/>
  <xs:element name="MoneyMarketFundPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_MoneyMarketFundPercentage"/>
  <xs:element name="OtherAssetsInExcessOfLiabilitiesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage"/>
  <xs:element name="TotalNetAssetsPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_TotalNetAssetsPercentage"/>
  <xs:element name="AgreementsDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AgreementsDisclosureTextBlock"/>
  <xs:element name="AgreementsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_AgreementsTable"/>
  <xs:element name="AgreementsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AgreementsLineItems"/>
  <xs:element name="OfferingCostsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OfferingCostsTextBlock"/>
  <xs:element name="FinancialHighlightsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_FinancialHighlightsTable"/>
  <xs:element name="FinancialHighlightsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FinancialHighlightsLineItems"/>
  <xs:element name="RiskTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_RiskTable"/>
  <xs:element name="RiskLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RiskLineItems"/>
  <xs:element name="EmergingGrowthCompanyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_EmergingGrowthCompanyPolicyTextBlock"/>
  <xs:element name="StatementsOfCashFlowsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_StatementsOfCashFlowsPolicyTextBlock"/>
  <xs:element name="FinalNetAssetValueForFiscalPeriodPolcyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock"/>
  <xs:element name="ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock"/>
  <xs:element name="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock"/>
  <xs:element name="ScheduleOfTransactionFeesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfTransactionFeesTableTextBlock"/>
  <xs:element name="ScheduleOfShareOutstandingTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ScheduleOfShareOutstandingTableTextBlock"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems"/>
  <xs:element name="CreateRedeemCutoffDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CreateRedeemCutoffDescription"/>
  <xs:element name="NAVCalculationTimeESTDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NAVCalculationTimeESTDescription"/>
  <xs:element name="NAVCalculationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NAVCalculationDate"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems"/>
  <xs:element name="AmountOfTotalTrust" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AmountOfTotalTrust"/>
  <xs:element name="TotalTrust" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_TotalTrust"/>
  <xs:element name="InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"/>
  <xs:element name="InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems"/>
  <xs:element name="ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome"/>
  <xs:element name="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"/>
  <xs:element name="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems"/>
  <xs:element name="GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition"/>
  <xs:element name="NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition"/>
  <xs:element name="InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable"/>
  <xs:element name="InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems"/>
  <xs:element name="AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne"/>
  <xs:element name="FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo"/>
  <xs:element name="CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable"/>
  <xs:element name="CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems"/>
  <xs:element name="FinancialHighlightsDetailsScheduleofshareoutstandingTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable"/>
  <xs:element name="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems"/>
  <xs:element name="NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts"/>
  <xs:element name="MarketValuePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_MarketValuePerShare"/>
  <xs:element name="InvestmentCompanyTotalReturnMarketValue" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_InvestmentCompanyTotalReturnMarketValue"/>
  <xs:element name="SignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_SignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="GrossRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_GrossRevenue"/>
  <xs:element name="NonconvertibleDebtSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NonconvertibleDebtSecurities"/>
  <xs:element name="NonaffiliatesExceeded" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_NonaffiliatesExceeded"/>
  <xs:element name="FundsAverageNetAssetsAnnually" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FundsAverageNetAssetsAnnually"/>
  <xs:element name="AgreementsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cik0001793497_AgreementsDetailsTable"/>
  <xs:element name="AgreementsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AgreementsDetailsLineItems"/>
  <xs:element name="AverageDailyNetAssetsRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AverageDailyNetAssetsRate"/>
  <xs:element name="SubadvisoryFeeRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SubadvisoryFeeRate"/>
  <xs:element name="AverageDailyNetAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AverageDailyNetAssets"/>
  <xs:element name="AuthorizedParticipantsPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AuthorizedParticipantsPercentage"/>
  <xs:element name="RelevantBenchmark" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_RelevantBenchmark"/>
  <xs:element name="AssetDerivativesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_AssetDerivativesMember"/>
  <xs:element name="CBOEVIXFuturesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_CBOEVIXFuturesMember"/>
  <xs:element name="ExpiringAugustTwoThousandTwentyTwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember"/>
  <xs:element name="ExpiringJulyTwoThousandTwentyTwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember"/>
  <xs:element name="FirstAmericanFundsIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FirstAmericanFundsIncMember"/>
  <xs:element name="ForeignCurrencyForwardContractsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_ForeignCurrencyForwardContractsMember"/>
  <xs:element name="FuturesContractsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_FuturesContractsMember"/>
  <xs:element name="LiabilityDerivativesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_LiabilityDerivativesMember"/>
  <xs:element name="OneShortVIXFuturesETFMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OneShortVIXFuturesETFMember"/>
  <xs:element name="OnexShortVIXFuturesETFMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_OnexShortVIXFuturesETFMember"/>
  <xs:element name="SVIXMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SVIXMember"/>
  <xs:element name="SwapAgreementsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_SwapAgreementsMember"/>
  <xs:element name="TwoXLongVIXFuturesETFMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_TwoXLongVIXFuturesETFMember"/>
  <xs:element name="TwoxLongVIXFuturesETFMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_TwoxLongVIXFuturesETFMember"/>
  <xs:element name="UVIXMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UVIXMember"/>
  <xs:element name="UnrealizedAppreciationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnrealizedAppreciationMember"/>
  <xs:element name="UnrealizedDepreciationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_UnrealizedDepreciationMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cik0001793497_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>cik0001793497-20220930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Nov 08 21:24:36 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedBalanceSheet" roleURI="http://www.vts.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedBalanceSheetAlt0" roleURI="http://www.vts.com/role/ConsolidatedBalanceSheetAlt0"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedIncomeStatement" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedIncomeStatement0" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement0"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedCashFlow" roleURI="http://www.vts.com/role/ConsolidatedCashFlow"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_InvestmentOwnedAtFairValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_InterestReceivable" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ReceivableForSharesSold" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ReceivableForSharesSold"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="cik0001793497_ReceivableForSharesSold" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommodityContractAssetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractAssetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_CommodityContractAssetCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VariationMarginReceivable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_VariationMarginReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="cik0001793497_VariationMarginReceivable" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesClassifiedCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeePayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeePayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_ManagementFeePayable" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_AccountsPayableOtherCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_LicensingAndRegistrationFeesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="cik0001793497_LicensingAndRegistrationFeesPayable" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_Assets" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_Liabilities" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedBalanceSheetAlt0">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InterestAndOtherIncome" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ManagementFeeExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ProfessionalFees" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_LegalFees" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FloorBrokerageExchangeAndClearanceFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_FloorBrokerageExchangeAndClearanceFees" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:to="us-gaap_CostsAndExpenses" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:to="us-gaap_InvestmentIncomeNet" order="2" weight="-1"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zePyEEX8UMXPGRT6jVEkkUQgWgaqqF9GQL9wFW7E0MzwxrclS2X/RqDmyKWx+zgnoR6LqD+eUXGVN9YGKC9bMazjBUuNr0QoSk5OC5n25Q7JXvz/Dx25JWaQ9hhM7s9dr2] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnEnergyContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnEnergyContracts"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsRealized" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ShortTermInvestmentsRealized"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_UnrealizedGainLossOnEnergyContracts" xlink:to="cik0001793497_ShortTermInvestmentsRealized" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContracts" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContracts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_UnrealizedGainLossOnEnergyContracts" xlink:to="cik0001793497_FuturesContracts" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ShortTermInvestmentsUnrealized"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_UnrealizedGainLossOnEnergyContracts" xlink:to="cik0001793497_ShortTermInvestmentsUnrealized" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContractsUnrealizedAppreciation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_UnrealizedGainLossOnEnergyContracts" xlink:to="cik0001793497_FuturesContractsUnrealizedAppreciation" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:to="us-gaap_UnrealizedGainLossOnEnergyContracts" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:to="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement0">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:to="us-gaap_GainLossOnInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldinShares" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SharesSoldinShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:to="cik0001793497_SharesSoldinShares" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:to="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease" xlink:to="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease" xlink:to="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInVariationMarginPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_IncreaseDecreaseInVariationMarginPayable" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInDueToCustodian"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_IncreaseDecreaseInDueToCustodian" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseInProfessionalFeesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_IncreaseInProfessionalFeesPayable" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_PurchasesOfInvestments" xlink:href="cik0001793497-20220930.xsd#cik0001793497_PurchasesOfInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_PurchasesOfInvestments" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_DecreaseIncreaseInVariationMarginReceivable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_DecreaseIncreaseInVariationMarginReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_DecreaseIncreaseInVariationMarginReceivable" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInPayableToSponsor" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInPayableToSponsor"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cik0001793497_IncreaseDecreaseInPayableToSponsor" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSaleOfUnits" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ProceedsFromSaleOfUnits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="cik0001793497_ProceedsFromSaleOfUnits" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>cik0001793497-20220930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Nov 08 21:24:36 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedBalanceSheet" roleURI="http://www.vts.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedIncomeStatement" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedIncomeStatement0" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement0"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedCashFlow" roleURI="http://www.vts.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofInvestmentsUnauditedTable" roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofInvestmentsUnauditedTable_Parentheticals" roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_Organization" roleURI="http://www.vts.com/role/Organization"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_SignificantAccountingPolicies" roleURI="http://www.vts.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_Investments" roleURI="http://www.vts.com/role/Investments"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_Agreements" roleURI="http://www.vts.com/role/Agreements"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_OfferingCosts" roleURI="http://www.vts.com/role/OfferingCosts"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_CreationandRedemptionofCreationUnits" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnits"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_FinancialHighlights" roleURI="http://www.vts.com/role/FinancialHighlights"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_Risk" roleURI="http://www.vts.com/role/Risk"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_SubsequentEvents" roleURI="http://www.vts.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_AccountingPoliciesByPolicy" roleURI="http://www.vts.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_SignificantAccountingPoliciesTables" roleURI="http://www.vts.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_InvestmentsTables" roleURI="http://www.vts.com/role/InvestmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_CreationandRedemptionofCreationUnitsTables" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_FinancialHighlightsTables" roleURI="http://www.vts.com/role/FinancialHighlightsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofcutofftimesandtimesofcalculationTable" roleURI="http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" roleURI="http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleoffairvalueofderivativeinstrumentsTable" roleURI="http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" roleURI="http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" roleURI="http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" roleURI="http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleoftransactionfeesTable" roleURI="http://www.vts.com/role/ScheduleoftransactionfeesTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofshareoutstandingTable" roleURI="http://www.vts.com/role/ScheduleofshareoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_SignificantAccountingPoliciesDetails" roleURI="http://www.vts.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_AgreementsDetails" roleURI="http://www.vts.com/role/AgreementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_CreationandRedemptionofCreationUnitsDetails" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_RiskDetails" roleURI="http://www.vts.com/role/RiskDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#DocumentAndEntityInformation" roleURI="http://www.vts.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_InvestmentOwnedAtFairValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_InterestReceivable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ReceivableForSharesSold" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ReceivableForSharesSold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="cik0001793497_ReceivableForSharesSold" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommodityContractAssetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractAssetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_CommodityContractAssetCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VariationMarginReceivable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_VariationMarginReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="cik0001793497_VariationMarginReceivable" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_Assets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_PayablesAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_PayablesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="cik0001793497_PayablesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesClassifiedCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeePayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeePayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="us-gaap_ManagementFeePayable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_LicensingAndRegistrationFeesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="cik0001793497_LicensingAndRegistrationFeesPayable" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_PayablesAbstract" xlink:to="us-gaap_Liabilities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetsConsistOfAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAssetsConsistOfAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_NetAssetsConsistOfAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetAssetsConsistOfAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetAssetsConsistOfAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAssetValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAssetValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_NetAssetValuePerShare" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentIncomeAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentIncomeAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_InvestmentIncomeAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncomeAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncomeAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentIncomeAbstract" xlink:to="cik0001793497_IncomeAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_IncomeAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_IncomeAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpensesAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentIncomeAbstract" xlink:to="cik0001793497_ExpensesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="us-gaap_ManagementFeeExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="us-gaap_ProfessionalFees" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="us-gaap_LegalFees" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FloorBrokerageExchangeAndClearanceFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="us-gaap_FloorBrokerageExchangeAndClearanceFees" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:to="us-gaap_CostsAndExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetRealizedGainLossOnAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:to="cik0001793497_NetRealizedGainLossOnAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsRealized" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ShortTermInvestmentsRealized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetRealizedGainLossOnAbstract" xlink:to="cik0001793497_ShortTermInvestmentsRealized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContracts" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContracts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetRealizedGainLossOnAbstract" xlink:to="cik0001793497_FuturesContracts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ShortTermInvestmentsUnrealized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="cik0001793497_ShortTermInvestmentsUnrealized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContractsUnrealizedAppreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="cik0001793497_FuturesContractsUnrealizedAppreciation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnEnergyContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnEnergyContracts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrealizedGainLossOnEnergyContracts" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement0">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInNetAssetsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInNetAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_IncreaseDecreaseInNetAssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OperationsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OperationsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_IncreaseDecreaseInNetAssetsAbstract" xlink:to="cik0001793497_OperationsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_OperationsAbstract" xlink:to="us-gaap_GainLossOnInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_OperationsAbstract" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_OperationsAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_OperationsAbstract" xlink:to="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CapitalShareTransactionsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CapitalShareTransactionsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_CapitalShareTransactionsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldinShares" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SharesSoldinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="cik0001793497_SharesSoldinShares" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_NetAssetsAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_NetAssetsAbstract" xlink:to="us-gaap_AssetsNet" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_PurchasesOfInvestments" xlink:href="cik0001793497-20220930.xsd#cik0001793497_PurchasesOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_PurchasesOfInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_DecreaseIncreaseInVariationMarginReceivable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_DecreaseIncreaseInVariationMarginReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_DecreaseIncreaseInVariationMarginReceivable" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInVariationMarginPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_IncreaseDecreaseInVariationMarginPayable" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInDueToCustodian"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_IncreaseDecreaseInDueToCustodian" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInPayableToSponsor" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInPayableToSponsor"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_IncreaseDecreaseInPayableToSponsor" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseInProfessionalFeesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_IncreaseInProfessionalFeesPayable" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSaleOfUnits" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ProceedsFromSaleOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="cik0001793497_ProceedsFromSaleOfUnits" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FirstAmericanFundsIncMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FirstAmericanFundsIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="cik0001793497_FirstAmericanFundsIncMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CBOEVIXFuturesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CBOEVIXFuturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="cik0001793497_CBOEVIXFuturesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherShortTermInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherInvestments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ContractsOblication" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ContractsOblication"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_ContractsOblication" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalContractsObligations" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TotalContractsObligations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_TotalContractsObligations" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FirstAmericanFundsIncMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FirstAmericanFundsIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="cik0001793497_FirstAmericanFundsIncMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CBOEVIXFuturesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CBOEVIXFuturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="cik0001793497_CBOEVIXFuturesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_MoneyMarketFundPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_MoneyMarketFundPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_MoneyMarketFundPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalNetAssetsPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TotalNetAssetsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cik0001793497_TotalNetAssetsPercentage" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/Organization">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/Investments">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_InvestmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/Agreements">
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_AgreementsLineItems" xlink:to="cik0001793497_AgreementsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDisclosureTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AgreementsLineItems" xlink:to="cik0001793497_AgreementsDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/OfferingCosts">
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OfferingCostsAbstract"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OfferingCostsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_OfferingCostsAbstract" xlink:to="cik0001793497_OfferingCostsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnits">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/FinancialHighlights">
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_FinancialHighlightsLineItems" xlink:to="cik0001793497_FinancialHighlightsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/Risk">
    <loc xlink:type="locator" xlink:label="cik0001793497_RiskLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RiskLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RiskTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RiskTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_RiskLineItems" xlink:to="cik0001793497_RiskTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_RiskLineItems" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zePyEEX8UMXPGRT6jVEkkUQgWgaqqF9GQL9wFW7E0MzwxrclS2X/RqDmyKWx+zgnoR6LqD+eUXGVN9YGKC9bMazjBUuNr0QoSkh6v89Az8mP0OQoUpDIDTPbkvPM9lW6Ur] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_EmergingGrowthCompanyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_StatementsOfCashFlowsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnremittedEarningsInForeignInvestmentPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokeragePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FloorBrokeragePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FloorBrokeragePolicy" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/InvestmentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfTransactionFeesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/FinancialHighlightsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfShareOutstandingTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreateRedeemCutoffDescription" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CreateRedeemCutoffDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:to="cik0001793497_CreateRedeemCutoffDescription" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NAVCalculationTimeESTDescription" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NAVCalculationTimeESTDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:to="cik0001793497_NAVCalculationTimeESTDescription" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NAVCalculationDate" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NAVCalculationDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:to="cik0001793497_NAVCalculationDate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContractsMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContractsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="cik0001793497_FuturesContractsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ForeignCurrencyForwardContractsMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ForeignCurrencyForwardContractsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="cik0001793497_ForeignCurrencyForwardContractsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SwapAgreementsMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SwapAgreementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="cik0001793497_SwapAgreementsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AmountOfTotalTrust" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AmountOfTotalTrust"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems" xlink:to="cik0001793497_AmountOfTotalTrust" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeContractTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnrealizedAppreciationMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnrealizedAppreciationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="cik0001793497_UnrealizedAppreciationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnrealizedDepreciationMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnrealizedDepreciationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="cik0001793497_UnrealizedDepreciationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AssetDerivativesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AssetDerivativesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="cik0001793497_AssetDerivativesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_LiabilityDerivativesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_LiabilityDerivativesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="cik0001793497_LiabilityDerivativesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalTrust" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TotalTrust"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="cik0001793497_TotalTrust" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoXLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoXLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoXLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesRealizedGainLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" xlink:to="us-gaap_DebtSecuritiesRealizedGainLoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" xlink:to="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20220930.xsd#cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" xlink:to="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" xlink:to="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" xlink:to="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" xlink:to="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleoftransactionfeesTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofshareoutstandingTable">
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAssetValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAssetValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="us-gaap_NetAssetValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_MarketValuePerShare" xlink:href="cik0001793497-20220930.xsd#cik0001793497_MarketValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="cik0001793497_MarketValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyTotalReturn" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyTotalReturn"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyTotalReturn" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentCompanyTotalReturnMarketValue" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentCompanyTotalReturnMarketValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="cik0001793497_InvestmentCompanyTotalReturnMarketValue" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RatiosToAverageNetAssets5Abstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="cik0001793497_RatiosToAverageNetAssets5Abstract" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:to="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossRatio"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:to="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SVIXMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SVIXMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="cik0001793497_SVIXMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UVIXMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UVIXMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="cik0001793497_UVIXMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossRevenue" xlink:href="cik0001793497-20220930.xsd#cik0001793497_GrossRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_GrossRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NonconvertibleDebtSecurities" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NonconvertibleDebtSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_NonconvertibleDebtSecurities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NonaffiliatesExceeded" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NonaffiliatesExceeded"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_NonaffiliatesExceeded" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FundsAverageNetAssetsAnnually" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FundsAverageNetAssetsAnnually"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_FundsAverageNetAssetsAnnually" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/AgreementsDetails">
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDetailsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDetailsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cik0001793497_AgreementsDetailsLineItems" xlink:to="cik0001793497_AgreementsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cik0001793497_AgreementsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SVIXMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SVIXMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="cik0001793497_SVIXMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UVIXMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UVIXMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="cik0001793497_UVIXMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AverageDailyNetAssetsRate" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AverageDailyNetAssetsRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AgreementsDetailsLineItems" xlink:to="cik0001793497_AverageDailyNetAssetsRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SubadvisoryFeeRate" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SubadvisoryFeeRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AgreementsDetailsLineItems" xlink:to="cik0001793497_SubadvisoryFeeRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AverageDailyNetAssets" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AverageDailyNetAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cik0001793497_AgreementsDetailsLineItems" xlink:to="cik0001793497_AverageDailyNetAssets" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharesIssued" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AuthorizedParticipantsPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AuthorizedParticipantsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="cik0001793497_AuthorizedParticipantsPercentage" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/RiskDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RelevantBenchmark" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RelevantBenchmark"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="cik0001793497_RelevantBenchmark" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.vts.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="cik0001793497_OneShortVIXFuturesETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentQuarterlyReport" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="31" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cik0001793497-20220930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Nov 08 21:24:36 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNet_lbl" xml:lang="en-US">NET ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AssetsNet_lbl0" xml:lang="en-US">Beginning of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AssetsNet_lbl1" xml:lang="en-US">End of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsNet_lbl2" xml:lang="en-US">Net Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl2"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Total Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff_lbl" xml:lang="en-US">Net Investment Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:to="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnEnergyContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnEnergyContracts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_UnrealizedGainLossOnEnergyContracts_lbl" xml:lang="en-US">Net realized and unrealized gain (loss) on investments and futures contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnEnergyContracts" xlink:to="us-gaap_UnrealizedGainLossOnEnergyContracts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease_lbl" xml:lang="en-US">Net increase (decrease) in net assets resulting from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:to="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease_lbl0" xml:lang="en-US">NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:to="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl" xml:lang="en-US">Net increase in net assets from capital share transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:to="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Total increase in net assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease" xlink:to="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">NET DECREASE IN CASH</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Beginning of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">End of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis_lbl" xml:lang="en-US">Financial Asset, Aging [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Creation and Redemption of Creation Units [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAssetValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAssetValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_NetAssetValuePerShare_lbl" xml:lang="en-US">Net Asset Value, Beginning of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAssetValuePerShare" xlink:to="us-gaap_NetAssetValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_NetAssetValuePerShare_lbl0" xml:lang="en-US">Net Asset Value, End of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAssetValuePerShare" xlink:to="us-gaap_NetAssetValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetAssetValuePerShare_lbl1" xml:lang="en-US">Net Asset Value, Offering and Redemption Price per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAssetValuePerShare" xlink:to="us-gaap_NetAssetValuePerShare_lbl1"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl" xml:lang="en-US">Investments in securities, at value *</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl0" xml:lang="en-US">Investments in securities, at cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestReceivable_lbl" xml:lang="en-US">Interest receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivable" xlink:to="us-gaap_InterestReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ReceivableForSharesSold" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ReceivableForSharesSold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ReceivableForSharesSold_lbl" xml:lang="en-US">Receivable for shares sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ReceivableForSharesSold" xlink:to="cik0001793497_ReceivableForSharesSold_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommodityContractAssetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractAssetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommodityContractAssetCurrent_lbl" xml:lang="en-US">Deposit at Broker for Futures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommodityContractAssetCurrent" xlink:to="us-gaap_CommodityContractAssetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VariationMarginReceivable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_VariationMarginReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_VariationMarginReceivable_lbl" xml:lang="en-US">Variation margin receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VariationMarginReceivable" xlink:to="cik0001793497_VariationMarginReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xml:lang="en-US">Due from Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract" xlink:to="cik0001793497_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_PayablesAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_PayablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_PayablesAbstract_lbl" xml:lang="en-US">Payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_PayablesAbstract" xlink:to="cik0001793497_PayablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Variation margin payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesClassifiedCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent_lbl" xml:lang="en-US">Due to Custodian</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeePayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeePayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ManagementFeePayable_lbl" xml:lang="en-US">Management fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementFeePayable" xlink:to="us-gaap_ManagementFeePayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl" xml:lang="en-US">Administrative, accounting and custodian fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Professional fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_LicensingAndRegistrationFeesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable_lbl" xml:lang="en-US">Licensing and registration fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_LicensingAndRegistrationFeesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract0" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract0" xlink:to="cik0001793497_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetsConsistOfAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAssetsConsistOfAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetAssetsConsistOfAbstract_lbl" xml:lang="en-US">NET ASSETS CONSIST OF:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetsConsistOfAbstract" xlink:to="cik0001793497_NetAssetsConsistOfAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract1" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract1" xlink:to="cik0001793497_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract_lbl" xml:lang="en-US">Net Asset Value (unlimited shares authorized):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract" xlink:to="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract_lbl" xml:lang="en-US">Class I (unlimited shares authorized):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract2" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract2" xlink:to="cik0001793497_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentIncomeAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_InvestmentIncomeAbstract_lbl" xml:lang="en-US">INVESTMENT INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentIncomeAbstract" xlink:to="cik0001793497_InvestmentIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncomeAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncomeAbstract_lbl" xml:lang="en-US">Income:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncomeAbstract" xlink:to="cik0001793497_IncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract3" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract3" xlink:to="cik0001793497_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpensesAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ExpensesAbstract_lbl" xml:lang="en-US">Expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="cik0001793497_ExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ManagementFeeExpense_lbl" xml:lang="en-US">Management fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementFeeExpense" xlink:to="us-gaap_ManagementFeeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Administrative, accounting and custodian fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Licensing and registration fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FloorBrokerageExchangeAndClearanceFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees_lbl" xml:lang="en-US">Broker interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:to="us-gaap_FloorBrokerageExchangeAndClearanceFees_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract4" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract4" xlink:to="cik0001793497_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract_lbl" xml:lang="en-US">REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES CONTRACTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:to="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetRealizedGainLossOnAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract_lbl" xml:lang="en-US">Net realized gain (loss) on:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedGainLossOnAbstract" xlink:to="cik0001793497_NetRealizedGainLossOnAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsRealized" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ShortTermInvestmentsRealized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ShortTermInvestmentsRealized_lbl" xml:lang="en-US">Short Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsRealized" xlink:to="cik0001793497_ShortTermInvestmentsRealized_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract_lbl" xml:lang="en-US">Net change in unrealized appreciation (depreciation) of:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ShortTermInvestmentsUnrealized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized_lbl" xml:lang="en-US">Short Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsUnrealized" xlink:to="cik0001793497_ShortTermInvestmentsUnrealized_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInNetAssetsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInNetAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseDecreaseInNetAssetsAbstract_lbl" xml:lang="en-US">INCREASE (DECREASE) IN NET ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInNetAssetsAbstract" xlink:to="cik0001793497_IncreaseDecreaseInNetAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OperationsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OperationsAbstract_lbl" xml:lang="en-US">OPERATIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OperationsAbstract" xlink:to="cik0001793497_OperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainLossOnInvestments_lbl" xml:lang="en-US">Net investment loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xml:lang="en-US">Net realized gain (loss) on investments and futures contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xml:lang="en-US">Net change in unrealized appreciation (depreciation) of investments and futures contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract5" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract5" xlink:to="cik0001793497_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CapitalShareTransactionsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CapitalShareTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CapitalShareTransactionsAbstract_lbl" xml:lang="en-US">CAPITAL SHARE TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="cik0001793497_CapitalShareTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract6" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract6" xlink:to="cik0001793497_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAssetsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetAssetsAbstract_lbl" xml:lang="en-US">NET ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetsAbstract" xlink:to="cik0001793497_NetAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOW FROM OPERATING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net increase (decrease) in net assets resulting from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl" xml:lang="en-US">Proceeds from sales or maturities of investments held</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:to="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInVariationMarginPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl" xml:lang="en-US">Increase (Decrease) in Variation margin payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:to="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInDueToCustodian"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian_lbl" xml:lang="en-US">Increase (Decrease) in Due to Custodian</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:to="cik0001793497_IncreaseDecreaseInDueToCustodian_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Increase (Decrease) in Administrative, accounting and custodian fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseInProfessionalFeesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable_lbl" xml:lang="en-US">Increase (Decrease) in Professional fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:to="cik0001793497_IncreaseInProfessionalFeesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl" xml:lang="en-US">Increase (Decrease) in Licensing and registration fees payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOW FROM FINANCING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ProceedsFromSaleOfUnits" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ProceedsFromSaleOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ProceedsFromSaleOfUnits_lbl" xml:lang="en-US">Proceeds from shares sold, net of cost from shares purchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSaleOfUnits" xlink:to="cik0001793497_ProceedsFromSaleOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherShortTermInvestments_lbl" xml:lang="en-US">TOTAL SHORT TERM INVESTMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherShortTermInvestments" xlink:to="us-gaap_OtherShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_MoneyMarketFundPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_MoneyMarketFundPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_MoneyMarketFundPercentage_lbl" xml:lang="en-US">Money market fund, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MoneyMarketFundPercentage" xlink:to="cik0001793497_MoneyMarketFundPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Cash pledged as collateral (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract7" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract7" xlink:to="cik0001793497_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherInvestments_lbl" xml:lang="en-US">Total Investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestments" xlink:to="us-gaap_OtherInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount_lbl" xml:lang="en-US">Other Assets in Excess of Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl" xml:lang="en-US">Other assets in excess of liabilities, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">TOTAL NET ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalNetAssetsPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TotalNetAssetsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_TotalNetAssetsPercentage_lbl" xml:lang="en-US">Total net assets, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalNetAssetsPercentage" xlink:to="cik0001793497_TotalNetAssetsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ContractsOblication" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ContractsOblication"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ContractsOblication_lbl" xml:lang="en-US">Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ContractsOblication" xlink:to="cik0001793497_ContractsOblication_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Market value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalContractsObligations" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TotalContractsObligations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_TotalContractsObligations_lbl" xml:lang="en-US">Total Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalContractsObligations" xlink:to="cik0001793497_TotalContractsObligations_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract8" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract8" xlink:to="cik0001793497_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Total distributable earnings (accumulated deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContracts" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContracts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_FuturesContracts_lbl" xml:lang="en-US">Futures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContracts" xlink:to="cik0001793497_FuturesContracts_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContractsUnrealizedAppreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl" xml:lang="en-US">Futures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:to="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldinShares" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SharesSoldinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_SharesSoldinShares_lbl" xml:lang="en-US">Shares sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SharesSoldinShares" xlink:to="cik0001793497_SharesSoldinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl" xml:lang="en-US">Shares redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:to="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_PurchasesOfInvestments" xlink:href="cik0001793497-20220930.xsd#cik0001793497_PurchasesOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_PurchasesOfInvestments_lbl" xml:lang="en-US">Purchase of investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_PurchasesOfInvestments" xlink:to="cik0001793497_PurchasesOfInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding_lbl" xml:lang="en-US">Decrease (Increase) in Deposits at broker for futures contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:to="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_DecreaseIncreaseInVariationMarginReceivable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_DecreaseIncreaseInVariationMarginReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_DecreaseIncreaseInVariationMarginReceivable_lbl" xml:lang="en-US">Decrease (Increase) in Variation margin receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_DecreaseIncreaseInVariationMarginReceivable" xlink:to="cik0001793497_DecreaseIncreaseInVariationMarginReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl" xml:lang="en-US">Decrease (Increase) in interest receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US">Decrease (Increase) in other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_lbl" xml:lang="en-US">Decrease (Increase) in Due from Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_IncreaseDecreaseInPayableToSponsor" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInPayableToSponsor"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cik0001793497_IncreaseDecreaseInPayableToSponsor_lbl" xml:lang="en-US">Increase (Decrease) in Payable to Sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInPayableToSponsor" xlink:to="cik0001793497_IncreaseDecreaseInPayableToSponsor_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Cost of shares redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OneShortVIXFuturesETFMember_lbl" xml:lang="en-US">-1x Short VIX Futures ETF</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OneShortVIXFuturesETFMember" xlink:to="cik0001793497_OneShortVIXFuturesETFMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cik0001793497_OneShortVIXFuturesETFMember_lbl0" xml:lang="en-US">1x Short VIX Futures ETF</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OneShortVIXFuturesETFMember" xlink:to="cik0001793497_OneShortVIXFuturesETFMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="cik0001793497_OneShortVIXFuturesETFMember_lbl1" xml:lang="en-US">-1x Short VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OneShortVIXFuturesETFMember" xlink:to="cik0001793497_OneShortVIXFuturesETFMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember_lbl" xml:lang="en-US">2x Long VIX Futures ETF</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember_lbl0" xml:lang="en-US">2x Long VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember_lbl1" xml:lang="en-US">2x Long VIX Futures ETF [Mmeber]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FirstAmericanFundsIncMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FirstAmericanFundsIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_FirstAmericanFundsIncMember_lbl" xml:lang="en-US">First American Funds Inc, [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FirstAmericanFundsIncMember" xlink:to="cik0001793497_FirstAmericanFundsIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember_lbl" xml:lang="en-US">Expiring July 2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember" xlink:to="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CBOEVIXFuturesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CBOEVIXFuturesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CBOEVIXFuturesMember_lbl" xml:lang="en-US">CBOE VIX Futures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CBOEVIXFuturesMember" xlink:to="cik0001793497_CBOEVIXFuturesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember_lbl" xml:lang="en-US">Expiring August 2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember" xlink:to="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember_lbl" xml:lang="en-US">1 x Short VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OnexShortVIXFuturesETFMember" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember_lbl0" xml:lang="en-US">-1x Short VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OnexShortVIXFuturesETFMember" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">ORGANIZATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl" xml:lang="en-US">Schedule of cut-off times and times of calculation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:to="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreateRedeemCutoffDescription" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CreateRedeemCutoffDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_CreateRedeemCutoffDescription_lbl" xml:lang="en-US">Create/Redeem Cut-off (EST)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreateRedeemCutoffDescription" xlink:to="cik0001793497_CreateRedeemCutoffDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NAVCalculationTimeESTDescription" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NAVCalculationTimeESTDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NAVCalculationTimeESTDescription_lbl" xml:lang="en-US">NAV Calculation Time (EST)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationTimeESTDescription" xlink:to="cik0001793497_NAVCalculationTimeESTDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NAVCalculationDate" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NAVCalculationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NAVCalculationDate_lbl" xml:lang="en-US">NAV Calculation Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationDate" xlink:to="cik0001793497_NAVCalculationDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of valuation of investments at using the fair value hierarchy</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AmountOfTotalTrust" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AmountOfTotalTrust"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AmountOfTotalTrust_lbl" xml:lang="en-US">Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountOfTotalTrust" xlink:to="cik0001793497_AmountOfTotalTrust_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract9" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract9" xlink:to="cik0001793497_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentTextBlock_lbl" xml:lang="en-US">INVESTMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTextBlock" xlink:to="us-gaap_InvestmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl" xml:lang="en-US">Schedule of fair value of derivative instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TotalTrust" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TotalTrust"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_TotalTrust_lbl" xml:lang="en-US">Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalTrust" xlink:to="cik0001793497_TotalTrust_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl" xml:lang="en-US">Schedule of effect of derivative instruments on the statement of operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsAndOrSwapAgreementsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAndOrSwapAgreementsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsAndOrSwapAgreementsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAndOrSwapAgreementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsAndOrSwapAgreementsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAndOrSwapAgreementsAbstract_lbl" xml:lang="en-US">VIX Futures Contracts Net realized gain (loss) on futures contracts and/or swap agreements/ changes in unrealized appreciation (depreciation) on futures contracts and/or swap agreements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsAndOrSwapAgreementsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAndOrSwapAgreementsAbstract" xlink:to="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsAndOrSwapAgreementsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAndOrSwapAgreementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesRealizedGainLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtSecuritiesRealizedGainLoss_lbl" xml:lang="en-US">Realized Gain (Loss) on Derivatives Recognized in Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesRealizedGainLoss" xlink:to="us-gaap_DebtSecuritiesRealizedGainLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome_lbl" xml:lang="en-US">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" xlink:to="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl" xml:lang="en-US">Schedule of pledged by funds fair values of derivative instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:to="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20220930.xsd#cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl" xml:lang="en-US">Gross Amounts of Recognized Assets presented in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl" xml:lang="en-US">Gross Amounts Offset in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl0" xml:lang="en-US">Net Amounts of Assets presented in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl" xml:lang="en-US">Schedule of gross amounts not offset in the statements of financial condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl" xml:lang="en-US">Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:to="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl" xml:lang="en-US">Financial Instruments for the Benefit of (the Funds) / the Counterparties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:to="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDisclosureTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AgreementsDisclosureTextBlock_lbl" xml:lang="en-US">AGREEMENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDisclosureTextBlock" xlink:to="cik0001793497_AgreementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OfferingCostsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_OfferingCostsTextBlock_lbl" xml:lang="en-US">OFFERING COSTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OfferingCostsTextBlock" xlink:to="cik0001793497_OfferingCostsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">CREATION AND REDEMPTION OF CREATION UNITS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfTransactionFeesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl" xml:lang="en-US">Schedule of transaction fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" xlink:to="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US">Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US">FINANCIAL HIGHLIGHTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfShareOutstandingTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl" xml:lang="en-US">Schedule of share outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" xlink:to="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_lbl" xml:lang="en-US">Net investment loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:to="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl" xml:lang="en-US">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_lbl" xml:lang="en-US">Net Increase (Decrease) in Net Asset Value Resulting from Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:to="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_MarketValuePerShare" xlink:href="cik0001793497-20220930.xsd#cik0001793497_MarketValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_MarketValuePerShare_lbl" xml:lang="en-US">Market Value Per Share, at September 30, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MarketValuePerShare" xlink:to="cik0001793497_MarketValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyTotalReturn" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyTotalReturn"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyTotalReturn_lbl" xml:lang="en-US">Total Return at Net Asset Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyTotalReturn" xlink:to="us-gaap_InvestmentCompanyTotalReturn_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentCompanyTotalReturnMarketValue" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentCompanyTotalReturnMarketValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_InvestmentCompanyTotalReturnMarketValue_lbl" xml:lang="en-US">Total Return at Market Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentCompanyTotalReturnMarketValue" xlink:to="cik0001793497_InvestmentCompanyTotalReturnMarketValue_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnlabeledAbstract10" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract10" xlink:to="cik0001793497_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RatiosToAverageNetAssets5Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract_lbl" xml:lang="en-US">Ratios to Average Net Assets: (5)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:to="cik0001793497_RatiosToAverageNetAssets5Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation_lbl" xml:lang="en-US">Expense ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" xlink:to="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossRatio"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio_lbl" xml:lang="en-US">Net Investment Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" xlink:to="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">RISK</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Money Market Fund [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level I - Quoted Prices [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FuturesContractsMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContractsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_FuturesContractsMember_lbl" xml:lang="en-US">Futures Contracts [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContractsMember" xlink:to="cik0001793497_FuturesContractsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ForeignCurrencyForwardContractsMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ForeignCurrencyForwardContractsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_ForeignCurrencyForwardContractsMember_lbl" xml:lang="en-US">Foreign Currency Forward Contracts [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ForeignCurrencyForwardContractsMember" xlink:to="cik0001793497_ForeignCurrencyForwardContractsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Level II - Other Significant Observable Inputs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SwapAgreementsMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SwapAgreementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_SwapAgreementsMember_lbl" xml:lang="en-US">Swap Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SwapAgreementsMember" xlink:to="cik0001793497_SwapAgreementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AssetDerivativesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AssetDerivativesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AssetDerivativesMember_lbl" xml:lang="en-US">Asset Derivatives [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AssetDerivativesMember" xlink:to="cik0001793497_AssetDerivativesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnrealizedAppreciationMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnrealizedAppreciationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnrealizedAppreciationMember_lbl" xml:lang="en-US">Unrealized Appreciation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnrealizedAppreciationMember" xlink:to="cik0001793497_UnrealizedAppreciationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_LiabilityDerivativesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_LiabilityDerivativesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_LiabilityDerivativesMember_lbl" xml:lang="en-US">Liability Derivatives	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_LiabilityDerivativesMember" xlink:to="cik0001793497_LiabilityDerivativesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UnrealizedDepreciationMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnrealizedDepreciationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UnrealizedDepreciationMember_lbl" xml:lang="en-US">Unrealized Depreciation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnrealizedDepreciationMember" xlink:to="cik0001793497_UnrealizedDepreciationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_TwoXLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoXLongVIXFuturesETFMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_TwoXLongVIXFuturesETFMember_lbl" xml:lang="en-US">2x Long VIX Futures ETF [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TwoXLongVIXFuturesETFMember" xlink:to="cik0001793497_TwoXLongVIXFuturesETFMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsMember_lbl" xml:lang="en-US">Assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesMember_lbl" xml:lang="en-US">Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesMember" xlink:to="us-gaap_OtherLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_GrossRevenue" xlink:href="cik0001793497-20220930.xsd#cik0001793497_GrossRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_GrossRevenue_lbl" xml:lang="en-US">Annual gross revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossRevenue" xlink:to="cik0001793497_GrossRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NonconvertibleDebtSecurities" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NonconvertibleDebtSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NonconvertibleDebtSecurities_lbl" xml:lang="en-US">Non-convertible debt securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonconvertibleDebtSecurities" xlink:to="cik0001793497_NonconvertibleDebtSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_NonaffiliatesExceeded" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NonaffiliatesExceeded"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_NonaffiliatesExceeded_lbl" xml:lang="en-US">Non-affiliates exceeded</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonaffiliatesExceeded" xlink:to="cik0001793497_NonaffiliatesExceeded_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FundsAverageNetAssetsAnnually" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FundsAverageNetAssetsAnnually"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_FundsAverageNetAssetsAnnually_lbl" xml:lang="en-US">Fund&#8217;s average net assets annually</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FundsAverageNetAssetsAnnually" xlink:to="cik0001793497_FundsAverageNetAssetsAnnually_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AverageDailyNetAssetsRate" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AverageDailyNetAssetsRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AverageDailyNetAssetsRate_lbl" xml:lang="en-US">Average daily net assets rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AverageDailyNetAssetsRate" xlink:to="cik0001793497_AverageDailyNetAssetsRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SubadvisoryFeeRate" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SubadvisoryFeeRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_SubadvisoryFeeRate_lbl" xml:lang="en-US">Sub-advisory fee rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SubadvisoryFeeRate" xlink:to="cik0001793497_SubadvisoryFeeRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AverageDailyNetAssets" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AverageDailyNetAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AverageDailyNetAssets_lbl" xml:lang="en-US">Average daily net assets (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AverageDailyNetAssets" xlink:to="cik0001793497_AverageDailyNetAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Shares of fund</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AuthorizedParticipantsPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AuthorizedParticipantsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_AuthorizedParticipantsPercentage_lbl" xml:lang="en-US">Authorized participants percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AuthorizedParticipantsPercentage" xlink:to="cik0001793497_AuthorizedParticipantsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RelevantBenchmark" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RelevantBenchmark"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_RelevantBenchmark_lbl" xml:lang="en-US">Relevant benchmark</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RelevantBenchmark" xlink:to="cik0001793497_RelevantBenchmark_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_EmergingGrowthCompanyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US">Emerging growth company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" xlink:to="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates &amp; Indemnifications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_StatementsOfCashFlowsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl" xml:lang="en-US">Statements of Cash Flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" xlink:to="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl" xml:lang="en-US">Final Net Asset Value for Fiscal Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:to="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment Valuation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnremittedEarningsInForeignInvestmentPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnremittedEarningsInForeignInvestmentPolicy_lbl" xml:lang="en-US">Investment Transactions and Related Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" xlink:to="us-gaap_UnremittedEarningsInForeignInvestmentPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokeragePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FloorBrokeragePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FloorBrokeragePolicy_lbl" xml:lang="en-US">Brokerage Commissions and Futures Account Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FloorBrokeragePolicy" xlink:to="us-gaap_FloorBrokeragePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Federal Income Tax</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zePyEEX8UMXPGRT6jVEkkUQgWgaqqF9GQL9wFW7E0MzwxrclS2X/RqDmyKWx+zgnoR6LqD+eUXGVN9YGKC9bMazjBUuNr0QoSkh6v89Az8mP31rCvkyMWSmNtO4lp6dk/T] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SVIXMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SVIXMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_SVIXMember_lbl" xml:lang="en-US">SVIX [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SVIXMember" xlink:to="cik0001793497_SVIXMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_UVIXMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UVIXMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cik0001793497_UVIXMember_lbl" xml:lang="en-US">UVIX [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UVIXMember" xlink:to="cik0001793497_UVIXMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US">Consolidated Entities [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US">Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsTable_lbl" xml:lang="en-US">Agreements [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsTable" xlink:to="cik0001793497_AgreementsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsLineItems_lbl" xml:lang="en-US">Agreements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsLineItems" xlink:to="cik0001793497_AgreementsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsTable_lbl" xml:lang="en-US">Financial Highlights [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsTable" xlink:to="cik0001793497_FinancialHighlightsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsLineItems_lbl" xml:lang="en-US">Financial Highlights Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsLineItems" xlink:to="cik0001793497_FinancialHighlightsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RiskTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RiskTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RiskTable_lbl" xml:lang="en-US">Risk [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RiskTable" xlink:to="cik0001793497_RiskTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_RiskLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RiskLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RiskLineItems_lbl" xml:lang="en-US">Risk [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RiskLineItems" xlink:to="cik0001793497_RiskLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeContractTypeDomain_lbl" xml:lang="en-US">Derivative Contract [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_DerivativeContractTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain_lbl" xml:lang="en-US">Financial Asset, Aging [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_lbl" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesFairValueLineItems_lbl" xml:lang="en-US">Derivatives, Fair Value [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="us-gaap_DerivativesFairValueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable_lbl" xml:lang="en-US">Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" xlink:to="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems_lbl" xml:lang="en-US">Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xml:lang="en-US">Balance Sheet Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable_lbl" xml:lang="en-US">Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" xlink:to="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems_lbl" xml:lang="en-US">Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable_lbl" xml:lang="en-US">Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" xlink:to="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems_lbl" xml:lang="en-US">Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" xlink:to="cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable_lbl" xml:lang="en-US">Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems_lbl" xml:lang="en-US">Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems" xlink:to="cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable_lbl" xml:lang="en-US">Financial Highlights (Details) - Schedule of share outstanding [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable" xlink:to="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems_lbl" xml:lang="en-US">Financial Highlights (Details) - Schedule of share outstanding [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsTable" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SignificantAccountingPoliciesDetailsLineItems" xlink:to="cik0001793497_SignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDetailsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsDetailsTable_lbl" xml:lang="en-US">Agreements (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDetailsTable" xlink:to="cik0001793497_AgreementsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDetailsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsDetailsLineItems_lbl" xml:lang="en-US">Agreements (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDetailsLineItems" xlink:to="cik0001793497_AgreementsDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AgreementsDisclosureTextBlock_lbl0" xml:lang="en-US">The entire disclosure of agreements disclosure.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDisclosureTextBlock" xlink:to="cik0001793497_AgreementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AmountOfTotalTrust_lbl0" xml:lang="en-US">Total amount of trust.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountOfTotalTrust" xlink:to="cik0001793497_AmountOfTotalTrust_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl0" xml:lang="en-US">The sales price you receive with any selling costs you paid deducted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:to="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AuthorizedParticipantsPercentage_lbl0" xml:lang="en-US">Percentage of authorized participants percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AuthorizedParticipantsPercentage" xlink:to="cik0001793497_AuthorizedParticipantsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AverageDailyNetAssets_lbl0" xml:lang="en-US">Average daily net assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AverageDailyNetAssets" xlink:to="cik0001793497_AverageDailyNetAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_AverageDailyNetAssetsRate_lbl0" xml:lang="en-US">Average daily net assets rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AverageDailyNetAssetsRate" xlink:to="cik0001793497_AverageDailyNetAssetsRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome_lbl0" xml:lang="en-US">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" xlink:to="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ContractsOblication_lbl0" xml:lang="en-US">Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ContractsOblication" xlink:to="cik0001793497_ContractsOblication_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_CreateRedeemCutoffDescription_lbl0" xml:lang="en-US">Create/Redeem Cut-off (EST) 2x Long VIX Futures ETF, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreateRedeemCutoffDescription" xlink:to="cik0001793497_CreateRedeemCutoffDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for emerging growth company.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" xlink:to="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl0" xml:lang="en-US">The entire disclosure of final net asset value for fiscal period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:to="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl0" xml:lang="en-US">The amount of financial instruments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:to="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_FuturesContracts_lbl0" xml:lang="en-US">The amount of futures contracts.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContracts" xlink:to="cik0001793497_FuturesContracts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl0" xml:lang="en-US">The amount of futures contracts unrealized appreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:to="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl0" xml:lang="en-US">The amount of gross amounts of recognized assets presented.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_GrossRevenue_lbl0" xml:lang="en-US">The amount of gross revenue.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossRevenue" xlink:to="cik0001793497_GrossRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl0" xml:lang="en-US">Increase decrease in variation margin payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:to="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl0" xml:lang="en-US">Increase in licensing and registration fees payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable_lbl0" xml:lang="en-US">Increase in professional fees payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:to="cik0001793497_IncreaseInProfessionalFeesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_InvestmentCompanyTotalReturnMarketValue_lbl0" xml:lang="en-US">Percentage increase (decrease) in fund market value, assuming reinvestment of dividends and capital gain distributions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentCompanyTotalReturnMarketValue" xlink:to="cik0001793497_InvestmentCompanyTotalReturnMarketValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable_lbl0" xml:lang="en-US">The amount of licensing and registration fees payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_LicensingAndRegistrationFeesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_MarketValuePerShare_lbl0" xml:lang="en-US">Per share excess of market value per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MarketValuePerShare" xlink:to="cik0001793497_MarketValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_MoneyMarketFundPercentage_lbl0" xml:lang="en-US">Money market fund, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MoneyMarketFundPercentage" xlink:to="cik0001793497_MoneyMarketFundPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NAVCalculationDate_lbl0" xml:lang="en-US">Date the NAV calculation date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationDate" xlink:to="cik0001793497_NAVCalculationDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NAVCalculationTimeESTDescription_lbl0" xml:lang="en-US">NAV Calculation Time (EST), description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationTimeESTDescription" xlink:to="cik0001793497_NAVCalculationTimeESTDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl1" xml:lang="en-US">The amount of net assets presented.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl0" xml:lang="en-US">The amount of net increase in net assets from capital share transactions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:to="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl0" xml:lang="en-US">Amount of realized and unrealized gain (loss) on investment, and future contracts.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NonaffiliatesExceeded_lbl0" xml:lang="en-US">The amount of non-affiliates exceeded.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonaffiliatesExceeded" xlink:to="cik0001793497_NonaffiliatesExceeded_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_NonconvertibleDebtSecurities_lbl0" xml:lang="en-US">The amount of non-convertible debt securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonconvertibleDebtSecurities" xlink:to="cik0001793497_NonconvertibleDebtSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_OfferingCostsTextBlock_lbl0" xml:lang="en-US">The entire disclosure of offering costs .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OfferingCostsTextBlock" xlink:to="cik0001793497_OfferingCostsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount_lbl0" xml:lang="en-US">Other assets in excess of liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl0" xml:lang="en-US">Other assets in excess of liabilities, percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ProceedsFromSaleOfUnits_lbl0" xml:lang="en-US">Proceeds from sale of units.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSaleOfUnits" xlink:to="cik0001793497_ProceedsFromSaleOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl0" xml:lang="en-US">Proceeds from sales or maturities of investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:to="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_PurchasesOfInvestments_lbl0" xml:lang="en-US">The cash outflow associated with the purchase of all investments during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_PurchasesOfInvestments" xlink:to="cik0001793497_PurchasesOfInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ReceivableForSharesSold_lbl0" xml:lang="en-US">It represent receivable for shares sold.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ReceivableForSharesSold" xlink:to="cik0001793497_ReceivableForSharesSold_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_RelevantBenchmark_lbl0" xml:lang="en-US">Percentage of relevant benchmark.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RelevantBenchmark" xlink:to="cik0001793497_RelevantBenchmark_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of cut-off times and times of calculation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:to="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of pledged by funds fair values of derivative instruments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:to="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of share outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" xlink:to="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of transaction fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" xlink:to="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl0" xml:lang="en-US">The amount of shares sold, net of shares redeemed.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:to="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ShortTermInvestmentsRealized_lbl0" xml:lang="en-US">Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsRealized" xlink:to="cik0001793497_ShortTermInvestmentsRealized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized_lbl0" xml:lang="en-US">Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsUnrealized" xlink:to="cik0001793497_ShortTermInvestmentsUnrealized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl0" xml:lang="en-US">The entire disclosure of statements of cash flows.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" xlink:to="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_SubadvisoryFeeRate_lbl0" xml:lang="en-US">Percentage of sub-advisory fee rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SubadvisoryFeeRate" xlink:to="cik0001793497_SubadvisoryFeeRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_TotalContractsObligations_lbl0" xml:lang="en-US">Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalContractsObligations" xlink:to="cik0001793497_TotalContractsObligations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_TotalNetAssetsPercentage_lbl0" xml:lang="en-US">Total net assets, percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalNetAssetsPercentage" xlink:to="cik0001793497_TotalNetAssetsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_TotalTrust_lbl0" xml:lang="en-US">Total Trust amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalTrust" xlink:to="cik0001793497_TotalTrust_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cik0001793497_VariationMarginReceivable_lbl0" xml:lang="en-US">Amount of variation margin receivable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VariationMarginReceivable" xlink:to="cik0001793497_VariationMarginReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember_lbl0" xml:lang="en-US">Expiring July Two Thousand Twenty Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember" xlink:to="cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_AgreementsDisclosureAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsDisclosureAbstract_lbl" xml:lang="en-US">Agreements Disclosure Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDisclosureAbstract" xlink:to="cik0001793497_AgreementsDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl0" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract_lbl0" xml:lang="en-US">Realized And Unrealized Gain Loss On Investments And Futures Contracts Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:to="cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl0" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OperationsAbstract_lbl0" xml:lang="en-US">Operations Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OperationsAbstract" xlink:to="cik0001793497_OperationsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnEnergyContracts_lbl0" xml:lang="en-US">Unrealized Gain (Loss) on Energy Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnEnergyContracts" xlink:to="us-gaap_UnrealizedGainLossOnEnergyContracts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl1" xml:lang="en-US">Increase In Licensing And Registration Fees Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl1" xml:lang="en-US">Financial Instruments For The Benefit Ofthe Funds The Counterparties Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:to="cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NAVCalculationDate_lbl1" xml:lang="en-US">NAVCalculation Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationDate" xlink:to="cik0001793497_NAVCalculationDate_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseDecreaseInNetAssetsAbstract_lbl0" xml:lang="en-US">Increase Decrease In Net Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInNetAssetsAbstract" xlink:to="cik0001793497_IncreaseDecreaseInNetAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ShortTermInvestmentsUnrealized_lbl1" xml:lang="en-US">Short Term Investments Unrealized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsUnrealized" xlink:to="cik0001793497_ShortTermInvestmentsUnrealized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract_lbl0" xml:lang="en-US">Net Asset Value Unlimited Shares Authorized Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract" xlink:to="cik0001793497_NetAssetValueUnlimitedSharesAuthorizedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Investment Company, Net Assets, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease" xlink:to="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl0" xml:lang="en-US">Due from Related Parties, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ShortTermInvestmentsRealized_lbl1" xml:lang="en-US">Short Term Investments Realized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ShortTermInvestmentsRealized" xlink:to="cik0001793497_ShortTermInvestmentsRealized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl1" xml:lang="en-US">Statements Of Cash Flows Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_StatementsOfCashFlowsPolicyTextBlock" xlink:to="cik0001793497_StatementsOfCashFlowsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetAssetValuePerShare_lbl2" xml:lang="en-US">Net Asset Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetAssetValuePerShare" xlink:to="us-gaap_NetAssetValuePerShare_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount_lbl1" xml:lang="en-US">Other Assets In Excess Of Liabilities Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl0" xml:lang="en-US">Accrued Professional Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract_lbl0" xml:lang="en-US">Class IUnlimited Shares Authorized Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl1" xml:lang="en-US">Net Realized And Unrealized Gain Loss On Investments And Futures Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:to="cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl1" xml:lang="en-US">Gross Amounts Of Recognized Assets Presented In The Statements Of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl0" xml:lang="en-US">Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SVIXMember_lbl0" xml:lang="en-US">SVIXMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SVIXMember" xlink:to="cik0001793497_SVIXMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInvestments_lbl0" xml:lang="en-US">Other Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestments" xlink:to="us-gaap_OtherInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Cutoff Times And Times Of Calculation Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:to="cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsMember_lbl0" xml:lang="en-US">Other Assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl1" xml:lang="en-US">Final Net Asset Value For Fiscal Period Polcy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:to="cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_LicensingAndRegistrationFeesPayable_lbl1" xml:lang="en-US">Licensing And Registration Fees Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_LicensingAndRegistrationFeesPayable" xlink:to="cik0001793497_LicensingAndRegistrationFeesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentIncomeAbstract_lbl0" xml:lang="en-US">Investment Income Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentIncomeAbstract" xlink:to="cik0001793497_InvestmentIncomeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_TotalContractsObligations_lbl1" xml:lang="en-US">Total Contracts Obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalContractsObligations" xlink:to="cik0001793497_TotalContractsObligations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_lbl0" xml:lang="en-US">Investment Company, Net Asset Value Per Share, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:to="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnremittedEarningsInForeignInvestmentPolicy_lbl0" xml:lang="en-US">Unremitted Earnings in Foreign Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" xlink:to="us-gaap_UnremittedEarningsInForeignInvestmentPolicy_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_OfferingCostsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OfferingCostsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OfferingCostsAbstract_lbl" xml:lang="en-US">Offering Costs Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OfferingCostsAbstract" xlink:to="cik0001793497_OfferingCostsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl0" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetRealizedGainLossOnAbstract_lbl0" xml:lang="en-US">Net Realized Gain Loss On Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetRealizedGainLossOnAbstract" xlink:to="cik0001793497_NetRealizedGainLossOnAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl1" xml:lang="en-US">Other Assets In Excess Of Liabilities Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage" xlink:to="cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfShareOutstandingAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfShareOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfShareOutstandingAbstract_lbl" xml:lang="en-US">Schedule Of Share Outstanding Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfShareOutstandingAbstract" xlink:to="cik0001793497_ScheduleOfShareOutstandingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NAVCalculationTimeESTDescription_lbl1" xml:lang="en-US">NAVCalculation Time ESTDescription</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NAVCalculationTimeESTDescription" xlink:to="cik0001793497_NAVCalculationTimeESTDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_VariationMarginReceivable_lbl1" xml:lang="en-US">Variation Margin Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VariationMarginReceivable" xlink:to="cik0001793497_VariationMarginReceivable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UVIXMember_lbl0" xml:lang="en-US">UVIXMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UVIXMember" xlink:to="cik0001793497_UVIXMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl0" xml:lang="en-US">Accounts Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract_lbl" xml:lang="en-US">Disclosure Text Block Supplement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_DisclosureTextBlockSupplementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyTotalReturn_lbl0" xml:lang="en-US">Investment Company, Total Return</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyTotalReturn" xlink:to="us-gaap_InvestmentCompanyTotalReturn_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ManagementFeeExpense_lbl0" xml:lang="en-US">Management Fee Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementFeeExpense" xlink:to="us-gaap_ManagementFeeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_PurchasesOfInvestments_lbl1" xml:lang="en-US">Purchases Of Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_PurchasesOfInvestments" xlink:to="cik0001793497_PurchasesOfInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OneShortVIXFuturesETFMember_lbl2" xml:lang="en-US">One Short VIXFutures ETFMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OneShortVIXFuturesETFMember" xlink:to="cik0001793497_OneShortVIXFuturesETFMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ForeignCurrencyForwardContractsMember_lbl0" xml:lang="en-US">Foreign Currency Forward Contracts Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ForeignCurrencyForwardContractsMember" xlink:to="cik0001793497_ForeignCurrencyForwardContractsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl1" xml:lang="en-US">Investment Owned, at Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTextBlock_lbl0" xml:lang="en-US">Investment [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTextBlock" xlink:to="us-gaap_InvestmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Interest Receivable, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl0" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CBOEVIXFuturesMember_lbl0" xml:lang="en-US">CBOEVIXFutures Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CBOEVIXFuturesMember" xlink:to="cik0001793497_CBOEVIXFuturesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract_lbl" xml:lang="en-US">Schedule Of Valuation Of Investments At Using The Fair Value Hierarchy Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract" xlink:to="cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl0" xml:lang="en-US">Realized Investment Gains (Losses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_LiabilityDerivativesMember_lbl0" xml:lang="en-US">Liability Derivatives Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_LiabilityDerivativesMember" xlink:to="cik0001793497_LiabilityDerivativesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl0" xml:lang="en-US">Unrealized Gain (Loss) on Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AverageDailyNetAssets_lbl1" xml:lang="en-US">Average Daily Net Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AverageDailyNetAssets" xlink:to="cik0001793497_AverageDailyNetAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:to="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_PayablesAbstract_lbl0" xml:lang="en-US">Payables Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_PayablesAbstract" xlink:to="cik0001793497_PayablesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesRealizedGainLoss_lbl0" xml:lang="en-US">Debt Securities, Realized Gain (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesRealizedGainLoss" xlink:to="us-gaap_DebtSecuritiesRealizedGainLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation_lbl0" xml:lang="en-US">Investment Company, Expense Ratio after Incentive Allocation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" xlink:to="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl0" xml:lang="en-US">Professional Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AssetDerivativesMember_lbl0" xml:lang="en-US">Asset Derivatives Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AssetDerivativesMember" xlink:to="cik0001793497_AssetDerivativesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl1" xml:lang="en-US">Proceeds From Sales Or Maturities Of Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments" xlink:to="cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_TotalNetAssetsPercentage_lbl1" xml:lang="en-US">Total Net Assets Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalNetAssetsPercentage" xlink:to="cik0001793497_TotalNetAssetsPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl2" xml:lang="en-US">Net Amounts Of Assets Presented In The Statements Of Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:to="cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract_lbl" xml:lang="en-US">Schedule Of Gross Amounts Not Offset In The Statements Of Financial Condition Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract" xlink:to="cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FloorBrokeragePolicy_lbl0" xml:lang="en-US">Floor Brokerage, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FloorBrokeragePolicy" xlink:to="us-gaap_FloorBrokeragePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl0" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_GrossRevenue_lbl1" xml:lang="en-US">Gross Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_GrossRevenue" xlink:to="cik0001793497_GrossRevenue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ContractsOblication_lbl1" xml:lang="en-US">Contracts Oblication</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ContractsOblication" xlink:to="cik0001793497_ContractsOblication_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_TwoxLongVIXFuturesETFMember_lbl2" xml:lang="en-US">Twox Long VIXFutures ETFMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TwoxLongVIXFuturesETFMember" xlink:to="cik0001793497_TwoxLongVIXFuturesETFMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseDecreaseInDueToCustodian_lbl0" xml:lang="en-US">Increase Decrease In Due To Custodian</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInDueToCustodian" xlink:to="cik0001793497_IncreaseDecreaseInDueToCustodian_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Of Derivative Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract" xlink:to="cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_TwoXLongVIXFuturesETFMember_lbl0" xml:lang="en-US">Two XLong VIXFutures ETFMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TwoXLongVIXFuturesETFMember" xlink:to="cik0001793497_TwoXLongVIXFuturesETFMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract10" xlink:to="cik0001793497_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FirstAmericanFundsIncMember_lbl0" xml:lang="en-US">First American Funds Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FirstAmericanFundsIncMember" xlink:to="cik0001793497_FirstAmericanFundsIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FuturesContractsMember_lbl0" xml:lang="en-US">Futures Contracts Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContractsMember" xlink:to="cik0001793497_FuturesContractsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract" xlink:to="cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseDecreaseInPayableToSponsor_lbl0" xml:lang="en-US">Increase Decrease In Payable To Sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInPayableToSponsor" xlink:to="cik0001793497_IncreaseDecreaseInPayableToSponsor_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl0" xml:lang="en-US">Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CapitalShareTransactionsAbstract_lbl0" xml:lang="en-US">Capital Share Transactions Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CapitalShareTransactionsAbstract" xlink:to="cik0001793497_CapitalShareTransactionsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FuturesContracts_lbl1" xml:lang="en-US">Futures Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContracts" xlink:to="cik0001793497_FuturesContracts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl0" xml:lang="en-US">Other Receivables, Net, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfCutOffTimesAndTimesOfCalculationAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfCutOffTimesAndTimesOfCalculationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfCutOffTimesAndTimesOfCalculationAbstract_lbl" xml:lang="en-US">Schedule Of Cut Off Times And Times Of Calculation Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfCutOffTimesAndTimesOfCalculationAbstract" xlink:to="cik0001793497_ScheduleOfCutOffTimesAndTimesOfCalculationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommodityContractAssetCurrent_lbl0" xml:lang="en-US">Commodity Contract Asset, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommodityContractAssetCurrent" xlink:to="us-gaap_CommodityContractAssetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AuthorizedParticipantsPercentage_lbl1" xml:lang="en-US">Authorized Participants Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AuthorizedParticipantsPercentage" xlink:to="cik0001793497_AuthorizedParticipantsPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl1" xml:lang="en-US">Shares Sold Net Of Shares Redeemedin Dollars Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:to="cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract_lbl0" xml:lang="en-US">Net Change In Unrealized Appreciation Depreciation Of Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ManagementFeePayable_lbl0" xml:lang="en-US">Management Fee Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementFeePayable" xlink:to="us-gaap_ManagementFeePayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl0" xml:lang="en-US">Legal Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract2" xlink:to="cik0001793497_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract1" xlink:to="cik0001793497_UnlabeledAbstract1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract4" xlink:to="cik0001793497_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_lbl0" xml:lang="en-US">Investment Company, Gain (Loss) on Investment, Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:to="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract3" xlink:to="cik0001793497_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl0" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract0" xlink:to="cik0001793497_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract9" xlink:to="cik0001793497_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnrealizedDepreciationMember_lbl0" xml:lang="en-US">Unrealized Depreciation Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnrealizedDepreciationMember" xlink:to="cik0001793497_UnrealizedDepreciationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract6" xlink:to="cik0001793497_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract5" xlink:to="cik0001793497_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract8" xlink:to="cik0001793497_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract7" xlink:to="cik0001793497_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Transaction Fees Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfTransactionFeesTableTextBlock" xlink:to="cik0001793497_ScheduleOfTransactionFeesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl0" xml:lang="en-US">Money Market Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NonconvertibleDebtSecurities_lbl1" xml:lang="en-US">Nonconvertible Debt Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonconvertibleDebtSecurities" xlink:to="cik0001793497_NonconvertibleDebtSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ProceedsFromSaleOfUnits_lbl1" xml:lang="en-US">Proceeds From Sale Of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ProceedsFromSaleOfUnits" xlink:to="cik0001793497_ProceedsFromSaleOfUnits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesMember_lbl0" xml:lang="en-US">Other Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesMember" xlink:to="us-gaap_OtherLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Share Outstanding Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfShareOutstandingTableTextBlock" xlink:to="cik0001793497_ScheduleOfShareOutstandingTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl1" xml:lang="en-US">Increase Decrease In Variation Margin Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseDecreaseInVariationMarginPayable" xlink:to="cik0001793497_IncreaseDecreaseInVariationMarginPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ExpensesAbstract_lbl0" xml:lang="en-US">Expenses Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ExpensesAbstract" xlink:to="cik0001793497_ExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_CreateRedeemCutoffDescription_lbl1" xml:lang="en-US">Create Redeem Cutoff Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_CreateRedeemCutoffDescription" xlink:to="cik0001793497_CreateRedeemCutoffDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SharesSoldinShares_lbl0" xml:lang="en-US">Shares Soldin Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SharesSoldinShares" xlink:to="cik0001793497_SharesSoldinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RelevantBenchmark_lbl1" xml:lang="en-US">Relevant Benchmark</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RelevantBenchmark" xlink:to="cik0001793497_RelevantBenchmark_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OfferingCostsTextBlock_lbl1" xml:lang="en-US">Offering Costs Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OfferingCostsTextBlock" xlink:to="cik0001793497_OfferingCostsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl1" xml:lang="en-US">Amounts Of Recognized Assets Liabilities Presented In The Statements Of Financial Condition One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:to="cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnlabeledAbstract" xlink:to="cik0001793497_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ReceivableForSharesSold_lbl1" xml:lang="en-US">Receivable For Shares Sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ReceivableForSharesSold" xlink:to="cik0001793497_ReceivableForSharesSold_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_OnexShortVIXFuturesETFMember_lbl1" xml:lang="en-US">Onex Short VIXFutures ETFMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_OnexShortVIXFuturesETFMember" xlink:to="cik0001793497_OnexShortVIXFuturesETFMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract_lbl" xml:lang="en-US">Schedule Of Effect Of Derivative Instruments On The Statement Of Operations Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract" xlink:to="cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees_lbl0" xml:lang="en-US">Floor Brokerage, Exchange and Clearance Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:to="us-gaap_FloorBrokerageExchangeAndClearanceFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl0" xml:lang="en-US">Assets Held-in-trust, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease_lbl1" xml:lang="en-US">Investment Company, Net Assets from Operations, Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:to="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_MarketValuePerShare_lbl1" xml:lang="en-US">Market Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MarketValuePerShare" xlink:to="cik0001793497_MarketValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestments_lbl0" xml:lang="en-US">Gain (Loss) on Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff_lbl0" xml:lang="en-US">Net Investment in Lease, Accrued Interest, Writeoff</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:to="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio_lbl0" xml:lang="en-US">Investment Company, Investment Income (Loss) Ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" xlink:to="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl0" xml:lang="en-US">Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl0" xml:lang="en-US">Accounts Payable, Other, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNet_lbl3" xml:lang="en-US">Net Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NonaffiliatesExceeded_lbl1" xml:lang="en-US">Nonaffiliates Exceeded</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NonaffiliatesExceeded" xlink:to="cik0001793497_NonaffiliatesExceeded_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_TotalTrust_lbl1" xml:lang="en-US">Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_TotalTrust" xlink:to="cik0001793497_TotalTrust_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl0" xml:lang="en-US">Investment Income, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetAssetsConsistOfAbstract_lbl0" xml:lang="en-US">Net Assets Consist Of Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetsConsistOfAbstract" xlink:to="cik0001793497_NetAssetsConsistOfAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_lbl0" xml:lang="en-US">Increase (Decrease) Due from Other Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl1" xml:lang="en-US">Futures Contracts Unrealized Appreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FuturesContractsUnrealizedAppreciation" xlink:to="cik0001793497_FuturesContractsUnrealizedAppreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_FundsAverageNetAssetsAnnually_lbl0" xml:lang="en-US">Funds Average Net Assets Annually</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_FundsAverageNetAssetsAnnually" xlink:to="cik0001793497_FundsAverageNetAssetsAnnually_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl0" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_MoneyMarketFundPercentage_lbl1" xml:lang="en-US">Money Market Fund Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_MoneyMarketFundPercentage" xlink:to="cik0001793497_MoneyMarketFundPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_InvestmentCompanyTotalReturnMarketValue_lbl1" xml:lang="en-US">Investment Company Total Return Market Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_InvestmentCompanyTotalReturnMarketValue" xlink:to="cik0001793497_InvestmentCompanyTotalReturnMarketValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfTransactionFeesAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfTransactionFeesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfTransactionFeesAbstract_lbl" xml:lang="en-US">Schedule Of Transaction Fees Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfTransactionFeesAbstract" xlink:to="cik0001793497_ScheduleOfTransactionFeesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember_lbl0" xml:lang="en-US">Expiring August Two Thousand Twenty Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember" xlink:to="cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SubadvisoryFeeRate_lbl1" xml:lang="en-US">Subadvisory Fee Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SubadvisoryFeeRate" xlink:to="cik0001793497_SubadvisoryFeeRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl1" xml:lang="en-US">Emerging Growth Company Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_EmergingGrowthCompanyPolicyTextBlock" xlink:to="cik0001793497_EmergingGrowthCompanyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_UnrealizedAppreciationMember_lbl0" xml:lang="en-US">Unrealized Appreciation Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_UnrealizedAppreciationMember" xlink:to="cik0001793497_UnrealizedAppreciationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AverageDailyNetAssetsRate_lbl1" xml:lang="en-US">Average Daily Net Assets Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AverageDailyNetAssetsRate" xlink:to="cik0001793497_AverageDailyNetAssetsRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl0" xml:lang="en-US">Document Quarterly Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AmountOfTotalTrust_lbl1" xml:lang="en-US">Amount Of Total Trust</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AmountOfTotalTrust" xlink:to="cik0001793497_AmountOfTotalTrust_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding_lbl0" xml:lang="en-US">Increase (Decrease) in Earnest Money Deposits Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:to="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetAssetsAbstract_lbl0" xml:lang="en-US">Net Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetAssetsAbstract" xlink:to="cik0001793497_NetAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsAndOrSwapAgreementsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAndOrSwapAgreementsAbstract_lbl0" xml:lang="en-US">Vix Futures Contracts Net Realized Gain Loss On Futures Contracts And Or Swap Agreements Changes In Unrealized Appreciation Depreciation On Futures Contracts And Or Swap Agreements Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsAndOrSwapAgreementsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAndOrSwapAgreementsAbstract" xlink:to="cik0001793497_VixFuturesContractsNetRealizedGainLossOnFuturesContractsAndOrSwapAgreementsChangesInUnrealizedAppreciationDepreciationOnFuturesContractsAndOrSwapAgreementsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_lbl0" xml:lang="en-US">Interest and Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncreaseInProfessionalFeesPayable_lbl1" xml:lang="en-US">Increase In Professional Fees Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncreaseInProfessionalFeesPayable" xlink:to="cik0001793497_IncreaseInProfessionalFeesPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome_lbl1" xml:lang="en-US">Change In Unrealized Appreciation Depreciation On Derivatives Recognized In Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" xlink:to="cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome_lbl1"/>
    <loc xlink:type="locator" xlink:label="cik0001793497_ScheduleOfInvestmentsUnauditedAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfInvestmentsUnauditedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_ScheduleOfInvestmentsUnauditedAbstract_lbl" xml:lang="en-US">Schedule Of Investments Unaudited Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_ScheduleOfInvestmentsUnauditedAbstract" xlink:to="cik0001793497_ScheduleOfInvestmentsUnauditedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_AgreementsDisclosureTextBlock_lbl1" xml:lang="en-US">Agreements Disclosure Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_AgreementsDisclosureTextBlock" xlink:to="cik0001793497_AgreementsDisclosureTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_RatiosToAverageNetAssets5Abstract_lbl0" xml:lang="en-US">Ratios To Average Net Assets5 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_RatiosToAverageNetAssets5Abstract" xlink:to="cik0001793497_RatiosToAverageNetAssets5Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_SwapAgreementsMember_lbl0" xml:lang="en-US">Swap Agreements Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_SwapAgreementsMember" xlink:to="cik0001793497_SwapAgreementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestReceivable_lbl0" xml:lang="en-US">Interest Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivable" xlink:to="us-gaap_InterestReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherShortTermInvestments_lbl0" xml:lang="en-US">Other Short-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherShortTermInvestments" xlink:to="us-gaap_OtherShortTermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl0" xml:lang="en-US">Quarterly Financial Information [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent_lbl0" xml:lang="en-US">Due to Other Related Parties, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_IncomeAbstract_lbl0" xml:lang="en-US">Income Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_IncomeAbstract" xlink:to="cik0001793497_IncomeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_DecreaseIncreaseInVariationMarginReceivable_lbl0" xml:lang="en-US">Decrease Increase In Variation Margin Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_DecreaseIncreaseInVariationMarginReceivable" xlink:to="cik0001793497_DecreaseIncreaseInVariationMarginReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl1" xml:lang="en-US">Net Increase In Net Assets From Capital Share Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:to="cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl0" xml:lang="en-US">Deferred Tax Assets, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cik0001793497-20220930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Nov 08 21:24:36 UTC 2022 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedBalanceSheet" roleURI="http://www.vts.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedIncomeStatement" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedIncomeStatement0" roleURI="http://www.vts.com/role/ConsolidatedIncomeStatement0"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ConsolidatedCashFlow" roleURI="http://www.vts.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofInvestmentsUnauditedTable" roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofInvestmentsUnauditedTable_Parentheticals" roleURI="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_Organization" roleURI="http://www.vts.com/role/Organization"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_SignificantAccountingPolicies" roleURI="http://www.vts.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_Investments" roleURI="http://www.vts.com/role/Investments"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_Agreements" roleURI="http://www.vts.com/role/Agreements"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_OfferingCosts" roleURI="http://www.vts.com/role/OfferingCosts"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_CreationandRedemptionofCreationUnits" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnits"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_FinancialHighlights" roleURI="http://www.vts.com/role/FinancialHighlights"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_Risk" roleURI="http://www.vts.com/role/Risk"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_SubsequentEvents" roleURI="http://www.vts.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_AccountingPoliciesByPolicy" roleURI="http://www.vts.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_SignificantAccountingPoliciesTables" roleURI="http://www.vts.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_InvestmentsTables" roleURI="http://www.vts.com/role/InvestmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_CreationandRedemptionofCreationUnitsTables" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_FinancialHighlightsTables" roleURI="http://www.vts.com/role/FinancialHighlightsTables"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofcutofftimesandtimesofcalculationTable" roleURI="http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" roleURI="http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleoffairvalueofderivativeinstrumentsTable" roleURI="http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" roleURI="http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" roleURI="http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" roleURI="http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleoftransactionfeesTable" roleURI="http://www.vts.com/role/ScheduleoftransactionfeesTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_ScheduleofshareoutstandingTable" roleURI="http://www.vts.com/role/ScheduleofshareoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_SignificantAccountingPoliciesDetails" roleURI="http://www.vts.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_AgreementsDetails" roleURI="http://www.vts.com/role/AgreementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_CreationandRedemptionofCreationUnitsDetails" roleURI="http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#cik0001793497_r_RiskDetails" roleURI="http://www.vts.com/role/RiskDetails"/>
  <roleRef xlink:type="simple" xlink:href="cik0001793497-20220930.xsd#DocumentAndEntityInformation" roleURI="http://www.vts.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_InvestmentOwnedAtFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_InterestReceivable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReceivableForSharesSold" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ReceivableForSharesSold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="ReceivableForSharesSold" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommodityContractAssetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommodityContractAssetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_CommodityContractAssetCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VariationMarginReceivable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_VariationMarginReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="VariationMarginReceivable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DueFromRelatedPartiesCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_Assets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PayablesAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_PayablesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="PayablesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesClassifiedCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="us-gaap_DueToOtherRelatedPartiesClassifiedCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeePayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeePayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="us-gaap_ManagementFeePayable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_LicensingAndRegistrationFeesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="LicensingAndRegistrationFeesPayable" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAbstract" xlink:to="us-gaap_Liabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NetAssetsConsistOfAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAssetsConsistOfAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NetAssetsConsistOfAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetAssetsConsistOfAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetAssetsConsistOfAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_AssetsNet_0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassIUnlimitedSharesAuthorizedAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassIUnlimitedSharesAuthorizedAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet_1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_AssetsNet_1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAssetValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAssetValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_NetAssetValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassIUnlimitedSharesAuthorizedAbstract" xlink:to="us-gaap_InvestmentOwnedAtFairValue_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InvestmentIncomeAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentIncomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="InvestmentIncomeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentIncomeAbstract" xlink:to="IncomeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ExpensesAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentIncomeAbstract" xlink:to="ExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="us-gaap_ManagementFeeExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="us-gaap_ProfessionalFees" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="us-gaap_LegalFees" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FloorBrokerageExchangeAndClearanceFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesAbstract" xlink:to="us-gaap_FloorBrokerageExchangeAndClearanceFees" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FloorBrokerageExchangeAndClearanceFees" xlink:to="us-gaap_CostsAndExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:label="RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetRealizedGainLossOnAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetRealizedGainLossOnAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:to="NetRealizedGainLossOnAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShortTermInvestmentsRealized" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ShortTermInvestmentsRealized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetRealizedGainLossOnAbstract" xlink:to="ShortTermInvestmentsRealized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FuturesContracts" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContracts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetRealizedGainLossOnAbstract" xlink:to="FuturesContracts" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract" xlink:to="NetChangeInUnrealizedAppreciationDepreciationOfAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShortTermInvestmentsUnrealized" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ShortTermInvestmentsUnrealized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="ShortTermInvestmentsUnrealized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FuturesContractsUnrealizedAppreciation" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContractsUnrealizedAppreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetChangeInUnrealizedAppreciationDepreciationOfAbstract" xlink:to="FuturesContractsUnrealizedAppreciation" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnEnergyContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnEnergyContracts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrealizedGainLossOnEnergyContracts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedIncomeStatement0">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInNetAssetsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInNetAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="IncreaseDecreaseInNetAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperationsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OperationsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInNetAssetsAbstract" xlink:to="OperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperationsAbstract" xlink:to="us-gaap_GainLossOnInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperationsAbstract" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperationsAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperationsAbstract" xlink:to="us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CapitalShareTransactionsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CapitalShareTransactionsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CapitalShareTransactionsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesSoldinShares" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SharesSoldinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalShareTransactionsAbstract" xlink:to="SharesSoldinShares" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="SharesSoldNetOfSharesRedeemedinDollarsPerShare" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalShareTransactionsAbstract" xlink:to="SharesSoldNetOfSharesRedeemedinDollarsPerShare" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NetIncreaseInNetAssetsFromCapitalShareTransactions" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalShareTransactionsAbstract" xlink:to="NetIncreaseInNetAssetsFromCapitalShareTransactions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalShareTransactionsAbstract" xlink:to="us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NetAssetsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NetAssetsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetAssetsAbstract" xlink:to="us-gaap_AssetsNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNet_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetAssetsAbstract" xlink:to="us-gaap_AssetsNet_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasesOfInvestments" xlink:href="cik0001793497-20220930.xsd#cik0001793497_PurchasesOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="PurchasesOfInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromSalesOrMaturitiesOfInvestments" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProceedsFromSalesOrMaturitiesOfInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseIncreaseInVariationMarginReceivable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_DecreaseIncreaseInVariationMarginReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DecreaseIncreaseInVariationMarginReceivable" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseDueFromOtherRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseDueFromOtherRelatedParties" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInVariationMarginPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInVariationMarginPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInVariationMarginPayable" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInDueToCustodian" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInDueToCustodian"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInDueToCustodian" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInPayableToSponsor" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseDecreaseInPayableToSponsor"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInPayableToSponsor" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseInProfessionalFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseInProfessionalFeesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseInProfessionalFeesPayable" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseInLicensingAndRegistrationFeesPayable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseInLicensingAndRegistrationFeesPayable" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseInLicensingAndRegistrationFeesPayable" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromSaleOfUnits" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ProceedsFromSaleOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromSaleOfUnits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfInvestmentsUnauditedAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfInvestmentsUnauditedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInvestmentsUnauditedAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ExpiringJulyTwoThousandTwentyTwoMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="ExpiringJulyTwoThousandTwentyTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpiringAugustTwoThousandTwentyTwoMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="ExpiringAugustTwoThousandTwentyTwoMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FirstAmericanFundsIncMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FirstAmericanFundsIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="FirstAmericanFundsIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CBOEVIXFuturesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CBOEVIXFuturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="CBOEVIXFuturesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OnexShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherShortTermInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherAssetsInExcessOfLiabilitiesAmount" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OtherAssetsInExcessOfLiabilitiesAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContractsOblication" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ContractsOblication"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ContractsOblication" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalContractsObligations" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TotalContractsObligations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="TotalContractsObligations" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfInvestmentsUnauditedAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfInvestmentsUnauditedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInvestmentsUnauditedAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ExpiringJulyTwoThousandTwentyTwoMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="ExpiringJulyTwoThousandTwentyTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpiringAugustTwoThousandTwentyTwoMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="ExpiringAugustTwoThousandTwentyTwoMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FirstAmericanFundsIncMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FirstAmericanFundsIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="FirstAmericanFundsIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CBOEVIXFuturesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CBOEVIXFuturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="CBOEVIXFuturesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OnexShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="MoneyMarketFundPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_MoneyMarketFundPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="MoneyMarketFundPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsOther" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherAssetsInExcessOfLiabilitiesPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OtherAssetsInExcessOfLiabilitiesPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalNetAssetsPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TotalNetAssetsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="TotalNetAssetsPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/Organization">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/Investments">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_InvestmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/Agreements">
    <loc xlink:type="locator" xlink:label="AgreementsDisclosureAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="AgreementsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsTable"/>
    <loc xlink:type="locator" xlink:label="AgreementsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDisclosureAbstract" xlink:to="AgreementsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsTable" xlink:to="AgreementsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AgreementsDisclosureTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsLineItems" xlink:to="AgreementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/OfferingCosts">
    <loc xlink:type="locator" xlink:label="OfferingCostsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OfferingCostsAbstract"/>
    <loc xlink:type="locator" xlink:label="OfferingCostsTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OfferingCostsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OfferingCostsAbstract" xlink:to="OfferingCostsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnits">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/FinancialHighlights">
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsTable"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="FinancialHighlightsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsTable" xlink:to="FinancialHighlightsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/Risk">
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <loc xlink:type="locator" xlink:label="RiskTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RiskTable"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSraoTMKpdMOVUMtRpuB8tV6eMGW/07nN8r724IYYtHu3Fk2iU8V8d5zePyEEX8UMXPGRT6jVEkkUQgWgaqqF9GQL9wFW7E0MzwxrclS2X/RqDmyKWx+zgnoR6LqD+eUXGVN9YGKC9bMazjBUuNr0QoSkh6v89Az8mP1ozHlVcPgwk+iGBs2iE5VZ] CSR-->
    <loc xlink:type="locator" xlink:label="RiskLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RiskLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="RiskTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RiskTable" xlink:to="RiskLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RiskLineItems" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="EmergingGrowthCompanyPolicyTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_EmergingGrowthCompanyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="EmergingGrowthCompanyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StatementsOfCashFlowsPolicyTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_StatementsOfCashFlowsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="StatementsOfCashFlowsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinalNetAssetValueForFiscalPeriodPolcyTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="FinalNetAssetValueForFiscalPeriodPolcyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnremittedEarningsInForeignInvestmentPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UnremittedEarningsInForeignInvestmentPolicy" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FloorBrokeragePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FloorBrokeragePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FloorBrokeragePolicy" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/InvestmentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfTransactionFeesTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfTransactionFeesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfTransactionFeesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/FinancialHighlightsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfShareOutstandingTableTextBlock" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfShareOutstandingTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="ScheduleOfShareOutstandingTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCutOffTimesAndTimesOfCalculationAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfCutOffTimesAndTimesOfCalculationAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCutOffTimesAndTimesOfCalculationAbstract" xlink:to="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable" xlink:to="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CreateRedeemCutoffDescription" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CreateRedeemCutoffDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:to="CreateRedeemCutoffDescription" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NAVCalculationTimeESTDescription" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NAVCalculationTimeESTDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:to="NAVCalculationTimeESTDescription" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NAVCalculationDate" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NAVCalculationDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems" xlink:to="NAVCalculationDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract" xlink:to="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_MoneyMarketFundsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FuturesContractsMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FuturesContractsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="FuturesContractsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ForeignCurrencyForwardContractsMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ForeignCurrencyForwardContractsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="ForeignCurrencyForwardContractsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SwapAgreementsMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SwapAgreementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="SwapAgreementsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" xlink:to="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AmountOfTotalTrust" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AmountOfTotalTrust"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems" xlink:to="AmountOfTotalTrust" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfDerivativeInstrumentsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfDerivativeInstrumentsAbstract" xlink:to="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AssetDerivativesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AssetDerivativesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="AssetDerivativesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LiabilityDerivativesMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_LiabilityDerivativesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="LiabilityDerivativesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="UnrealizedAppreciationMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnrealizedAppreciationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="UnrealizedAppreciationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrealizedDepreciationMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UnrealizedDepreciationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="UnrealizedDepreciationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="us-gaap_DerivativesFairValueLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TotalTrust" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TotalTrust"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativesFairValueLineItems" xlink:to="TotalTrust" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract" xlink:to="InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OnexShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OnexShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OnexShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoXLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoXLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoXLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" xlink:to="InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesRealizedGainLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" xlink:to="us-gaap_DebtSecuritiesRealizedGainLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems" xlink:to="ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract" xlink:to="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherAssetsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherLiabilitiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" xlink:to="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20220930.xsd#cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" xlink:to="GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" xlink:to="NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_0" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems" xlink:to="NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract" xlink:to="InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" xlink:to="InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" xlink:to="AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems" xlink:to="FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleoftransactionfeesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTransactionFeesAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfTransactionFeesAbstract"/>
    <loc xlink:type="locator" xlink:label="CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable"/>
    <loc xlink:type="locator" xlink:label="CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionFeesAbstract" xlink:to="CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable" xlink:to="CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/ScheduleofshareoutstandingTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareOutstandingAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_ScheduleOfShareOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsDetailsScheduleofshareoutstandingTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable"/>
    <loc xlink:type="locator" xlink:label="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareOutstandingAbstract" xlink:to="FinancialHighlightsDetailsScheduleofshareoutstandingTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="OneShortVIXFuturesETFMember" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingTable" xlink:to="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAssetValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAssetValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="us-gaap_NetAssetValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetAssetValuePerShare_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetAssetValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="us-gaap_NetAssetValuePerShare_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="MarketValuePerShare" xlink:href="cik0001793497-20220930.xsd#cik0001793497_MarketValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="MarketValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyTotalReturn" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyTotalReturn"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="us-gaap_InvestmentCompanyTotalReturn" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentCompanyTotalReturnMarketValue" xlink:href="cik0001793497-20220930.xsd#cik0001793497_InvestmentCompanyTotalReturnMarketValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="InvestmentCompanyTotalReturnMarketValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RatiosToAverageNetAssets5Abstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RatiosToAverageNetAssets5Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialHighlightsDetailsScheduleofshareoutstandingLineItems" xlink:to="RatiosToAverageNetAssets5Abstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RatiosToAverageNetAssets5Abstract" xlink:to="us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentCompanyInvestmentIncomeLossRatio"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RatiosToAverageNetAssets5Abstract" xlink:to="us-gaap_InvestmentCompanyInvestmentIncomeLossRatio" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SVIXMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SVIXMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="SVIXMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UVIXMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UVIXMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="UVIXMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="SignificantAccountingPoliciesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="GrossRevenue" xlink:href="cik0001793497-20220930.xsd#cik0001793497_GrossRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="GrossRevenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NonconvertibleDebtSecurities" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NonconvertibleDebtSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="NonconvertibleDebtSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NonaffiliatesExceeded" xlink:href="cik0001793497-20220930.xsd#cik0001793497_NonaffiliatesExceeded"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="NonaffiliatesExceeded" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FundsAverageNetAssetsAnnually" xlink:href="cik0001793497-20220930.xsd#cik0001793497_FundsAverageNetAssetsAnnually"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="FundsAverageNetAssetsAnnually" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/AgreementsDetails">
    <loc xlink:type="locator" xlink:label="AgreementsDisclosureAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="AgreementsDetailsTable" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="AgreementsDetailsLineItems" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AgreementsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDisclosureAbstract" xlink:to="AgreementsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SVIXMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SVIXMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="SVIXMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UVIXMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_UVIXMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="UVIXMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDetailsTable" xlink:to="AgreementsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AverageDailyNetAssetsRate" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AverageDailyNetAssetsRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDetailsLineItems" xlink:to="AverageDailyNetAssetsRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubadvisoryFeeRate" xlink:href="cik0001793497-20220930.xsd#cik0001793497_SubadvisoryFeeRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDetailsLineItems" xlink:to="SubadvisoryFeeRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AverageDailyNetAssets" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AverageDailyNetAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementsDetailsLineItems" xlink:to="AverageDailyNetAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AuthorizedParticipantsPercentage" xlink:href="cik0001793497-20220930.xsd#cik0001793497_AuthorizedParticipantsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="AuthorizedParticipantsPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/RiskDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <loc xlink:type="locator" xlink:label="RelevantBenchmark" xlink:href="cik0001793497-20220930.xsd#cik0001793497_RelevantBenchmark"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="RelevantBenchmark" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.vts.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="cik0001793497-20220930.xsd#cik0001793497_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OneShortVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_OneShortVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="OneShortVIXFuturesETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoxLongVIXFuturesETFMember" xlink:href="cik0001793497-20220930.xsd#cik0001793497_TwoxLongVIXFuturesETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="TwoxLongVIXFuturesETFMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentQuarterlyReport" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166923160912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VS
Trust<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">12,140,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001793497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-6704517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2000
PGA Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 4440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palm
Beach Gardens<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">261-0273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SVIX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">-1x Short VIX Futures ETF<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CboeBZX<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">UVIX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2x Long VIX Futures ETF<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CboeBZX<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166925488000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Assets and Liabilities (Unaudited)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investments in securities, at value *</a></td>
<td class="nump">$ 16,492,725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="nump">22,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ReceivableForSharesSold', window );">Receivable for shares sold</a></td>
<td class="nump">4,444,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommodityContractAssetCurrent', window );">Deposit at Broker for Futures</a></td>
<td class="nump">36,207,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_VariationMarginReceivable', window );">Variation margin receivable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivable</a></td>
<td class="nump">1,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from Other</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">57,169,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_PayablesAbstract', window );"><strong>Payables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Variation margin payable</a></td>
<td class="nump">774,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToOtherRelatedPartiesClassifiedCurrent', window );">Due to Custodian</a></td>
<td class="nump">575,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeePayable', window );">Management fees payable</a></td>
<td class="nump">44,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Administrative, accounting and custodian fees payable</a></td>
<td class="nump">38,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Professional fees payable</a></td>
<td class="nump">70,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_LicensingAndRegistrationFeesPayable', window );">Licensing and registration fees payable</a></td>
<td class="nump">50,564<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">1,554,835<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">NET ASSETS</a></td>
<td class="nump">55,614,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAssetsConsistOfAbstract', window );"><strong>NET ASSETS CONSIST OF:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital</a></td>
<td class="nump">58,167,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Total distributable earnings (accumulated deficit)</a></td>
<td class="num">(2,552,524)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net Assets</a></td>
<td class="nump">55,614,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract', window );"><strong>Class I (unlimited shares authorized):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net Assets</a></td>
<td class="nump">$ 55,614,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net Asset Value, Offering and Redemption Price per Share (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investments in securities, at cost</a></td>
<td class="nump">$ 16,492,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investments in securities, at value *</a></td>
<td class="nump">31,236,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="nump">69,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ReceivableForSharesSold', window );">Receivable for shares sold</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommodityContractAssetCurrent', window );">Deposit at Broker for Futures</a></td>
<td class="nump">56,663,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_VariationMarginReceivable', window );">Variation margin receivable</a></td>
<td class="nump">2,708,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from Other</a></td>
<td class="nump">3,727,069<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">94,405,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_PayablesAbstract', window );"><strong>Payables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Variation margin payable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToOtherRelatedPartiesClassifiedCurrent', window );">Due to Custodian</a></td>
<td class="nump">264,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeePayable', window );">Management fees payable</a></td>
<td class="nump">177,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Administrative, accounting and custodian fees payable</a></td>
<td class="nump">49,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Professional fees payable</a></td>
<td class="nump">71,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_LicensingAndRegistrationFeesPayable', window );">Licensing and registration fees payable</a></td>
<td class="nump">58,460<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">622,499<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">NET ASSETS</a></td>
<td class="nump">93,782,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAssetsConsistOfAbstract', window );"><strong>NET ASSETS CONSIST OF:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital</a></td>
<td class="nump">89,025,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Total distributable earnings (accumulated deficit)</a></td>
<td class="nump">4,757,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net Assets</a></td>
<td class="nump">93,782,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract', window );"><strong>Class I (unlimited shares authorized):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net Assets</a></td>
<td class="nump">$ 93,782,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net Asset Value, Offering and Redemption Price per Share (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 13.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investments in securities, at cost</a></td>
<td class="nump">$ 31,236,527<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_LicensingAndRegistrationFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of licensing and registration fees payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_LicensingAndRegistrationFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetAssetsConsistOfAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetAssetsConsistOfAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_PayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_PayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ReceivableForSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represent receivable for shares sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ReceivableForSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_VariationMarginReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variation margin receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_VariationMarginReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommodityContractAssetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the asset arising from commodity contracts such as futures contracts tied to the movement of a particular commodity, which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommodityContractAssetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToOtherRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount payable to related parties classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToOtherRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column C))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of the unpaid portion of the fee payable to the managing member or general partner for management of the fund or trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 35<br> -Paragraph 54B<br> -URI https://asc.fasb.org/extlink&amp;oid=126972413&amp;loc=SL7495116-110257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10246-115837<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10246-115837<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL6742756-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 35<br> -Paragraph 59<br> -URI https://asc.fasb.org/extlink&amp;oid=126972413&amp;loc=SL6740821-110257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166924317904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">1x Short VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncomeAbstract', window );"><strong>Income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income</a></td>
<td class="nump">$ 43,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Total Income</a></td>
<td class="nump">43,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeeExpense', window );">Management fees</a></td>
<td class="nump">146,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Administrative, accounting and custodian fees</a></td>
<td class="nump">15,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">80,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Licensing and registration fees</a></td>
<td class="nump">27,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FloorBrokerageExchangeAndClearanceFees', window );">Broker interest expense</a></td>
<td class="nump">4,038<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Expenses</a></td>
<td class="nump">274,252<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff', window );">Net Investment Loss</a></td>
<td class="num">(230,841)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetRealizedGainLossOnAbstract', window );"><strong>Net realized gain (loss) on:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ShortTermInvestmentsRealized', window );">Short Term Investments</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FuturesContracts', window );">Futures</a></td>
<td class="nump">8,077,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract', window );"><strong>Net change in unrealized appreciation (depreciation) of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ShortTermInvestmentsUnrealized', window );">Short Term Investments</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FuturesContractsUnrealizedAppreciation', window );">Futures</a></td>
<td class="num">(6,278,300)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnEnergyContracts', window );">Net realized and unrealized gain (loss) on investments and futures contracts</a></td>
<td class="nump">1,799,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease', window );">NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS</a></td>
<td class="nump">1,568,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncomeAbstract', window );"><strong>Income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income</a></td>
<td class="nump">126,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Total Income</a></td>
<td class="nump">126,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeeExpense', window );">Management fees</a></td>
<td class="nump">464,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Administrative, accounting and custodian fees</a></td>
<td class="nump">25,723<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">81,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Licensing and registration fees</a></td>
<td class="nump">34,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FloorBrokerageExchangeAndClearanceFees', window );">Broker interest expense</a></td>
<td class="nump">16,295<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Expenses</a></td>
<td class="nump">622,647<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff', window );">Net Investment Loss</a></td>
<td class="num">(495,724)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetRealizedGainLossOnAbstract', window );"><strong>Net realized gain (loss) on:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ShortTermInvestmentsRealized', window );">Short Term Investments</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FuturesContracts', window );">Futures</a></td>
<td class="num">(22,686,414)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract', window );"><strong>Net change in unrealized appreciation (depreciation) of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ShortTermInvestmentsUnrealized', window );">Short Term Investments</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FuturesContractsUnrealizedAppreciation', window );">Futures</a></td>
<td class="nump">20,574,735<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnEnergyContracts', window );">Net realized and unrealized gain (loss) on investments and futures contracts</a></td>
<td class="num">(2,111,678)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease', window );">NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS</a></td>
<td class="num">$ (2,607,402)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FuturesContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of futures contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FuturesContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FuturesContractsUnrealizedAppreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of futures contracts unrealized appreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FuturesContractsUnrealizedAppreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetRealizedGainLossOnAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetRealizedGainLossOnAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ShortTermInvestmentsRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ShortTermInvestmentsRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ShortTermInvestmentsUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ShortTermInvestmentsUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FloorBrokerageExchangeAndClearanceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense during the period for floor brokerage fees paid to other broker-dealers to execute trades on their behalf, stock exchange fees, order flow fees, and clearance fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FloorBrokerageExchangeAndClearanceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net assets from operations of investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874234-224268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of writeoff of accrued interest on net investment in sales-type and direct financing leases recognized by reversing interest income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3D<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267969-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnEnergyContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of open agreements to purchase or sell energy at some future point, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnEnergyContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166925373600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Changes in Net Assets (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OperationsAbstract', window );"><strong>OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net investment loss</a></td>
<td class="num">$ (230,841)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized gain (loss) on investments and futures contracts</a></td>
<td class="nump">8,077,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Net change in unrealized appreciation (depreciation) of investments and futures contracts</a></td>
<td class="num">(6,278,300)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="nump">1,568,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CapitalShareTransactionsAbstract', window );"><strong>CAPITAL SHARE TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SharesSoldinShares', window );">Shares sold</a></td>
<td class="nump">37,128,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare', window );">Shares redeemed</a></td>
<td class="num">(29,971,993)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions', window );">Net increase in net assets from capital share transactions</a></td>
<td class="nump">7,156,508<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease', window );">Total increase in net assets</a></td>
<td class="nump">8,725,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAssetsAbstract', window );"><strong>NET ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Beginning of Period</a></td>
<td class="nump">46,889,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">End of Period</a></td>
<td class="nump">55,614,526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OperationsAbstract', window );"><strong>OPERATIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net investment loss</a></td>
<td class="num">(495,724)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized gain (loss) on investments and futures contracts</a></td>
<td class="num">(22,686,414)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Net change in unrealized appreciation (depreciation) of investments and futures contracts</a></td>
<td class="nump">20,574,735<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="num">(2,607,402)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CapitalShareTransactionsAbstract', window );"><strong>CAPITAL SHARE TRANSACTIONS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SharesSoldinShares', window );">Shares sold</a></td>
<td class="nump">148,158,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare', window );">Shares redeemed</a></td>
<td class="num">(112,204,673)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions', window );">Net increase in net assets from capital share transactions</a></td>
<td class="nump">35,953,605<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease', window );">Total increase in net assets</a></td>
<td class="nump">33,346,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAssetsAbstract', window );"><strong>NET ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Beginning of Period</a></td>
<td class="nump">60,436,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">End of Period</a></td>
<td class="nump">$ 93,782,658<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CapitalShareTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CapitalShareTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net increase in net assets from capital share transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_OperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_OperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares sold, net of shares redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SharesSoldinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SharesSoldinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net assets from operations of investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874234-224268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in net assets of investment company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166925505872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">1x Short VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOW FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="nump">$ 1,568,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_PurchasesOfInvestments', window );">Purchase of investments</a></td>
<td class="num">(73,580,457)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments', window );">Proceeds from sales or maturities of investments held</a></td>
<td class="nump">65,379,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding', window );">Decrease (Increase) in Deposits at broker for futures contracts</a></td>
<td class="nump">3,665,556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_DecreaseIncreaseInVariationMarginReceivable', window );">Decrease (Increase) in Variation margin receivable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Decrease (Increase) in interest receivable</a></td>
<td class="num">(13,363)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Decrease (Increase) in other receivables</a></td>
<td class="num">(1,333)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseDueFromOtherRelatedParties', window );">Decrease (Increase) in Due from Other</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInVariationMarginPayable', window );">Increase (Decrease) in Variation margin payable</a></td>
<td class="nump">191,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInDueToCustodian', window );">Increase (Decrease) in Due to Custodian</a></td>
<td class="nump">575,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInPayableToSponsor', window );">Increase (Decrease) in Payable to Sponsor</a></td>
<td class="num">(17,753)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Increase (Decrease) in Administrative, accounting and custodian fees payable</a></td>
<td class="nump">16,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseInProfessionalFeesPayable', window );">Increase (Decrease) in Professional fees payable</a></td>
<td class="nump">55,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable', window );">Increase (Decrease) in Licensing and registration fees payable</a></td>
<td class="nump">14,922<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(2,145,481)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOW FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ProceedsFromSaleOfUnits', window );">Proceeds from shares sold, net of cost from shares purchased</a></td>
<td class="nump">32,683,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Cost of shares redeemed</a></td>
<td class="num">(34,077,640)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(1,394,049)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">NET DECREASE IN CASH</a></td>
<td class="num">(3,539,530)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of Period</a></td>
<td class="nump">3,539,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of Period</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOW FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net increase (decrease) in net assets resulting from operations</a></td>
<td class="num">(2,607,402)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_PurchasesOfInvestments', window );">Purchase of investments</a></td>
<td class="num">(189,402,007)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments', window );">Proceeds from sales or maturities of investments held</a></td>
<td class="nump">175,315,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding', window );">Decrease (Increase) in Deposits at broker for futures contracts</a></td>
<td class="num">(16,108,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_DecreaseIncreaseInVariationMarginReceivable', window );">Decrease (Increase) in Variation margin receivable</a></td>
<td class="num">(1,274,983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Decrease (Increase) in interest receivable</a></td>
<td class="num">(57,469)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Decrease (Increase) in other receivables</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseDueFromOtherRelatedParties', window );">Decrease (Increase) in Due from Other</a></td>
<td class="num">(4,743,330)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInVariationMarginPayable', window );">Increase (Decrease) in Variation margin payable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInDueToCustodian', window );">Increase (Decrease) in Due to Custodian</a></td>
<td class="nump">264,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseDecreaseInPayableToSponsor', window );">Increase (Decrease) in Payable to Sponsor</a></td>
<td class="nump">107,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Increase (Decrease) in Administrative, accounting and custodian fees payable</a></td>
<td class="nump">27,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseInProfessionalFeesPayable', window );">Increase (Decrease) in Professional fees payable</a></td>
<td class="nump">56,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable', window );">Increase (Decrease) in Licensing and registration fees payable</a></td>
<td class="nump">21,029<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(38,401,864)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOW FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ProceedsFromSaleOfUnits', window );">Proceeds from shares sold, net of cost from shares purchased</a></td>
<td class="nump">150,498,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Cost of shares redeemed</a></td>
<td class="num">(112,204,673)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">38,294,083<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">NET DECREASE IN CASH</a></td>
<td class="num">(107,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of Period</a></td>
<td class="nump">107,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of Period</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_DecreaseIncreaseInVariationMarginReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_DecreaseIncreaseInVariationMarginReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreaseDecreaseInDueToCustodian">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreaseDecreaseInDueToCustodian</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreaseDecreaseInPayableToSponsor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreaseDecreaseInPayableToSponsor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreaseDecreaseInVariationMarginPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in variation margin payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreaseDecreaseInVariationMarginPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in licensing and registration fees payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_IncreaseInProfessionalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in professional fees payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_IncreaseInProfessionalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ProceedsFromSaleOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ProceedsFromSaleOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sales or maturities of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_PurchasesOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_PurchasesOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseDueFromOtherRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables due from related parties classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseDueFromOtherRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of deposits given by the reporting entity to a seller which shows that the prospective buyer is serious about purchasing a property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166925640384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Investments (Unaudited)<br></strong></div></th>
<th class="th" colspan="2">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalContractsObligations', window );">Total Contracts</a></td>
<td class="num">$ (5,577,769)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">1 x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">TOTAL SHORT TERM INVESTMENT</a></td>
<td class="nump">16,492,725<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Total Investment</a></td>
<td class="nump">16,492,725<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount', window );">Other Assets in Excess of Liabilities</a></td>
<td class="nump">39,121,801<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">TOTAL NET ASSETS</a></td>
<td class="nump">55,614,526<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">TOTAL SHORT TERM INVESTMENT</a></td>
<td class="nump">31,236,527<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Total Investment</a></td>
<td class="nump">31,236,527<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount', window );">Other Assets in Excess of Liabilities</a></td>
<td class="nump">62,546,131<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">TOTAL NET ASSETS</a></td>
<td class="nump">93,782,658<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalContractsObligations', window );">Total Contracts</a></td>
<td class="nump">20,593,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cik0001793497_FirstAmericanFundsIncMember', window );">First American Funds Inc, [Member] | 1 x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">TOTAL SHORT TERM INVESTMENT</a></td>
<td class="nump">16,492,725<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cik0001793497_FirstAmericanFundsIncMember', window );">First American Funds Inc, [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">TOTAL SHORT TERM INVESTMENT</a></td>
<td class="nump">31,236,527<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember', window );">Expiring July 2022 [Member] | CBOE VIX Futures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ContractsOblication', window );">Contracts</a></td>
<td class="num">(4,642,568)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember', window );">Expiring July 2022 [Member] | CBOE VIX Futures [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ContractsOblication', window );">Contracts</a></td>
<td class="nump">16,904,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember', window );">Expiring August 2022 [Member] | CBOE VIX Futures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ContractsOblication', window );">Contracts</a></td>
<td class="num">(935,201)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember', window );">Expiring August 2022 [Member] | CBOE VIX Futures [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ContractsOblication', window );">Contracts</a></td>
<td class="nump">$ 3,689,234<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">$35,432,706 of cash is pledged as collateral for futures contracts.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">$59,371,717 of cash is pledged as collateral for futures contracts.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Represents annualized seven-day yield at September 30, 2022.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ContractsOblication">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ContractsOblication</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other assets in excess of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_TotalContractsObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_TotalContractsObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f,g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cik0001793497_FirstAmericanFundsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cik0001793497_FirstAmericanFundsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cik0001793497_CBOEVIXFuturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cik0001793497_CBOEVIXFuturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166923019376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Investments (Unaudited) (Parentheticals)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">1 x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_MoneyMarketFundPercentage', window );">Money market fund, percentage</a></td>
<td class="nump">29.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Cash pledged as collateral (in Dollars) | $</a></td>
<td class="nump">$ 16,492,725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage', window );">Other assets in excess of liabilities, percentage</a></td>
<td class="nump">70.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalNetAssetsPercentage', window );">Total net assets, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_MoneyMarketFundPercentage', window );">Money market fund, percentage</a></td>
<td class="nump">33.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Cash pledged as collateral (in Dollars) | $</a></td>
<td class="nump">$ 31,236,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage', window );">Other assets in excess of liabilities, percentage</a></td>
<td class="nump">66.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalNetAssetsPercentage', window );">Total net assets, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cik0001793497_FirstAmericanFundsIncMember', window );">First American Funds Inc, [Member] | 1 x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_MoneyMarketFundPercentage', window );">Money market fund, percentage</a></td>
<td class="nump">2.77%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=cik0001793497_FirstAmericanFundsIncMember', window );">First American Funds Inc, [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_MoneyMarketFundPercentage', window );">Money market fund, percentage</a></td>
<td class="nump">2.77%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember', window );">Expiring July 2022 [Member] | CBOE VIX Futures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Market value (in Dollars per share)</a></td>
<td class="nump">$ 33,566,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember', window );">Expiring July 2022 [Member] | CBOE VIX Futures [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Market value (in Dollars per share)</a></td>
<td class="nump">113,228,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember', window );">Expiring August 2022 [Member] | CBOE VIX Futures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Market value (in Dollars per share)</a></td>
<td class="nump">22,053,090<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember', window );">Expiring August 2022 [Member] | CBOE VIX Futures [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Market value (in Dollars per share)</a></td>
<td class="nump">$ 74,355,720<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_MoneyMarketFundPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Money market fund, percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_MoneyMarketFundPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other assets in excess of liabilities, percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_TotalNetAssetsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total net assets, percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_TotalNetAssetsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cik0001793497_FirstAmericanFundsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cik0001793497_FirstAmericanFundsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cik0001793497_CBOEVIXFuturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cik0001793497_CBOEVIXFuturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166923144656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8211; ORGANIZATION</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VS
Trust (the &#8220;Trust&#8221;) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series
(each, a &#8220;Fund&#8221; and collectively, the &#8220;Funds&#8221;). As of September 30, 2022, the following two series of the Trust
have commenced investment operations: -1x Short VIX Futures ETF (&#8220;SVIX&#8221;) and 2x Long VIX Futures ETF (&#8220;UVIX&#8221;).
Each of the Funds listed above issues common units of beneficial interest (&#8220;Shares&#8221;), which represent units of fractional
undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (&#8220;Cboe
BZX&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Funds&#8217; inception of operation was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other
than matters relating to its organization and the registration of each series under the Securities Act of 1933.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Fund&#8217;s investment exposure to&#160;VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each
Fund to regulation under the Commodity Exchange&#160;Act&#160;of&#160;1934 (&#8220;CEA&#8221;) and Commodity Futures Trading Commission
(&#8220;CFTC&#8221;) rules. The Sponsor is registered as a Commodity Pool Operator (&#8220;CPO&#8221;) and the Fund will be operated
in accordance with applicable CFTC rules. Registration as a CPO imposes additional compliance obligations on the Sponsor and the Funds
related to additional laws, regulations and enforcement policies, which could increase compliance costs and may affect the operations
and financial performance of the Funds.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility
Shares LLC (the &#8220;Sponsor&#8221;) is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust&#8217;s commodity
pool operator. The Funds are commodity pools, as defined under the Commodity Exchange&#160;Act (the &#8220;CEA&#8221;), and the applicable
regulations of the CFTC and are operated by the Sponsor, which is registered as a commodity pool operator with the CFTC.&#160;The Trust
is not an investment company registered under the Investment Company Act&#160;of&#160;1940.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166929368256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8211; SIGNIFICANT ACCOUNTING POLICIES</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Fund is an investment company, as defined by Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification
(&#8220;ASC&#8221;) Topic 946 &#8220;Financial Services &#8212; Investment Companies.&#8221; As such, the Funds follow the investment
company accounting and reporting guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable,
in preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United
States of America (&#8220;GAAP&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited financial statements were prepared in accordance with GAAP for interim financial information and with the instructions
for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). In the opinion of management,
all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period
financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
growth company</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act&#160;of&#160;2012. It will remain
an emerging growth company until the earlier of (1)&#160;the beginning of the first fiscal year following the fifth anniversary of its
initial public offering, (2)&#160;the beginning of the first fiscal year after annual gross revenue is $1.07&#160;billion (subject to
adjustment for inflation) or more, (3)&#160;the date on which the Fund has, during the previous three-year&#160;period, issued more than
$1.0&#160;billion in non-convertible&#160;debt securities and (4)&#160;as of the end of any fiscal year in which the market value of
common equity held by non-affiliates&#160;exceeded $700&#160;million as of the end of the second quarter of that fiscal year.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
as long as the Trust remains an &#8220;emerging growth company,&#8221; it may take advantage of certain exemptions from the various reporting
requirements that are applicable to public companies that are not &#8220;emerging growth companies&#8221; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley&#160;Act, reduced
disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions
from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden
parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an &#8220;emerging
growth company.&#8221;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Estimates &amp; Indemnifications</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications.
The Trust&#8217;s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Presentation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for
each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect
to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any
other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or
distributed to the Trust for the purchase of Shares in that Fund.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements
of Cash Flows</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated September
30, 2022, and represents cash, segregated cash balances with brokers for futures contracts, segregated cash with brokers for swap agreements
but does not include short-term investments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Final
Net Asset Value for Fiscal Period</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cut-off times and the times of the calculation of the Funds&#8217; final net asset value for creation and redemption of fund Shares for
the three months ended September 30, 2022 were typically as follows. All times are Eastern Standard Time:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Create/Redeem</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV Calculation</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; width: 52%; font-weight: bold">Fund</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Cut-off*(EST)</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Time (EST)</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Calculation Date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; text-align: left">-1x Short VIX Futures ETF and</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">2:00 p.m.</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">4:00 p.m.</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">September 30, 2022</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="white-space: nowrap; text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">2:00 p.m.</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">4:00 p.m.</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">September 30, 2022</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
                                            the Funds&#8217; shares may continue to trade on secondary markets subsequent to the calculation
                                            of the final NAV, these times represent the final opportunity to transact in creation or
                                            redemption units for the three months ended September 30, 2022.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
value per Share is determined at the close of Cboe BZX and may be later than when the Funds&#8217; NAV per Share is calculated.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly,
the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds&#8217;
final creation/redemption NAV for the three months ended September 30, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Valuation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term
investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each
of these situations, valuations are typically categorized as Level I in the fair value hierarchy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivatives
(e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties
or other procedures as determined by the Sponsor. Futures contracts are generally valued at the last settled price on the applicable
exchange on which that future trades. For financial reporting purposes, all futures contracts are generally valued at the last settled
price. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically
categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as
the basis for determining the market value of such position. Such fair value prices would generally be determined based on available
inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor
deems fair and equitable so long as such principles are consistent with industry standards. The Sponsor may fair value an asset of a
Fund pursuant to the policies the Sponsor has adopted. Depending on the source and relevant significance of valuation inputs, these instruments
may be classified as Level II or Level III in the fair value hierarchy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value pricing may require subjective determinations about the value of an investment. While the Funds&#8217; policies are intended to
result in a calculation of its respective Fund&#8217;s NAV that fairly reflects investment values as of the time of pricing, such Fund
cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that
a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or
distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the
differences could be material to the financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
Value of Financial Instruments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure
fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions
developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds&#8217; own assumptions
about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs).
The three levels defined by the disclosure requirements hierarchy are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
I &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability
to access at the measurement date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
II &#8211; Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or
indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for
identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the
asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means
(market-corroborated inputs).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
III &#8211; Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure
fair value to the extent that observable inputs are not available.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair
value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant
to the fair value measurement in its entirety.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly
decreased, as well as when circumstances indicate that a transaction is not orderly.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the valuation of investments at September 30, 2022 using the fair value hierarchy:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level I - Quoted Prices</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level II - Other Significant<br/> Observable Inputs</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Money Market Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Futures Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Foreign</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Currency</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Forward</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contracts</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Swap</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Agreements</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">-1x Short VIX Futures ETF </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">16,492,725</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(55,619,690</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">&#160;&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(39,126,965</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,236,527</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,584,120</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218,820,647</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Total Trust </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">47,729,252</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">131,964,430</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-24"/></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-25"/></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">179,693,682</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of
                                            Investments. Only current day&#8217;s variation margin is reported within the Statements
                                            of Financial Condition in receivable/payable on open futures.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Transactions and Related Income</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily.
Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized
appreciation (depreciation) between periods are reflected in the Statements of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as
Interest Income in the Statement of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Brokerage
Commissions and Futures Account Fees</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (&#8220;NFA&#8221;)
fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities
for each Fund&#8217;s investment in U.S. Commodity Futures Trading Commission (&#8220;CFTC&#8221;) regulated investments. The effects
of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities
or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are
recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized
when the transaction is closed). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed
variable create/redeem fees collected by more than 0.04% and 0.09%, for SVIX and UVIX, respectively, of each Fund&#8217;s average net assets annually.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Federal
Income Tax</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly,
no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund&#8217;s Shares is required to take
into account its allocable share of its Fund&#8217;s income, gain, loss, deductions and other items for its Fund&#8217;s taxable year
ending with or within the beneficial owner&#8217;s taxable year.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since
then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income
tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is
reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing
basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary
based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140167015211024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Disclosure Text Block Supplement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">INVESTMENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; INVESTMENTS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Short-Term
Investments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Funds may purchase U.S. Treasury Bills, agency securities, and other high-credit quality short-term fixed income or similar securities
with original maturities of one year or less. A portion of these investments may be posted as collateral in connection with swap agreements,
futures, and/or forward contracts.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting
for Derivative Instruments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
seeking to achieve each Fund&#8217;s investment objective, the Sponsor uses a mathematical approach to investing. Using this approach,
the Sponsor determines the type, quantity and mix of investment positions, including derivative positions, which the Sponsor believes
in combination, should produce returns consistent with a Fund&#8217;s objective.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
open derivative positions at period end are reflected on each respective Fund&#8217;s Schedule of Investments. Certain Funds utilized
a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objectives during
the period. While the volume of open positions may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve
the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective
Fund at the date of this report is generally representative of open positions throughout the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
is a description of the derivative instruments used by the Funds during the reporting period, including the primary underlying risk exposures
related to each instrument type.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Futures
Contracts</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Funds may enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or
shorting), an underlying benchmark. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery
of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally
be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase
of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration
of contract.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
entering into a futures contract, each Fund is required to deposit and maintain as collateral at least such initial margin as required
by the exchange on which the transaction is affected. The initial margin is segregated as cash and/or securities balances with brokers
for futures contracts, as disclosed in the Statements of Financial Condition, and is restricted as to its use. The Funds that enter into
futures contracts maintain collateral at the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund
generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract.
Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize
a gain or loss upon closing of a futures transaction.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">Futures contracts involve,
to varying degrees, elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility
risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure
each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation
between movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility
of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures
contracts are exchange-traded and the credit risk resides with the Funds&#8217; clearing broker or clearinghouse itself. Many futures
exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the
daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended
for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with
little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses.
If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund
will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will
be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Option Contracts</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">An option is a contract
that gives the buyer the right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific
(or strike) price within a specified period of time, regardless of the market price of that instrument. There are two types of options:
calls and puts. A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any
time during the life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated
price at any time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds
an offsetting position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor&#8217;s entire investment
(i.e., the premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the
option expires. Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin,
and the risk of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price
which may, upon exercise of the option, be significantly different from the market value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">When a Fund writes a call
or put, an amount equal to the premium received is recorded and subsequently marked to market to reflect the current value of the option
written. Premiums received from writing options which expire are treated as realized gains. Premiums received from writing options which
are exercised or closed are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction
to determine the realized gain (loss).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">When a Fund purchases an
option, the Fund pays a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market
to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk
associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised
or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized
gain (loss) when the underlying transaction is executed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">Certain options transactions
may subject the writer (seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or
delivered. The value of a Fund&#8217;s options transactions, if any, will be affected by, among other things, changes in the value of
a Fund&#8217;s underlying benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility
of the Fund&#8217;s underlying benchmark, and the remaining time until the options expire, or any combination thereof. The value of the
options should not be expected to increase or decrease at the same rate as the level of the Fund&#8217;s underlying benchmark, which may
contribute to tracking error. Options may be less liquid than certain other securities. A Fund&#8217;s ability to trade options will be
dependent on the willingness of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have
difficulty closing out certain option positions at desired times and prices. A Fund may experience substantial downside from specific
option positions and certain option positions may expire worthless. Over-the-counter options generally are not assignable except by agreement
between the parties concerned, and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for
options is relatively illiquid, particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity
risk and counterparty credit risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell
options on futures contracts, which may present even greater volatility and risk of loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Swap Agreements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">The Funds may enter into
swap agreements for purposes of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying
Index or to create an economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered
into primarily with institutional investors in over-the-counter (&#8220;OTC&#8221;) markets for a specified period, ranging from a day
to more than one year. However, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#8220;Dodd-Frank Act&#8221;) provides
for significant reforms of the OTC derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated
market and/or to clear such transactions through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties
agree to exchange the returns earned or realized on a particular predetermined investment, instrument or Index in exchange for a fixed
or floating rate of return in respect of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark
level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to a notional amount and
the benchmark returns to which the swap is linked. Swap agreements do not involve the delivery of underlying instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">Generally, swap agreements
entered into by the Funds calculate and settle the obligations of the parties to the agreement on a &#8220;net basis&#8221; with a single
payment. Consequently, each Fund&#8217;s current obligations (or rights) under a swap agreement will generally be equal only to the net
amount to be paid or received under the agreement based on the relative values of such obligations (or rights) (the &#8220;net amount&#8221;).
In a typical swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark
increases and would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted
for any transaction costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX,
the Fund would be required to make payments to the swap counterparties in the event the level of the benchmark increases and would be
entitled to settlement payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads
on the notional amount the Funds may pay.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">The net amount of the excess,
if any, of each Fund&#8217;s obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and
an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the
counterparty in a segregated account by the Funds&#8217; Custodian. The net amount of the excess, if any, of each Fund&#8217;s entitlements
over its obligations with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having
an aggregate value at least equal to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third
party custodian. Until a swap agreement is settled in cash, the gain or loss on the notional amount less any transaction costs or trading
spreads payable by each Fund on the notional amount are recorded as &#8220;unrealized appreciation or depreciation on swap agreements&#8221;
and, when cash is exchanged, the gain or loss realized is recorded as &#8220;realized gains or losses on swap agreements.&#8221; Swap
agreements are generally valued at the last settled price of the benchmark referenced asset.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">Swap agreements contain
various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default
on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in
an amount equal to the net positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction
with the same counterparty, enter into a transaction with a different counterparty or seek to achieve its investment objective through
any number of different investments or investment techniques.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">Swap agreements involve,
to varying degrees, elements of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts
reflect the extent of the total investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional
risks associated with the use of swap agreements are imperfect correlations between movements in the notional amount and the price of
the underlying reference Index and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected
to be received under a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically
enter into swap agreements only with major global financial institutions. The creditworthiness of each of the firms that is a party to
a swap agreement is monitored by the Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination
and payment, using different counterparties, limiting the net amount due from any individual counterparty and generally requiring collateral
to be posted by the counterparty in an amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually
terminate within one month but may be terminated without penalty by either party at any time. Upon termination, the Fund is obligated
to pay or receive the &#8220;unrealized appreciation or depreciation&#8221; amount.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">The Funds, as applicable,
collateralize swap agreements by segregating or designating cash and/or certain securities as indicated on the Statements of Financial
Condition or Schedules of Investments. As noted above, collateral posted in connection with OTC derivative transactions is held for the
benefit of the counterparty in a segregated tri-party account at the Custodian to protect the counterparty against non-payment by the
Funds. The collateral held in this account is restricted as to its use. In the event of a default by the counterparty, the Funds will
seek withdrawal of this collateral from the segregated account and may incur certain costs in exercising its right with respect to the
collateral. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, the Funds
may experience significant delays in obtaining any recovery in a bankruptcy or other reorganizational proceeding. The Funds may obtain
only limited recovery or may obtain no recovery in such circumstances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">The Funds remain subject
to credit risk with respect to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these
risks in connection with OTC swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit
of the Fund, marked to market daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum
thresholds. In the event of a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty,
generally as of the day prior to the bankruptcy, because there is a one day time lag between the Fund&#8217;s request for collateral and
the delivery of such collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as
described above, including the possible delays in recovering amounts as a result of bankruptcy proceedings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">The counterparty/credit
risk for cleared derivative transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted
for each counterparty to a cleared derivative contract and, in effect, guarantees the parties&#8217; performance under the contract as
each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative
transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>Fair Value of Derivative
Instruments as of September 30, 2022</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="5" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset
    Derivatives</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability
    Derivatives</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives
    Not Accounted<br/> for as Hedging Instruments</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements
    of <br/>
Financial Condition<br/> Location</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized<br/>
Appreciation</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements
of <br/>
Financial Condition<br/>
Location &#160;&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized<br/>
Depreciation</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables on open futures contracts, unrealized appreciation
    on swap agreements</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payable on open futures contracts, unrealized depreciation
    on swap agreements</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td/><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 20%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX
    Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 20%; text-align: right"/><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,577,769</span></td><td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)*</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 25%; text-align: right"/><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-26"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td style="width: 1%; text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; ">
    <td/><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"/><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,593,993</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-27; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 13.5pt"/><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Trust</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,296,435</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-28"/></td><td style="font-weight: bold; text-align: left">*</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b>&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>The Effect of Derivative
Instruments on the Statement of Operations</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>For the three months
ended September 30, 2022</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; padding: 0; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Derivatives Not Accounted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>for as Hedging Instruments</b></p></td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Location of Gain</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Loss) on Derivatives</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Recognized in Income</b></p></td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; text-indent: 0">Fund</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="3" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Realized
Gain<br/>
(Loss) on<br/>
Derivatives<br/>
Recognized in<br/>
Income</b></p></td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="3" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in<br/> Unrealized<br/>
                                                                                 Appreciation<br/> (Depreciation)<br/>
on</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Derivatives<br/>
Recognized in<br/>
Income</b></p></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">VIX Futures Contracts</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">Net realized gain (loss) on futures contracts and/or swap agreements/ changes in unrealized appreciation (depreciation) on futures contracts and/or swap agreements</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; width: 16%; text-indent: 0"/><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 38%; text-indent: 0"/><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 20%; text-align: left; text-indent: 0">-1x Short VIX Futures ETF</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">8,077,788</td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">(6,278,300</td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0"/><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-indent: 0"/><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">2x Long VIX Futures ETF</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">(22,686,414</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">20,574,735</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><b>&#160;</b></td><td style="padding: 0; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; text-indent: 0"><b>&#160;</b></td><td style="padding: 0; font-weight: bold; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; font-weight: bold; text-align: left; text-indent: 0"><b>Total Trust</b></td><td style="padding: 0; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; text-align: left; text-indent: 0"><b>$</b></td><td style="padding: 0; text-align: right; text-indent: 0"><b>(14,608,626</b></td><td style="padding: 0; text-align: left; text-indent: 0"><b>)</b></td><td style="padding: 0; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; text-align: left; text-indent: 0"><b>$</b></td><td style="padding: 0; text-align: right; text-indent: 0"><b>14,296,435</b></td><td style="padding: 0; text-align: left; text-indent: 0"><b>&#160;</b></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Offsetting Assets and Liabilities</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund is subject to master netting agreements
or similar arrangements that allow for amounts owed between each Fund and the counterparty to be netted upon an early termination. The
party that has the larger payable pays the excess of the larger amount over the smaller amount to the other party. The master netting
agreements or similar arrangements do not apply to amounts owed to/from different counterparties. As described above, the Funds utilize
derivative instruments to achieve their investment objective during the year. The amounts shown in the Statements of Financial Condition
do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">For financial reporting purposes, the Funds
do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition.
The following table presents each Fund&#8217;s derivatives by investment type and by counterparty net of amounts available for offset
under a master netting agreement and the related collateral received or pledged by the Funds as of September 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="19" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Values of Derivative Instruments as of September 30, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts<br/> of Recognized<br/> Assets presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts<br/> Offset in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net Amounts of Assets presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross Amounts<br/> of Recognized<br/> Liabilities<br/> presented <br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts<br/> Offset in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts of<br/> Liabilities<br/> presented <br/> in the<br/> Statements of<br/> Financial<br/> Condition</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">-1x Short VIX Futures ETF </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29"/></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"><div style="-sec-ix-hidden: hidden-fact-30"/></td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">774,721</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left"/><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">774,721</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,708,079</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">2,708,079</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">&#160;</div></td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">&#160;</div></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Asset (Liability) amounts shown in the table
below represent amounts owed to (by) the Funds for the derivative-related investments at September 30, 2022. These amounts may be collateralized
by cash or financial instruments, segregated for the benefit of the Funds or the counterparties, depending on whether the related contracts
are in an appreciated or depreciated position at period end. Amounts shown in the column labeled &#8220;Net Amount&#8221; represent the
uncollateralized portions of these amounts at period end. These amounts may be un-collateralized due to timing differences related to
market movements or due to minimum thresholds for collateral movement, as further described above under the caption &#8220;Accounting
for Derivative Instruments&#8221;.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross Amounts Not Offset in the Statements of Financial Condition as of September 30, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments<br/> for the<br/> Benefit of <br/> (the Funds) /<br/> the<br/> Counterparties</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>Cash Collateral<br/> for the Benefit<br/> of (the Funds) /<br/> the<br/> Counterparties</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net<br/> Amount</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(774,721</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: left">$</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: left">$</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(774,721</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,708,079</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,708,079</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140167010423856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AgreementsLineItems', window );"><strong>Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AgreementsDisclosureTextBlock', window );">AGREEMENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 4 &#8211; AGREEMENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Management Fee</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">SVIX pays the Sponsor a management fee (the &#8220;Management Fee&#8221;),
monthly in arrears, in an amount equal to <b>1.35</b>% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee,
monthly in arrears, in an amount equal to <b>1.65</b>% per annum of its average daily net assets. &#8220;Average daily net assets&#8221;
is calculated by dividing the month-end net assets of each Fund by the number of calendar&#160;days in such month.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">No other Management Fee is paid by the Funds. The Management Fee is
paid in consideration of the Sponsor&#8217;s trading advisory services and the other services provided to the Fund that the Sponsor pays
directly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Pursuant to the Sponsor Agreement between Sponsor and the Trust, on
behalf of the Funds, the Sponsor oversees and pays Milliman FRM (&#8220;Commodity Sub-Adviser&#8221;) for its services as Commodity Sub-Adviser.
The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory fee of 0.25% based on each Fund&#8217;s average daily net assets
(total assets of the Fund, minus the sum of its accrued liabilities). The commodity sub-advisory fee is waived for the first 6&#160;months
of each Fund&#8217;s operations or until a Fund reaches $35&#160;million in average daily net assets. The Funds do not directly pay the
Commodity Sub-Adviser.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Non-Recurring Fees and Expenses</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund pays all its non-recurring and unusual
fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses that are unexpected
or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material expenses which are not
currently anticipated obligations of the Funds.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>The Administrator, Transfer Agent and Custodian</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">U.S.&#160;Bancorp Fund Services, LLC, doing business as U.S.&#160;Bank
Global Fund Services (&#8220;Fund Services&#8221;), an indirect subsidiary of U.S.&#160;Bancorp, serves as the Fund&#8217;s fund accountant,
administrator and transfer agent pursuant to certain fund accounting servicing, fund administration servicing and transfer agent servicing
agreements. U.S.&#160;Bank National Association, a subsidiary of U.S.&#160;Bancorp and parent company of Fund Services, intends to serve
as the Fund&#8217;s custodian pursuant to a custody agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>The Marketing Agent</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Foreside Fund Services, LLC (the &#8220;Marketing Agent&#8221;) serves
as the Marketing Agent of the Funds. Its principal duties are: (i)&#160;to work with the Transfer Agent to review and approve orders placed
by Authorized Participants and transmitted to the Transfer Agent; (ii)&#160;maintain copies of confirmations of Creation Unit creation
and redemption order acceptances; (iii)&#160;maintain telephonic, facsimile and/or access to direct computer communications links with
the Transfer Agent; and (iv)&#160;review and approve, prior to use, all Trust marketing materials for compliance with applicable SEC and
FINRA advertising rules.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Marketing Agent retains all marketing materials separately for
the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As compensation for the services it provides, the Marketing Agent receives
a fee from the Funds.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AgreementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of agreements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AgreementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166928920528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Offering Costs<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OfferingCostsAbstract', window );"><strong>Offering Costs Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_OfferingCostsTextBlock', window );">OFFERING COSTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 5 &#8211; OFFERING COSTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Offering costs will be amortized by the Funds
over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge its Management
Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred in connection
with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_OfferingCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_OfferingCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_OfferingCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of offering costs .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_OfferingCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166929236912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Creation and Redemption of Creation Units<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Creation and Redemption of Creation Units [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">CREATION AND REDEMPTION OF CREATION UNITS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 6 &#8211; CREATION AND REDEMPTION
OF CREATION UNITS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund issues and redeems shares from time
to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares of a Fund. Creation Units may be
created or redeemed only by Authorized Participants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Except when aggregated in Creation Units,
the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares directly
from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of a broker.
Thus, some of the information contained in these Notes to Financial Statements&#8212;such as references to the Transaction Fees imposed
on purchases and redemptions is not relevant to retail investors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Transaction Fees on Creation and Redemption
Transactions</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The manner by which Creation Units are purchased
or redeemed is governed by the terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing
a purchase order, an Authorized Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its
sole discretion, enter into or arrange for an exchange of futures contract for related position or block trade with the relevant fund
whereby the Authorized Participant would also transfer to such Fund a number and type of exchange-traded futures contracts at or near
the closing settlement price for such contracts on the purchase order date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Authorized Participants may pay a fee up to
0.20% of the value of each order they place with each order to create or redeem a Creation Unit in order to compensate the Administrator,
the Custodian and the Transfer Agent of each Fund and its Shares, for services in processing the creation and redemption of Creation Units
and to offset the costs of increasing or decreasing derivative positions, unless the transaction fee is waived or otherwise adjusted by
the Sponsor. The Sponsor provides such Authorized Participant with prompt notice in advance of any such waiver or adjustment of the transaction
fee. Authorized Participants may sell the Shares included in the Creation Units they purchase from the Funds to other investors in the
secondary market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Transaction fees for the three months ended
September 30, 2022 were as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> September&#160;30, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">20,124</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">78,086</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">98,210</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166927586240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialHighlightsLineItems', window );"><strong>Financial Highlights Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">FINANCIAL HIGHLIGHTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 7 &#8211; FINANCIAL HIGHLIGHTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Selected data is for a Share outstanding throughout
the three months ended September 30, 2022</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.6pt; text-indent: -21.6pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">-1x Short VIX<br/>
Futures<br/>
ETF</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2x Long VIX<br/>
Futures<br/>
ETF</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September&#160;30, 2022<br/> (Unaudited)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September&#160;30, 2022<br/> (Unaudited)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Net Asset Value, Beginning of Period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;10.40</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">17.12</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.05</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.00</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3.20</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.06</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3.25</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10.34</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13.87</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-size: 10pt">Market Value Per Share, at September 30, 2022 <sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.40</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-0.58</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-18.97</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-0.87</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-18.21</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.34</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.35</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net Investment Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-2.06</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.93</td><td style="text-align: left">%</td></tr>
</table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds&#8217; net asset value is calculated.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages are not annualized for the period ended September 30, 2022. <b>&#160;</b></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages are annualized.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expense ratio would be 2.23% and 2.27% respectively, if brokerage commissions and futures and futures account fees were excluded.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FinancialHighlightsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FinancialHighlightsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI https://asc.fasb.org/topic&amp;trid=2126967<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL124452896-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166928938960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risk<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RiskLineItems', window );"><strong>Risk [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">RISK</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 8 &#8211; RISK</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Correlation and Compounding Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Funds do not seek to achieve their stated
investment objective over a period of time greater than a single day (as measured from NAV calculation time to NAV calculation time).
The return of a Fund for a period longer than a single day is the result of its return for each day compounded over the period and usually
will differ in amount and possibly even direction from the inverse (-1x) or two times (2x) the return of the Fund&#8217;s benchmark for
the period. A Fund will lose money if its benchmark performance is flat over time, and it is possible for a Fund to lose money over time
even if the performance of its benchmark increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing,
the benchmark&#8217;s volatility, compounding, and other factors. Compounding is the cumulative effect of applying investment gains and
losses and income to the principal amount invested over time. Gains or losses experienced over a given period will increase or reduce
the principal amount invested from which the subsequent period&#8217;s returns are calculated. The effects of compounding will likely
cause the performance of a Fund to differ from the Fund&#8217;s stated multiple times the return of its benchmark for the same period.
The effect of compounding becomes more pronounced as benchmark volatility and holding period increase. The impact of compounding will
impact each shareholder differently depending on the period of time an investment in a Fund is held and the volatility of the benchmark
during the holding period of an investment in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater
leverage each affect the impact of compounding on a Fund&#8217;s returns. Daily compounding of a Fund&#8217;s investment returns can dramatically
and adversely affect its longer-term performance during periods of high volatility. Volatility may be at least as important to a Fund&#8217;s
return for a period as the return of the Fund&#8217;s underlying benchmark.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund uses leverage and should produce
daily returns that are more volatile than that of its benchmark. For example, the daily return of UVIX should be approximately two times
as volatile on a daily basis as is the return of a fund with an objective of matching the same benchmark. The daily return of SVIX is
designed to return the inverse (-1x) of the return that would be expected of a fund with an objective of matching the same benchmark.
<b><i>The Funds are not appropriate for all investors and present significant risks not applicable to other types of funds. </i></b>The
Funds use leverage and are riskier than similarly benchmarked exchange-traded funds that do not use leverage. An investor should only
consider an investment in a Fund if he or she understands the consequences of seeking daily leveraged or daily inverse investment results.
Shareholders who invest in the Funds should actively manage and monitor their investments, as frequently as daily.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">While the Funds seek to meet their investment
objectives, there is no guarantee they will do so. Factors that may affect a Fund&#8217;s ability to meet its investment objective include:
(1) the Sponsor&#8217;s ability to purchase and sell Financial Instruments in a manner that correlates to a Fund&#8217;s objective; (2)
an imperfect correlation between the performance of Financial Instruments held by a Fund and the performance of the applicable benchmark;
(3) bid-ask spreads on such Financial Instruments; (4) fees, expenses, transaction costs, financing costs associated with the use of Financial
Instruments and commission costs; (5) holding or trading instruments in a market that has become illiquid or disrupted; (6) a Fund&#8217;s
Share prices being rounded to the nearest cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated
in advance; (8) the need to conform a Fund&#8217;s portfolio holdings to comply with investment restrictions or policies or regulatory
or tax law requirements; (9) early and unanticipated closings of the markets on which the holdings of a Fund trade, resulting in the inability
of the Fund to execute intended portfolio transactions; (10) accounting standards; and (11) differences caused by a Fund obtaining exposure
to only a representative sample of the components of a benchmark, over weighting or under weighting certain components of a benchmark
or obtaining exposure to assets that are not included in a benchmark.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">A number of factors may affect a Fund&#8217;s
ability to achieve a high degree of correlation with its benchmark, and there can be no guarantee that a Fund will achieve a high degree
of correlation. Failure to achieve a high degree of correlation may prevent a Fund from achieving its investment objective. In order to
achieve a high degree of correlation with their underlying benchmarks, the Funds seek to rebalance their portfolios daily to keep exposure
consistent with their investment objectives. Being materially under- or over-exposed to the benchmark may prevent such Funds from achieving
a high degree of correlation with such benchmark. Market disruptions or closure, large amounts of assets into or out of the Funds, regulatory
restrictions, extreme market volatility, and other factors will adversely affect such Funds&#8217; ability to adjust exposure to requisite
levels. The target amount of portfolio exposure is impacted dynamically by the benchmarks&#8217; movements during each day. Other things
being equal, more significant movement in the value of its benchmark up or down will require more significant adjustments to a Fund&#8217;s
portfolio. Because of this, it is unlikely that the Funds will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark
at the end of each day, and the likelihood of being materially under- or over-exposed is higher on days when the benchmark levels are
volatile near the close of the trading day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund seeks to rebalance its portfolio
on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending upon market conditions
and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios as frequently, each
Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate exposure to
the underlying benchmarks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Counterparty Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each Fund may use derivatives such as swap
agreements and forward contracts (collectively referred to herein as &#8220;derivatives&#8221;) in the manner described herein as a means
to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><span style="text-decoration:underline">Regulatory Treatment</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Derivatives are generally traded in OTC markets
and have only recently become subject to comprehensive regulation in the United States. Cash-settled forwards are generally regulated
as &#8220;swaps&#8221;, whereas physically settled forwards are generally not subject to regulation (in the case of commodities other
than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (&#8220;Title
VII&#8221;) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible
for the regulation of &#8220;security-based swaps.&#8221; The SEC requirements have largely yet to be made effective, but the CFTC requirements
are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage,
including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated
market participants, such as &#8220;swap dealers,&#8221; &#8220;security-based swap dealers,&#8221; &#8220;major swap participants,&#8221;
and &#8220;major security-based swap participants&#8221; who are, or will be, subject to significant new capital, registration, recordkeeping,
reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be
developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades
and the counterparties with which the Fund engages in transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">As noted, the CFTC rules may not apply to
all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection of CFTC
regulation or the statutory scheme of the Commodity Exchange Act (the &#8220;CEA&#8221;) in connection with each Fund&#8217;s swap agreements
or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain circumstances,
including in the event of trading abuses or financial failure by participants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><span style="text-decoration:underline">Counterparty Credit Risk</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Funds will be subject to the credit risk
of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing corporation
in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to the credit
risk of the counterparty to the transaction &#8211; typically a single bank or financial institution. As a result, a Fund is subject to
increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into as part of
that Fund&#8217;s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due
to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor&#8217;s investment in
a Fund may decline.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Funds have sought to mitigate these risks
by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily,
subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest in swap agreements
or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are delays in accessing
the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering amounts as
a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">OTC derivatives of the type that may be utilized
by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have uniform terms and
conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit support, such
as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various conditions,
events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms
of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to
the net positions owed to the party under the agreement. For example, if the level of the Fund&#8217;s benchmark has a dramatic intraday
move that would cause a material decline in the Fund&#8217;s NAV, the terms of the swap may permit the counterparty to immediately close
out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other
Financial Instruments necessary to achieve the desired exposure consistent with the Fund&#8217;s objective. This, in turn, may prevent
the Fund from achieving its investment objective, particularly if the level of the Fund&#8217;s benchmark reverses all or part of its
intraday move by the end of the day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">In addition, cleared derivatives benefit from
daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To the extent the
Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts, which are
required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap customer
collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions
but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default.
For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted
to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer
of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the
commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do
not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a &#8220;swap dealer&#8221;
with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions
because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing
the Funds to suffer a loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Sponsor regularly reviews the performance
of its counterparties for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers
the addition of new counterparties and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio
holdings as of the prior Business Day. Each Fund&#8217;s portfolio holdings identifies its counterparties, as applicable. This portfolio
holdings information may be accessed through the web on the Sponsor&#8217;s website at www.volatilityshares.com.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Each counterparty and/or any of its affiliates
may be an Authorized Participant or shareholder of a Fund, subject to applicable law.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The counterparty risk for cleared derivatives
transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and
is a Fund&#8217;s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative.
Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations
to a Fund.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Leverage Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Funds may utilize leverage in seeking
to achieve their respective investment objectives and will lose more money in market environments adverse to their respective daily investment
objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged positions increases the risk of total
loss of an investor&#8217;s investment, even over periods as short as a single day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">For example, because UVIX includes a two times
(2x) multiplier, a single-day movement in the relevant benchmark approaching 50% at any point in the day could result in the total loss
or almost total loss of an investor&#8217;s investment if that movement is contrary to the investment objective of the Fund in which an
investor has invested, even if such Fund&#8217;s benchmark subsequently moves in an opposite direction, eliminating all or a portion of
the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund or upward single-day
or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than zero at all times.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Liquidity Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Financial Instruments cannot always be liquidated
at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of buy and sell orders
in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract counterparty at
a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds may acquire increases
the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred while trying to
do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically invest in Financial
Instruments related to one benchmark, which in many cases is highly concentrated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#8220;Contango&#8221; and &#8220;Backwardation&#8221;
Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The Funds typically hold futures contracts.
As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for example, a
contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may be replaced
by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as &#8220;rolling.&#8221;
Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts
have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred
to as &#8220;backwardation.&#8221; In these circumstances, absent other factors, the sale of the January 2020 contract would take place
at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling.
While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not
exist in these markets at all times.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Since the introduction of VIX futures contracts,
there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in time. This can result
in a loss from &#8220;rolling&#8221; the VIX futures to maintain the constant weighted average maturity of the applicable Fund benchmark.
Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely affect
the value of a Fund and, accordingly, decrease the return of a Fund.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Natural Disaster/Epidemic Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Natural or environmental disasters, such as
earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease, including
pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and markets
and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster and
health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays,
shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding
results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of
infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment
opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy
of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely
impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual
companies (including, but not limited to, the Funds&#8217; Sponsor and third party service providers), sectors, industries, markets, securities
and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the
value of the Funds&#8217; investments. These factors can cause substantial market volatility, exchange trading suspensions and closures
and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary
market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long
such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact
on a Fund&#8217;s performance, resulting in losses to your investment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Risk that Current Assumptions and Expectations
Could Become Outdated As a Result of Global Economic Shocks</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">The onset of the novel coronavirus (COVID-19)
has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow and contain
the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies as economic
activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at least equal
to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market in the fastest
such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US, oil experienced
shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as of the date hereof
may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting in significant
losses.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_RiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_RiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166923035008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>NOTE 9 &#8211; SUBSEQUENT EVENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">Management has evaluated the possibility of
subsequent events existing in the Trust&#8217;s and the Funds&#8217; financial statements through the date the financial statements were
issued. Management has determined that there are no material events that would require disclosure in the Trust&#8217;s or the Funds&#8217;
financial statements through this date.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166923002512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging growth company</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
growth company</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Trust is an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act&#160;of&#160;2012. It will remain
an emerging growth company until the earlier of (1)&#160;the beginning of the first fiscal year following the fifth anniversary of its
initial public offering, (2)&#160;the beginning of the first fiscal year after annual gross revenue is $1.07&#160;billion (subject to
adjustment for inflation) or more, (3)&#160;the date on which the Fund has, during the previous three-year&#160;period, issued more than
$1.0&#160;billion in non-convertible&#160;debt securities and (4)&#160;as of the end of any fiscal year in which the market value of
common equity held by non-affiliates&#160;exceeded $700&#160;million as of the end of the second quarter of that fiscal year.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>For
as long as the Trust remains an &#8220;emerging growth company,&#8221; it may take advantage of certain exemptions from the various reporting
requirements that are applicable to public companies that are not &#8220;emerging growth companies&#8221; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley&#160;Act, reduced
disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions
from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden
parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an &#8220;emerging
growth company.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates &amp; Indemnifications</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Estimates &amp; Indemnifications</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications.
The Trust&#8217;s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Presentation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for
each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect
to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any
other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or
distributed to the Trust for the purchase of Shares in that Fund.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_StatementsOfCashFlowsPolicyTextBlock', window );">Statements of Cash Flows</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements
of Cash Flows</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated September
30, 2022, and represents cash, segregated cash balances with brokers for futures contracts, segregated cash with brokers for swap agreements
but does not include short-term investments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock', window );">Final Net Asset Value for Fiscal Period</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Final
Net Asset Value for Fiscal Period</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cut-off times and the times of the calculation of the Funds&#8217; final net asset value for creation and redemption of fund Shares for
the three months ended September 30, 2022 were typically as follows. All times are Eastern Standard Time:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Create/Redeem</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV Calculation</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; width: 52%; font-weight: bold">Fund</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Cut-off*(EST)</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Time (EST)</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Calculation Date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; text-align: left">-1x Short VIX Futures ETF and</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">2:00 p.m.</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">4:00 p.m.</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">September 30, 2022</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="white-space: nowrap; text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">2:00 p.m.</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">4:00 p.m.</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">September 30, 2022</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
                                            the Funds&#8217; shares may continue to trade on secondary markets subsequent to the calculation
                                            of the final NAV, these times represent the final opportunity to transact in creation or
                                            redemption units for the three months ended September 30, 2022.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
value per Share is determined at the close of Cboe BZX and may be later than when the Funds&#8217; NAV per Share is calculated.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly,
the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds&#8217;
final creation/redemption NAV for the three months ended September 30, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment Valuation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Valuation</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term
investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each
of these situations, valuations are typically categorized as Level I in the fair value hierarchy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivatives
(e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties
or other procedures as determined by the Sponsor. Futures contracts are generally valued at the last settled price on the applicable
exchange on which that future trades. For financial reporting purposes, all futures contracts are generally valued at the last settled
price. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically
categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as
the basis for determining the market value of such position. Such fair value prices would generally be determined based on available
inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor
deems fair and equitable so long as such principles are consistent with industry standards. The Sponsor may fair value an asset of a
Fund pursuant to the policies the Sponsor has adopted. Depending on the source and relevant significance of valuation inputs, these instruments
may be classified as Level II or Level III in the fair value hierarchy.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value pricing may require subjective determinations about the value of an investment. While the Funds&#8217; policies are intended to
result in a calculation of its respective Fund&#8217;s NAV that fairly reflects investment values as of the time of pricing, such Fund
cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that
a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or
distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the
differences could be material to the financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
Value of Financial Instruments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure
fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions
developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds&#8217; own assumptions
about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs).
The three levels defined by the disclosure requirements hierarchy are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
I &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability
to access at the measurement date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
II &#8211; Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or
indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for
identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the
asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means
(market-corroborated inputs).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
III &#8211; Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure
fair value to the extent that observable inputs are not available.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair
value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant
to the fair value measurement in its entirety.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly
decreased, as well as when circumstances indicate that a transaction is not orderly.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the valuation of investments at September 30, 2022 using the fair value hierarchy:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level I - Quoted Prices</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level II - Other Significant<br/> Observable Inputs</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Money Market Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Futures Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Foreign</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Currency</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Forward</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contracts</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Swap</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Agreements</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">-1x Short VIX Futures ETF </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">16,492,725</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(55,619,690</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">&#160;&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(39,126,965</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,236,527</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,584,120</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218,820,647</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Total Trust </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">47,729,252</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">131,964,430</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-24"/></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-25"/></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">179,693,682</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of
                                            Investments. Only current day&#8217;s variation margin is reported within the Statements
                                            of Financial Condition in receivable/payable on open futures.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnremittedEarningsInForeignInvestmentPolicy', window );">Investment Transactions and Related Income</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Transactions and Related Income</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily.
Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized
appreciation (depreciation) between periods are reflected in the Statements of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as
Interest Income in the Statement of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FloorBrokeragePolicy', window );">Brokerage Commissions and Futures Account Fees</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Brokerage
Commissions and Futures Account Fees</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (&#8220;NFA&#8221;)
fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities
for each Fund&#8217;s investment in U.S. Commodity Futures Trading Commission (&#8220;CFTC&#8221;) regulated investments. The effects
of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities
or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are
recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized
when the transaction is closed). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed
variable create/redeem fees collected by more than 0.04% and 0.09%, for SVIX and UVIX, respectively, of each Fund&#8217;s average net assets annually.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Federal Income Tax</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Federal
Income Tax</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly,
no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund&#8217;s Shares is required to take
into account its allocable share of its Fund&#8217;s income, gain, loss, deductions and other items for its Fund&#8217;s taxable year
ending with or within the beneficial owner&#8217;s taxable year.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since
then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income
tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is
reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing
basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary
based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for emerging growth company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of final net asset value for fiscal period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_StatementsOfCashFlowsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of statements of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_StatementsOfCashFlowsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FloorBrokeragePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the recognition and recording of fees paid to other broker dealers for executing trades. Broker-dealers often use other brokers to execute trades on their behalf. The trading broker-dealer becomes a customer of the executing broker-dealer and pays a floor brokerage fee. Such fees are paid periodically either directly to the executing broker-dealer or through a clearinghouse. These include fees paid to clearing brokers and market specialists.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=35710059&amp;loc=d3e41357-110954<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FloorBrokeragePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnremittedEarningsInForeignInvestmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for tax treatment of unremitted earnings in a foreign investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121829422&amp;loc=d3e41263-109329<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnremittedEarningsInForeignInvestmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166929284048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock', window );">Schedule of cut-off times and times of calculation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">Create/Redeem</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV Calculation</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">NAV</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; width: 52%; font-weight: bold">Fund</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Cut-off*(EST)</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Time (EST)</td><td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center">Calculation Date</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; text-align: left">-1x Short VIX Futures ETF and</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">2:00 p.m.</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">4:00 p.m.</td><td style="white-space: nowrap; text-align: center">&#160;</td>
    <td style="white-space: nowrap; text-align: center">September 30, 2022</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="white-space: nowrap; text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">2:00 p.m.</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">4:00 p.m.</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt">September 30, 2022</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; ">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of valuation of investments at using the fair value hierarchy</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level I - Quoted Prices</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level II - Other Significant<br/> Observable Inputs</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Money Market Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Futures Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Foreign</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Currency</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Forward</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contracts</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Swap</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Agreements</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">-1x Short VIX Futures ETF </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">16,492,725</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(55,619,690</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">&#160;&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">&#160;&#160;&#160;&#160;&#160;&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(39,126,965</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,236,527</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,584,120</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218,820,647</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Total Trust </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">47,729,252</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">131,964,430</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-24"/></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-25"/></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">179,693,682</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cut-off times and times of calculation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166924417232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Disclosure Text Block Supplement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of fair value of derivative instruments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="5" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset
    Derivatives</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liability
    Derivatives</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivatives
    Not Accounted<br/> for as Hedging Instruments</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements
    of <br/>
Financial Condition<br/> Location</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized<br/>
Appreciation</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements
of <br/>
Financial Condition<br/>
Location &#160;&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized<br/>
Depreciation</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIX Futures Contracts</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables on open futures contracts, unrealized appreciation
    on swap agreements</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payable on open futures contracts, unrealized depreciation
    on swap agreements</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td/><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 20%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX
    Futures ETF</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 20%; text-align: right"/><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,577,769</span></td><td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)*</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 25%; text-align: right"/><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-26"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></td><td style="width: 1%; text-align: left">*</td></tr>
  <tr style="vertical-align: bottom; ">
    <td/><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"/><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,593,993</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"/><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-27; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 13.5pt"/><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Trust</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,296,435</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-28"/></td><td style="font-weight: bold; text-align: left">*</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "><b>&#160;</b>&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of effect of derivative instruments on the statement of operations</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; padding: 0; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Derivatives Not Accounted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>for as Hedging Instruments</b></p></td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Location of Gain</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Loss) on Derivatives</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Recognized in Income</b></p></td><td style="padding: 0; font-weight: bold; text-indent: 0">&#160;</td>
    <td style="padding: 0; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; text-indent: 0">Fund</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="3" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Realized
Gain<br/>
(Loss) on<br/>
Derivatives<br/>
Recognized in<br/>
Income</b></p></td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td colspan="3" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Change in<br/> Unrealized<br/>
                                                                                 Appreciation<br/> (Depreciation)<br/>
on</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Derivatives<br/>
Recognized in<br/>
Income</b></p></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">VIX Futures Contracts</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">Net realized gain (loss) on futures contracts and/or swap agreements/ changes in unrealized appreciation (depreciation) on futures contracts and/or swap agreements</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0">&#160;</td>
    <td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; width: 16%; text-indent: 0"/><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 38%; text-indent: 0"/><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 20%; text-align: left; text-indent: 0">-1x Short VIX Futures ETF</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">8,077,788</td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; width: 1%; text-indent: 0">&#160;</td>
    <td style="padding: 0; width: 1%; text-align: left; text-indent: 0">$</td><td style="padding: 0; width: 9%; text-align: right; text-indent: 0">(6,278,300</td><td style="padding: 0; width: 1%; text-align: left; text-indent: 0">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0; text-indent: 0"/><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-indent: 0"/><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">2x Long VIX Futures ETF</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">(22,686,414</td><td style="padding: 0; text-align: left; text-indent: 0">)</td><td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-align: left; text-indent: 0">&#160;</td><td style="padding: 0; text-align: right; text-indent: 0">20,574,735</td><td style="padding: 0; text-align: left; text-indent: 0">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0; text-indent: 0"><b>&#160;</b></td><td style="padding: 0; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; text-indent: 0"><b>&#160;</b></td><td style="padding: 0; font-weight: bold; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; font-weight: bold; text-align: left; text-indent: 0"><b>Total Trust</b></td><td style="padding: 0; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; text-align: left; text-indent: 0"><b>$</b></td><td style="padding: 0; text-align: right; text-indent: 0"><b>(14,608,626</b></td><td style="padding: 0; text-align: left; text-indent: 0"><b>)</b></td><td style="padding: 0; text-indent: 0"><b>&#160;</b></td>
    <td style="padding: 0; text-align: left; text-indent: 0"><b>$</b></td><td style="padding: 0; text-align: right; text-indent: 0"><b>14,296,435</b></td><td style="padding: 0; text-align: left; text-indent: 0"><b>&#160;</b></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock', window );">Schedule of pledged by funds fair values of derivative instruments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="19" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Values of Derivative Instruments as of September 30, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts<br/> of Recognized<br/> Assets presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts<br/> Offset in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net Amounts of Assets presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross Amounts<br/> of Recognized<br/> Liabilities<br/> presented <br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts<br/> Offset in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Amounts of<br/> Liabilities<br/> presented <br/> in the<br/> Statements of<br/> Financial<br/> Condition</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">-1x Short VIX Futures ETF </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29"/></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"><div style="-sec-ix-hidden: hidden-fact-30"/></td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">774,721</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left"/><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">774,721</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,708,079</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">2,708,079</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">&#160;</div></td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">&#160;</div></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of gross amounts not offset in the statements of financial condition</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross Amounts Not Offset in the Statements of Financial Condition as of September 30, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments<br/> for the<br/> Benefit of <br/> (the Funds) /<br/> the<br/> Counterparties</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>Cash Collateral<br/> for the Benefit<br/> of (the Funds) /<br/> the<br/> Counterparties</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net<br/> Amount</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(774,721</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: left">$</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: left">$</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(774,721</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2x Long VIX Futures ETF</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,708,079</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,708,079</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of pledged by funds fair values of derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166929454576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Creation and Redemption of Creation Units (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Creation and Redemption of Creation Units [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ScheduleOfTransactionFeesTableTextBlock', window );">Schedule of transaction fees</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> September&#160;30, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">20,124</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">78,086</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">98,210</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ScheduleOfTransactionFeesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of transaction fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ScheduleOfTransactionFeesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166929469280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ScheduleOfShareOutstandingTableTextBlock', window );">Schedule of share outstanding</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">-1x Short VIX<br/>
Futures<br/>
ETF</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2x Long VIX<br/>
Futures<br/>
ETF</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Quarter Ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September&#160;30, 2022<br/> (Unaudited)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September&#160;30, 2022<br/> (Unaudited)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Net Asset Value, Beginning of Period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;10.40</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">17.12</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-size: 10pt">Net investment loss <sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.05</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.00</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3.20</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.06</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3.25</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">10.34</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13.87</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-size: 10pt">Market Value Per Share, at September 30, 2022 <sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.40</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Total Return at Net Asset Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-0.58</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-18.97</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Total Return at Market Value <sup>(4)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-0.87</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-18.21</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(5)</sup></b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">Expense ratio <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.34</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.35</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net Investment Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-2.06</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1.93</td><td style="text-align: left">%</td></tr>
</table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds&#8217; net asset value is calculated.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages are not annualized for the period ended September 30, 2022. <b>&#160;</b></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages are annualized.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expense ratio would be 2.23% and 2.27% respectively, if brokerage commissions and futures and futures account fees were excluded.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ScheduleOfShareOutstandingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of share outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ScheduleOfShareOutstandingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166923098176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossRevenue', window );">Annual gross revenue</a></td>
<td class="nump">$ 1,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NonconvertibleDebtSecurities', window );">Non-convertible debt securities</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NonaffiliatesExceeded', window );">Non-affiliates exceeded</a></td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cik0001793497_SVIXMember', window );">SVIX [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FundsAverageNetAssetsAnnually', window );">Fund&#8217;s average net assets annually</a></td>
<td class="nump">0.04%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cik0001793497_UVIXMember', window );">UVIX [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FundsAverageNetAssetsAnnually', window );">Fund&#8217;s average net assets annually</a></td>
<td class="nump">0.09%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FundsAverageNetAssetsAnnually">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FundsAverageNetAssetsAnnually</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_GrossRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gross revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_GrossRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NonaffiliatesExceeded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-affiliates exceeded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NonaffiliatesExceeded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NonconvertibleDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-convertible debt securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NonconvertibleDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cik0001793497_SVIXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cik0001793497_SVIXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cik0001793497_UVIXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cik0001793497_UVIXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166925337472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr><th class="th" colspan="2"><div>Sep. 30, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreateRedeemCutoffDescription', window );">Create/Redeem Cut-off (EST)</a></td>
<td class="text">2:00 p.m.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NAVCalculationTimeESTDescription', window );">NAV Calculation Time (EST)</a></td>
<td class="text">4:00 p.m.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NAVCalculationDate', window );">NAV Calculation Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreateRedeemCutoffDescription', window );">Create/Redeem Cut-off (EST)</a></td>
<td class="text">2:00 p.m.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NAVCalculationTimeESTDescription', window );">NAV Calculation Time (EST)</a></td>
<td class="text">4:00 p.m.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NAVCalculationDate', window );">NAV Calculation Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Although the Funds&#8217; shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended September 30, 2022.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CreateRedeemCutoffDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Create/Redeem Cut-off (EST) 2x Long VIX Futures ETF, description</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CreateRedeemCutoffDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NAVCalculationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the NAV calculation date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NAVCalculationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NAVCalculationTimeESTDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>NAV Calculation Time (EST), description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NAVCalculationTimeESTDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166923899408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy<br></strong></div></th>
<th class="th" colspan="2">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="nump">$ 179,693,682<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="num">(39,126,965)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="nump">218,820,647<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I - Quoted Prices [Member] | Money Market Fund [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="nump">47,729,252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I - Quoted Prices [Member] | Money Market Fund [Member] | -1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="nump">16,492,725<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I - Quoted Prices [Member] | Money Market Fund [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="nump">31,236,527<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I - Quoted Prices [Member] | Futures Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="nump">131,964,430<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I - Quoted Prices [Member] | Futures Contracts [Member] | -1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="num">(55,619,690)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level I - Quoted Prices [Member] | Futures Contracts [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="nump">187,584,120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II - Other Significant Observable Inputs [Member] | Foreign Currency Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II - Other Significant Observable Inputs [Member] | Foreign Currency Forward Contracts [Member] | -1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II - Other Significant Observable Inputs [Member] | Foreign Currency Forward Contracts [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II - Other Significant Observable Inputs [Member] | Swap Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II - Other Significant Observable Inputs [Member] | Swap Agreements [Member] | -1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level II - Other Significant Observable Inputs [Member] | Swap Agreements [Member] | 2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems', window );"><strong>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountOfTotalTrust', window );">Total Trust</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AmountOfTotalTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of trust.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AmountOfTotalTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=cik0001793497_FuturesContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=cik0001793497_FuturesContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=cik0001793497_ForeignCurrencyForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=cik0001793497_ForeignCurrencyForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=cik0001793497_SwapAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=cik0001793497_SwapAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166925659200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Details) - Schedule of fair value of derivative instruments<br></strong></div></th>
<th class="th" colspan="2">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember', window );">Asset Derivatives [Member] | Unrealized Appreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust', window );">Total Trust</a></td>
<td class="nump">$ 14,296,435<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember', window );">Asset Derivatives [Member] | -1x Short VIX Futures ETF [Member] | Unrealized Appreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust', window );">Total Trust</a></td>
<td class="num">(5,577,769)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember', window );">Asset Derivatives [Member] | 2x Long VIX Futures ETF [Mmeber] | Unrealized Appreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust', window );">Total Trust</a></td>
<td class="nump">20,593,993<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember', window );">Liability Derivatives [Member] | Unrealized Depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust', window );">Total Trust</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember', window );">Liability Derivatives [Member] | -1x Short VIX Futures ETF [Member] | Unrealized Depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust', window );">Total Trust</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember', window );">Liability Derivatives [Member] | 2x Long VIX Futures ETF [Mmeber] | Unrealized Depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_TotalTrust', window );">Total Trust</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day&#8217;s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_TotalTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Trust amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_TotalTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_AssetDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=cik0001793497_UnrealizedAppreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesPeriodPastDueAxis=cik0001793497_UnrealizedAppreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=cik0001793497_LiabilityDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=cik0001793497_UnrealizedDepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesPeriodPastDueAxis=cik0001793497_UnrealizedDepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166923099168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - Schedule of effect of derivative instruments on the statement of operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems', window );"><strong>Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesRealizedGainLoss', window );">Realized Gain (Loss) on Derivatives Recognized in Income</a></td>
<td class="num">$ (14,608,626)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome', window );">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</a></td>
<td class="nump">14,296,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems', window );"><strong>Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesRealizedGainLoss', window );">Realized Gain (Loss) on Derivatives Recognized in Income</a></td>
<td class="nump">8,077,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome', window );">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</a></td>
<td class="num">(6,278,300)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoXLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems', window );"><strong>Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesRealizedGainLoss', window );">Realized Gain (Loss) on Derivatives Recognized in Income</a></td>
<td class="num">(22,686,414)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome', window );">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</a></td>
<td class="nump">$ 20,574,735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OnexShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoXLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoXLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166925276416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - Schedule of pledged by funds fair values of derivative instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member] | Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems', window );"><strong>Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts of Recognized Assets presented in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts Offset in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition', window );">Net Amounts of Assets presented in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member] | Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems', window );"><strong>Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts of Recognized Assets presented in the Statements of Financial Condition</a></td>
<td class="nump">774,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts Offset in the Statements of Financial Condition</a></td>
<td class="nump">774,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition', window );">Net Amounts of Assets presented in the Statements of Financial Condition</a></td>
<td class="nump">774,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member] | Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems', window );"><strong>Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts of Recognized Assets presented in the Statements of Financial Condition</a></td>
<td class="nump">2,708,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts Offset in the Statements of Financial Condition</a></td>
<td class="nump">2,708,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition', window );">Net Amounts of Assets presented in the Statements of Financial Condition</a></td>
<td class="nump">2,708,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member] | Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems', window );"><strong>Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts of Recognized Assets presented in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition', window );">Gross Amounts Offset in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition', window );">Net Amounts of Assets presented in the Statements of Financial Condition</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gross amounts of recognized assets presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net assets presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166924944128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems', window );"><strong>Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne', window );">Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition</a></td>
<td class="num">$ (774,721)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo', window );">Financial Instruments for the Benefit of (the Funds) / the Counterparties</a></td>
<td class="num">(774,721)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems', window );"><strong>Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne', window );">Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition</a></td>
<td class="nump">2,708,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo', window );">Financial Instruments for the Benefit of (the Funds) / the Counterparties</a></td>
<td class="nump">$ 2,708,079<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sales price you receive with any selling costs you paid deducted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166923884272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Agreements (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AgreementsDetailsLineItems', window );"><strong>Agreements (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_SubadvisoryFeeRate', window );">Sub-advisory fee rate</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AverageDailyNetAssets', window );">Average daily net assets (in Dollars)</a></td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cik0001793497_SVIXMember', window );">SVIX [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AgreementsDetailsLineItems', window );"><strong>Agreements (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AverageDailyNetAssetsRate', window );">Average daily net assets rate</a></td>
<td class="nump">1.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cik0001793497_UVIXMember', window );">UVIX [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AgreementsDetailsLineItems', window );"><strong>Agreements (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AverageDailyNetAssetsRate', window );">Average daily net assets rate</a></td>
<td class="nump">1.65%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AgreementsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AgreementsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AverageDailyNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average daily net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AverageDailyNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AverageDailyNetAssetsRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average daily net assets rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AverageDailyNetAssetsRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_SubadvisoryFeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of sub-advisory fee rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_SubadvisoryFeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cik0001793497_SVIXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cik0001793497_SVIXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cik0001793497_UVIXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cik0001793497_UVIXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166928155472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Creation and Redemption of Creation Units (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Creation and Redemption of Creation Units [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares of fund</a></td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_AuthorizedParticipantsPercentage', window );">Authorized participants percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_AuthorizedParticipantsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of authorized participants percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_AuthorizedParticipantsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166925379344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Creation and Redemption of Creation Units (Details) - Schedule of transaction fees<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems', window );"><strong>Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Total Trust</a></td>
<td class="nump">$ 98,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems', window );"><strong>Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Total Trust</a></td>
<td class="nump">20,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems', window );"><strong>Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Total Trust</a></td>
<td class="nump">$ 78,086<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166923217888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Highlights (Details) - Schedule of share outstanding<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Sep. 30, 2022 </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember', window );">-1x Short VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems', window );"><strong>Financial Highlights (Details) - Schedule of share outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net Asset Value, Beginning of Period</a></td>
<td class="nump">$ 10.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare', window );">Net investment loss</a></td>
<td class="num">(0.06)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts', window );">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease', window );">Net Increase (Decrease) in Net Asset Value Resulting from Operations</a></td>
<td class="num">(0.06)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net Asset Value, End of Period</a></td>
<td class="nump">10.34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_MarketValuePerShare', window );">Market Value Per Share, at September 30, 2022</a></td>
<td class="nump">$ 10.52<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTotalReturn', window );">Total Return at Net Asset Value</a></td>
<td class="num">(0.58%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentCompanyTotalReturnMarketValue', window );">Total Return at Market Value</a></td>
<td class="num">(0.87%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RatiosToAverageNetAssets5Abstract', window );"><strong>Ratios to Average Net Assets: (5)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation', window );">Expense ratio</a></td>
<td class="nump">2.34%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio', window );">Net Investment Loss</a></td>
<td class="num">(2.06%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember', window );">2x Long VIX Futures ETF [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems', window );"><strong>Financial Highlights (Details) - Schedule of share outstanding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net Asset Value, Beginning of Period</a></td>
<td class="nump">$ 17.12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare', window );">Net investment loss</a></td>
<td class="num">(0.05)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts', window );">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts</a></td>
<td class="num">(3.2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease', window );">Net Increase (Decrease) in Net Asset Value Resulting from Operations</a></td>
<td class="num">(3.25)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">Net Asset Value, End of Period</a></td>
<td class="nump">13.87<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_MarketValuePerShare', window );">Market Value Per Share, at September 30, 2022</a></td>
<td class="nump">$ 13.4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyTotalReturn', window );">Total Return at Net Asset Value</a></td>
<td class="num">(18.97%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_InvestmentCompanyTotalReturnMarketValue', window );">Total Return at Market Value</a></td>
<td class="num">(18.21%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RatiosToAverageNetAssets5Abstract', window );"><strong>Ratios to Average Net Assets: (5)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation', window );">Expense ratio</a></td>
<td class="nump">2.35%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio', window );">Net Investment Loss</a></td>
<td class="num">(1.93%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds&#8217; net asset value is calculated.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Percentages are not annualized for the period ended September 30, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages are annualized.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expense ratio would be 2.23% and 2.27% respectively, if brokerage commissions and futures and futures account fees were excluded.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_InvestmentCompanyTotalReturnMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage increase (decrease) in fund market value, assuming reinvestment of dividends and capital gain distributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_InvestmentCompanyTotalReturnMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_MarketValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share excess of market value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_MarketValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment, and future contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_RatiosToAverageNetAssets5Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_RatiosToAverageNetAssets5Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of expense, after incentive allocation, to average net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10342-115837<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10246-115837<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyInvestmentIncomeLossRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of investment income (loss) to average net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10328-115837<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyInvestmentIncomeLossRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit amount of increase (decrease) in net asset value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10246-115837<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyTotalReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10411-115837<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10396-115837<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10403-115837<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyTotalReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 35<br> -Paragraph 54B<br> -URI https://asc.fasb.org/extlink&amp;oid=126972413&amp;loc=SL7495116-110257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10246-115837<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=25866437&amp;loc=d3e10246-115837<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL6742756-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 35<br> -Paragraph 59<br> -URI https://asc.fasb.org/extlink&amp;oid=126972413&amp;loc=SL6740821-110257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_OneShortVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cik0001793497_TwoxLongVIXFuturesETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140166929428592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risk (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cik0001793497_RelevantBenchmark', window );">Relevant benchmark</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cik0001793497_RelevantBenchmark">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of relevant benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cik0001793497_RelevantBenchmark</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cik0001793497_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>f10q0922_vstrust_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cik0001793497="http://www.vts.com/20220930"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cik0001793497-20220930.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:FirstAmericanFundsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:FirstAmericanFundsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cik0001793497:ExpiringJulyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cik0001793497:ExpiringAugustTwoThousandTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:FirstAmericanFundsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:FirstAmericanFundsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cik0001793497:ExpiringJulyTwoThousandTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cik0001793497:ExpiringAugustTwoThousandTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cik0001793497:CBOEVIXFuturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cik0001793497:SVIXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cik0001793497:UVIXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:ForeignCurrencyForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:SwapAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:ForeignCurrencyForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:SwapAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:FuturesContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:ForeignCurrencyForwardContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">cik0001793497:SwapAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedAppreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedAppreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:AssetDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedAppreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cik0001793497:LiabilityDerivativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">cik0001793497:UnrealizedDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OnexShortVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoXLongVIXFuturesETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:OneShortVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cik0001793497:TwoxLongVIXFuturesETFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cik0001793497:SVIXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001793497</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cik0001793497:UVIXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c0">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0">001-34200</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">VS Trust</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0">84-6704517</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0">2000 PGA Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0">Suite 4440</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0">Palm Beach Gardens</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0">33408</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">(866)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">261-0273</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c1">-1x Short VIX Futures ETF</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c1">SVIX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c2">CboeBZX</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c2">2x Long VIX Futures ETF</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c2">UVIX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c1">CboeBZX</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness contextRef="c0">true</dei:EntitySmallBusiness>
    <dei:EntityExTransitionPeriod contextRef="c0">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="c0">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">12140000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c4" decimals="0" unitRef="usd">16492725</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c5" decimals="0" unitRef="usd">31236527</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InterestReceivable contextRef="c4" decimals="0" unitRef="usd">22965</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable contextRef="c5" decimals="0" unitRef="usd">69844</us-gaap:InterestReceivable>
    <cik0001793497:ReceivableForSharesSold contextRef="c4" decimals="0" unitRef="usd">4444910</cik0001793497:ReceivableForSharesSold>
    <us-gaap:CommodityContractAssetCurrent contextRef="c4" decimals="0" unitRef="usd">36207427</us-gaap:CommodityContractAssetCurrent>
    <us-gaap:CommodityContractAssetCurrent contextRef="c5" decimals="0" unitRef="usd">56663638</us-gaap:CommodityContractAssetCurrent>
    <cik0001793497:VariationMarginReceivable contextRef="c5" decimals="0" unitRef="usd">2708079</cik0001793497:VariationMarginReceivable>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c4" decimals="0" unitRef="usd">1333</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent contextRef="c5" decimals="0" unitRef="usd">3727069</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:Assets contextRef="c4" decimals="0" unitRef="usd">57169361</us-gaap:Assets>
    <us-gaap:Assets contextRef="c5" decimals="0" unitRef="usd">94405157</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c4" decimals="0" unitRef="usd">774721</us-gaap:AccountsPayableCurrent>
    <us-gaap:DueToOtherRelatedPartiesClassifiedCurrent contextRef="c4" decimals="0" unitRef="usd">575655</us-gaap:DueToOtherRelatedPartiesClassifiedCurrent>
    <us-gaap:DueToOtherRelatedPartiesClassifiedCurrent contextRef="c5" decimals="0" unitRef="usd">264682</us-gaap:DueToOtherRelatedPartiesClassifiedCurrent>
    <us-gaap:ManagementFeePayable contextRef="c4" decimals="0" unitRef="usd">44372</us-gaap:ManagementFeePayable>
    <us-gaap:ManagementFeePayable contextRef="c5" decimals="0" unitRef="usd">177469</us-gaap:ManagementFeePayable>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c4" decimals="0" unitRef="usd">38976</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c5" decimals="0" unitRef="usd">49916</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="c4" decimals="0" unitRef="usd">70547</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="c5" decimals="0" unitRef="usd">71973</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <cik0001793497:LicensingAndRegistrationFeesPayable contextRef="c4" decimals="0" unitRef="usd">50564</cik0001793497:LicensingAndRegistrationFeesPayable>
    <cik0001793497:LicensingAndRegistrationFeesPayable contextRef="c5" decimals="0" unitRef="usd">58460</cik0001793497:LicensingAndRegistrationFeesPayable>
    <us-gaap:Liabilities contextRef="c4" decimals="0" unitRef="usd">1554835</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c5" decimals="0" unitRef="usd">622499</us-gaap:Liabilities>
    <us-gaap:AssetsNet contextRef="c4" decimals="0" unitRef="usd">55614526</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" unitRef="usd">93782658</us-gaap:AssetsNet>
    <us-gaap:AdditionalPaidInCapital contextRef="c4" decimals="0" unitRef="usd">-58167050</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c5" decimals="0" unitRef="usd">-89025195</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="0" unitRef="usd">2552524</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c5" decimals="0" unitRef="usd">-4757463</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AssetsNet contextRef="c4" decimals="0" unitRef="usd">55614526</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" unitRef="usd">93782658</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c4" decimals="0" unitRef="usd">55614526</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" unitRef="usd">93782658</us-gaap:AssetsNet>
    <us-gaap:NetAssetValuePerShare contextRef="c4" decimals="2" unitRef="usdPershares">10.34</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare contextRef="c5" decimals="2" unitRef="usdPershares">13.87</us-gaap:NetAssetValuePerShare>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c4" decimals="0" unitRef="usd">16492725</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c5" decimals="0" unitRef="usd">31236527</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InterestAndOtherIncome contextRef="c6" decimals="0" unitRef="usd">43411</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c7" decimals="0" unitRef="usd">126917</us-gaap:InterestAndOtherIncome>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c7" decimals="0" unitRef="usd">7</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InvestmentIncomeNet contextRef="c6" decimals="0" unitRef="usd">43411</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c7" decimals="0" unitRef="usd">126924</us-gaap:InvestmentIncomeNet>
    <us-gaap:ManagementFeeExpense contextRef="c6" decimals="0" unitRef="usd">146457</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c7" decimals="0" unitRef="usd">464768</us-gaap:ManagementFeeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c6" decimals="0" unitRef="usd">15331</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c7" decimals="0" unitRef="usd">25723</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ProfessionalFees contextRef="c6" decimals="0" unitRef="usd">80462</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c7" decimals="0" unitRef="usd">81792</us-gaap:ProfessionalFees>
    <us-gaap:LegalFees contextRef="c6" decimals="0" unitRef="usd">27963</us-gaap:LegalFees>
    <us-gaap:LegalFees contextRef="c7" decimals="0" unitRef="usd">34070</us-gaap:LegalFees>
    <us-gaap:FloorBrokerageExchangeAndClearanceFees contextRef="c6" decimals="0" unitRef="usd">4038</us-gaap:FloorBrokerageExchangeAndClearanceFees>
    <us-gaap:FloorBrokerageExchangeAndClearanceFees contextRef="c7" decimals="0" unitRef="usd">16295</us-gaap:FloorBrokerageExchangeAndClearanceFees>
    <us-gaap:CostsAndExpenses contextRef="c6" decimals="0" unitRef="usd">274252</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c7" decimals="0" unitRef="usd">622647</us-gaap:CostsAndExpenses>
    <us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff contextRef="c6" decimals="0" unitRef="usd">230841</us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff>
    <us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff contextRef="c7" decimals="0" unitRef="usd">495724</us-gaap:NetInvestmentInLeaseAccruedInterestWriteoff>
    <cik0001793497:FuturesContracts contextRef="c6" decimals="0" unitRef="usd">-8077788</cik0001793497:FuturesContracts>
    <cik0001793497:FuturesContracts contextRef="c7" decimals="0" unitRef="usd">22686414</cik0001793497:FuturesContracts>
    <cik0001793497:FuturesContractsUnrealizedAppreciation contextRef="c6" decimals="0" unitRef="usd">6278300</cik0001793497:FuturesContractsUnrealizedAppreciation>
    <cik0001793497:FuturesContractsUnrealizedAppreciation contextRef="c7" decimals="0" unitRef="usd">-20574735</cik0001793497:FuturesContractsUnrealizedAppreciation>
    <us-gaap:UnrealizedGainLossOnEnergyContracts contextRef="c6" decimals="0" unitRef="usd">1799488</us-gaap:UnrealizedGainLossOnEnergyContracts>
    <us-gaap:UnrealizedGainLossOnEnergyContracts contextRef="c7" decimals="0" unitRef="usd">-2111678</us-gaap:UnrealizedGainLossOnEnergyContracts>
    <us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease contextRef="c6" decimals="0" unitRef="usd">1568647</us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease contextRef="c7" decimals="0" unitRef="usd">-2607402</us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease>
    <us-gaap:GainLossOnInvestments contextRef="c6" decimals="0" unitRef="usd">-230841</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c7" decimals="0" unitRef="usd">-495724</us-gaap:GainLossOnInvestments>
    <us-gaap:RealizedInvestmentGainsLosses contextRef="c6" decimals="0" unitRef="usd">8077788</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses contextRef="c7" decimals="0" unitRef="usd">-22686414</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c6" decimals="0" unitRef="usd">-6278300</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c7" decimals="0" unitRef="usd">20574735</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease contextRef="c6" decimals="0" unitRef="usd">1568647</us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease contextRef="c7" decimals="0" unitRef="usd">-2607402</us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease>
    <cik0001793497:SharesSoldinShares contextRef="c6" decimals="0" unitRef="usd">-37128501</cik0001793497:SharesSoldinShares>
    <cik0001793497:SharesSoldinShares contextRef="c7" decimals="0" unitRef="usd">-148158278</cik0001793497:SharesSoldinShares>
    <cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare contextRef="c6" decimals="0" unitRef="usd">29971993</cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare>
    <cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare contextRef="c7" decimals="0" unitRef="usd">112204673</cik0001793497:SharesSoldNetOfSharesRedeemedinDollarsPerShare>
    <cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions contextRef="c6" decimals="0" unitRef="usd">7156508</cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions>
    <cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions contextRef="c7" decimals="0" unitRef="usd">35953605</cik0001793497:NetIncreaseInNetAssetsFromCapitalShareTransactions>
    <us-gaap:InvestmentCompanyNetAssetsPeriodIncreaseDecrease contextRef="c6" decimals="0" unitRef="usd">8725155</us-gaap:InvestmentCompanyNetAssetsPeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetsPeriodIncreaseDecrease contextRef="c7" decimals="0" unitRef="usd">33346203</us-gaap:InvestmentCompanyNetAssetsPeriodIncreaseDecrease>
    <us-gaap:AssetsNet contextRef="c8" decimals="0" unitRef="usd">46889371</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c9" decimals="0" unitRef="usd">60436455</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c4" decimals="0" unitRef="usd">55614526</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" unitRef="usd">93782658</us-gaap:AssetsNet>
    <us-gaap:NetIncomeLoss contextRef="c6" decimals="0" unitRef="usd">1568647</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="0" unitRef="usd">-2607402</us-gaap:NetIncomeLoss>
    <cik0001793497:PurchasesOfInvestments contextRef="c6" decimals="0" unitRef="usd">73580457</cik0001793497:PurchasesOfInvestments>
    <cik0001793497:PurchasesOfInvestments contextRef="c7" decimals="0" unitRef="usd">189402007</cik0001793497:PurchasesOfInvestments>
    <cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments contextRef="c6" decimals="0" unitRef="usd">65379064</cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments>
    <cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments contextRef="c7" decimals="0" unitRef="usd">175315240</cik0001793497:ProceedsFromSalesOrMaturitiesOfInvestments>
    <us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding contextRef="c6" decimals="0" unitRef="usd">-3665556</us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding>
    <us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding contextRef="c7" decimals="0" unitRef="usd">16108875</us-gaap:IncreaseDecreaseInEarnestMoneyDepositsOutstanding>
    <cik0001793497:DecreaseIncreaseInVariationMarginReceivable contextRef="c7" decimals="0" unitRef="usd">1274983</cik0001793497:DecreaseIncreaseInVariationMarginReceivable>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c6" decimals="0" unitRef="usd">13363</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="c7" decimals="0" unitRef="usd">57469</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c6" decimals="0" unitRef="usd">1333</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseDueFromOtherRelatedParties contextRef="c7" decimals="0" unitRef="usd">4743330</us-gaap:IncreaseDecreaseDueFromOtherRelatedParties>
    <cik0001793497:IncreaseDecreaseInVariationMarginPayable contextRef="c6" decimals="0" unitRef="usd">191690</cik0001793497:IncreaseDecreaseInVariationMarginPayable>
    <cik0001793497:IncreaseDecreaseInDueToCustodian contextRef="c6" decimals="0" unitRef="usd">575655</cik0001793497:IncreaseDecreaseInDueToCustodian>
    <cik0001793497:IncreaseDecreaseInDueToCustodian contextRef="c7" decimals="0" unitRef="usd">264682</cik0001793497:IncreaseDecreaseInDueToCustodian>
    <cik0001793497:IncreaseDecreaseInPayableToSponsor contextRef="c6" decimals="0" unitRef="usd">17753</cik0001793497:IncreaseDecreaseInPayableToSponsor>
    <cik0001793497:IncreaseDecreaseInPayableToSponsor contextRef="c7" decimals="0" unitRef="usd">-107134</cik0001793497:IncreaseDecreaseInPayableToSponsor>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c6" decimals="0" unitRef="usd">16555</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c7" decimals="0" unitRef="usd">27319</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <cik0001793497:IncreaseInProfessionalFeesPayable contextRef="c6" decimals="0" unitRef="usd">55336</cik0001793497:IncreaseInProfessionalFeesPayable>
    <cik0001793497:IncreaseInProfessionalFeesPayable contextRef="c7" decimals="0" unitRef="usd">56798</cik0001793497:IncreaseInProfessionalFeesPayable>
    <cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable contextRef="c6" decimals="0" unitRef="usd">14922</cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable>
    <cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable contextRef="c7" decimals="0" unitRef="usd">21029</cik0001793497:IncreaseInLicensingAndRegistrationFeesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c6" decimals="0" unitRef="usd">-2145481</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c7" decimals="0" unitRef="usd">-38401864</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cik0001793497:ProceedsFromSaleOfUnits contextRef="c6" decimals="0" unitRef="usd">32683591</cik0001793497:ProceedsFromSaleOfUnits>
    <cik0001793497:ProceedsFromSaleOfUnits contextRef="c7" decimals="0" unitRef="usd">150498756</cik0001793497:ProceedsFromSaleOfUnits>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c6" decimals="0" unitRef="usd">34077640</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c7" decimals="0" unitRef="usd">112204673</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c6" decimals="0" unitRef="usd">-1394049</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c7" decimals="0" unitRef="usd">38294083</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c6" decimals="0" unitRef="usd">-3539530</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c7" decimals="0" unitRef="usd">-107781</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c8" decimals="0" unitRef="usd">3539530</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c9" decimals="0" unitRef="usd">107781</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <cik0001793497:MoneyMarketFundPercentage contextRef="c11" decimals="4" unitRef="pure">0.0277</cik0001793497:MoneyMarketFundPercentage>
    <us-gaap:OtherShortTermInvestments contextRef="c10" decimals="0" id="ix_1_fact" unitRef="usd">16492725</us-gaap:OtherShortTermInvestments>
    <us-gaap:DeferredTaxAssetsOther contextRef="c12" decimals="0" unitRef="usd">16492725</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:OtherShortTermInvestments contextRef="c12" decimals="0" unitRef="usd">16492725</us-gaap:OtherShortTermInvestments>
    <cik0001793497:MoneyMarketFundPercentage contextRef="c13" decimals="3" unitRef="pure">0.297</cik0001793497:MoneyMarketFundPercentage>
    <us-gaap:OtherInvestments contextRef="c12" decimals="0" unitRef="usd">16492725</us-gaap:OtherInvestments>
    <cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage contextRef="c12" decimals="3" unitRef="pure">0.703</cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage>
    <cik0001793497:OtherAssetsInExcessOfLiabilitiesAmount contextRef="c12" decimals="0" id="ix_0_fact" unitRef="usd">39121801</cik0001793497:OtherAssetsInExcessOfLiabilitiesAmount>
    <cik0001793497:TotalNetAssetsPercentage contextRef="c12" decimals="3" unitRef="pure">1</cik0001793497:TotalNetAssetsPercentage>
    <us-gaap:OtherAssets contextRef="c12" decimals="0" unitRef="usd">55614526</us-gaap:OtherAssets>
    <cik0001793497:ContractsOblication contextRef="c14" decimals="0" unitRef="usd">-4642568</cik0001793497:ContractsOblication>
    <cik0001793497:ContractsOblication contextRef="c15" decimals="0" unitRef="usd">-935201</cik0001793497:ContractsOblication>
    <cik0001793497:TotalContractsObligations contextRef="c3" decimals="0" unitRef="usd">-5577769</cik0001793497:TotalContractsObligations>
    <cik0001793497:MoneyMarketFundPercentage contextRef="c17" decimals="4" unitRef="pure">0.0277</cik0001793497:MoneyMarketFundPercentage>
    <us-gaap:OtherShortTermInvestments contextRef="c16" decimals="0" id="ix_2_fact" unitRef="usd">31236527</us-gaap:OtherShortTermInvestments>
    <us-gaap:DeferredTaxAssetsOther contextRef="c5" decimals="0" unitRef="usd">31236527</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:OtherShortTermInvestments contextRef="c5" decimals="0" unitRef="usd">31236527</us-gaap:OtherShortTermInvestments>
    <cik0001793497:MoneyMarketFundPercentage contextRef="c7" decimals="3" unitRef="pure">0.333</cik0001793497:MoneyMarketFundPercentage>
    <us-gaap:OtherInvestments contextRef="c5" decimals="0" unitRef="usd">31236527</us-gaap:OtherInvestments>
    <cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage contextRef="c5" decimals="3" unitRef="pure">0.667</cik0001793497:OtherAssetsInExcessOfLiabilitiesPercentage>
    <cik0001793497:OtherAssetsInExcessOfLiabilitiesAmount contextRef="c5" decimals="0" id="ix_3_fact" unitRef="usd">62546131</cik0001793497:OtherAssetsInExcessOfLiabilitiesAmount>
    <cik0001793497:TotalNetAssetsPercentage contextRef="c5" decimals="3" unitRef="pure">1</cik0001793497:TotalNetAssetsPercentage>
    <us-gaap:OtherAssets contextRef="c5" decimals="0" unitRef="usd">93782658</us-gaap:OtherAssets>
    <cik0001793497:ContractsOblication contextRef="c18" decimals="0" unitRef="usd">16904759</cik0001793497:ContractsOblication>
    <cik0001793497:ContractsOblication contextRef="c19" decimals="0" unitRef="usd">3689234</cik0001793497:ContractsOblication>
    <cik0001793497:TotalContractsObligations contextRef="c5" decimals="0" unitRef="usd">20593993</cik0001793497:TotalContractsObligations>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2013; ORGANIZATION&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VS
Trust (the &#x201c;Trust&#x201d;) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series
(each, a &#x201c;Fund&#x201d; and collectively, the &#x201c;Funds&#x201d;). As of September 30, 2022, the following two series of the Trust
have commenced investment operations: -1x Short VIX Futures ETF (&#x201c;SVIX&#x201d;) and 2x Long VIX Futures ETF (&#x201c;UVIX&#x201d;).
Each of the Funds listed above issues common units of beneficial interest (&#x201c;Shares&#x201d;), which represent units of fractional
undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (&#x201c;Cboe
BZX&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Funds&#x2019; inception of operation was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other
than matters relating to its organization and the registration of each series under the Securities Act of 1933.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Fund&#x2019;s investment exposure to&#160;VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each
Fund to regulation under the Commodity Exchange&#160;Act&#160;of&#160;1934 (&#x201c;CEA&#x201d;) and Commodity Futures Trading Commission
(&#x201c;CFTC&#x201d;) rules. The Sponsor is registered as a Commodity Pool Operator (&#x201c;CPO&#x201d;) and the Fund will be operated
in accordance with applicable CFTC rules. Registration as a CPO imposes additional compliance obligations on the Sponsor and the Funds
related to additional laws, regulations and enforcement policies, which could increase compliance costs and may affect the operations
and financial performance of the Funds.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Volatility
Shares LLC (the &#x201c;Sponsor&#x201d;) is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust&#x2019;s commodity
pool operator. The Funds are commodity pools, as defined under the Commodity Exchange&#160;Act (the &#x201c;CEA&#x201d;), and the applicable
regulations of the CFTC and are operated by the Sponsor, which is registered as a commodity pool operator with the CFTC.&#160;The Trust
is not an investment company registered under the Investment Company Act&#160;of&#160;1940.&lt;/span&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Fund is an investment company, as defined by Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 946 &#x201c;Financial Services &#x2014; Investment Companies.&#x201d; As such, the Funds follow the investment
company accounting and reporting guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable,
in preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United
States of America (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited financial statements were prepared in accordance with GAAP for interim financial information and with the instructions
for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). In the opinion of management,
all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period
financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Emerging
growth company&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust is an &#x201c;emerging growth company,&#x201d; as defined in the Jumpstart Our Business Startups Act&#160;of&#160;2012. It will remain
an emerging growth company until the earlier of (1)&#160;the beginning of the first fiscal year following the fifth anniversary of its
initial public offering, (2)&#160;the beginning of the first fiscal year after annual gross revenue is $1.07&#160;billion (subject to
adjustment for inflation) or more, (3)&#160;the date on which the Fund has, during the previous three-year&#160;period, issued more than
$1.0&#160;billion in non-convertible&#160;debt securities and (4)&#160;as of the end of any fiscal year in which the market value of
common equity held by non-affiliates&#160;exceeded $700&#160;million as of the end of the second quarter of that fiscal year.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
as long as the Trust remains an &#x201c;emerging growth company,&#x201d; it may take advantage of certain exemptions from the various reporting
requirements that are applicable to public companies that are not &#x201c;emerging growth companies&#x201d; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley&#160;Act, reduced
disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions
from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden
parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an &#x201c;emerging
growth company.&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Use
of Estimates &amp;amp; Indemnifications&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications.
The Trust&#x2019;s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basis
of Presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for
each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect
to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any
other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or
distributed to the Trust for the purchase of Shares in that Fund.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements
of Cash Flows&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated September
30, 2022, and represents cash, segregated cash balances with brokers for futures contracts, segregated cash with brokers for swap agreements
but does not include short-term investments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Final
Net Asset Value for Fiscal Period&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cut-off times and the times of the calculation of the Funds&#x2019; final net asset value for creation and redemption of fund Shares for
the three months ended September 30, 2022 were typically as follows. All times are Eastern Standard Time:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Create/Redeem&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV Calculation&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; width: 52%; font-weight: bold"&gt;Fund&lt;/td&gt;&lt;td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center"&gt;Cut-off*(EST)&lt;/td&gt;&lt;td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center"&gt;Time (EST)&lt;/td&gt;&lt;td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center"&gt;Calculation Date&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;-1x Short VIX Futures ETF and&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;2:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;4:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;September 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;2:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;4:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;September 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Although
                                            the Funds&#x2019; shares may continue to trade on secondary markets subsequent to the calculation
                                            of the final NAV, these times represent the final opportunity to transact in creation or
                                            redemption units for the three months ended September 30, 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Market
value per Share is determined at the close of Cboe BZX and may be later than when the Funds&#x2019; NAV per Share is calculated.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly,
the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds&#x2019;
final creation/redemption NAV for the three months ended September 30, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Investment
Valuation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term
investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each
of these situations, valuations are typically categorized as Level I in the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Derivatives
(e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties
or other procedures as determined by the Sponsor. Futures contracts are generally valued at the last settled price on the applicable
exchange on which that future trades. For financial reporting purposes, all futures contracts are generally valued at the last settled
price. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically
categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as
the basis for determining the market value of such position. Such fair value prices would generally be determined based on available
inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor
deems fair and equitable so long as such principles are consistent with industry standards. The Sponsor may fair value an asset of a
Fund pursuant to the policies the Sponsor has adopted. Depending on the source and relevant significance of valuation inputs, these instruments
may be classified as Level II or Level III in the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value pricing may require subjective determinations about the value of an investment. While the Funds&#x2019; policies are intended to
result in a calculation of its respective Fund&#x2019;s NAV that fairly reflects investment values as of the time of pricing, such Fund
cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that
a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or
distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the
differences could be material to the financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
Value of Financial Instruments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure
fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions
developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds&#x2019; own assumptions
about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs).
The three levels defined by the disclosure requirements hierarchy are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
I &#x2013; Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability
to access at the measurement date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
II &#x2013; Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or
indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for
identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the
asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means
(market-corroborated inputs).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
III &#x2013; Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure
fair value to the extent that observable inputs are not available.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair
value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant
to the fair value measurement in its entirety.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly
decreased, as well as when circumstances indicate that a transaction is not orderly.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the valuation of investments at September 30, 2022 using the fair value hierarchy:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level I - Quoted Prices&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level II - Other Significant&lt;br/&gt; Observable Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Money Market Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Futures Contracts*&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Foreign&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Forward&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Contracts&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Swap&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Agreements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;-1x Short VIX Futures ETF &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;16,492,725&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(55,619,690&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-20"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-21"&gt;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(39,126,965&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,236,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;187,584,120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-22"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-23"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;218,820,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Total Trust &lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;47,729,252&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;131,964,430&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-24"/&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-25"/&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;179,693,682&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
                                            cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of
                                            Investments. Only current day&#x2019;s variation margin is reported within the Statements
                                            of Financial Condition in receivable/payable on open futures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Investment
Transactions and Related Income&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investment
transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily.
Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized
appreciation (depreciation) between periods are reflected in the Statements of Operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as
Interest Income in the Statement of Operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Brokerage
Commissions and Futures Account Fees&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (&#x201c;NFA&#x201d;)
fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities
for each Fund&#x2019;s investment in U.S. Commodity Futures Trading Commission (&#x201c;CFTC&#x201d;) regulated investments. The effects
of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities
or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are
recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized
when the transaction is closed). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed
variable create/redeem fees collected by more than 0.04% and 0.09%, for SVIX and UVIX, respectively, of each Fund&#x2019;s average net assets annually.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Federal
Income Tax&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly,
no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund&#x2019;s Shares is required to take
into account its allocable share of its Fund&#x2019;s income, gain, loss, deductions and other items for its Fund&#x2019;s taxable year
ending with or within the beneficial owner&#x2019;s taxable year.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since
then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income
tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is
reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing
basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary
based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <cik0001793497:EmergingGrowthCompanyPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Emerging
growth company&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Trust is an &#x201c;emerging growth company,&#x201d; as defined in the Jumpstart Our Business Startups Act&#160;of&#160;2012. It will remain
an emerging growth company until the earlier of (1)&#160;the beginning of the first fiscal year following the fifth anniversary of its
initial public offering, (2)&#160;the beginning of the first fiscal year after annual gross revenue is $1.07&#160;billion (subject to
adjustment for inflation) or more, (3)&#160;the date on which the Fund has, during the previous three-year&#160;period, issued more than
$1.0&#160;billion in non-convertible&#160;debt securities and (4)&#160;as of the end of any fiscal year in which the market value of
common equity held by non-affiliates&#160;exceeded $700&#160;million as of the end of the second quarter of that fiscal year.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in;"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;For
as long as the Trust remains an &#x201c;emerging growth company,&#x201d; it may take advantage of certain exemptions from the various reporting
requirements that are applicable to public companies that are not &#x201c;emerging growth companies&#x201d; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley&#160;Act, reduced
disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions
from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden
parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an &#x201c;emerging
growth company.</cik0001793497:EmergingGrowthCompanyPolicyTextBlock>
    <cik0001793497:GrossRevenue contextRef="c0" decimals="-7" unitRef="usd">1070000000.00</cik0001793497:GrossRevenue>
    <cik0001793497:NonconvertibleDebtSecurities contextRef="c0" decimals="-8" unitRef="usd">1000000000</cik0001793497:NonconvertibleDebtSecurities>
    <cik0001793497:NonaffiliatesExceeded contextRef="c0" decimals="-6" unitRef="usd">700000000</cik0001793497:NonaffiliatesExceeded>
    <us-gaap:UseOfEstimates contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Use
of Estimates &amp;amp; Indemnifications&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications.
The Trust&#x2019;s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basis
of Presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for
each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect
to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any
other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or
distributed to the Trust for the purchase of Shares in that Fund.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <cik0001793497:StatementsOfCashFlowsPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements
of Cash Flows&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated September
30, 2022, and represents cash, segregated cash balances with brokers for futures contracts, segregated cash with brokers for swap agreements
but does not include short-term investments.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</cik0001793497:StatementsOfCashFlowsPolicyTextBlock>
    <cik0001793497:FinalNetAssetValueForFiscalPeriodPolcyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Final
Net Asset Value for Fiscal Period&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
cut-off times and the times of the calculation of the Funds&#x2019; final net asset value for creation and redemption of fund Shares for
the three months ended September 30, 2022 were typically as follows. All times are Eastern Standard Time:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Create/Redeem&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV Calculation&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; width: 52%; font-weight: bold"&gt;Fund&lt;/td&gt;&lt;td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center"&gt;Cut-off*(EST)&lt;/td&gt;&lt;td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center"&gt;Time (EST)&lt;/td&gt;&lt;td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center"&gt;Calculation Date&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;-1x Short VIX Futures ETF and&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;2:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;4:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;September 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;2:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;4:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;September 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Although
                                            the Funds&#x2019; shares may continue to trade on secondary markets subsequent to the calculation
                                            of the final NAV, these times represent the final opportunity to transact in creation or
                                            redemption units for the three months ended September 30, 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Market
value per Share is determined at the close of Cboe BZX and may be later than when the Funds&#x2019; NAV per Share is calculated.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly,
the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds&#x2019;
final creation/redemption NAV for the three months ended September 30, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</cik0001793497:FinalNetAssetValueForFiscalPeriodPolcyTextBlock>
    <cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;Create/Redeem&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV Calculation&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;NAV&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; width: 52%; font-weight: bold"&gt;Fund&lt;/td&gt;&lt;td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center"&gt;Cut-off*(EST)&lt;/td&gt;&lt;td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center"&gt;Time (EST)&lt;/td&gt;&lt;td style="text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 15%; font-weight: bold; text-align: center"&gt;Calculation Date&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;-1x Short VIX Futures ETF and&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;2:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;4:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center"&gt;September 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="white-space: nowrap; text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;2:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;4:00 p.m.&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt"&gt;September 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock>
    <cik0001793497:CreateRedeemCutoffDescription contextRef="c6" id="ix_4_fact">2:00 p.m.</cik0001793497:CreateRedeemCutoffDescription>
    <cik0001793497:NAVCalculationTimeESTDescription contextRef="c6">4:00 p.m.</cik0001793497:NAVCalculationTimeESTDescription>
    <cik0001793497:NAVCalculationDate contextRef="c6">2022-09-30</cik0001793497:NAVCalculationDate>
    <cik0001793497:CreateRedeemCutoffDescription contextRef="c7" id="ix_5_fact">2:00 p.m.</cik0001793497:CreateRedeemCutoffDescription>
    <cik0001793497:NAVCalculationTimeESTDescription contextRef="c7">4:00 p.m.</cik0001793497:NAVCalculationTimeESTDescription>
    <cik0001793497:NAVCalculationDate contextRef="c7">2022-09-30</cik0001793497:NAVCalculationDate>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Investment
Valuation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term
investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each
of these situations, valuations are typically categorized as Level I in the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Derivatives
(e.g., futures contracts, options, swap agreements) are generally valued using independent sources and/or agreements with counterparties
or other procedures as determined by the Sponsor. Futures contracts are generally valued at the last settled price on the applicable
exchange on which that future trades. For financial reporting purposes, all futures contracts are generally valued at the last settled
price. Futures contracts valuations are typically categorized as Level I in the fair value hierarchy. Swap agreement valuations are typically
categorized as Level II in the fair value hierarchy. The Sponsor may in its sole discretion choose to determine a fair value price as
the basis for determining the market value of such position. Such fair value prices would generally be determined based on available
inputs about the current value of the underlying financial instrument or commodity and would be based on principles that the Sponsor
deems fair and equitable so long as such principles are consistent with industry standards. The Sponsor may fair value an asset of a
Fund pursuant to the policies the Sponsor has adopted. Depending on the source and relevant significance of valuation inputs, these instruments
may be classified as Level II or Level III in the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value pricing may require subjective determinations about the value of an investment. While the Funds&#x2019; policies are intended to
result in a calculation of its respective Fund&#x2019;s NAV that fairly reflects investment values as of the time of pricing, such Fund
cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that
a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or
distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the
differences could be material to the financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
Value of Financial Instruments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure
fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions
developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds&#x2019; own assumptions
about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs).
The three levels defined by the disclosure requirements hierarchy are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
I &#x2013; Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability
to access at the measurement date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
II &#x2013; Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or
indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for
identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the
asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means
(market-corroborated inputs).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
III &#x2013; Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure
fair value to the extent that observable inputs are not available.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair
value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant
to the fair value measurement in its entirety.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly
decreased, as well as when circumstances indicate that a transaction is not orderly.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the valuation of investments at September 30, 2022 using the fair value hierarchy:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level I - Quoted Prices&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level II - Other Significant&lt;br/&gt; Observable Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Money Market Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Futures Contracts*&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Foreign&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Forward&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Contracts&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Swap&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Agreements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;-1x Short VIX Futures ETF &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;16,492,725&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(55,619,690&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-20"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-21"&gt;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(39,126,965&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,236,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;187,584,120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-22"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-23"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;218,820,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Total Trust &lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;47,729,252&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;131,964,430&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-24"/&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-25"/&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;179,693,682&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0"/&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
                                            cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of
                                            Investments. Only current day&#x2019;s variation margin is reported within the Statements
                                            of Financial Condition in receivable/payable on open futures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level I - Quoted Prices&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Level II - Other Significant&lt;br/&gt; Observable Inputs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Money Market Fund&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Futures Contracts*&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Foreign&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Forward&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Contracts&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Swap&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Agreements&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;-1x Short VIX Futures ETF &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;16,492,725&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(55,619,690&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-20"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-21"&gt;&#160;&#160;&#160;&#160;&#160;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(39,126,965&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,236,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;187,584,120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-22"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-23"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;218,820,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Total Trust &lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;47,729,252&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;131,964,430&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-24"/&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-25"/&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;179,693,682&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <cik0001793497:AmountOfTotalTrust contextRef="c22" decimals="0" unitRef="usd">16492725</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c23" decimals="0" id="ix_6_fact" unitRef="usd">-55619690</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c4" decimals="0" unitRef="usd">-39126965</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c26" decimals="0" unitRef="usd">31236527</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c27" decimals="0" id="ix_7_fact" unitRef="usd">187584120</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c5" decimals="0" unitRef="usd">218820647</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c30" decimals="0" unitRef="usd">47729252</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c31" decimals="0" id="ix_8_fact" unitRef="usd">131964430</cik0001793497:AmountOfTotalTrust>
    <cik0001793497:AmountOfTotalTrust contextRef="c3" decimals="0" unitRef="usd">179693682</cik0001793497:AmountOfTotalTrust>
    <us-gaap:UnremittedEarningsInForeignInvestmentPolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Investment
Transactions and Related Income&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Investment
transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily.
Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized
appreciation (depreciation) between periods are reflected in the Statements of Operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as
Interest Income in the Statement of Operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:UnremittedEarningsInForeignInvestmentPolicy>
    <us-gaap:FloorBrokeragePolicy contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Brokerage
Commissions and Futures Account Fees&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (&#x201c;NFA&#x201d;)
fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities
for each Fund&#x2019;s investment in U.S. Commodity Futures Trading Commission (&#x201c;CFTC&#x201d;) regulated investments. The effects
of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities
or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are
recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized
when the transaction is closed). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed
variable create/redeem fees collected by more than 0.04% and 0.09%, for SVIX and UVIX, respectively, of each Fund&#x2019;s average net assets annually.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:FloorBrokeragePolicy>
    <cik0001793497:FundsAverageNetAssetsAnnually contextRef="c20" decimals="4" unitRef="pure">0.0004</cik0001793497:FundsAverageNetAssetsAnnually>
    <cik0001793497:FundsAverageNetAssetsAnnually contextRef="c21" decimals="4" unitRef="pure">0.0009</cik0001793497:FundsAverageNetAssetsAnnually>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Federal
Income Tax&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly,
no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund&#x2019;s Shares is required to take
into account its allocable share of its Fund&#x2019;s income, gain, loss, deductions and other items for its Fund&#x2019;s taxable year
ending with or within the beneficial owner&#x2019;s taxable year.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since
then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income
tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is
reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing
basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary
based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InvestmentTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2013; INVESTMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Short-Term
Investments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Funds may purchase U.S. Treasury Bills, agency securities, and other high-credit quality short-term fixed income or similar securities
with original maturities of one year or less. A portion of these investments may be posted as collateral in connection with swap agreements,
futures, and/or forward contracts.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accounting
for Derivative Instruments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
seeking to achieve each Fund&#x2019;s investment objective, the Sponsor uses a mathematical approach to investing. Using this approach,
the Sponsor determines the type, quantity and mix of investment positions, including derivative positions, which the Sponsor believes
in combination, should produce returns consistent with a Fund&#x2019;s objective.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
open derivative positions at period end are reflected on each respective Fund&#x2019;s Schedule of Investments. Certain Funds utilized
a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objectives during
the period. While the volume of open positions may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve
the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective
Fund at the date of this report is generally representative of open positions throughout the reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
is a description of the derivative instruments used by the Funds during the reporting period, including the primary underlying risk exposures
related to each instrument type.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Futures
Contracts&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Funds may enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or
shorting), an underlying benchmark. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery
of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally
be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase
of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration
of contract.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
entering into a futures contract, each Fund is required to deposit and maintain as collateral at least such initial margin as required
by the exchange on which the transaction is affected. The initial margin is segregated as cash and/or securities balances with brokers
for futures contracts, as disclosed in the Statements of Financial Condition, and is restricted as to its use. The Funds that enter into
futures contracts maintain collateral at the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund
generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract.
Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize
a gain or loss upon closing of a futures transaction.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;Futures contracts involve,
to varying degrees, elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility
risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure
each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation
between movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility
of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures
contracts are exchange-traded and the credit risk resides with the Funds&#x2019; clearing broker or clearinghouse itself. Many futures
exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the
daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended
for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with
little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses.
If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund
will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will
be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Option Contracts&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;An option is a contract
that gives the buyer the right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific
(or strike) price within a specified period of time, regardless of the market price of that instrument. There are two types of options:
calls and puts. A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any
time during the life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated
price at any time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds
an offsetting position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor&#x2019;s entire investment
(i.e., the premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the
option expires. Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin,
and the risk of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price
which may, upon exercise of the option, be significantly different from the market value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;When a Fund writes a call
or put, an amount equal to the premium received is recorded and subsequently marked to market to reflect the current value of the option
written. Premiums received from writing options which expire are treated as realized gains. Premiums received from writing options which
are exercised or closed are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction
to determine the realized gain (loss).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;When a Fund purchases an
option, the Fund pays a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market
to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk
associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised
or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized
gain (loss) when the underlying transaction is executed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;Certain options transactions
may subject the writer (seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or
delivered. The value of a Fund&#x2019;s options transactions, if any, will be affected by, among other things, changes in the value of
a Fund&#x2019;s underlying benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility
of the Fund&#x2019;s underlying benchmark, and the remaining time until the options expire, or any combination thereof. The value of the
options should not be expected to increase or decrease at the same rate as the level of the Fund&#x2019;s underlying benchmark, which may
contribute to tracking error. Options may be less liquid than certain other securities. A Fund&#x2019;s ability to trade options will be
dependent on the willingness of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have
difficulty closing out certain option positions at desired times and prices. A Fund may experience substantial downside from specific
option positions and certain option positions may expire worthless. Over-the-counter options generally are not assignable except by agreement
between the parties concerned, and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for
options is relatively illiquid, particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity
risk and counterparty credit risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell
options on futures contracts, which may present even greater volatility and risk of loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Swap Agreements&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;The Funds may enter into
swap agreements for purposes of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying
Index or to create an economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered
into primarily with institutional investors in over-the-counter (&#x201c;OTC&#x201d;) markets for a specified period, ranging from a day
to more than one year. However, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#x201c;Dodd-Frank Act&#x201d;) provides
for significant reforms of the OTC derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated
market and/or to clear such transactions through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties
agree to exchange the returns earned or realized on a particular predetermined investment, instrument or Index in exchange for a fixed
or floating rate of return in respect of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark
level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to a notional amount and
the benchmark returns to which the swap is linked. Swap agreements do not involve the delivery of underlying instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;Generally, swap agreements
entered into by the Funds calculate and settle the obligations of the parties to the agreement on a &#x201c;net basis&#x201d; with a single
payment. Consequently, each Fund&#x2019;s current obligations (or rights) under a swap agreement will generally be equal only to the net
amount to be paid or received under the agreement based on the relative values of such obligations (or rights) (the &#x201c;net amount&#x201d;).
In a typical swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark
increases and would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted
for any transaction costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX,
the Fund would be required to make payments to the swap counterparties in the event the level of the benchmark increases and would be
entitled to settlement payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads
on the notional amount the Funds may pay.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;The net amount of the excess,
if any, of each Fund&#x2019;s obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and
an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the
counterparty in a segregated account by the Funds&#x2019; Custodian. The net amount of the excess, if any, of each Fund&#x2019;s entitlements
over its obligations with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having
an aggregate value at least equal to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third
party custodian. Until a swap agreement is settled in cash, the gain or loss on the notional amount less any transaction costs or trading
spreads payable by each Fund on the notional amount are recorded as &#x201c;unrealized appreciation or depreciation on swap agreements&#x201d;
and, when cash is exchanged, the gain or loss realized is recorded as &#x201c;realized gains or losses on swap agreements.&#x201d; Swap
agreements are generally valued at the last settled price of the benchmark referenced asset.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;Swap agreements contain
various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default
on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in
an amount equal to the net positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction
with the same counterparty, enter into a transaction with a different counterparty or seek to achieve its investment objective through
any number of different investments or investment techniques.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;Swap agreements involve,
to varying degrees, elements of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts
reflect the extent of the total investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional
risks associated with the use of swap agreements are imperfect correlations between movements in the notional amount and the price of
the underlying reference Index and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected
to be received under a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically
enter into swap agreements only with major global financial institutions. The creditworthiness of each of the firms that is a party to
a swap agreement is monitored by the Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination
and payment, using different counterparties, limiting the net amount due from any individual counterparty and generally requiring collateral
to be posted by the counterparty in an amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually
terminate within one month but may be terminated without penalty by either party at any time. Upon termination, the Fund is obligated
to pay or receive the &#x201c;unrealized appreciation or depreciation&#x201d; amount.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;The Funds, as applicable,
collateralize swap agreements by segregating or designating cash and/or certain securities as indicated on the Statements of Financial
Condition or Schedules of Investments. As noted above, collateral posted in connection with OTC derivative transactions is held for the
benefit of the counterparty in a segregated tri-party account at the Custodian to protect the counterparty against non-payment by the
Funds. The collateral held in this account is restricted as to its use. In the event of a default by the counterparty, the Funds will
seek withdrawal of this collateral from the segregated account and may incur certain costs in exercising its right with respect to the
collateral. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, the Funds
may experience significant delays in obtaining any recovery in a bankruptcy or other reorganizational proceeding. The Funds may obtain
only limited recovery or may obtain no recovery in such circumstances.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;The Funds remain subject
to credit risk with respect to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these
risks in connection with OTC swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit
of the Fund, marked to market daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum
thresholds. In the event of a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty,
generally as of the day prior to the bankruptcy, because there is a one day time lag between the Fund&#x2019;s request for collateral and
the delivery of such collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as
described above, including the possible delays in recovering amounts as a result of bankruptcy proceedings.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;The counterparty/credit
risk for cleared derivative transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted
for each counterparty to a cleared derivative contract and, in effect, guarantees the parties&#x2019; performance under the contract as
each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative
transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "&gt;&lt;b&gt;Fair Value of Derivative
Instruments as of September 30, 2022&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Asset
    Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Liability
    Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Derivatives
    Not Accounted&lt;br/&gt; for as Hedging Instruments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fund&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements
    of &lt;br/&gt;
Financial Condition&lt;br/&gt; Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized&lt;br/&gt;
Appreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements
of &lt;br/&gt;
Financial Condition&lt;br/&gt;
Location &#160;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized&lt;br/&gt;
Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VIX Futures Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Receivables on open futures contracts, unrealized appreciation
    on swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payable on open futures contracts, unrealized depreciation
    on swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td/&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-1x Short VIX
    Futures ETF&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: right"/&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,577,769&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: right"/&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-26"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;*&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td/&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2x Long VIX Futures ETF&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"/&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,593,993&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-27; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 13.5pt"/&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Trust&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,296,435&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-28"/&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;*&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: justify"&gt;Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#x2019;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "&gt;&lt;b&gt;The Effect of Derivative
Instruments on the Statement of Operations&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "&gt;&lt;b&gt;For the three months
ended September 30, 2022&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; padding: 0; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Derivatives Not Accounted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;for as Hedging Instruments&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Location of Gain&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;(Loss) on Derivatives&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Recognized in Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; text-indent: 0"&gt;Fund&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Realized
Gain&lt;br/&gt;
(Loss) on&lt;br/&gt;
Derivatives&lt;br/&gt;
Recognized in&lt;br/&gt;
Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Change in&lt;br/&gt; Unrealized&lt;br/&gt;
                                                                                 Appreciation&lt;br/&gt; (Depreciation)&lt;br/&gt;
on&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Derivatives&lt;br/&gt;
Recognized in&lt;br/&gt;
Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;VIX Futures Contracts&lt;/td&gt;&lt;td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;Net realized gain (loss) on futures contracts and/or swap agreements/ changes in unrealized appreciation (depreciation) on futures contracts and/or swap agreements&lt;/td&gt;&lt;td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; width: 16%; text-indent: 0"/&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 38%; text-indent: 0"/&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 20%; text-align: left; text-indent: 0"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; width: 9%; text-align: right; text-indent: 0"&gt;8,077,788&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; width: 9%; text-align: right; text-indent: 0"&gt;(6,278,300&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-indent: 0"/&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-indent: 0"/&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;(22,686,414&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;20,574,735&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding: 0; font-weight: bold; text-align: left; text-indent: 0"&gt;&lt;b&gt;Total Trust&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&lt;b&gt;(14,608,626&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&lt;b&gt;14,296,435&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: justify"&gt;Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#x2019;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Offsetting Assets and Liabilities&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Each Fund is subject to master netting agreements
or similar arrangements that allow for amounts owed between each Fund and the counterparty to be netted upon an early termination. The
party that has the larger payable pays the excess of the larger amount over the smaller amount to the other party. The master netting
agreements or similar arrangements do not apply to amounts owed to/from different counterparties. As described above, the Funds utilize
derivative instruments to achieve their investment objective during the year. The amounts shown in the Statements of Financial Condition
do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;For financial reporting purposes, the Funds
do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition.
The following table presents each Fund&#x2019;s derivatives by investment type and by counterparty net of amounts available for offset
under a master netting agreement and the related collateral received or pledged by the Funds as of September 30, 2022.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="19" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Values of Derivative Instruments as of September 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Liabilities&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Amounts&lt;br/&gt; of Recognized&lt;br/&gt; Assets presented&lt;br/&gt; in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Amounts&lt;br/&gt; Offset in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Net Amounts of Assets presented&lt;br/&gt; in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross Amounts&lt;br/&gt; of Recognized&lt;br/&gt; Liabilities&lt;br/&gt; presented &lt;br/&gt; in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Amounts&lt;br/&gt; Offset in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amounts of&lt;br/&gt; Liabilities&lt;br/&gt; presented &lt;br/&gt; in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;-1x Short VIX Futures ETF &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-29"/&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-30"/&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;774,721&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"/&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;774,721&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,708,079&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,708,079&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-31"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-32"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Asset (Liability) amounts shown in the table
below represent amounts owed to (by) the Funds for the derivative-related investments at September 30, 2022. These amounts may be collateralized
by cash or financial instruments, segregated for the benefit of the Funds or the counterparties, depending on whether the related contracts
are in an appreciated or depreciated position at period end. Amounts shown in the column labeled &#x201c;Net Amount&#x201d; represent the
uncollateralized portions of these amounts at period end. These amounts may be un-collateralized due to timing differences related to
market movements or due to minimum thresholds for collateral movement, as further described above under the caption &#x201c;Accounting
for Derivative Instruments&#x201d;.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross Amounts Not Offset in the Statements of Financial Condition as of September 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Assets /&lt;br/&gt; (Liabilities)&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Financial&lt;br/&gt; Instruments&lt;br/&gt; for the&lt;br/&gt; Benefit of &lt;br/&gt; (the Funds) /&lt;br/&gt; the&lt;br/&gt; Counterparties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;b&gt;Cash Collateral&lt;br/&gt; for the Benefit&lt;br/&gt; of (the Funds) /&lt;br/&gt; the&lt;br/&gt; Counterparties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net&lt;br/&gt; Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(774,721&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(774,721&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,708,079&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,708,079&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:InvestmentTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Asset
    Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Liability
    Derivatives&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Derivatives
    Not Accounted&lt;br/&gt; for as Hedging Instruments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fund&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements
    of &lt;br/&gt;
Financial Condition&lt;br/&gt; Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized&lt;br/&gt;
Appreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statements
of &lt;br/&gt;
Financial Condition&lt;br/&gt;
Location &#160;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized&lt;br/&gt;
Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;VIX Futures Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Receivables on open futures contracts, unrealized appreciation
    on swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payable on open futures contracts, unrealized depreciation
    on swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td/&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-1x Short VIX
    Futures ETF&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 20%; text-align: right"/&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5,577,769&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: right"/&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-26"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;*&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td/&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2x Long VIX Futures ETF&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"/&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,593,993&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"/&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-27; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 13.5pt"/&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Trust&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,296,435&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-28"/&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;*&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;*&lt;/td&gt;&lt;td style="text-align: justify"&gt;Includes cumulative appreciation (depreciation) of futures contracts
as reported in the Schedule of Investments. Only current day&#x2019;s variation margin is reported within the Statements of Financial
Condition in receivable/payable on open futures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <cik0001793497:TotalTrust contextRef="c34" decimals="0" id="ix_9_fact" unitRef="usd">-5577769</cik0001793497:TotalTrust>
    <cik0001793497:TotalTrust contextRef="c36" decimals="0" unitRef="usd">20593993</cik0001793497:TotalTrust>
    <cik0001793497:TotalTrust contextRef="c38" decimals="0" id="ix_10_fact" unitRef="usd">14296435</cik0001793497:TotalTrust>
    <us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; padding: 0; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Derivatives Not Accounted&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;for as Hedging Instruments&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Location of Gain&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;(Loss) on Derivatives&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Recognized in Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; text-indent: 0"&gt;Fund&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Realized
Gain&lt;br/&gt;
(Loss) on&lt;br/&gt;
Derivatives&lt;br/&gt;
Recognized in&lt;br/&gt;
Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="padding: 0; border-bottom: Black 1.5pt solid; text-align: center; text-indent: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Change in&lt;br/&gt; Unrealized&lt;br/&gt;
                                                                                 Appreciation&lt;br/&gt; (Depreciation)&lt;br/&gt;
on&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Derivatives&lt;br/&gt;
Recognized in&lt;br/&gt;
Income&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;VIX Futures Contracts&lt;/td&gt;&lt;td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;Net realized gain (loss) on futures contracts and/or swap agreements/ changes in unrealized appreciation (depreciation) on futures contracts and/or swap agreements&lt;/td&gt;&lt;td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; vertical-align: top; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; vertical-align: top; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; width: 16%; text-indent: 0"/&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 38%; text-indent: 0"/&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 20%; text-align: left; text-indent: 0"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; width: 9%; text-align: right; text-indent: 0"&gt;8,077,788&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;$&lt;/td&gt;&lt;td style="padding: 0; width: 9%; text-align: right; text-indent: 0"&gt;(6,278,300&lt;/td&gt;&lt;td style="padding: 0; width: 1%; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0; text-indent: 0"/&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-indent: 0"/&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;(22,686,414&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;)&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;20,574,735&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; font-weight: bold; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding: 0; font-weight: bold; text-align: left; text-indent: 0"&gt;&lt;b&gt;Total Trust&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&lt;b&gt;(14,608,626&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-align: right; text-indent: 0"&gt;&lt;b&gt;14,296,435&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0; text-align: left; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DebtSecuritiesRealizedGainLoss contextRef="c40" decimals="0" unitRef="usd">8077788</us-gaap:DebtSecuritiesRealizedGainLoss>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome contextRef="c40" decimals="0" unitRef="usd">-6278300</cik0001793497:ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome>
    <us-gaap:DebtSecuritiesRealizedGainLoss contextRef="c41" decimals="0" unitRef="usd">-22686414</us-gaap:DebtSecuritiesRealizedGainLoss>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome contextRef="c41" decimals="0" unitRef="usd">20574735</cik0001793497:ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome>
    <us-gaap:DebtSecuritiesRealizedGainLoss contextRef="c42" decimals="0" unitRef="usd">-14608626</us-gaap:DebtSecuritiesRealizedGainLoss>
    <cik0001793497:ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome contextRef="c42" decimals="0" unitRef="usd">14296435</cik0001793497:ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome>
    <cik0001793497:ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="19" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Values of Derivative Instruments as of September 30, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="8" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Liabilities&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Amounts&lt;br/&gt; of Recognized&lt;br/&gt; Assets presented&lt;br/&gt; in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Amounts&lt;br/&gt; Offset in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Net Amounts of Assets presented&lt;br/&gt; in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross Amounts&lt;br/&gt; of Recognized&lt;br/&gt; Liabilities&lt;br/&gt; presented &lt;br/&gt; in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Amounts&lt;br/&gt; Offset in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Amounts of&lt;br/&gt; Liabilities&lt;br/&gt; presented &lt;br/&gt; in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;-1x Short VIX Futures ETF &lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-29"/&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-30"/&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;774,721&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"/&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;774,721&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,708,079&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,708,079&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-31"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-32"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;</cik0001793497:ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock>
    <cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition contextRef="c44" decimals="0" unitRef="usd">774721</cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition>
    <cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition contextRef="c44" decimals="0" unitRef="usd">774721</cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition>
    <cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition contextRef="c45" decimals="0" unitRef="usd">2708079</cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition>
    <cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition contextRef="c45" decimals="0" unitRef="usd">2708079</cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross Amounts Not Offset in the Statements of Financial Condition as of September 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amounts of&lt;br/&gt; Recognized&lt;br/&gt; Assets /&lt;br/&gt; (Liabilities)&lt;br/&gt; presented&lt;br/&gt; in the&lt;br/&gt; Statements of&lt;br/&gt; Financial&lt;br/&gt; Condition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Financial&lt;br/&gt; Instruments&lt;br/&gt; for the&lt;br/&gt; Benefit of &lt;br/&gt; (the Funds) /&lt;br/&gt; the&lt;br/&gt; Counterparties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;b&gt;Cash Collateral&lt;br/&gt; for the Benefit&lt;br/&gt; of (the Funds) /&lt;br/&gt; the&lt;br/&gt; Counterparties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net&lt;br/&gt; Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(774,721&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(774,721&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,708,079&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,708,079&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne contextRef="c6" decimals="0" unitRef="usd">-774721</cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne>
    <cik0001793497:FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo contextRef="c6" decimals="0" unitRef="usd">-774721</cik0001793497:FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo>
    <cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne contextRef="c7" decimals="0" unitRef="usd">2708079</cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne>
    <cik0001793497:FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo contextRef="c7" decimals="0" unitRef="usd">2708079</cik0001793497:FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo>
    <cik0001793497:AgreementsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;NOTE 4 &#x2013; AGREEMENTS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Management Fee&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;SVIX pays the Sponsor a management fee (the &#x201c;Management Fee&#x201d;),
monthly in arrears, in an amount equal to &lt;b&gt;1.35&lt;/b&gt;% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee,
monthly in arrears, in an amount equal to &lt;b&gt;1.65&lt;/b&gt;% per annum of its average daily net assets. &#x201c;Average daily net assets&#x201d;
is calculated by dividing the month-end net assets of each Fund by the number of calendar&#160;days in such month.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;No other Management Fee is paid by the Funds. The Management Fee is
paid in consideration of the Sponsor&#x2019;s trading advisory services and the other services provided to the Fund that the Sponsor pays
directly.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Pursuant to the Sponsor Agreement between Sponsor and the Trust, on
behalf of the Funds, the Sponsor oversees and pays Milliman FRM (&#x201c;Commodity Sub-Adviser&#x201d;) for its services as Commodity Sub-Adviser.
The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory fee of 0.25% based on each Fund&#x2019;s average daily net assets
(total assets of the Fund, minus the sum of its accrued liabilities). The commodity sub-advisory fee is waived for the first 6&#160;months
of each Fund&#x2019;s operations or until a Fund reaches $35&#160;million in average daily net assets. The Funds do not directly pay the
Commodity Sub-Adviser.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Non-Recurring Fees and Expenses&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Each Fund pays all its non-recurring and unusual
fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses that are unexpected
or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material expenses which are not
currently anticipated obligations of the Funds.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;The Administrator, Transfer Agent and Custodian&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;U.S.&#160;Bancorp Fund Services, LLC, doing business as U.S.&#160;Bank
Global Fund Services (&#x201c;Fund Services&#x201d;), an indirect subsidiary of U.S.&#160;Bancorp, serves as the Fund&#x2019;s fund accountant,
administrator and transfer agent pursuant to certain fund accounting servicing, fund administration servicing and transfer agent servicing
agreements. U.S.&#160;Bank National Association, a subsidiary of U.S.&#160;Bancorp and parent company of Fund Services, intends to serve
as the Fund&#x2019;s custodian pursuant to a custody agreement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;The Marketing Agent&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Foreside Fund Services, LLC (the &#x201c;Marketing Agent&#x201d;) serves
as the Marketing Agent of the Funds. Its principal duties are: (i)&#160;to work with the Transfer Agent to review and approve orders placed
by Authorized Participants and transmitted to the Transfer Agent; (ii)&#160;maintain copies of confirmations of Creation Unit creation
and redemption order acceptances; (iii)&#160;maintain telephonic, facsimile and/or access to direct computer communications links with
the Transfer Agent; and (iv)&#160;review and approve, prior to use, all Trust marketing materials for compliance with applicable SEC and
FINRA advertising rules.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;The Marketing Agent retains all marketing materials separately for
the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;As compensation for the services it provides, the Marketing Agent receives
a fee from the Funds.&lt;/p&gt;</cik0001793497:AgreementsDisclosureTextBlock>
    <cik0001793497:AverageDailyNetAssetsRate contextRef="c47" decimals="4" unitRef="pure">0.0135</cik0001793497:AverageDailyNetAssetsRate>
    <cik0001793497:AverageDailyNetAssetsRate contextRef="c48" decimals="4" unitRef="pure">0.0165</cik0001793497:AverageDailyNetAssetsRate>
    <cik0001793497:SubadvisoryFeeRate contextRef="c3" decimals="4" unitRef="pure">0.0025</cik0001793497:SubadvisoryFeeRate>
    <cik0001793497:AverageDailyNetAssets contextRef="c3" decimals="-6" unitRef="usd">35000000</cik0001793497:AverageDailyNetAssets>
    <cik0001793497:OfferingCostsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;NOTE 5 &#x2013; OFFERING COSTS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Offering costs will be amortized by the Funds
over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge its Management
Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred in connection
with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.&lt;/p&gt;</cik0001793497:OfferingCostsTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;NOTE 6 &#x2013; CREATION AND REDEMPTION
OF CREATION UNITS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Each Fund issues and redeems shares from time
to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares of a Fund. Creation Units may be
created or redeemed only by Authorized Participants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Except when aggregated in Creation Units,
the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares directly
from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of a broker.
Thus, some of the information contained in these Notes to Financial Statements&#x2014;such as references to the Transaction Fees imposed
on purchases and redemptions is not relevant to retail investors.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Transaction Fees on Creation and Redemption
Transactions&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;The manner by which Creation Units are purchased
or redeemed is governed by the terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing
a purchase order, an Authorized Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its
sole discretion, enter into or arrange for an exchange of futures contract for related position or block trade with the relevant fund
whereby the Authorized Participant would also transfer to such Fund a number and type of exchange-traded futures contracts at or near
the closing settlement price for such contracts on the purchase order date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Authorized Participants may pay a fee up to
0.20% of the value of each order they place with each order to create or redeem a Creation Unit in order to compensate the Administrator,
the Custodian and the Transfer Agent of each Fund and its Shares, for services in processing the creation and redemption of Creation Units
and to offset the costs of increasing or decreasing derivative positions, unless the transaction fee is waived or otherwise adjusted by
the Sponsor. The Sponsor provides such Authorized Participant with prompt notice in advance of any such waiver or adjustment of the transaction
fee. Authorized Participants may sell the Shares included in the Creation Units they purchase from the Funds to other investors in the
secondary market.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Transaction fees for the three months ended
September 30, 2022 were as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Three Months Ended&lt;br/&gt; September&#160;30, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20,124&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;78,086&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total Trust&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;98,210&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SharesIssued contextRef="c3" decimals="0" unitRef="shares">10000</us-gaap:SharesIssued>
    <cik0001793497:AuthorizedParticipantsPercentage contextRef="c0" decimals="4" unitRef="pure">0.002</cik0001793497:AuthorizedParticipantsPercentage>
    <cik0001793497:ScheduleOfTransactionFeesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Fund&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Three Months Ended&lt;br/&gt; September&#160;30, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;-1x Short VIX Futures ETF&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20,124&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2x Long VIX Futures ETF&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;78,086&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total Trust&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;98,210&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cik0001793497:ScheduleOfTransactionFeesTableTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c4" decimals="0" unitRef="usd">20124</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c5" decimals="0" unitRef="usd">78086</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="c3" decimals="0" unitRef="usd">98210</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;NOTE 7 &#x2013; FINANCIAL HIGHLIGHTS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Selected data is for a Share outstanding throughout
the three months ended September 30, 2022&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.6pt; text-indent: -21.6pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;-1x Short VIX&lt;br/&gt;
Futures&lt;br/&gt;
ETF&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2x Long VIX&lt;br/&gt;
Futures&lt;br/&gt;
ETF&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;September&#160;30, 2022&lt;br/&gt; (Unaudited)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;September&#160;30, 2022&lt;br/&gt; (Unaudited)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Net Asset Value, Beginning of Period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;10.40&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17.12&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Net investment loss &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts &lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(0.00&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3.20&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net Increase (Decrease) in Net Asset Value Resulting from Operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(0.06&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3.25&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Net Asset Value, End of Period&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10.34&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;13.87&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Market Value Per Share, at September 30, 2022 &lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total Return at Net Asset Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-0.58&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-18.97&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total Return at Market Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-0.87&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-18.21&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Ratios to Average Net Assets: &lt;sup&gt;(5)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Expense ratio &lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.35&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Net Investment Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-2.06&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-1.93&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds&#x2019; net asset value is calculated.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Percentages are not annualized for the period ended September 30, 2022. &lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Percentages are annualized.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The expense ratio would be 2.23% and 2.27% respectively, if brokerage commissions and futures and futures account fees were excluded.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <cik0001793497:ScheduleOfShareOutstandingTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;-1x Short VIX&lt;br/&gt;
Futures&lt;br/&gt;
ETF&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2x Long VIX&lt;br/&gt;
Futures&lt;br/&gt;
ETF&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Quarter Ended&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;September&#160;30, 2022&lt;br/&gt; (Unaudited)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;September&#160;30, 2022&lt;br/&gt; (Unaudited)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Net Asset Value, Beginning of Period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&#160;&#160;&#160;&#160;10.40&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17.12&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Net investment loss &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.05&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts &lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(0.00&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3.20&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net Increase (Decrease) in Net Asset Value Resulting from Operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(0.06&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3.25&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Net Asset Value, End of Period&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10.34&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;13.87&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Market Value Per Share, at September 30, 2022 &lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;13.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total Return at Net Asset Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-0.58&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-18.97&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total Return at Market Value &lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-0.87&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-18.21&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Ratios to Average Net Assets: &lt;sup&gt;(5)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Expense ratio &lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.35&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Net Investment Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-2.06&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-1.93&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds&#x2019; net asset value is calculated.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Percentages are not annualized for the period ended September 30, 2022. &lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Percentages are annualized.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The expense ratio would be 2.23% and 2.27% respectively, if brokerage commissions and futures and futures account fees were excluded.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</cik0001793497:ScheduleOfShareOutstandingTableTextBlock>
    <us-gaap:NetAssetValuePerShare contextRef="c8" decimals="2" unitRef="usdPershares">10.4</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare contextRef="c9" decimals="2" unitRef="usdPershares">17.12</us-gaap:NetAssetValuePerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c6"
      decimals="2"
      id="ix_17_fact"
      unitRef="usdPershares">-0.06</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare
      contextRef="c7"
      decimals="2"
      id="ix_18_fact"
      unitRef="usdPershares">-0.05</us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare>
    <cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts
      contextRef="c6"
      decimals="2"
      id="ix_23_fact"
      unitRef="usdPershares">0</cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts>
    <cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts
      contextRef="c7"
      decimals="2"
      id="ix_24_fact"
      unitRef="usdPershares">-3.2</cik0001793497:NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease contextRef="c6" decimals="2" unitRef="usdPershares">-0.06</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease contextRef="c7" decimals="2" unitRef="usdPershares">-3.25</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:NetAssetValuePerShare contextRef="c4" decimals="2" unitRef="usdPershares">10.34</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare contextRef="c5" decimals="2" unitRef="usdPershares">13.87</us-gaap:NetAssetValuePerShare>
    <cik0001793497:MarketValuePerShare
      contextRef="c4"
      decimals="2"
      id="ix_21_fact"
      unitRef="usdPershares">10.52</cik0001793497:MarketValuePerShare>
    <cik0001793497:MarketValuePerShare
      contextRef="c5"
      decimals="2"
      id="ix_22_fact"
      unitRef="usdPershares">13.4</cik0001793497:MarketValuePerShare>
    <us-gaap:InvestmentCompanyTotalReturn contextRef="c6" decimals="4" id="ix_11_fact" unitRef="pure">-0.0058</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn contextRef="c7" decimals="4" id="ix_12_fact" unitRef="pure">-0.1897</us-gaap:InvestmentCompanyTotalReturn>
    <cik0001793497:InvestmentCompanyTotalReturnMarketValue contextRef="c6" decimals="4" id="ix_13_fact" unitRef="pure">-0.0087</cik0001793497:InvestmentCompanyTotalReturnMarketValue>
    <cik0001793497:InvestmentCompanyTotalReturnMarketValue contextRef="c7" decimals="4" id="ix_14_fact" unitRef="pure">-0.1821</cik0001793497:InvestmentCompanyTotalReturnMarketValue>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation contextRef="c6" decimals="4" id="ix_19_fact" unitRef="pure">0.0234</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation contextRef="c7" decimals="4" id="ix_20_fact" unitRef="pure">0.0235</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio contextRef="c6" decimals="4" id="ix_15_fact" unitRef="pure">-0.0206</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio contextRef="c7" decimals="4" id="ix_16_fact" unitRef="pure">-0.0193</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;NOTE 8 &#x2013; RISK&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Correlation and Compounding Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;The Funds do not seek to achieve their stated
investment objective over a period of time greater than a single day (as measured from NAV calculation time to NAV calculation time).
The return of a Fund for a period longer than a single day is the result of its return for each day compounded over the period and usually
will differ in amount and possibly even direction from the inverse (-1x) or two times (2x) the return of the Fund&#x2019;s benchmark for
the period. A Fund will lose money if its benchmark performance is flat over time, and it is possible for a Fund to lose money over time
even if the performance of its benchmark increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing,
the benchmark&#x2019;s volatility, compounding, and other factors. Compounding is the cumulative effect of applying investment gains and
losses and income to the principal amount invested over time. Gains or losses experienced over a given period will increase or reduce
the principal amount invested from which the subsequent period&#x2019;s returns are calculated. The effects of compounding will likely
cause the performance of a Fund to differ from the Fund&#x2019;s stated multiple times the return of its benchmark for the same period.
The effect of compounding becomes more pronounced as benchmark volatility and holding period increase. The impact of compounding will
impact each shareholder differently depending on the period of time an investment in a Fund is held and the volatility of the benchmark
during the holding period of an investment in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater
leverage each affect the impact of compounding on a Fund&#x2019;s returns. Daily compounding of a Fund&#x2019;s investment returns can dramatically
and adversely affect its longer-term performance during periods of high volatility. Volatility may be at least as important to a Fund&#x2019;s
return for a period as the return of the Fund&#x2019;s underlying benchmark.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Each Fund uses leverage and should produce
daily returns that are more volatile than that of its benchmark. For example, the daily return of UVIX should be approximately two times
as volatile on a daily basis as is the return of a fund with an objective of matching the same benchmark. The daily return of SVIX is
designed to return the inverse (-1x) of the return that would be expected of a fund with an objective of matching the same benchmark.
&lt;b&gt;&lt;i&gt;The Funds are not appropriate for all investors and present significant risks not applicable to other types of funds. &lt;/i&gt;&lt;/b&gt;The
Funds use leverage and are riskier than similarly benchmarked exchange-traded funds that do not use leverage. An investor should only
consider an investment in a Fund if he or she understands the consequences of seeking daily leveraged or daily inverse investment results.
Shareholders who invest in the Funds should actively manage and monitor their investments, as frequently as daily.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;While the Funds seek to meet their investment
objectives, there is no guarantee they will do so. Factors that may affect a Fund&#x2019;s ability to meet its investment objective include:
(1) the Sponsor&#x2019;s ability to purchase and sell Financial Instruments in a manner that correlates to a Fund&#x2019;s objective; (2)
an imperfect correlation between the performance of Financial Instruments held by a Fund and the performance of the applicable benchmark;
(3) bid-ask spreads on such Financial Instruments; (4) fees, expenses, transaction costs, financing costs associated with the use of Financial
Instruments and commission costs; (5) holding or trading instruments in a market that has become illiquid or disrupted; (6) a Fund&#x2019;s
Share prices being rounded to the nearest cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated
in advance; (8) the need to conform a Fund&#x2019;s portfolio holdings to comply with investment restrictions or policies or regulatory
or tax law requirements; (9) early and unanticipated closings of the markets on which the holdings of a Fund trade, resulting in the inability
of the Fund to execute intended portfolio transactions; (10) accounting standards; and (11) differences caused by a Fund obtaining exposure
to only a representative sample of the components of a benchmark, over weighting or under weighting certain components of a benchmark
or obtaining exposure to assets that are not included in a benchmark.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;A number of factors may affect a Fund&#x2019;s
ability to achieve a high degree of correlation with its benchmark, and there can be no guarantee that a Fund will achieve a high degree
of correlation. Failure to achieve a high degree of correlation may prevent a Fund from achieving its investment objective. In order to
achieve a high degree of correlation with their underlying benchmarks, the Funds seek to rebalance their portfolios daily to keep exposure
consistent with their investment objectives. Being materially under- or over-exposed to the benchmark may prevent such Funds from achieving
a high degree of correlation with such benchmark. Market disruptions or closure, large amounts of assets into or out of the Funds, regulatory
restrictions, extreme market volatility, and other factors will adversely affect such Funds&#x2019; ability to adjust exposure to requisite
levels. The target amount of portfolio exposure is impacted dynamically by the benchmarks&#x2019; movements during each day. Other things
being equal, more significant movement in the value of its benchmark up or down will require more significant adjustments to a Fund&#x2019;s
portfolio. Because of this, it is unlikely that the Funds will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark
at the end of each day, and the likelihood of being materially under- or over-exposed is higher on days when the benchmark levels are
volatile near the close of the trading day.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Each Fund seeks to rebalance its portfolio
on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending upon market conditions
and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios as frequently, each
Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate exposure to
the underlying benchmarks.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Counterparty Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Each Fund may use derivatives such as swap
agreements and forward contracts (collectively referred to herein as &#x201c;derivatives&#x201d;) in the manner described herein as a means
to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Regulatory Treatment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Derivatives are generally traded in OTC markets
and have only recently become subject to comprehensive regulation in the United States. Cash-settled forwards are generally regulated
as &#x201c;swaps&#x201d;, whereas physically settled forwards are generally not subject to regulation (in the case of commodities other
than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (&#x201c;Title
VII&#x201d;) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible
for the regulation of &#x201c;security-based swaps.&#x201d; The SEC requirements have largely yet to be made effective, but the CFTC requirements
are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage,
including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated
market participants, such as &#x201c;swap dealers,&#x201d; &#x201c;security-based swap dealers,&#x201d; &#x201c;major swap participants,&#x201d;
and &#x201c;major security-based swap participants&#x201d; who are, or will be, subject to significant new capital, registration, recordkeeping,
reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be
developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades
and the counterparties with which the Fund engages in transactions.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;As noted, the CFTC rules may not apply to
all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection of CFTC
regulation or the statutory scheme of the Commodity Exchange Act (the &#x201c;CEA&#x201d;) in connection with each Fund&#x2019;s swap agreements
or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain circumstances,
including in the event of trading abuses or financial failure by participants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Counterparty Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;The Funds will be subject to the credit risk
of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing corporation
in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to the credit
risk of the counterparty to the transaction &#x2013; typically a single bank or financial institution. As a result, a Fund is subject to
increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into as part of
that Fund&#x2019;s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due
to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor&#x2019;s investment in
a Fund may decline.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;The Funds have sought to mitigate these risks
by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily,
subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest in swap agreements
or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are delays in accessing
the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering amounts as
a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;OTC derivatives of the type that may be utilized
by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have uniform terms and
conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit support, such
as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various conditions,
events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms
of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to
the net positions owed to the party under the agreement. For example, if the level of the Fund&#x2019;s benchmark has a dramatic intraday
move that would cause a material decline in the Fund&#x2019;s NAV, the terms of the swap may permit the counterparty to immediately close
out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other
Financial Instruments necessary to achieve the desired exposure consistent with the Fund&#x2019;s objective. This, in turn, may prevent
the Fund from achieving its investment objective, particularly if the level of the Fund&#x2019;s benchmark reverses all or part of its
intraday move by the end of the day.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;In addition, cleared derivatives benefit from
daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To the extent the
Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts, which are
required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap customer
collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions
but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default.
For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted
to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer
of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the
commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do
not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a &#x201c;swap dealer&#x201d;
with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions
because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing
the Funds to suffer a loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;The Sponsor regularly reviews the performance
of its counterparties for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers
the addition of new counterparties and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio
holdings as of the prior Business Day. Each Fund&#x2019;s portfolio holdings identifies its counterparties, as applicable. This portfolio
holdings information may be accessed through the web on the Sponsor&#x2019;s website at www.volatilityshares.com.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Each counterparty and/or any of its affiliates
may be an Authorized Participant or shareholder of a Fund, subject to applicable law.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;The counterparty risk for cleared derivatives
transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and
is a Fund&#x2019;s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative.
Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations
to a Fund.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Leverage Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;The Funds may utilize leverage in seeking
to achieve their respective investment objectives and will lose more money in market environments adverse to their respective daily investment
objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged positions increases the risk of total
loss of an investor&#x2019;s investment, even over periods as short as a single day.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;For example, because UVIX includes a two times
(2x) multiplier, a single-day movement in the relevant benchmark approaching 50% at any point in the day could result in the total loss
or almost total loss of an investor&#x2019;s investment if that movement is contrary to the investment objective of the Fund in which an
investor has invested, even if such Fund&#x2019;s benchmark subsequently moves in an opposite direction, eliminating all or a portion of
the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund or upward single-day
or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than zero at all times.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Liquidity Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Financial Instruments cannot always be liquidated
at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of buy and sell orders
in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract counterparty at
a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds may acquire increases
the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred while trying to
do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically invest in Financial
Instruments related to one benchmark, which in many cases is highly concentrated.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#x201c;Contango&#x201d; and &#x201c;Backwardation&#x201d;
Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;The Funds typically hold futures contracts.
As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for example, a
contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may be replaced
by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as &#x201c;rolling.&#x201d;
Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts
have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred
to as &#x201c;backwardation.&#x201d; In these circumstances, absent other factors, the sale of the January 2020 contract would take place
at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling.
While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not
exist in these markets at all times.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Since the introduction of VIX futures contracts,
there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in time. This can result
in a loss from &#x201c;rolling&#x201d; the VIX futures to maintain the constant weighted average maturity of the applicable Fund benchmark.
Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely affect
the value of a Fund and, accordingly, decrease the return of a Fund.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Natural Disaster/Epidemic Risk&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Natural or environmental disasters, such as
earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease, including
pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and markets
and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster and
health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays,
shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding
results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of
infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment
opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy
of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely
impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual
companies (including, but not limited to, the Funds&#x2019; Sponsor and third party service providers), sectors, industries, markets, securities
and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the
value of the Funds&#x2019; investments. These factors can cause substantial market volatility, exchange trading suspensions and closures
and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary
market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long
such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact
on a Fund&#x2019;s performance, resulting in losses to your investment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;Risk that Current Assumptions and Expectations
Could Become Outdated As a Result of Global Economic Shocks&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;The onset of the novel coronavirus (COVID-19)
has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow and contain
the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies as economic
activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at least equal
to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market in the fastest
such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US, oil experienced
shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as of the date hereof
may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting in significant
losses.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <cik0001793497:RelevantBenchmark contextRef="c0" decimals="2" unitRef="pure">0.50</cik0001793497:RelevantBenchmark>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&lt;b&gt;NOTE 9 &#x2013; SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; "&gt;Management has evaluated the possibility of
subsequent events existing in the Trust&#x2019;s and the Funds&#x2019; financial statements through the date the financial statements were
issued. Management has determined that there are no material events that would require disclosure in the Trust&#x2019;s or the Funds&#x2019;
financial statements through this date.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <cik0001793497:ReceivableForSharesSold
      contextRef="c5"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:VariationMarginReceivable
      contextRef="c4"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="c5"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="c4"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AccountsPayableCurrent
      contextRef="c5"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c6"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsRealized
      contextRef="c6"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsRealized
      contextRef="c7"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsUnrealized
      contextRef="c6"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:ShortTermInvestmentsUnrealized
      contextRef="c7"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:DecreaseIncreaseInVariationMarginReceivable
      contextRef="c6"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c7"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseDueFromOtherRelatedParties
      contextRef="c6"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:IncreaseDecreaseInVariationMarginPayable
      contextRef="c7"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c4"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c5"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c14"
      decimals="0"
      id="hidden-fact-16"
      unitRef="usdPershares">33566600</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c15"
      decimals="0"
      id="hidden-fact-17"
      unitRef="usdPershares">22053090</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c18"
      decimals="0"
      id="hidden-fact-18"
      unitRef="usdPershares">113228400</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c19"
      decimals="0"
      id="hidden-fact-19"
      unitRef="usdPershares">74355720</us-gaap:CommonStockParOrStatedValuePerShare>
    <cik0001793497:AmountOfTotalTrust
      contextRef="c24"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:AmountOfTotalTrust
      contextRef="c25"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:AmountOfTotalTrust
      contextRef="c28"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:AmountOfTotalTrust
      contextRef="c29"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:AmountOfTotalTrust
      contextRef="c32"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:AmountOfTotalTrust
      contextRef="c33"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:TotalTrust
      contextRef="c35"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:TotalTrust
      contextRef="c37"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:TotalTrust
      contextRef="c39"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition
      contextRef="c43"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition
      contextRef="c43"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition
      contextRef="c46"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition
      contextRef="c46"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001793497</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">$35,432,706 of cash is pledged as collateral for futures contracts.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents annualized seven-day yield at September 30, 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">$59,371,717 of cash is pledged as collateral for futures contracts.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Although the Funds&#x2019; shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended September 30, 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-28"
          xlink:label="hidden-fact-28"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-26"
          xlink:label="hidden-fact-26"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day&#x2019;s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-28"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-26"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Percentages are not annualized for the period ended September 30, 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expense ratio would be 2.23% and 2.27% respectively, if brokerage commissions and futures and futures account fees were excluded.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_8_footnote" xlink:label="ix_8_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentages are annualized.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_9_footnote" xlink:label="ix_9_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds&#x2019; net asset value is calculated.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_10_footnote" xlink:label="ix_10_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>45
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !6(:%4'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  5B&A5'C3S4.T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)TU!)'1S6?&D(+B@> O)[&ZP24,RTN[;V\;=+J(/X#$S?[[Y
M!J8S49HAX7,:(B9RF&\FWX<L3=RP(U&4 -D<T>M<SXDP-_=#\IKF9SI U.9#
M'Q $Y[?@D;35I&$!5G$E,M59(TU"34,ZXZU9\?$S]05F#6"/'@-E:.H&F%HF
MQM/4=W %+##"Y/-W >U*+-4_L:4#[)R<LEM3XSC68UMR\PX-O#T]OI1U*Q<R
MZ6!P_I6=I%/$#;M,?FVW][L'I@07HFJ:BM_MA)"<RU:\+ZX__*["?K!N[_ZQ
M\450=?#K+M074$L#!!0    ( !6(:%697)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MS.<SI?3+B_HY_OIG&)-_ 5!+ P04    "  5B&A52B[6 +8%  ![&P  &
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M@",=NE3L]D%ZASX+$'#C.529W5<(;,OW>!RH(KPI(/$'V%4_NTD0>)/8]4A
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M<G4#YM0"!]VVCSSD[ Z<4[KA')"SJK1V<3N?Y'9+;E?+?2/GA(.!$$15-$W
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M$6Q61#SY+P\\QD9\HA CH:5<L(,)K66*9\YEIQ$P:@I'2#(,!C7G=8ZU]$A
MES&LZ6XM!^"\K>Z<Z 7_25D1.?FHER*7D89,DJ#&G%T\?TVROB]7_8JX(.@
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M)/C3=OM K5549@#JT>FJY -"T#,2J/K"@2@GJQ(B?I*,B_G==_O( !0@4P?
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M$*4',&3&D9Z:&)T1[D/Y2U)_4?ZQ,B!MGT7J0*3, R(UE)L#L1I*W8%8J9J
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M@C66J_C+<(D&;XT>=WKI^" 0I\@')!C'#IUEN &D3GNZ4!CM<"IX<\Z<=&[
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M_D%->6]EP\._T(&&SS"K3"$<MY\S]@$_]Q)]U-63\/]Q>)B_O$2/^%I](HH
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M;0'GB _ [\NFZ<(?N$!\*_.;?P-02P,$%     @ %8AH518ZY<:Z!@  S \
M !D   !X;"]W;W)K<VAE971S+W-H965T,3$N>&ULA5=K;]LV%/VN7T&X6Y$
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M[\MI *;M:>W$Z<KWD:5VU)7\,*?/ !H.H/U,:[>=\ '=AV7R#U!+ P04
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M,-[:]A2HJ3IX":WDJ8I7\+@(VZ=G\*UHVW'_\WJ3=?9ZF@%7K0P\*D&V+C7
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MUD@:^$AII+>;T^Z-.T06E2,&%PNX(IU%98VIJ8V(B3*AK>#="#;JE9)[ZRX
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MO.N12T^@- BVB<^.N0UXQ,3/$J]&=K(!ZPN+WKT9B(+=._3L_U!+ P04
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M]9KC=?9597L\]_%%(*!3VEC92)D&/]4P]8BUV$H6\V[+;MRMZ-%P]^J&'_7
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M);B ?E\[PF_Z 0^([VE^\7]02P,$%     @ %8AH5;?I>WZL @  % 8  !D
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M%X? D8[.COX,&!;P'B;M,*@VV;2TWYKH<#I],)J2(^FF#!W.]MP@ HA,#1T
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MH-K'I16,K)J!OI*&GH=FF=%[C,HJT/E:4@GL!>N@>^$G_P!02P,$%     @
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M/!Y%8)LW2[/PI@KOA)GQ].H(TX*>>6CY /V?&^-7"U:P?CA._P=02P,$%
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M%(6'[T%GS+JZ8 \02VN7"L%(,(HE9 T!&JDYH?24AJ@[-)K2U87&;Q62Q^Q
M MSV"%G&-J5<L!QHE=[9JL;:4 K=T;>AS2!9EI0+5(*;AWIFH2DU!2X@MD?:
MH2H*3; H7<V.U4 )N$,QF4*$8IWSH,UY@);5N!NJ25M:=]W?2OH*5$N7"VMP
M]\;ZA6Q:FWQ[ZK+,G]I/;![>UAX-9VWCIV&? OJM/8--2N\_4EI_$%PPM>1"
M0XXIT0MZA_1BJG6.O:X86;HT=2$-);VNF-%W"2H[@/I3*<VF8B=HOG0F/P!0
M2P,$%     @ %8AH5<()'5;N!0  J2H  !D   !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&ULU5K_;]HX%/]7+'::-NG68#LDT%&DCEUU2*W6&]ONI&D_N(D!
M:TF<.0X4Z?[XLT.(Z:"F"\MT^:6-';\O?N^3O ]Y'JZX^)HM*)7@/HZ2[**S
MD#(]=YPL6-"89&<\I8FZ,^,B)E(-Q=S)4D%)6 C%D8.Z7<^)"4LZHV$Q=RM&
M0Y[+B"7T5H LCV,BUF]HQ%<7'=C93KQG\X74$\YHF)(YG5+Y,;T5:N146D(6
MTR1C/ &"SBXZE_!\[/I:H%CQB=%5MG,-]%;N./^J!Y/PHM/5'M&(!E*K(.K?
MDHYI%&E-RH]OI=).95,+[EYOM5\5FU>;N2,9'?/H;Q;*Q46GWP$AG9$\DN_Y
MZD]:;JBG]04\RHJ_8%6N[79 D&>2QZ6P\B!FR>8_N2\#L2. T","J!1 WPE
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M]]5GE.?=DGP@66H:#@LF)8O-ZQJC"'.]0:TO&9/[@0Y0]JPF_P-02P,$%
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M5+?\*,P!O3_C7*TF)D#W)R+Z#5!+ P04    "  5B&A5W#X-S)X#  #N$P
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M%4U5K4AE&%FXYW\I#343;IA2^X;*.M!Z(J6Y,VR"IB&<? =02P,$%     @
M%8AH59:5'J&% @  4 @  !D   !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL
MM99A;]HP$(;_BI554RMMQ 0(E(5(4#2UTBI51>TF5?M@R %6G3BS#;3_?F<G
MS5@5,JVB7XCMW+WW^,[.$>VD>M1K $.>4I'ID;<V)A_ZOEZL(66Z)7/(\,U2
MJI09G*J5KW,%+'%.J? #2D,_93SSXLBMW:@XDALC> 8WBNA-FC+U/ $A=R.O
M[;TLW/+5VM@%/XYRMH(9F+O\1N',KU02GD*FN<R(@N7(&[>'DS:U#L[BGL-.
M[XV)W<I<RD<[N4I&'K5$(&!AK 3#QQ8N0 BKA!R_2E&OBFD=]\<OZE_=YG$S
M<Z;A0HKO/#'KD3?P2 )+MA'F5NXNH=Q0S^HMI-#NE^P*VPX:+S;:R+1T1H*4
M9\63/96)V',(@@,.0>D0..XBD*.<,L/B2,D=4=8:U>S ;=5Y(QS/;%5F1N%;
MCGXF'J\4 &;9:'(Z!<.XT&?DA/",7',A,&\Z\@W&L=;^HM2<%)K! <T9Y"W2
MH9](0(. W,VFY/3D[&\9'S$KUJ!B#9QNYW]8'[ZA%;DRD.J?=:B%9+=>TI[Y
MH<[9 D8>'FH-:@M>_/%#.Z1?&H [%7"G23V>;>:?6;+E6JIGL@0@BAFH@RQD
M!D[&WJ-M3%N4!KW(W]:$[U;ANXWAQUM0>+-(@IEZ)AE><:8UV.QA>:=2"*;T
M61U.(1ONX70.H/0JE%YS)NZO?I"':TCGH&K+U.C^QC*%%5QX_',5O@-POP+N
MOZVPA\Y7O^Y\M0\5=5!A#!HQ[OY5U$;W-^;HO(([/WY1S]\!N$W_?(KI<<M:
MZKVN:_BZKOY>?["]]IJI%<\T$;!$1]KJX^U31?LJ)D;FKF7,I<$&Y(9K;/F@
MK &^7TII7B:V"U5_(N+?4$L#!!0    ( !6(:%7OM@J<1@(  $D%   9
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M"   &0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6S-5FU/VS 0_BNG;)I
M&B1UWU*61AJP"B20$ 4V">V#VUP:"R?.;*?M_OUL)T3=5BH-Q,27QF??/?<\
MEW,OT4K(!Y4A:ECGO%!C+].Z//)]-<\PI^I0E%B8DU3(G&ICRH6O2HDT<4$Y
M]TD0#/R<LL*+([=W)>-(5)JS J\DJ"K/J?QYC%RLQE['>]RX9HM,VPT_CDJZ
MP"GJV_)*&LMO41*68Z&8*$!B.O8^=XZ.1];?.=PQ7*F--5@E,R$>K'&>C+W
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M'NR8[)K64-MT,JX#^MMJ3GM;-GJ5;E#Q1V4^+>QT9-.'(F.WFN5\V?27>6<
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M;',O=V]R:V)O;VLN>&UL+G)E;'/-V,V.@C 4AN%;(;T RSE5U(FXFHW;B3=
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M4NW'=^V\_;1\WEQ\*A/.&HX.C[]02P,$%     @ %8AH51R:"5V, 0  YQ0
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M_O76KDDM57/P9]W_S=D74$L! A0#%     @ %8AH50=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  5
MB&A5'C3S4.T    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    "  5B&A5F5R<(Q &  "<)P  $P
M@ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !6(:%6T)91Z
MT04   @;   8              " @0P(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    "  5B&A5<7@@&[(&  "2(0  &
M@($3#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ %8AH
M54HNU@"V!0  >QL  !@              ("!^Q0  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( !6(:%7PLOBLT00  "L4   8
M      " @><:  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M"  5B&A5G0A Y P'  !Y(P  &               @('N'P  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ %8AH58&%$:&]!   '!0  !@
M             ("!,"<  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( !6(:%7$RU5Q)@0  .T1   8              " @2,L  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    "  5B&A5 ,U5Y*H%   S
M#0  &               @(%_,   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ %8AH58=B*UMM%@  QSP  !@              ("!7S8
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( !6(:%4C$6@L
MK1P  *%9   9              " @0)-  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ %8AH518ZY<:Z!@  S \  !D
M ("!YFD  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    "  5
MB&A5@5>^@>X"  !D!@  &0              @('7<   >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( !6(:%6*_1^C2@8  ),.   9
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M970Q-RYX;6Q02P$"% ,4    "  5B&A5PMT4H7X#  #M!P  &0
M    @('"M@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M !6(:%4$AKR5Z00  -(-   9              " @7>Z  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ %8AH52XPA*]? @  5 4  !D
M             ("!E[\  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    "  5B&A515EHH;X$  !$"@  &0              @($MP@  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( !6(:%4@N[=M]P(
M ,,)   9              " @2+'  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ %8AH5:\H9F*I P  ]0P  !D              ("!
M4,H  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  5B&A5
MP@D=5NX%  "I*@  &0              @($PS@  >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( !6(:%5A8D#;*@0  +\2   9
M      " @574  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ %8AH5>:EF%LZ P  4 P  !D              ("!MM@  'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    "  5B&A5W#X-S)X#  #N$P
M&0              @($GW   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( !6(:%4]AOQ]# ,  !P*   9              " @?S?  !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ %8AH59:5'J&%
M @  4 @  !D              ("!/^,  'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    "  5B&A5[[8*G$8"  !)!0  &0
M@('[Y0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( !6(
M:%6D:GSZAP(  *((   9              " @7CH  !X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ %8AH51U"FSY@!@  '!H  !D
M         ("!-NL  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
M    "  5B&A5PY23WQ0"  ""!   &0              @('-\0  >&PO=V]R
M:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( !6(:%45W]QA. ,  ,@3
M   -              "  1CT  !X;"]S='EL97,N>&UL4$L! A0#%     @
M%8AH59>*NQS     $P(   L              ( !>_<  %]R96QS+RYR96QS
M4$L! A0#%     @ %8AH5?8U90$P P  8A8   \              ( !9/@
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( !6(:%7@/0E7: $  $H4   :
M              "  <'[  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( !6(:%4<F@E=C $  .<4   3              "  6']  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     I "D %@L  ![_      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>49</ContextCount>
  <ElementCount>161</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>26</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Statements of Assets and Liabilities (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Statements of Assets and Liabilities (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Statements of Changes in Net Assets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ConsolidatedIncomeStatement0</Role>
      <ShortName>Statements of Changes in Net Assets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Schedule of Investments (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable</Role>
      <ShortName>Schedule of Investments (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Schedule of Investments (Unaudited) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals</Role>
      <ShortName>Schedule of Investments (Unaudited) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/Agreements</Role>
      <ShortName>Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Offering Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/OfferingCosts</Role>
      <ShortName>Offering Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Creation and Redemption of Creation Units</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/CreationandRedemptionofCreationUnits</Role>
      <ShortName>Creation and Redemption of Creation Units</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Financial Highlights</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/FinancialHighlights</Role>
      <ShortName>Financial Highlights</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/Risk</Role>
      <ShortName>Risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.vts.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vts.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vts.com/role/Investments</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Creation and Redemption of Creation Units (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables</Role>
      <ShortName>Creation and Redemption of Creation Units (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vts.com/role/CreationandRedemptionofCreationUnits</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Financial Highlights (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/FinancialHighlightsTables</Role>
      <ShortName>Financial Highlights (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.vts.com/role/FinancialHighlights</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Investments (Details) - Schedule of fair value of derivative instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable</Role>
      <ShortName>Investments (Details) - Schedule of fair value of derivative instruments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/InvestmentsTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Investments (Details) - Schedule of effect of derivative instruments on the statement of operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable</Role>
      <ShortName>Investments (Details) - Schedule of effect of derivative instruments on the statement of operations</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/InvestmentsTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Investments (Details) - Schedule of pledged by funds fair values of derivative instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable</Role>
      <ShortName>Investments (Details) - Schedule of pledged by funds fair values of derivative instruments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/InvestmentsTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable</Role>
      <ShortName>Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/InvestmentsTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/AgreementsDetails</Role>
      <ShortName>Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/Agreements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Creation and Redemption of Creation Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails</Role>
      <ShortName>Creation and Redemption of Creation Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of transaction fees</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleoftransactionfeesTable</Role>
      <ShortName>Creation and Redemption of Creation Units (Details) - Schedule of transaction fees</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Financial Highlights (Details) - Schedule of share outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/ScheduleofshareoutstandingTable</Role>
      <ShortName>Financial Highlights (Details) - Schedule of share outstanding</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/FinancialHighlightsTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="f10q0922_vstrust.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vts.com/role/RiskDetails</Role>
      <ShortName>Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.vts.com/role/Risk</ParentRole>
      <Position>33</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommonStockParOrStatedValuePerShare -  f10q0922_vstrust.htm 3695, 3696, 3697, 3698</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="f10q0922_vstrust.htm">f10q0922_vstrust.htm</File>
    <File>cik0001793497-20220930.xsd</File>
    <File>cik0001793497-20220930_cal.xml</File>
    <File>cik0001793497-20220930_def.xml</File>
    <File>cik0001793497-20220930_lab.xml</File>
    <File>cik0001793497-20220930_pre.xml</File>
    <File>f10q0922ex31-1_vstrust.htm</File>
    <File>f10q0922ex31-2_vstrust.htm</File>
    <File>f10q0922ex32-1_vstrust.htm</File>
    <File>f10q0922ex32-2_vstrust.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="153">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="34">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>51
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f10q0922_vstrust.htm": {
   "axisCustom": 0,
   "axisStandard": 10,
   "contextCount": 49,
   "dts": {
    "calculationLink": {
     "local": [
      "cik0001793497-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cik0001793497-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "f10q0922_vstrust.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cik0001793497-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cik0001793497-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cik0001793497-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd"
     ]
    }
   },
   "elementCount": 271,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 12,
    "http://www.vts.com/20220930": 21,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 37
   },
   "keyCustom": 56,
   "keyStandard": 105,
   "memberCustom": 17,
   "memberStandard": 5,
   "nsprefix": "cik0001793497",
   "nsuri": "http://www.vts.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.vts.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Investments",
     "role": "http://www.vts.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:AgreementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Agreements",
     "role": "http://www.vts.com/role/Agreements",
     "shortName": "Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:AgreementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:OfferingCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Offering Costs",
     "role": "http://www.vts.com/role/OfferingCosts",
     "shortName": "Offering Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:OfferingCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Creation and Redemption of Creation Units",
     "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnits",
     "shortName": "Creation and Redemption of Creation Units",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Financial Highlights",
     "role": "http://www.vts.com/role/FinancialHighlights",
     "shortName": "Financial Highlights",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Risk",
     "role": "http://www.vts.com/role/Risk",
     "shortName": "Risk",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Subsequent Events",
     "role": "http://www.vts.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:EmergingGrowthCompanyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - Accounting Policies, by Policy (Policies)",
     "role": "http://www.vts.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:EmergingGrowthCompanyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://www.vts.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Investments (Tables)",
     "role": "http://www.vts.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c4",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedAtFairValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Statements of Assets and Liabilities (Unaudited)",
     "role": "http://www.vts.com/role/ConsolidatedBalanceSheet",
     "shortName": "Statements of Assets and Liabilities (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c4",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:InterestReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfTransactionFeesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Creation and Redemption of Creation Units (Tables)",
     "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables",
     "shortName": "Creation and Redemption of Creation Units (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfTransactionFeesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfShareOutstandingTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - Financial Highlights (Tables)",
     "role": "http://www.vts.com/role/FinancialHighlightsTables",
     "shortName": "Financial Highlights (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:ScheduleOfShareOutstandingTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": "-7",
      "first": true,
      "lang": null,
      "name": "cik0001793497:GrossRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - Significant Accounting Policies (Details)",
     "role": "http://www.vts.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": "-7",
      "first": true,
      "lang": null,
      "name": "cik0001793497:GrossRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c6",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:CreateRedeemCutoffDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation",
     "role": "http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c6",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cik0001793497:CreateRedeemCutoffDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:AmountOfTotalTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy",
     "role": "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:AmountOfTotalTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c38",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:TotalTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Investments (Details) - Schedule of fair value of derivative instruments",
     "role": "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable",
     "shortName": "Investments (Details) - Schedule of fair value of derivative instruments",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c38",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:TotalTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c42",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Investments (Details) - Schedule of effect of derivative instruments on the statement of operations",
     "role": "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable",
     "shortName": "Investments (Details) - Schedule of effect of derivative instruments on the statement of operations",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c42",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cik0001793497:ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c44",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Investments (Details) - Schedule of pledged by funds fair values of derivative instruments",
     "role": "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable",
     "shortName": "Investments (Details) - Schedule of pledged by funds fair values of derivative instruments",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cik0001793497:ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c44",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition",
     "role": "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable",
     "shortName": "Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c3",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "cik0001793497:SubadvisoryFeeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - Agreements (Details)",
     "role": "http://www.vts.com/role/AgreementsDetails",
     "shortName": "Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c3",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "cik0001793497:SubadvisoryFeeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestAndOtherIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Statements of Operations (Unaudited)",
     "role": "http://www.vts.com/role/ConsolidatedIncomeStatement",
     "shortName": "Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestAndOtherIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - Creation and Redemption of Creation Units (Details)",
     "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails",
     "shortName": "Creation and Redemption of Creation Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cik0001793497:ScheduleOfTransactionFeesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of transaction fees",
     "role": "http://www.vts.com/role/ScheduleoftransactionfeesTable",
     "shortName": "Creation and Redemption of Creation Units (Details) - Schedule of transaction fees",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cik0001793497:ScheduleOfTransactionFeesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cik0001793497:ScheduleOfShareOutstandingTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c8",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetAssetValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - Financial Highlights (Details) - Schedule of share outstanding",
     "role": "http://www.vts.com/role/ScheduleofshareoutstandingTable",
     "shortName": "Financial Highlights (Details) - Schedule of share outstanding",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "cik0001793497:ScheduleOfShareOutstandingTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c8",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetAssetValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cik0001793497:RelevantBenchmark",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - Risk (Details)",
     "role": "http://www.vts.com/role/RiskDetails",
     "shortName": "Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cik0001793497:RelevantBenchmark",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Statements of Changes in Net Assets (Unaudited)",
     "role": "http://www.vts.com/role/ConsolidatedIncomeStatement0",
     "shortName": "Statements of Changes in Net Assets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Statements of Cash Flows (Unaudited)",
     "role": "http://www.vts.com/role/ConsolidatedCashFlow",
     "shortName": "Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c6",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:TotalContractsObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - Schedule of Investments (Unaudited)",
     "role": "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
     "shortName": "Schedule of Investments (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c3",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cik0001793497:TotalContractsObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c13",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "cik0001793497:MoneyMarketFundPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "006 - Statement - Schedule of Investments (Unaudited) (Parentheticals)",
     "role": "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
     "shortName": "Schedule of Investments (Unaudited) (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c13",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "cik0001793497:MoneyMarketFundPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - Organization",
     "role": "http://www.vts.com/role/Organization",
     "shortName": "Organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - Significant Accounting Policies",
     "role": "http://www.vts.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f10q0922_vstrust.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 26,
   "tag": {
    "cik0001793497_AgreementsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreements (Details) [Line Items]"
       }
      }
     },
     "localname": "AgreementsDetailsLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AgreementsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreements (Details) [Table]"
       }
      }
     },
     "localname": "AgreementsDetailsTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AgreementsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreements Disclosure Abstract"
       }
      }
     },
     "localname": "AgreementsDisclosureAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AgreementsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of agreements disclosure.",
        "label": "Agreements Disclosure Text Block",
        "terseLabel": "AGREEMENTS"
       }
      }
     },
     "localname": "AgreementsDisclosureTextBlock",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/Agreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_AgreementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreements [Abstract]"
       }
      }
     },
     "localname": "AgreementsLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/Agreements"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AgreementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agreements [Table]"
       }
      }
     },
     "localname": "AgreementsTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/Agreements"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_AmountOfTotalTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of trust.",
        "label": "Amount Of Total Trust",
        "terseLabel": "Total Trust"
       }
      }
     },
     "localname": "AmountOfTotalTrust",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sales price you receive with any selling costs you paid deducted.",
        "label": "Amounts Of Recognized Assets Liabilities Presented In The Statements Of Financial Condition One",
        "terseLabel": "Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition"
       }
      }
     },
     "localname": "AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_AssetDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Derivatives Member",
        "terseLabel": "Asset Derivatives [Member]"
       }
      }
     },
     "localname": "AssetDerivativesMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_AuthorizedParticipantsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of authorized participants percentage.",
        "label": "Authorized Participants Percentage",
        "terseLabel": "Authorized participants percentage"
       }
      }
     },
     "localname": "AuthorizedParticipantsPercentage",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_AverageDailyNetAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average daily net assets.",
        "label": "Average Daily Net Assets",
        "terseLabel": "Average daily net assets (in Dollars)"
       }
      }
     },
     "localname": "AverageDailyNetAssets",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_AverageDailyNetAssetsRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average daily net assets rate.",
        "label": "Average Daily Net Assets Rate",
        "terseLabel": "Average daily net assets rate"
       }
      }
     },
     "localname": "AverageDailyNetAssetsRate",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_CBOEVIXFuturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CBOEVIXFutures Member",
        "terseLabel": "CBOE VIX Futures [Member]"
       }
      }
     },
     "localname": "CBOEVIXFuturesMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_CapitalShareTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Share Transactions Abstract",
        "terseLabel": "CAPITAL SHARE TRANSACTIONS"
       }
      }
     },
     "localname": "CapitalShareTransactionsAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income",
        "label": "Change In Unrealized Appreciation Depreciation On Derivatives Recognized In Income",
        "terseLabel": "Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income"
       }
      }
     },
     "localname": "ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_ClassIUnlimitedSharesAuthorizedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class IUnlimited Shares Authorized Abstract",
        "terseLabel": "Class I (unlimited shares authorized):"
       }
      }
     },
     "localname": "ClassIUnlimitedSharesAuthorizedAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ContractsOblication": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contracts Oblication",
        "terseLabel": "Contracts"
       }
      }
     },
     "localname": "ContractsOblication",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_CreateRedeemCutoffDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Create/Redeem Cut-off (EST) 2x Long VIX Futures ETF, description",
        "label": "Create Redeem Cutoff Description",
        "terseLabel": "Create/Redeem Cut-off (EST)"
       }
      }
     },
     "localname": "CreateRedeemCutoffDescription",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Line Items]"
       }
      }
     },
     "localname": "CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleoftransactionfeesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Table]"
       }
      }
     },
     "localname": "CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleoftransactionfeesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_DecreaseIncreaseInVariationMarginReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease Increase In Variation Margin Receivable",
        "negatedLabel": "Decrease (Increase) in Variation margin receivable"
       }
      }
     },
     "localname": "DecreaseIncreaseInVariationMarginReceivable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_EmergingGrowthCompanyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for emerging growth company.",
        "label": "Emerging Growth Company Policy Text Block",
        "terseLabel": "Emerging growth company"
       }
      }
     },
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_ExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses Abstract",
        "terseLabel": "Expenses:"
       }
      }
     },
     "localname": "ExpensesAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ExpiringAugustTwoThousandTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring August Two Thousand Twenty Two Member",
        "terseLabel": "Expiring August 2022 [Member]"
       }
      }
     },
     "localname": "ExpiringAugustTwoThousandTwentyTwoMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_ExpiringJulyTwoThousandTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiring July Two Thousand Twenty Two Member",
        "terseLabel": "Expiring July 2022 [Member]"
       }
      }
     },
     "localname": "ExpiringJulyTwoThousandTwentyTwoMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of final net asset value for fiscal period.",
        "label": "Final Net Asset Value For Fiscal Period Polcy Text Block",
        "terseLabel": "Final Net Asset Value for Fiscal Period"
       }
      }
     },
     "localname": "FinalNetAssetValueForFiscalPeriodPolcyTextBlock",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights (Details) - Schedule of share outstanding [Line Items]"
       }
      }
     },
     "localname": "FinancialHighlightsDetailsScheduleofshareoutstandingLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights (Details) - Schedule of share outstanding [Table]"
       }
      }
     },
     "localname": "FinancialHighlightsDetailsScheduleofshareoutstandingTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialHighlightsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights Disclosure [Abstract]"
       }
      }
     },
     "localname": "FinancialHighlightsLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlights"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialHighlightsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Table]"
       }
      }
     },
     "localname": "FinancialHighlightsTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlights"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial instruments.",
        "label": "Financial Instruments For The Benefit Ofthe Funds The Counterparties Two",
        "terseLabel": "Financial Instruments for the Benefit of (the Funds) / the Counterparties"
       }
      }
     },
     "localname": "FinancialInstrumentsForTheBenefitOftheFundsTheCounterpartiesTwo",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_FirstAmericanFundsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First American Funds Inc Member",
        "terseLabel": "First American Funds Inc, [Member]"
       }
      }
     },
     "localname": "FirstAmericanFundsIncMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_ForeignCurrencyForwardContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Forward Contracts Member",
        "terseLabel": "Foreign Currency Forward Contracts [Member]"
       }
      }
     },
     "localname": "ForeignCurrencyForwardContractsMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_FundsAverageNetAssetsAnnually": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Funds Average Net Assets Annually",
        "terseLabel": "Fund\u2019s average net assets annually"
       }
      }
     },
     "localname": "FundsAverageNetAssetsAnnually",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_FuturesContracts": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_UnrealizedGainLossOnEnergyContracts",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of futures contracts.",
        "label": "Futures Contracts",
        "negatedLabel": "Futures"
       }
      }
     },
     "localname": "FuturesContracts",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_FuturesContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Futures Contracts Member",
        "terseLabel": "Futures Contracts [Member]"
       }
      }
     },
     "localname": "FuturesContractsMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_FuturesContractsUnrealizedAppreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "us-gaap_UnrealizedGainLossOnEnergyContracts",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of futures contracts unrealized appreciation.",
        "label": "Futures Contracts Unrealized Appreciation",
        "negatedLabel": "Futures"
       }
      }
     },
     "localname": "FuturesContractsUnrealizedAppreciation",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gross amounts of recognized assets presented.",
        "label": "Gross Amounts Of Recognized Assets Presented In The Statements Of Financial Condition",
        "terseLabel": "Gross Amounts of Recognized Assets presented in the Statements of Financial Condition"
       }
      }
     },
     "localname": "GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_GrossRevenue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gross revenue.",
        "label": "Gross Revenue",
        "terseLabel": "Annual gross revenue"
       }
      }
     },
     "localname": "GrossRevenue",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Abstract",
        "terseLabel": "Income:"
       }
      }
     },
     "localname": "IncomeAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_IncreaseDecreaseInDueToCustodian": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Due To Custodian",
        "terseLabel": "Increase (Decrease) in Due to Custodian"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToCustodian",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncreaseDecreaseInNetAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Net Assets Abstract",
        "terseLabel": "INCREASE (DECREASE) IN NET ASSETS:"
       }
      }
     },
     "localname": "IncreaseDecreaseInNetAssetsAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_IncreaseDecreaseInPayableToSponsor": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Payable To Sponsor",
        "negatedLabel": "Increase (Decrease) in Payable to Sponsor"
       }
      }
     },
     "localname": "IncreaseDecreaseInPayableToSponsor",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncreaseDecreaseInVariationMarginPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in variation margin payable.",
        "label": "Increase Decrease In Variation Margin Payable",
        "terseLabel": "Increase (Decrease) in Variation margin payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInVariationMarginPayable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in licensing and registration fees payable.",
        "label": "Increase In Licensing And Registration Fees Payable",
        "terseLabel": "Increase (Decrease) in Licensing and registration fees payable"
       }
      }
     },
     "localname": "IncreaseInLicensingAndRegistrationFeesPayable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_IncreaseInProfessionalFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in professional fees payable.",
        "label": "Increase In Professional Fees Payable",
        "terseLabel": "Increase (Decrease) in Professional fees payable"
       }
      }
     },
     "localname": "IncreaseInProfessionalFeesPayable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_InvestmentCompanyTotalReturnMarketValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage increase (decrease) in fund market value, assuming reinvestment of dividends and capital gain distributions.",
        "label": "Investment Company Total Return Market Value",
        "terseLabel": "Total Return at Market Value"
       }
      }
     },
     "localname": "InvestmentCompanyTotalReturnMarketValue",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_InvestmentIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Income Abstract",
        "terseLabel": "INVESTMENT INCOME"
       }
      }
     },
     "localname": "InvestmentIncomeAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Line Items]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Table]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition [Line Items]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition [Table]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Line Items]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Table]"
       }
      }
     },
     "localname": "InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_LiabilityDerivativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Derivatives Member",
        "terseLabel": "Liability Derivatives\t[Member]"
       }
      }
     },
     "localname": "LiabilityDerivativesMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_LicensingAndRegistrationFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of licensing and registration fees payable.",
        "label": "Licensing And Registration Fees Payable",
        "terseLabel": "Licensing and registration fees payable"
       }
      }
     },
     "localname": "LicensingAndRegistrationFeesPayable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_MarketValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share excess of market value per share.",
        "label": "Market Value Per Share",
        "terseLabel": "Market Value Per Share, at September 30, 2022"
       }
      }
     },
     "localname": "MarketValuePerShare",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cik0001793497_MoneyMarketFundPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money market fund, percentage",
        "label": "Money Market Fund Percentage",
        "terseLabel": "Money market fund, percentage"
       }
      }
     },
     "localname": "MoneyMarketFundPercentage",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_NAVCalculationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the NAV calculation date.",
        "label": "NAVCalculation Date",
        "terseLabel": "NAV Calculation Date"
       }
      }
     },
     "localname": "NAVCalculationDate",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable"
     ],
     "xbrltype": "dateItemType"
    },
    "cik0001793497_NAVCalculationTimeESTDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NAV Calculation Time (EST), description.",
        "label": "NAVCalculation Time ESTDescription",
        "terseLabel": "NAV Calculation Time (EST)"
       }
      }
     },
     "localname": "NAVCalculationTimeESTDescription",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net assets presented.",
        "label": "Net Amounts Of Assets Presented In The Statements Of Financial Condition",
        "terseLabel": "Gross Amounts Offset in the Statements of Financial Condition",
        "verboseLabel": "Net Amounts of Assets presented in the Statements of Financial Condition"
       }
      }
     },
     "localname": "NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NetAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Assets Abstract",
        "terseLabel": "NET ASSETS"
       }
      }
     },
     "localname": "NetAssetsAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_NetAssetsConsistOfAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Assets Consist Of Abstract",
        "terseLabel": "NET ASSETS CONSIST OF:"
       }
      }
     },
     "localname": "NetAssetsConsistOfAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_NetChangeInUnrealizedAppreciationDepreciationOfAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Change In Unrealized Appreciation Depreciation Of Abstract",
        "terseLabel": "Net change in unrealized appreciation (depreciation) of:"
       }
      }
     },
     "localname": "NetChangeInUnrealizedAppreciationDepreciationOfAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net increase in net assets from capital share transactions.",
        "label": "Net Increase In Net Assets From Capital Share Transactions",
        "totalLabel": "Net increase in net assets from capital share transactions"
       }
      }
     },
     "localname": "NetIncreaseInNetAssetsFromCapitalShareTransactions",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment, and future contracts.",
        "label": "Net Realized And Unrealized Gain Loss On Investments And Futures Contracts",
        "terseLabel": "Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts"
       }
      }
     },
     "localname": "NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "cik0001793497_NetRealizedGainLossOnAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Realized Gain Loss On Abstract",
        "terseLabel": "Net realized gain (loss) on:"
       }
      }
     },
     "localname": "NetRealizedGainLossOnAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_NonaffiliatesExceeded": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-affiliates exceeded.",
        "label": "Nonaffiliates Exceeded",
        "terseLabel": "Non-affiliates exceeded"
       }
      }
     },
     "localname": "NonaffiliatesExceeded",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_NonconvertibleDebtSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-convertible debt securities.",
        "label": "Nonconvertible Debt Securities",
        "terseLabel": "Non-convertible debt securities"
       }
      }
     },
     "localname": "NonconvertibleDebtSecurities",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_OfferingCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Costs Abstract"
       }
      }
     },
     "localname": "OfferingCostsAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_OfferingCostsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of offering costs .",
        "label": "Offering Costs Text Block",
        "terseLabel": "OFFERING COSTS"
       }
      }
     },
     "localname": "OfferingCostsTextBlock",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/OfferingCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_OneShortVIXFuturesETFMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Short VIXFutures ETFMember",
        "netLabel": "-1x Short VIX Futures ETF [Member]",
        "terseLabel": "-1x Short VIX Futures ETF",
        "verboseLabel": "1x Short VIX Futures ETF"
       }
      }
     },
     "localname": "OneShortVIXFuturesETFMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedCashFlow",
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/DocumentAndEntityInformation",
      "http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable",
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable",
      "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable",
      "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable",
      "http://www.vts.com/role/ScheduleofshareoutstandingTable",
      "http://www.vts.com/role/ScheduleoftransactionfeesTable",
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_OnexShortVIXFuturesETFMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Onex Short VIXFutures ETFMember",
        "terseLabel": "1 x Short VIX Futures ETF [Member]",
        "verboseLabel": "-1x Short VIX Futures ETF [Member]"
       }
      }
     },
     "localname": "OnexShortVIXFuturesETFMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
      "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_OperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operations Abstract",
        "terseLabel": "OPERATIONS"
       }
      }
     },
     "localname": "OperationsAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_OtherAssetsInExcessOfLiabilitiesAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other assets in excess of liabilities.",
        "label": "Other Assets In Excess Of Liabilities Amount",
        "terseLabel": "Other Assets in Excess of Liabilities"
       }
      }
     },
     "localname": "OtherAssetsInExcessOfLiabilitiesAmount",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other assets in excess of liabilities, percentage.",
        "label": "Other Assets In Excess Of Liabilities Percentage",
        "terseLabel": "Other assets in excess of liabilities, percentage"
       }
      }
     },
     "localname": "OtherAssetsInExcessOfLiabilitiesPercentage",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_PayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables Abstract",
        "terseLabel": "Payables"
       }
      }
     },
     "localname": "PayablesAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ProceedsFromSaleOfUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of units.",
        "label": "Proceeds From Sale Of Units",
        "terseLabel": "Proceeds from shares sold, net of cost from shares purchased"
       }
      }
     },
     "localname": "ProceedsFromSaleOfUnits",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sales or maturities of investments.",
        "label": "Proceeds From Sales Or Maturities Of Investments",
        "terseLabel": "Proceeds from sales or maturities of investments held"
       }
      }
     },
     "localname": "ProceedsFromSalesOrMaturitiesOfInvestments",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_PurchasesOfInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments during the period.",
        "label": "Purchases Of Investments",
        "negatedLabel": "Purchase of investments"
       }
      }
     },
     "localname": "PurchasesOfInvestments",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_RatiosToAverageNetAssets5Abstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ratios To Average Net Assets5 Abstract",
        "terseLabel": "Ratios to Average Net Assets: (5)"
       }
      }
     },
     "localname": "RatiosToAverageNetAssets5Abstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Realized And Unrealized Gain Loss On Investments And Futures Contracts Abstract",
        "terseLabel": "REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES CONTRACTS"
       }
      }
     },
     "localname": "RealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContractsAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ReceivableForSharesSold": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represent receivable for shares sold.",
        "label": "Receivable For Shares Sold",
        "terseLabel": "Receivable for shares sold"
       }
      }
     },
     "localname": "ReceivableForSharesSold",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_RelevantBenchmark": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of relevant benchmark.",
        "label": "Relevant Benchmark",
        "terseLabel": "Relevant benchmark"
       }
      }
     },
     "localname": "RelevantBenchmark",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/RiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_RiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Abstract]"
       }
      }
     },
     "localname": "RiskLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/Risk"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_RiskTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Table]"
       }
      }
     },
     "localname": "RiskTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/Risk"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SVIXMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SVIXMember",
        "terseLabel": "SVIX [Member]"
       }
      }
     },
     "localname": "SVIXMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails",
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_ScheduleOfCutOffTimesAndTimesOfCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Cut Off Times And Times Of Calculation Abstract"
       }
      }
     },
     "localname": "ScheduleOfCutOffTimesAndTimesOfCalculationAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cut-off times and times of calculation.",
        "label": "Schedule Of Cutoff Times And Times Of Calculation Table Text Block",
        "terseLabel": "Schedule of cut-off times and times of calculation"
       }
      }
     },
     "localname": "ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Effect Of Derivative Instruments On The Statement Of Operations Abstract"
       }
      }
     },
     "localname": "ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Of Derivative Instruments Abstract"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfDerivativeInstrumentsAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Gross Amounts Not Offset In The Statements Of Financial Condition Abstract"
       }
      }
     },
     "localname": "ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfInvestmentsUnauditedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Investments Unaudited Abstract"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsUnauditedAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Abstract"
       }
      }
     },
     "localname": "ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of pledged by funds fair values of derivative instruments.",
        "label": "Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Table Text Block",
        "terseLabel": "Schedule of pledged by funds fair values of derivative instruments"
       }
      }
     },
     "localname": "ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_ScheduleOfShareOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Outstanding Abstract"
       }
      }
     },
     "localname": "ScheduleOfShareOutstandingAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfShareOutstandingTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of share outstanding.",
        "label": "Schedule Of Share Outstanding Table Text Block",
        "terseLabel": "Schedule of share outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareOutstandingTableTextBlock",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlightsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_ScheduleOfTransactionFeesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Transaction Fees Abstract"
       }
      }
     },
     "localname": "ScheduleOfTransactionFeesAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_ScheduleOfTransactionFeesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of transaction fees.",
        "label": "Schedule Of Transaction Fees Table Text Block",
        "terseLabel": "Schedule of transaction fees"
       }
      }
     },
     "localname": "ScheduleOfTransactionFeesTableTextBlock",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Valuation Of Investments At Using The Fair Value Hierarchy Abstract"
       }
      }
     },
     "localname": "ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract",
     "nsuri": "http://www.vts.com/20220930",
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 2.0,
       "parentTag": "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of shares sold, net of shares redeemed.",
        "label": "Shares Sold Net Of Shares Redeemedin Dollars Per Share",
        "negatedLabel": "Shares redeemed"
       }
      }
     },
     "localname": "SharesSoldNetOfSharesRedeemedinDollarsPerShare",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_SharesSoldinShares": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 1.0,
       "parentTag": "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Soldin Shares",
        "negatedLabel": "Shares sold"
       }
      }
     },
     "localname": "SharesSoldinShares",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_ShortTermInvestmentsRealized": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_UnrealizedGainLossOnEnergyContracts",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short Term Investments Realized",
        "terseLabel": "Short Term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsRealized",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_ShortTermInvestmentsUnrealized": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_UnrealizedGainLossOnEnergyContracts",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short Term Investments Unrealized",
        "terseLabel": "Short Term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsUnrealized",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of cut-off times and times of calculation [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofcutofftimesandtimesofcalculationTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_SignificantAccountingPoliciesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsTable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cik0001793497_StatementsOfCashFlowsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of statements of cash flows.",
        "label": "Statements Of Cash Flows Policy Text Block",
        "terseLabel": "Statements of Cash Flows"
       }
      }
     },
     "localname": "StatementsOfCashFlowsPolicyTextBlock",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cik0001793497_SubadvisoryFeeRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of sub-advisory fee rate.",
        "label": "Subadvisory Fee Rate",
        "terseLabel": "Sub-advisory fee rate"
       }
      }
     },
     "localname": "SubadvisoryFeeRate",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_SwapAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Swap Agreements Member",
        "terseLabel": "Swap Agreements [Member]"
       }
      }
     },
     "localname": "SwapAgreementsMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_TotalContractsObligations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Total Contracts Obligations",
        "terseLabel": "Total Contracts"
       }
      }
     },
     "localname": "TotalContractsObligations",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_TotalNetAssetsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total net assets, percentage.",
        "label": "Total Net Assets Percentage",
        "terseLabel": "Total net assets, percentage"
       }
      }
     },
     "localname": "TotalNetAssetsPercentage",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "percentItemType"
    },
    "cik0001793497_TotalTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Trust amount.",
        "label": "Total Trust",
        "terseLabel": "Total Trust"
       }
      }
     },
     "localname": "TotalTrust",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cik0001793497_TwoXLongVIXFuturesETFMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two XLong VIXFutures ETFMember",
        "terseLabel": "2x Long VIX Futures ETF [Member]"
       }
      }
     },
     "localname": "TwoXLongVIXFuturesETFMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_TwoxLongVIXFuturesETFMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Twox Long VIXFutures ETFMember",
        "netLabel": "2x Long VIX Futures ETF [Mmeber]",
        "terseLabel": "2x Long VIX Futures ETF",
        "verboseLabel": "2x Long VIX Futures ETF [Member]"
       }
      }
     },
     "localname": "TwoxLongVIXFuturesETFMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedCashFlow",
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/DocumentAndEntityInformation",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
      "http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable",
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable",
      "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable",
      "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable",
      "http://www.vts.com/role/ScheduleofshareoutstandingTable",
      "http://www.vts.com/role/ScheduleoftransactionfeesTable",
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_UVIXMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UVIXMember",
        "terseLabel": "UVIX [Member]"
       }
      }
     },
     "localname": "UVIXMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails",
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_UnrealizedAppreciationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Appreciation Member",
        "terseLabel": "Unrealized Appreciation [Member]"
       }
      }
     },
     "localname": "UnrealizedAppreciationMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_UnrealizedDepreciationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Depreciation Member",
        "terseLabel": "Unrealized Depreciation [Member]"
       }
      }
     },
     "localname": "UnrealizedDepreciationMember",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "cik0001793497_VariationMarginReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variation margin receivable.",
        "label": "Variation Margin Receivable",
        "terseLabel": "Variation margin receivable"
       }
      }
     },
     "localname": "VariationMarginReceivable",
     "nsuri": "http://www.vts.com/20220930",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.vts.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r40",
      "r83",
      "r88",
      "r94",
      "r150",
      "r151",
      "r152",
      "r153",
      "r177",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedCashFlow",
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
      "http://www.vts.com/role/ScheduleofcutofftimesandtimesofcalculationTable",
      "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable",
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable",
      "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable",
      "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable",
      "http://www.vts.com/role/ScheduleofshareoutstandingTable",
      "http://www.vts.com/role/ScheduleoftransactionfeesTable",
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r40",
      "r83",
      "r88",
      "r94",
      "r150",
      "r151",
      "r152",
      "r153",
      "r177",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals",
      "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable",
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable",
      "http://www.vts.com/role/ScheduleoftransactionfeesTable",
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r14",
      "r180"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Variation margin payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableOtherCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable, Other, Current",
        "terseLabel": "Administrative, accounting and custodian fees payable"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r202",
      "r210"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accrued Professional Fees",
        "terseLabel": "Professional fees payable"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r11",
      "r180"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "negatedLabel": "Paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r7",
      "r38",
      "r64",
      "r66",
      "r70",
      "r77",
      "r83",
      "r84",
      "r85",
      "r87",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r94",
      "r95",
      "r150",
      "r152",
      "r171",
      "r178",
      "r180",
      "r201",
      "r206"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Assets Held-in-trust, Noncurrent",
        "terseLabel": "Total Trust"
       }
      }
     },
     "localname": "AssetsHeldInTrustNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleoftransactionfeesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r1",
      "r217",
      "r227",
      "r231",
      "r232"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Net Assets",
        "periodEndLabel": "End of Period",
        "periodStartLabel": "Beginning of Period",
        "terseLabel": "Net Assets",
        "totalLabel": "NET ASSETS"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r30",
      "r35",
      "r36"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "End of Period",
        "periodStartLabel": "Beginning of Period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r30",
      "r172"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "NET DECREASE IN CASH"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommodityContractAssetCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the asset arising from commodity contracts such as futures contracts tied to the movement of a particular commodity, which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer.",
        "label": "Commodity Contract Asset, Current",
        "terseLabel": "Deposit at Broker for Futures"
       }
      }
     },
     "localname": "CommodityContractAssetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Market value (in Dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "RISK"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/Risk"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesRealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Realized Gain (Loss)",
        "terseLabel": "Realized Gain (Loss) on Derivatives Recognized in Income"
       }
      }
     },
     "localname": "DebtSecuritiesRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r146",
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Cash pledged as collateral (in Dollars)"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r16",
      "r156",
      "r157",
      "r160",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r110",
      "r111",
      "r137",
      "r138",
      "r139",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "CREATION AND REDEMPTION OF CREATION UNITS"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creation and Redemption of Creation Units [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureTextBlockSupplementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Text Block Supplement [Abstract]"
       }
      }
     },
     "localname": "DisclosureTextBlockSupplementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r3",
      "r9",
      "r39",
      "r86",
      "r88",
      "r89",
      "r93",
      "r94",
      "r95",
      "r174"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Due from Other"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToOtherRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r14",
      "r39",
      "r174"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount payable to related parties classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Due to Other Related Parties, Current",
        "terseLabel": "Due to Custodian"
       }
      }
     },
     "localname": "DueToOtherRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r96",
      "r97",
      "r98",
      "r101",
      "r102",
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r109",
      "r167",
      "r183",
      "r184",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r96",
      "r101",
      "r102",
      "r107",
      "r109",
      "r167",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level I - Quoted Prices [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r96",
      "r97",
      "r98",
      "r101",
      "r102",
      "r107",
      "r109",
      "r167",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level II - Other Significant Observable Inputs [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r96",
      "r97",
      "r98",
      "r101",
      "r102",
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r109",
      "r183",
      "r184",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r155",
      "r158",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablesPeriodPastDueAxis": {
     "auth_ref": [
      "r72",
      "r80",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by period in which financial asset is past due or not past due.",
        "label": "Financial Asset, Aging [Axis]"
       }
      }
     },
     "localname": "FinancingReceivablesPeriodPastDueAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FloorBrokerageExchangeAndClearanceFees": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense during the period for floor brokerage fees paid to other broker-dealers to execute trades on their behalf, stock exchange fees, order flow fees, and clearance fees.",
        "label": "Floor Brokerage, Exchange and Clearance Fees",
        "terseLabel": "Broker interest expense"
       }
      }
     },
     "localname": "FloorBrokerageExchangeAndClearanceFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FloorBrokeragePolicy": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the recognition and recording of fees paid to other broker dealers for executing trades. Broker-dealers often use other brokers to execute trades on their behalf. The trading broker-dealer becomes a customer of the executing broker-dealer and pays a floor brokerage fee. Such fees are paid periodically either directly to the executing broker-dealer or through a clearinghouse. These include fees paid to clearing brokers and market specialists.",
        "label": "Floor Brokerage, Policy [Policy Text Block]",
        "terseLabel": "Brokerage Commissions and Futures Account Fees"
       }
      }
     },
     "localname": "FloorBrokeragePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r26",
      "r33",
      "r73"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "terseLabel": "Net investment loss"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "Administrative, accounting and custodian fees"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r19",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Federal Income Tax"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseDueFromOtherRelatedParties": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables due from related parties classified as other.",
        "label": "Increase (Decrease) Due from Other Related Parties",
        "negatedLabel": "Decrease (Increase) in Due from Other"
       }
      }
     },
     "localname": "IncreaseDecreaseDueFromOtherRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.",
        "label": "Increase (Decrease) in Accrued Interest Receivable, Net",
        "negatedLabel": "Decrease (Increase) in interest receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedInterestReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of deposits given by the reporting entity to a seller which shows that the prospective buyer is serious about purchasing a property.",
        "label": "Increase (Decrease) in Earnest Money Deposits Outstanding",
        "negatedLabel": "Decrease (Increase) in Deposits at broker for futures contracts"
       }
      }
     },
     "localname": "IncreaseDecreaseInEarnestMoneyDepositsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
        "terseLabel": "Increase (Decrease) in Administrative, accounting and custodian fees payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Decrease (Increase) in other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of expense, after incentive allocation, to average net assets.",
        "label": "Investment Company, Expense Ratio after Incentive Allocation",
        "terseLabel": "Expense ratio"
       }
      }
     },
     "localname": "InvestmentCompanyExpenseRatioAfterIncentiveAllocation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment.",
        "label": "Investment Company, Gain (Loss) on Investment, Per Share",
        "terseLabel": "Net investment loss"
       }
      }
     },
     "localname": "InvestmentCompanyGainLossOnInvestmentPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_InvestmentCompanyInvestmentIncomeLossRatio": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of investment income (loss) to average net assets.",
        "label": "Investment Company, Investment Income (Loss) Ratio",
        "terseLabel": "Net Investment Loss"
       }
      }
     },
     "localname": "InvestmentCompanyInvestmentIncomeLossRatio",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit amount of increase (decrease) in net asset value.",
        "label": "Investment Company, Net Asset Value Per Share, Period Increase (Decrease)",
        "terseLabel": "Net Increase (Decrease) in Net Asset Value Resulting from Operations"
       }
      }
     },
     "localname": "InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease": {
     "auth_ref": [
      "r216",
      "r229"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in net assets from operations of investment company.",
        "label": "Investment Company, Net Assets from Operations, Increase (Decrease)",
        "terseLabel": "NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS",
        "totalLabel": "Net increase (decrease) in net assets resulting from operations"
       }
      }
     },
     "localname": "InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r217"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in net assets of investment company.",
        "label": "Investment Company, Net Assets, Period Increase (Decrease)",
        "totalLabel": "Total increase in net assets"
       }
      }
     },
     "localname": "InvestmentCompanyNetAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentCompanyTotalReturn": {
     "auth_ref": [
      "r220",
      "r221",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.",
        "label": "Investment Company, Total Return",
        "terseLabel": "Total Return at Net Asset Value"
       }
      }
     },
     "localname": "InvestmentCompanyTotalReturn",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r25",
      "r27"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "totalLabel": "Total Income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r226",
      "r233",
      "r234"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.",
        "label": "Investment Owned, at Fair Value",
        "terseLabel": "Investments in securities, at value *",
        "verboseLabel": "Investments in securities, at cost"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r76",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment Valuation"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r74",
      "r75",
      "r78",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "INVESTMENTS"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "terseLabel": "Licensing and registration fees"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r15",
      "r38",
      "r67",
      "r77",
      "r83",
      "r84",
      "r85",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r94",
      "r95",
      "r151",
      "r152",
      "r153",
      "r171",
      "r178",
      "r179"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ManagementFeeExpense": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).",
        "label": "Management Fee Expense",
        "terseLabel": "Management fees"
       }
      }
     },
     "localname": "ManagementFeeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ManagementFeePayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of the unpaid portion of the fee payable to the managing member or general partner for management of the fund or trust.",
        "label": "Management Fee Payable",
        "terseLabel": "Management fees payable"
       }
      }
     },
     "localname": "ManagementFeePayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Fund [Member]"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetAssetValuePerShare": {
     "auth_ref": [
      "r164",
      "r165",
      "r168",
      "r223",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.",
        "label": "Net Asset Value Per Share",
        "periodEndLabel": "Net Asset Value, End of Period",
        "periodStartLabel": "Net Asset Value, Beginning of Period",
        "terseLabel": "Net Asset Value, Offering and Redemption Price per Share (in Dollars per share)"
       }
      }
     },
     "localname": "NetAssetValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ScheduleofshareoutstandingTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOW FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r30",
      "r31",
      "r34"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOW FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r17",
      "r18",
      "r20",
      "r21",
      "r34",
      "r38",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r64",
      "r65",
      "r68",
      "r69",
      "r71",
      "r77",
      "r83",
      "r84",
      "r85",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r94",
      "r95",
      "r163",
      "r171",
      "r204",
      "r211"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net increase (decrease) in net assets resulting from operations"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of writeoff of accrued interest on net investment in sales-type and direct financing leases recognized by reversing interest income.",
        "label": "Net Investment in Lease, Accrued Interest, Writeoff",
        "negatedTotalLabel": "Net Investment Loss"
       }
      }
     },
     "localname": "NetInvestmentInLeaseAccruedInterestWriteoff",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "ORGANIZATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/Organization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r6",
      "r200",
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "terseLabel": "TOTAL NET ASSETS"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r155",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestments": {
     "auth_ref": [
      "r5",
      "r208"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments classified as other.",
        "label": "Other Investments",
        "terseLabel": "Total Investment"
       }
      }
     },
     "localname": "OtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r155",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Liabilities [Member]"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivable"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherShortTermInvestments": {
     "auth_ref": [
      "r13",
      "r203",
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term investments classified as other.",
        "label": "Other Short-Term Investments",
        "terseLabel": "TOTAL SHORT TERM INVESTMENT"
       }
      }
     },
     "localname": "OtherShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Cost of shares redeemed"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r228",
      "r230"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r53",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "FINANCIAL HIGHLIGHTS"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/FinancialHighlights"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Net realized gain (loss) on investments and futures contracts"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r108",
      "r173",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r108",
      "r173",
      "r174",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/AgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r108",
      "r173",
      "r176",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r12",
      "r100",
      "r180",
      "r207",
      "r214",
      "r215"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Total distributable earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of gross amounts not offset in the statements of financial condition"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of fair value of derivative instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of valuation of investments at using the fair value hierarchy"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of effect of derivative instruments on the statement of operations"
       }
      }
     },
     "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "terseLabel": "Shares of fund"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedCashFlow",
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r42",
      "r43",
      "r44",
      "r55",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedBalanceSheet",
      "http://www.vts.com/role/ConsolidatedCashFlow",
      "http://www.vts.com/role/ConsolidatedIncomeStatement",
      "http://www.vts.com/role/ConsolidatedIncomeStatement0",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable",
      "http://www.vts.com/role/ScheduleofInvestmentsUnauditedTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrealizedGainLossOnEnergyContracts": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of open agreements to purchase or sell energy at some future point, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Energy Contracts",
        "totalLabel": "Net realized and unrealized gain (loss) on investments and futures contracts"
       }
      }
     },
     "localname": "UnrealizedGainLossOnEnergyContracts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.vts.com/role/ConsolidatedIncomeStatement0": {
       "order": 3.0,
       "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Net change in unrealized appreciation (depreciation) of investments and futures contracts"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/ConsolidatedIncomeStatement0"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnremittedEarningsInForeignInvestmentPolicy": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for tax treatment of unremitted earnings in a foreign investment.",
        "label": "Unremitted Earnings in Foreign Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment Transactions and Related Income"
       }
      }
     },
     "localname": "UnremittedEarningsInForeignInvestmentPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates &amp; Indemnifications"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.vts.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121829422&loc=d3e41263-109329"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "59",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL6740821-110257"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=35710059&loc=d3e41357-110954"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.5)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f,g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10328-115837"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10342-115837"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10396-115837"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10403-115837"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10411-115837"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(h)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874234-224268"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r236": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r237": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r238": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r239": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r240": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r241": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r242": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL124452896-108306"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "https://asc.fasb.org/topic&trid=2126967"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "https://asc.fasb.org/topic&trid=75115024"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "https://asc.fasb.org/topic&trid=2197064"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL120267969-210447"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>52
<FILENAME>0001213900-22-070181-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-22-070181-xbrl.zip
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MAB+K!'"!YT;7!\8=GACE4Z-:.:^^/3]Z9_2Z=:-:KE:#+#^]G])S:@W!R#2
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M;/R\6,C>S&:KO44&)H+/HKQLA2ZDR'-C3IAV+B&U7$Q] MB79.[]9%#2]>
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M%\66V,M10_858N7-FLC!9"3R:OBZA$)PP[[UOL3H4FL(1J9P+?X'4$L#!!0
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MOH!@RBA#J =@@A=HGN4LEN\!,/S[G#'(V2)C$IT)>#O0= %[L:.->T=!,EB
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M',>?.<Y_/5:U9EF]!7"0L*C1M[=K38>P<TH"6\$C/-HP;B9O$0'=QA "<[2
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MU5KK"4M,$X@7J8=(A!%49R5)XX$GEP'G=52-D\ZDT:X]"6HE1\9\TDA0%7E
M-,_,8=,6PE!KB+;+?[!<8FA%<S(NX?9G%8WE0MQ,[Y_U.TDQ)>CMM2WR"UOY
M%'K0%%'3FI9<#WS.-0VB\EQDM4,I?BA%?K>$>!?>BVJ5RHNJIOI7D0^Z0A#/
MUB5O4NDM* _'#N]$&@%7F\N1*UFRR[0!6F\.7K"A,*/-!4)#9&&V'[Z$T=_:
MZIH-Q3"7&>+3K#B^]3.FC+?5GQP*YJSZQOJ^L;YOK.\;Z_O&^KZQOF^L[QOK
M^\;ZOUQC?3;<':)-7"S?YUU+N:N;!@&,ZK4DX= VNQ-)G100,IY[:6"!!>ZL
M !E-S?B%V5S%6Y!B'J93GN7FEVG4*\9'VZR.*$VSY<7X$R: \BZ8:E[&%Q"?
M>FH T])%65,*:2$%N7_+J!8SCGZ7/O_85>U*9R&KFD EAN9$DY7"22*3[47?
MLN%&+=DN-Z,U14AO']KVDA8'13\+EU=SA(R_P7C-KZAXFH=%<\%TRY*NW=$T
M^B>[*IR:$I7BTG-=@$GQ,",!+7$Q,=_.HD*%?'AJW0Z'G:>Y?0CSS64/*-[H
MTI21Z3><N(I%4*UWIVJC'&I@CF<;BVY*V'?A&$03O8OCK/J02\D40U6#3_<P
MA"E/6BD_6?1-3O?EM*CJ$;^U44G+C007@,RO7>_Y4%C7?0M!WT+0MQ#T+01]
M"T'?0M"W$/0M!'T+P3??0I ZI\OBQSOLK1P:?9ZO'P@K,(V2(40#NE%<Z;Q"
M4D" /6A"%X%52_TNRMMX"\C*4.I5EZ)M=A<M;L>Y4^M;M&H]H=@5(G\$<25P
MXMU#&JA;C@LSG">>V36I1<3N7^:C13&Z+Y8-L#4'!)+1M+0LS_TJ+2%F=F7K
M7"\%]]26X*FY(D5EMR"TPX3Z&+B4/;X%- 0(I5:B6GX&?REU-\!=VWR_?/L<
MNWN',K[U$%Q?PJ5'')^, I_X -GT"967-)KR-^C+==N'A%*4SE++VNE6BN3O
MSP!')U!O 9XYB"(!G97$#91-.'S#ZI> 7>G4FG(SW)FBM)5 QX3<1LS-M8*;
M<PK5VM T,BXO1GPS>,)<]4Z/@^$W[!.:P*[ECK5=QI<!#'L-\]?!:]9[!6,3
M_4NF#:!*#[57[DKM%_*FN/-BDKN.FIO\M^OR1?&.]?Y62_8\+P8U0?J8% G/
M=H#HC)=:LG^E+6$]QK&*WVG*!>0%B(UKXHV7K*P@6BGA(&PTM6Y:SWF88TV?
MJ6F;J(DC:"CI!?398S'8N/0HN-1WJ;V,)'_=@(]/44FZ2,M0Q>V&='>DNYH7
M?SG=;UCMC2%.5*SEQ/"6_XUCL6X,*CZR[^$LOC_!0RK5S</CKQ;L<2*?6(&R
M8T/-:YK&:O(=.+8BM$[$:O6:*L(E EP["% [-]>#427 _O9@5,*J<?+X;JEI
M-'V@H*FJYR74#+Z>Q<VXOBZW 4O/O0_4.X0OE]%T['O6TY"0@%U'$5X[H7BM
M5;+J9 \-IP+YL-35Y,0IN#'':30_RF/>8IY3VW 0QI_]N?HS<%;4 83CZJG1
M.59\XB5\QZ=_D?ID\0&UJQ?+#5BE-KEYYIZ^1:ZF4ZC\?=JR\'OP+FY;G5KF
M^TH]1)=,S.!.SLRZ5F:*?(U@[9P!'%MS: <N]*:9L?. 8D$%CXXH]4<"^R.!
MK1P)W&1JG@&V)_2#O&<!F[0E9VAKC)45' @LP4-+_B \UG]./:'-3NI3>4$$
M!&;.,/0*Y^OM9^)@,!1L*QVR[UR /H$%Y#]%V&0)Z1"QA=-O!0<1*RT]LR"U
MJ$53O*U#6+[3CUVP(B.G*(T:DO+#ES9TH@MOP]-NZQKW3Z#UW<Q;T2#)B11/
M?]CJNXB6KL6NP-<7/KKJ:YL8DXA^K8.N!S=#2-=FH-*+5IA+ FGV:94?P-AE
M4>FMFD-JQ*4T1)7+"?2C(5H8#:%J%&@_&J(?#=&/AJB],,_!Q!\L('8L@*X#
M9+-AK5)#"*HHFBGJE,4+!1?=5:'!F>X2'5I[/KK:3CN0TD AJ?;SG/RP%S^[
MUCL($'Q1/Q*EG*2!6K3$0)0*:/0N@GXD2KE>S-VJ<O6R=+"#9O\,W#658C+W
M @*0/7FF,1[[A92".(F;')F@,:>85S,OV$K3I\4B#()90'QM&J\E;_ ^'2,J
MK\=;T^2CL)6[Z.9FQ4G+<CY[4+>O $E+)T_(3[,NS%XH(H!_P[M#) +$\'1#
M./!VB*Y>+$C(:)HZU#!8L',/HJ$B'_'.C@D2@XIG/+/X2HD$T+%(8LI[L3X2
M%.I/VTOL5).[PT>/+MTG^ZE$8-.-:@&E#K\).&!0>N9])_[W?.!FF,Z S)T-
MY?2Z:NG<>-0?..],6]+O=S2*1'3I^M2&7-)W*?5=2H=]EY*!VE3?I=1W*?5=
M2OMB17V74M^EU'<I]5U*"B'MNY3Z+J6^2ZGO4NJ[E/HN)1-] 7V74M^EU'<I
M]5U*?9=2WZ6T-RTK?9=2WZ6DNTLI*T9XY\0MP$_09Z'/'=WM4?9@)CKWKYS>
M?I1!*_!0&YHDPEW"*<28E2]?HFZ#L/% <>*XA(G)R4%\1;TR=!2G#9IUX$@O
MD@8,S,[M4MFW5+"4E%TM7]#*L+F"75I;I>3VIK>F'! ]TXR\Q<)#X4"P.X!'
M.!35_@S< -ZQGD_Z"E7LWW@X=EA;C8#CZ8EJH1EGA&< .5^C1BW!EMP4B>WF
MB"F%OGCI5H<9*?OG:!K/AP/N!D== TO5R"0:#$AQOW0(,P6Z29Q059Y33D]=
M J=(/*-K4JGY95I'E6N1:S9I&QUXS@PY4Y8G]>-1]70'<T>?SV(3&T5[+_*D
M=-T^6\Y(\%5'MX(.#7/26J5*KH1)U^*4$L7L[1RU^D^O+CG(NS-D+WWV0KSQ
ML\!=C(/E,NIQU+2,^'A*W$&7 *-KJ11Q,)AK;*3#["TB!4AUQ\(',PQARL#%
M=W1;2KGXN>%FKHB2['YS2[.@^UI LHG..S%R7=;<2.?WE;D'E^ZY5J&$VCA8
M0"6="5Z5:*LJQJQ),[>QLYQ.(<N,1T/$Y2J^:5+%;T/^I%TA+=E48YJHK+F6
M$#.30FR@B()<8@DL?!U*+=CH!89AY G81&<;+I;L']XT^75TI82*J&XT31>C
MXJM 0UC"=-!CJA2E:]<D*8QP',C--UV/T[:]DI7&;")?C4%E*C.RVNG,6MXD
M87YR9G.7_O&;IS)V.\IR%&7CUDJ2<FU1!:1EXMA2<OKBI9J8ED<=16V!9;#(
MGRP4<XB_! #[$+OKC6A#-/7P(EQWNOP>)],N!!F\>FZ*)\]1EI9\U;U#GB2=
M$R,AZXVR-.3<#Z,EXV^VWS?F8 HAS7N4U).:<B$7'F*UW^CV0B:/_J(1%\OV
MFX,X-=@,N,[LH<?!(X%_!E3BJY5DAGF7E*9=1BF;T+O\^%]'1P?__O7V\YO_
M_/N+M0Q>?D-OSNRO;U>SW];HX3)X_O@6G[W]^?2/A\F:N&]7UM<3]Y_^L3^&
M__SZ]O73RROKQC_YU_7UZ?CGX]7+^<5O)RM[C($WN?UY:=^./C_<^O?+X/R=
M__D'>/OQU^.3M^C3._SV]/OA;[_Y/P6OKY].G8=WG]_9;[["N_75U9=W#[=?
M[C[>3W[XX_/5T]/#+[-?9^#//Z_//OYR<_9\_>O;JY/;K\\OV'+'IU^.[_^\
M7*Q__O7E[U]GR+O_X>;/R[_#AR\?/W\Z^^WCSQ=GC[?@ZQ_G#\$G?/*+-WZ:
M_[!Z=S;X^FYQ=S+ZQ7M87@XO)W>/3ZN[VS/WUQ\>\'\.+L;W1T>")>9=G'4M
M^W(^9ALQ:JPY<^ZX'*JN%&3SM:[S=?C36F+%[V$]=J>W=@'QC%+]B+UG?\YV
MIP#%L,CFV+A(F^RKY"NFBN"E97;' X&CZ17Q'1IU*[]$<X>XP1)?LQ+W+BB:
MYE3&E?0=V:H7BJHVA3JF9M-E0AT)M3CJ'+"X;2 :3=G-@M>N]TS4N#PNTOOF
M\OCPTGAI-\LY;'IRPQ;/:P]?TTT%<*/+**DP\KIKRF4?EITDCFIG.>9;,?2Z
MSW(^>]3"50%6;7>SX+ON&C@XM(Y4T^4041&#T G$,;-:7?'Q[+[G;(AA[;A(
MH3@18;AP?'9T%F!$!29#1!<Z=&9HUYI4!Y$-..^#^Q1"--;I6[5.D[YT/7R.
MO2>(P0SJ68-%+/;(519#%*OCG6HO.426MX 3\*+[)5;"9F]V:.5 Q:HY,Y\"
MKNR(9F4(B?&X>Y\B2F8)T^@_\+WI=.(L*&EDAW^S+8%K!6Y4"&102>^A1-EU
M/SI0A:N>T; ;<3;!2W0(DHJ4.IMZ"P&KY-@C= ^M +/6LW!37Z5[^0RY4MFZ
M;RB:=,(S)ZO=XQP;Y]H?Z-A1^"7=D:_HZE_!U+YAB#;)F-3&XLXCH5HV-J)_
M&:J1;A\/DBC7D.J)416^XR=HL]I%2MQT;F\K+<1A;P^RV)26W$/<>%;MVUZ'
MQ]<JO;F1*PHLL24%:QRSN'V6.Y<^ [3/U^%XP<V3D9+UICCDE.-N,K!H;$::
M%*"V<I.W]:0"L7TXX&Z?O:TPM)D41I,H"OQ+0\QYK]OJR.$313'H7_#X29D+
MF6! .5MAQ .KUZ2 CZZFWI&U)GMV1!!:WM'W9LZ*R*;2*KO0M]AK6EU-N2M;
M3J'%C *?^-2-T?!.\7JJ(6\N,A94=]7RJ8.2)[/6ZO5M5I@:]%E*D$H<_DU_
MN9,:;/CNV@&G*OE]"7W@N(1?GAO)XQ*ZI!&X]4.G8#*G.'1(TMI%=:W:7H$G
MT*'%=J_/^ZM=F]+:,N2^@:6=6S\TZ;*_@:6_@66O;F 9(:C^)HK*BRC:WS]*
MW$4A=16%Q.#@_B:*4JV8NXDBS&M!ENF"BZBIX!(2"SMAVDM0+]4T.S#9J?4@
ML@9EC;[PT^!SNBV$"G\UGLBKN)9L%T86M*[F>K Y1NLK4_8E-3DEZ@T)&:B\
M=TJ;$9H=*E1LGW4%W !$90IGVR@#_(!0A/PYC>,<S#X#YP[$%/?Y.LD!M9C?
M:"YDNXDA&?GD"MF:Q6PO<20JF[8BN-)<D@(#ELTN"2M?P404J7-!Y^MMP\D&
M';B"+F\*2N1@4#53C0&*U@25I ,H/')4HQY=_68;IG$W:O@D>4GXDULB5L+%
M6^.>I3+U);:0"G7,AW$G5,V7.].I; .9M995S7<[N] 4+$#F V2SOZ[^#!SJ
MB\*.!?6.OH+1/E8>%#KV*A7H4?H]E1<[%NM8*>1=_-NB[)^T64B)8MK1UR^>
MM)[E4.<:L]2J)2AW_+*V8/ ]T)XE\+T*%%7'^IJS%L_/584NSSKV->B^!MW7
MH-6<BMVYY%A/D%/"Q.1Q$A4A8/J55H8C;\.RZ.BHJ/Y*#2=L$2U4'_^$J&)B
M9B>9J%(4'VX::YOQ0)6+ &.(K#7])[LJ7I'FN&A_DXKD0U5I3+$3/3V#Y?8^
M)2DU%I(RUY^N1V/%>.F]!KSOL>I[K/9+*VWV6.52LD.T#'P2IF]?:0D(JSB9
MC J%:CR%6>TB")7'@E5<3UM3W.FWJKC3!NM-ZM+0!<NYC*83SP?N! =$]%["
M D)[U@BEI6VA"-_N7,^Q>?;-LWE3>S.)P-F91"!ZC'M#<+LJ<LBI.J5=R4MX
M0.1F4$.*_CEPV9"/\1Q"/YGJ<;[>?B#9!TPH@_-U/#WD$A)JDV7'U-2Y2/6"
MMGBK42/#*72D&O1DZJJDHL$@[.(?#67B2E8FNX#:6X>9JR4KD==3$RP66TM?
M3R4K8^6#)F9?K*PBX-I7EO(";:VZ#%9@52JKK['NG</D*JE6*K.OJO95U;ZJ
MJJ:J&@]T0;-[:$&ZI-E8H/@*$D#\RP#JZ"3GXJDM2=,Q?]A0$TKK0]R\]?2*
M<W)M8>56]8@W62&-%*HWWN1DK[XIO(%6C<:ANA6K)3;-Y@O9=2C =;Y">[!<
M8F@YH8N1*DQ5DC0X)KJAB\KG5JNQ4CK(OXSQ)52NI *2WX:2BK#J9YOT=?>^
M[FY\MDEX\44J))922 DQLQU@/(G5@NI="2ZJ#_]EN2:WCZQ5::2"H-&QZD(Z
MJ4)'ZR*1+I%G2^/&0:\IJI4_? ?KUW ZA99?4KRFQC6')+FLP9MZ2XC#*(0H
MF>Z1NG(GUU,@*%=.(0TM3:M(TGL<#=+)C.[0)HZAP:]MV&/>0>A3:C\"MKWC
M>+J79C\'MJ\6]=6B#E2+<OF %_7)DG*2!A):$JF2"FCT;@0GS]X7Y<F24HI[
MERPIQT;3(85+^.B/V2V@H83W<5[S(Y7SQB/JN_$JF75@.&Q;@28O_!H=Y,4<
MH!D<HN*20SJS/4*I'?8]M+P98A\?HNBN;L%UJXZ_\:9\,]L3A0KDF4S;>@)D
M&=TL^+B>LA/@FW9^HK"?GU^-#871F>T0%D7VW:U0*%W)#2$Q-.U3)7(:LM;6
M+)<AICOI'$:?PE"1PI!9>$I2%WWRHD]>],D+54V.19V;&KI;2]GHTDJ'/%X]
MU*K[^ZLX:FE:K6"D?[!A19MJG777J8?;$:K5CO+VTVK]&&TX5:,BWK;2OA>N
M[X7K>^'TI7='_ASBL.5+SRC"/'V3W5?U[]>T]RK 1LM[)>23M'@YQ7UO:A21
M9[)GVBA 26,&_"/V"(FFF9#1=)L7C6SBCBY0&C^R-.ED#L=)DI9^<G._./4"
MMN,[PA>I*12@X[43]0DME<K3VF/Y"?H;,5NS+$FF7;C KUUSDM42SXG'5JLG
M,[8^0/1(R&/WX=&'<C+U)@K7-'D4*WF45/^HIE*!J&0Z:RKR,C5MRM,OFZX:
MBYP\+0Y=,F"2S0HODIIM>WY37X31ND355&/Z8DQ?C.F+,?VIVS[3V&<:#9RZ
M+=N0IS([3396U+X$M:E#DDXW&FJ,8;5H5>?=( G'[>P^<NUA*M<Y1%1S_FA*
M80DOEJ&_NV /!_$28/8<=.T(6IPLU[^J=4EKJW.Y%Q\#1(#%:$XA5',D]P+#
M,(,.D'T/;;A81F.]DU\_T$?(:VU'$-D,BEH9I _=JA!')DFBCK^A8[5:;*J@
M45V=GOJ#L^TE/)0OK_ZD;)_?Z/,;?7YCCW;2?7ZCBUHQT4D5;7A_@B[;X+*A
M09\\9(77)/H\KJM!*T\5)Q/]/"W%C%Q =W!.$YD##+W I_M@NN=%,S4%],VF
M^"=G-G?IGP)4=SG+;N_D>$KZ.Q'F,ILW<7X:?67-?DV)450D8)I#KZ($W6_)
MN+=DTHM$Q1:LWX'U.[!^!];OP/H=6+\#:W,'QEITV=X@G.]Z!_&8O>@4[[V*
M>;0_VE93W%<#I983S=NJXH6W6 *T3J8;C=#VOS2ILQGO#IRA4*[IANCS#@(2
M/PN1S+@:('L[N*A(*$(_$?N69):VZ,96FNVW9!FJ-1*;S&ME)E-JNH5>*[JY
M8X@L*CF!ES#Z6[<?:2+*MV0\:G03F\SWFKS,+<!/E6$"M^,HHO0MJ9,#MUA7
M;_0O[W >_SVD_D7U.(Q*5ETXZZ9_?6; C77Z@Y9M4Q7KE(4)KDA>ZM_N*N7&
M-];R6TU>]I[5>\C$&ZP@!C.8O #(F\$C"6,#00W7TS7>**E)LQR(QCI]5Z53
M)<[XZF4)$8&A2(.I#S%]B]/_=59PX+KQ87[=7II+ABZX;^ZE4.FB^2!7/I&O
M5)[M+Z(QL6P[$ JG6^_EC,V7O]6HN@):SJE);92XG1ERIHX%D#^P+-9V3=W8
MG><Z%DL01OY.NL[-PR3G.AN^49KQD,KD\["2J5KST]>V5&IJU$(*S;\+&P"I
MH 8MXB_OH<LRYG< ^^O)MK^%G*_3_Z-A=F,#QMJ,H&'=NO&R2'O/)D K+@@5
MB:!E8&,! V/E:W$#+].:UK&->4;*QS66:,?@E$;5NM$_KW'\>?A%JGB:(F#N
MJLER1U#P"DL]L=JNFBR?!UED'_8-V8<\LA56*SD@[AZN(!+.5V5(=&&OJB@^
MRT*C4PFL_=>C^R7L.S1 R%Z8(UH/K")I/+ND2$/5N'$4>J54!J93QW7HBB97
M+Q:$J4UG<UT5T#*?"%"GI2*H:HNJ$HW6["#U;OIB@%! -W9K0255T^Q +EZ1
MMFJPXZEKMI.[&<PPA.F3_%(7(^6HR69D*@C*#B#9I2R3;2DA9NX 0+TB"H9W
ME"#2>NM^S=ZEO4Q)IU(CU0;+D0?1,QJNAJGV)$B>5PL[[N;)$)X==@%L:K>#
M7$RU)D6*M=7%#(F0PGBS(WUZA,=;R&9*^E2)&,K-LB8R,5@4(%_2M]FF+Y"5
M-X7#L%)ZIAOSA>*Q<G0T'C$:!X_ 7CG$P^MK""6444#(>,9$1 U%@/!TORM>
M%BJ71 >R(LH6!$]?>3M;Z08##PX% [=+A["'"S <35F'"(UO0MJQH[_PB$_"
M=MQ'0)C?7T?=^(5]=O*7M,L)(UQC#6F2(2'!;JY0^I$RI$U>B:-&T>FX-8N:
MSC+3(/#G'F9G0UC@X5C.$E#9[NA>E\I(UZ^H)ZLC:Z9HHEYC3='LS*B3>X<\
MB;=[;8)62H6$1XPLB"DQ%)["UN/"JGG)+0.J>+BBNCJ'R)HO 'X2M/L\';.&
MSJ6?@I[E/!R\':HMF.ZE9X7S9.ESA2>;UT,T]? B:J5M: 8V='Y/Z*7(E*3"
M,S9,H/7=S%O1YW4B\Z4_;*VVEG#C5VH)Q8)4N+R8[:?$>17!C+4:B;8O4&'2
MW, 9<"-CK,EXUZMCEY:NC5AM2IO'X!)UY !0WM'.N$0,:M/4]1AG".G*-U2F
MH"NL)L$T^[3: :W,)3>'U$B>N"&JG"G@?@9,5:Q1MC#53WWIQ[XH4H3LH!=!
M/W,/9PX+/9'_"2SD8I9"@@92EDW#EF(@%/L@QFB" 3N@.%XO'CU7"NHL)1.)
MEJ8@[SP[STT20E'XA'Y.2>0=$FJ_["$:<T?/K7Q$"&-Q$<V$O7:(!=S?(,!7
MR+[,U34:PEQ*U)R?;@)[.2;UK6EBCOK"6RP\-/8]ZRE*18ZV1YX5N.U*\ONA
M$QZ<ZH=L--7.@(IG,Q&O72"GB"RE?7#J.\]>.^U"T/(A&X'D#I$-7WZ&:Q7&
MOD/12-^LH'GO@L$S?$(0]\C'W<,EW1^P=[</_$ NCU))>!\LOAJ9VJ$18HJX
M=ER(+^C;9>9A%>:?I;=/SGT'B1CO,W7>/!$I&JBE(M IIK@7'J<$C&1GI#;M
ME3#;AE37]#=JDOV[-/?!TY3BD<"OZ Q8GE>D;M7HIZGN05*@ I)$ <JZE[;^
M;;P KGL>$"H54?&FS=+;)T^_@T2">=7.5@SRJP7$,_H._XB]9W\>CXU1 'TQ
MW>XG%"I12=10OKL5M/LY=%UUV&?([8.S+T(AP5KA7C76[4O8RQSB$#DV%>:>
M)[I/[J8(DT0!JJ8WIB7[)0#8A]A=1WL()>_979K[8/BE>"3@5^QKA5/$&TTK
M!#]'=#^LOQR31 %5$Q#%M[.?@GR93W@O&Q/;BSU5'H($Z(I=K##4;.@=IOH,
M90JOB@]O]<;K"\]64>RKIK\'83X73$FQ2ED=?,MY EZ&-I4U/#+/N"M;&&64
M]\,OU:"3:$1E=39N3[%M3'<<\5],OE<*E%%$=6]61R$DB08T;(+S_$ZUJ.!T
MGU5PNE5!9;572@47],<1GGC/*CK[\C3W(4 MQ2-!7WFA-^85OH9&^ Y[*P=9
M*E[6)83W3@LY9!)5*-\IQPSO/.(#]U_.4E'45$AVCZ+78E@2+51MEP6:3Q@_
M#($T]!E"W4_#99\[P;9\-]RX.]YC:>VYAU1LQ7+$]L*8\Q D,%=._6\,=3P-
M;OWJ]''B^)('0W+$]@+J/ 0)U&IWO0F?JQ=K#M ,2O>T%A+<@["Q&(BD/5##
M1G:(?,@.L#DK> E\<)'<(Z\@Q5!(>'^BEC)D$F54UW%+SN[]>,PXL:.P[&/_
M#U!+ P04    "  6B&A55U?AZ^5?  !^GP0 '@   &-I:S P,#$W.3,T.3<M
M,C R,C Y,S!?;&%B+GAM;.U]:W/C-K;@Y]U?@9NMVG+OVNFV.TFGLS-W2Y;E
MCN[8EB/)/9E)34W1(B1SFB(5DK*M_/K%@P^0!$"0H CTU'Z8B=LF@//"P<'!
M>?SI_[YN?? ,H]@+@S]_<_[MNV\ #%:AZP6;/W_SL#@;+<;3Z3?_]S\!^.]_
M^H^S,_ )!C!R$NB"QP,8A]O=8N6!9>0$\3J,MN DV;X!9^ I278_O7W[\O+R
M[0I]$Z^\",;A/EK!&/\"G)VA";,IQQ'$$_X$EGL([L)G\.Y'<''^T\5W/[W_
M 3PLQ^#BW<4%'?+?_^1[P9=')X8 P1W$?_Z&6>GU,?*_#:/-VXMW[]Z_S3[\
MAG[YTRO^1>G[E_?DZ_./'S^^)7_-/XT]WH=HVO.WO][>+%9/<.N<>4&<.,$*
M+Q![/\7DES?ARDD()1OA L(O\+_.LL_.\*_.SB_.WI]_^QJ[WU"Z ?"G*/3A
M'*X!@?RGY+"#?_XF]K8['P-$?O<4P34?$#^*WN+Q;P.XP:3'BWS$BYS_@!?Y
M'^FOEV'B^#?.(_2_ ?CSA_E4B-C'TH3,R+=#0MP)V"/!F=1A3-K"EQ2P8<A\
M_*\;!$$)-OB:P,"%;@8='BL10#(U$?<,8SQSN"K-Z6-!#J-L2K+PG[]QH??/
M&T0T?Q(D7G(8O7IQG20Q6I6L&,/5MYOP^2T:]19O8?S#&?Z!4(,W5XIGAFD)
MHDR!M,*2DKL)AW_ZCS[9^^@;K/9@</:P^.8_R5> ?@9^PQ_^XT]T2D(X%M)1
M5":?$ZVR9=&/#:"F7[Q=A4B;[)*S$M3K*-Q*"9^$8IS>MN;P/C[;.,[NGZ,X
MAHF,N6LG?B0HI",HAZ&?Q-EO"E97)D50]<GDA-%2$EP$3"::"M!/&.X.R%L^
MR3%;.0ATY^B-YSQZOI=XL&^VLC,/S5MF;2F#F>_,<IG#!I;557QT=_ =3(ZR
MB?&\?6MKQ8V,EA:P^FZR!*/%8K)<L'K:V%9F:%_?S1D6;VMGB38==S#R0G>1
M.%&B3,UW'')>PHT7!.@B ,(UN">3FCK_VA/V7=^JB%)U$KC*-#WGT!2-YU'3
M:E*>]Z[5T743*I/Q@K?385(_LRTGXP5#1B5-'D?)/\=A$(>^Y^)["C'NT,'0
M8';G2AV-9Q0Z^E>AS*53]\QMGA$N6U^@W-G/0?9]W2P?4 14^(.EH1%9YB!M
M=<1/@V<8)UL8)--@%6YA_X<];X7!CWT.$%);CWZ5RX0!I2!A#*L>1(B5;8)6
M(C$.XR0>!>[D=0>#N'=3OS;]T/9^%0"I(&0?F3XC1$QA98&+6'?K'XD2*UTW
MT(GA:+6*]M"=!NC\17_Y:^0E,%RO>Q:1-BOW:?P*'9#:!!+=-I -4DP!;L(X
M-GSMZ,!T5@3;DN3M?W84SH<@@H[O_0'=3XX78,+-@DD H\T!'9-)Y*QZ]SRI
MK/BVRK;C:S,%L"3"EXT%#KI4[/.IP ;-!4Y\--L;$ ; RWD:DR_7^V2/L &K
M; F3)V4+46!%595P^I85?N)R@@.B-S7FKQ'XLQU^ O.028?.[0AODRM(_WLT
M\ZLE&$,?RUT!E4BWEWX*3MSTXS?H=R! ?W+(S$C^X[V?8/\$EBD0YJL85L.Z
MPL,W$3L0]@@:K>GFK@,OSP>%77K3N_%\,EI,P,G5A/[T!OT.%-X^,)\L'FZ6
MT[M/X'H^NP6S^\E\M)S.[A:F+3];1.%=ESO%ROOR[MV[\P\?WW_W\0.U#NB,
MTZ"T]-C9>4@_+)Z<"))( *1^,2!E95B:C:BZ=Q_?OR/J3GNAH=2=+J JZJZL
MXXAF6]'I0(SG PDSH2%-UY=D8/'NA:;=+TKB745]M,9.>,'R1W@OT#C=^4!*
M+^5\0;?#6]-.!-24LX1$G2]0:/*Q$S_=1^&SYT+W\O 0XSM:>@8$FQ':&L_'
M>.IML?#;_QQ:3-6!D^CA%9H![-(I<(S;R1[-@H3U369@(GO3R6<R^YC<7@XJ
M]_TV]&KY>M&PRK47.,'*@*SR%K9&5CG =9/5=3:1[;(JD0,%6171JZ.LXB7P
M_R:_[[UGQ\<NDSE2ZY&W2J"+_S *W/(OF"_YBG[RNO+W.)H6_?"$& CG3@(G
MZS5<]?U6,S#P!MQEPV(H"3+)[J'X&CH>+7XV?<TT([>EYXOA6=/5MZ<%JDU[
M]C@1+HUQ0UHP"S:5+-3H:]M/O6^/(_GRE *:M 'G.?4$05!?G^H\"JL[^>KR
MB*,7)W*7Z$/5(*$VD9^EN8_@B.!%"G$7%V@1\@W 'QD.UY=RHQ0@5L.JLT\@
M%:V*0!U!#"0+#1 YU@R%*'X,7Y;P^R?Y@1EC-(9,G7M5'2-!OKLW]-KQHL^.
MOX>7A_S'GST8(4R>#C?P&1&D?X%27'1@A:,&E4#8\ A AH!\#!&^N]%G*^2M
M':-9V6M!E\ZZ[ I9!L\.NM'#:8!.RCWVJ\Z]^,L1A$^ZU, B)X-%(&C%$%",
MJ4J8 ?E2X2 K58VH=Y:EW$4TARN(UGCT87KAO'?BY&I_#$M);<W>O8Y2=:8"
MDDB;T;%9GMPI&&WP5<V\E+7B;4F)*5.CHR?QTO%Q;OCB"<(D2PH_@J )EQDB
MD[8)"-%=GWX.R/<@&V#%J=C$-5:$I%AKW."NO'CEA_$^@K,U?DN$04SFGD,?
M![:2.&'R"(ZK R!Q/9#(OM%C3,+>^CX=]8 95,/IP2JZ->#:%%@\L?$VAR[<
M[L@_PS7(__00>.06D<[T#\,>C7X$J'0XZU.V^^,A.7*(E8D4-%FE_W="SAIF
M?*M<6"0O@.1C>M$X!?)\33-/?F+N55[W!&@;<GL* >+&*%89P?=O?I4,J#HC
MAXDB%8+#2ZFMD7^V7B/*XZ?OLLZ^CSQD=B#^ S(?./$"<!7ZOA/%Y+<DO.[-
MU\VO\RZF!RX?<A6NR*4+.R,E"K:YIDMIHJ$2AZL+BV[+Z2?$1VR"T2)*9T5<
M:CBTOO:RL_RR1\<-C/S#'.["2&8;JK.U.F?_H3,J/*Y T<3N_'- OS=DH2GP
MIBH(/$0U=_A]=@!>(>.M%YDHSSA@UH$0B":!H!^3@QI_;EH5<%E2%84Z@BV-
M:G:R:V32._[?H!-=H]_H5?$2S6E&-52@:)($^CG WP,RP&2)KP;N5"6"AZKN
M\8\CZSUZN>OMS*A-.J1-*0.DT4S(OZ\>'*9L!@%[:O8##]&V 5-X0EI0[MKS
MX=U^^P@C+7FH33;P45%=7\#^M.(?_@[0#TWJ!!$',I9SD>IP,M!YYG#C8;=-
MD-PY6SWK@#MA[\5#FOE=AD#.\^);@#\VXSYIXD:9\QSTVK__%]/A2B014AG$
MP;=(D*DQ#O=!$AW&H=N'/,CG-R >4H#DTE(:>@K(8!!&()T X!D,7C5:,+0L
M4LTDT9&PI?,Z==$9Y:T]^FK2V\DBFGEH<T,*C5RDT"!0'E4[@HQ(40/3RO(C
MP[R[$3)R7<2I./W/C1? \QYDAC>K 2W$ 4,N*.F7I]D/ (\!L\#XF25A4UE*
M1"CKZ);ZG!='D9$+.V3DHHN,+%]"^V3D0E5&+OJ2D3'Z<18MPY>@/PEAYAS6
M^2& 0E$\\ !LM^ AAL\9(7.X<E'!M*/OHS0E,7=F$4DT#%9]6+R"B0T*2 44
M12G)S=MLG!VB(F 85UYXB/<A-/=AG#C^W[U=3Y<D[K1&G"4\2!3EA8X!:%#U
M(F127+BLX@I+'><.7A6LH481=+0%HS31D,^J[,*B("G"=_1-A=$#\YE'ZXRS
M-2PZ/:SB.#___BD,^O"&UB8;>(-7UQ=U0<&? ?*=!=Y0$0?R+B@\I#KLVP5<
M[2,D,^<7CTLOX77^:<'IVF0#<[JZOJ@^#_X;#EPZOSAY? .R42;9+6)#QFXN
M9AW8O8P<G&F^.&P?0U^+U^69AC7R2FN+F$R_ ?0C<X<RE^(96^N(=+32,OG(
M2@AH/VIP)QS4%\"#0,#K[%.0?6OX44/&C>J.KJ&G<^4?[Z,()Q21MU L6.@>
MH!GT()W8Q-V.#XK<5D_'@'P0H*/,OW?*.5:VUR68:UWN2-%K4CX)7CF)DR[3
MRQL8=V(34L,'I>G9*Q^#HZ><3(S,2XV<8]5'+B'F6E*#7^*CL9/ 31@=>@J7
M*.8S\Y15@J$Y:B("V;>FXF4DK*C'390QZ_Y M=@ZOG^YC[T QGT<+N7YS'"^
M!(.<\^13D'UKEO-<5I0Y7\>L.^<G6QCAE-A/4?B2/*450'N0 /Z\0WI_)'#(
MI2$; N@8D XR[064<JHL(&*D._F.TDE?B] \&M#;AYC4)S6C+>J - C)*QMB
M:; IG@J#*M+!1U7C]'B"OM^?ZBA-9\*R9 %H.#CPEQP%8>CHX/"A<G)4,=.R
M%]%$6QQE%:Z^D"RN>+9/<&-Y[ #IXX8JF]Z,EI"!U'!?)2,!&7I*L_ABP(PV
M+CPJS*Q<7IN(T46CC+8P<$F&@._H"5%YIF'U2&EM4<FW[!N /S)G77 IGG&Z
MCDA'C9%>4HN\CSZRN(23#JT=1("(7AU3YQ6;P5-+Z!K^$;*!1?F#I S9+GN^
MG!1$39*^<[O860=U>@O!4$SO2O/]:@E>1O.[.#SB9WA5\=5RA4/<'\V?!BY\
M_0OLP]*LSF@D3J4"1(,903\&Y&N /C?KK!"PI&(G<!#L6%2%]B4Y4L6@RN2#
M:0G^^B*K@;0-,UX=ELN'>O_P:B&=MIN_WJ-F]A) =Y3D]1M[E@')0D-WDA>#
M(A"-*=,MTPM 3)\C/1B? B<!SZ2DY_\R6U:GF8_\SD1<"O2OK9]A]!CJ<(57
M8T?.EE48)_\^/-$J )YUZBT*&_:^N6L+F"@15 =#N*'IAR#*OS3B8FQF4%E"
MN.BU]CR7N^L5LUV'M&90O C]B@M:N5&C:+;!SGPE< 1B47P-UF%:^RD&,1I@
MRBQHQ:IZYT09^AKZA/BG7.*HHHV5B4W2' O1J;*\=*W!34DI.,)ZS+LP]A)\
M*%U&X1<8$>FZIBVW#9>85^%DJ<I\(_[:364_.Y%',D1O'?S6)CJTE%62>+ZA
M#$]%> 3BDW\/MF0 ]] RIY0:V5572W(*=.]4,$N>8,14;[X[EE*2+#3T948,
MBD"<R !;#)]FCK'*IP'7[H)SM8>XG7!:N_;>B? MXCBB(UW*A-$L TATH*'[
M+FE"31AB5(!4.%<J6]R$K:8U_1"07Z/[&]>5IGQHU><94C8:8!&(A0VGD9#^
M]5.(CU;GGA(WGO/H^<3_<"0W*F^%P0U@#A"B)+'IZ')Z,UU.)\:]JA+>L,I!
MA)NV27OO',B!I:D4:M,,]_8N!T0@ =EG=MR>14RH:P8N>ET?5E8K7"<I3N<\
MCE$A6&0X\9 #HGJQV=%1)JMMR]E5>H<1H]I15)!ML@Q3&[=DGOA.''MK#[I'
M,TD5UQWZ<J,,F<1034(PWL=)Z'J.F4(FG=E;L5M;4*+[3>C6"9P-)&$&$*:B
MW;.X<9<8,$! !H= CHI/P1K"N*:HC,B3C%6LZ CQ[-HLNZ+YB%0.<JZ55C)^
MN+'0B&(*W*T7D$J<.*7L%#ATAJP/Q2K32R*I,A."T,Q>R3E8HTIWNRG:(S47
MA6N(-%P8.#X2W^RJ/@K<.X3)L81.>643#IL6\(GL<F:H10JM \LK@MB*+IJ>
MGAMO!8,8;672NWN3[O(PP&MR#T[E:Y[*S&:>+A0@$SD#LI%$\47,6"MT7V?6
MUB^/JC1J;Z,UN*_>]>5J?&?JM;X.2;.GT2)7XSNQ4 @PTW8L93V?XG&(9"Y.
M9FM-%Y-D0E/.)C%(HB9XDR6@T9Q@/+M;3!=+,+O^R0J9:>97778:\&]I7S7(
MY7E?2F3 BLE-D'Q52N2\A1(Y[U>)D&!#M(BW]1+HTG"AT3YY"B/O#^T'K9:+
MF%8V:F"J=>$$)_MLHBRFS,FG>O.3#<]FW41 K*M:D$]+?Q'WU_18,JLZ^X#.
MJTX BI+E\&@P_0K$LR6;ZW+9AE!MW6(-2OJBKQ-UP/KR39!\52?J18L3]:*?
M$[6(Y<=M4[904P\)IS.F>$00B>+M[SY/%LO;R=T23._&L]N)D8>8=CRJ2XL4
M:3VMT9.8V"(<*B)!/OK)"D%09;\VTZN9'*/ )?YR.G7/?FS!(L._F_ !:4K-
M\<A75J3E\-G$2\WAH-CQ_8-,<Q<&X0YB_V&PH5-.7G<PB/L6E8;%##S.RB&2
MAC9;(#AJS*N%-LOQ[=DN?=^77?K>&KOT_5=EE[X7'S4"S+3MTE2<=.,0:].8
M\M94 1&5>$@_^\E$9)D:!^HRP,6MXV%2"@$YSA'"7<)T5(_\N*A$]9B.NY Q
M21C/HW- 9!-^@@$Z='QDNY3C58XC*$VK#1UCV !/'Y$])@-:%9G+"I@*1;I'
M&%;C,WH6K]KT0\M3%0#5&!RSL3<BKK!RP<6LNR#<P,U1)*"8=_CDF&SI;E$P
MID^@&D=*R3$EW#2J!US[81C11'ATCF4]/9"V&?O0B1P$Y1&$0G%1$_%\:J )
M)"HM*.!E7A-(=;3)$Z<=?UD1:T&)OM,TO^OK-OR=-;?A[[ZJV_!WK$ H8:9]
M&YY#QR>O?X'[$$3I/SXY7G 3QO$L8,I+H2_2<AU9V0O=*W0_:QMS\?<"OJ@*
MSV1T,_W[Y J,[J[ PUW^ST^CZ1TXN9DM%F_ [ X4;TH+\N7UP_)A/B$A7\OY
M:,R6\C-8L*='">.5]^F+"WJ^Q3N8S&NKZ\<+2>8T)OA2L"3A0!EWP :- B<^
M&O<&A($5T15*[./&^C200D^J%D]AE"QAM&7D.%NPHU!)IS1T;LM@$O7PPT,
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M5/* $4C;<D:#B6;S)5A.YK=,&KOYBI4RYM6*50J1UM-,MV$ #[=.] 4FU_O
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M5GPBRB<R?U?MP/RZ\FU+.@W7;'V/I(G5T[15:K$4,BB.KI"EB_?U&J2CC&4
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MN]$F@A2?\1,2*XC.,7ZEU2M8_*PT7[6Q?,N#Z6O S- %]2L@C4!9L3%M^30
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MJ9<P@&LOF:W107F-$QC1[\9X"\.(W(AAO'P)94)1>-.*I!0FW=&.\U83?X6
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MPS<Y=6D]:*0]?NS;>DD"W8D3!4C%Q], F5'0VP356G>RLD%T"I#-@3N*I[.
MUD4 #5444J0"UY/9EH@E*[1#Y>39>@UQB6;JNM8KF<R?RT0E0QX@HA(HZ;>
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ML1,_X?]-?M][SXZ/16".P(J\50)=_ <$8/D7S)?"?EOHLU. _Q\P7Y^"8B)
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M&6K[.U';OQW<7:)-%*A>6EY+N<,-BK@$8ZBY0QJ;*V)40,A8>3FO&H9^O4
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M)=;K'.W+)M72T'Y7-4!OW4P<:8L-,LQVYE:DGK8B[5&6]X1\)B!M78]<'E'
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M'R*6*'28['0>>'WXR*R(3^BX=I]8$-([AB*1TGD^LW^YH"JZ ,LZJ<;IT7,
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ME%5(+(235+O>EOSBSO0')B@NM=L7ATWC>!F&JZUH"-NPXF!G*@SNLP?3IU0
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M3&:K8. X)4%/M=@4C+-?Q^:+/8[&2>% G,D)NS5]'T/SG);A)KDO0/_N>L\
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MKH1F#B;X1G8@9L,^@50D_+#=2807.? BX6/A Y&3#^,OJ66!0U,1U"$&.*N
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MC!?D?!08HCE[-!,O>3*TQ7R^B6,.&8\NR7UB>9'8*D]RQ8\,HBDC;Y'8-MY
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MP"6+U."T"9[R@Z;.,,^;Q,F'%"I$G)>(P#],B[,G4F Q< BJ*0\7)*OR6]8
M;4-N-(N#4L8C8>  61,LXG)W+*BB$SP88K8IW;SR2I3 $_H1/.0<-K' (.*1
M#;H@'D[QN'/%I$>D&JA=)Z73E'L;QHFI9%_;,NM>#=7B4^C,0:M!(3&Y&[I6
M-/WM2;QCTP*P!)(OQ.S"B/%=(RUTP%)VV-C\+C5JTK1CO7@AB^74*=;4Y9J1
M2TGU\9XQBI*Q;WP<_2C$ $AK'@@?5VQ&SK=^HB 6CR(3IQ:BAT>+75XKS_T\
M@CWQ"FGTIG-&=;JUVLSEZYPW>W=>@UR)@MMF"BJGO.4!CQD/="%0S-12-K1*
MMH!HGDR\QK:I>$M.?(X]QF*W1,P"-6*S#Q2));.87)*\U^;#8Y@D;>.O$@>F
M0=GUT50Z+[,]IF1>)I(>GA7E-DDH276A#K5C7"[T[>_L1# 646*C+B_B\2C[
M;*SN00>*;SF*VB;T!45E,4/EH\18,-\?5;]GCYRZ/(&/ !2\UU#K%"PX(FU+
M'_(B"WGK3VP:2%$A?CL#.?QKG*F8DHESXI?#("3=C>\9?^-.-7(H*\+,L4>Q
M4L6_2BF&<$/K[DS<6<Y=:>JN]#R[XO0,LM%'K<-%MBNDCA#@SX\>2C5RC?A"
MQ U!B*"<.!XST^6K"Z\15Y ]QPJTM*=:<OH37"ERQ0JGH&=RI4PT]IAM]&%*
M8C"2MK+P:S("A.Y)9.HE=5PHB'TU?5-3:FED^Z^)::/W/THY4T0#EN!$6@6<
MTER3P@[J;GC$Y-GD 1(>8R 8<*")GB)^^$C(+MMO:.)E\I&C(^@?'+M5@I?W
M %!Z@)TAIHGM!P#5DP1TAAI&$7?EV%+8HO],U3G,Q KA/,C0I#Z<@JF-GBM1
M]D$N2N4C4J3+0(ZE1&](8PE)9TA"'!0?4@(P$^SV(50904 :=\C"_@WN\&(O
MS!_:P0R>&J1*IHIN+'LT8M0#G'R&LR9-4:*](D(I3R9L8]M4V"4G_@>BL& ,
MB**4AXBL5J/H4V@HSMF44U82G'#P6K(SC2]-,L12\C/AI<ZUYR37<&*AR[;O
M*:N5HX@F*.=4_\(_&23?) S!OY,K57(\PCQ.BUS"),6X:=_M>DMJW/CD:&QQ
MHY%\_%2Y9EFB5I9@XV%3'/(-<U:IF_3!Q#U!?,J3#4)CZSS.)Z=,\\07/U79
MF9:J#>.Y)LJQ]&.D^),W1BAY4H8;V^8,YR04*<A00=%4,98T,3-C A&UBK(.
M3Q2%2_[I972?7-17=BE%:?DI2D%[0L-1$FA>FXYDZ$,:BMJL%TQ9&-4DJE)-
M-#D23$DUXIPH7VNK*?K4EM!GF@CG:#1-PG,TJN0ZJCK&0J+4%*),>G\I"\Y$
M+.$(PP@CEF^+@//D*C>V359><F*9\BMQ1O4X:&,S]N_0[9 H]/5CKB&=\.IG
MB:=IQ8I?)WF78LT5FZ %+--Q&VOWO#@Z:?OF^9I0L62P.B;=V0SYC!/PY!(7
MM"VIS<G -VC^!F(\D@O9?FC./< +"Q*'M)FO9>4!S:7M<I.1GS2ULBV[[6+<
M8/ZC(B^'8M_CB8/&I1(H4 KNEV['B'W P"S@CHFHT$;"<AU'X7R!8&<\.<J=
MJO4*<2ES&O:)>A_(@@8TQ@<L5>8>7SD58(A_"].)4G(H;"+4[CBW/.?A8E6:
M.\+M :9RA>3D'%+N$/-]ST],/FDTH(DB'&34<$]6[W,T4*/\YS,-X$27@%!X
MC!,^RW$+$)5\OVXLO_ /L!-7N  4[[[-\P#X.N3J2Q93?/-D,)JI/2LQ!_&*
MH9JPC^83; 2,!32?8;-Q1!VDS#!%Z^EB DQ_\F-'-7D8R 4MH<"S\%[0QT$Q
M4M7:LKQG%P,+7$N,G2;SGT$IMV@/8GV4JK$I"9<'A%\#:-0$[&(P*5D58D@+
MB%A,X!(-3QGPO,$TJ4J, TAQ'(O[%& _+ME^+F*PSB,O2HJ93[$$)(K$R406
M)P4N^-7Q+RO=0KW972>7IBD27K(+S#44(25#<7U@=@?L1'DJ&*..H#(X_CT1
M3\OB@#RB1_:+=,[S+\F0H^B0H<2=E(B1[&X07]O0]H>@=H0\[T?<&3JZ8SUO
MH4Q04W6(%B,>8T-A$D,EJ\.H0NJZJ%T@P:(_D.;E*[R1%DQ]M"(N[T)VL%;R
M2/N0/%)N\DCCD#RR'KT4I3+G*:]I;%M?HQSC#IT.YW%Y^]L+ >4I#FEL6QVR
MY,1IN:!D<,XT%I!V+A=H.-T"TS"%NW]AZ>"Z"?]ZG/"?SO?7XAP1C.Z2Z,$'
M,,;JC>VA_L@LH*78HQ6K-J?ZW<PQ1'RG)L1M4L> +G54X'B@G#NPL601]18"
M"YC-%!SF55(8K18EEOQDW.,M0P2\<'%6%9&=SV^5QN=</0E$(LML1,L -=U]
MB+MB82'E%/TJ2<]JV6#B5/^;]\S(/X[ZP"?/LFI7\/)W_1^HN-R%/E9&?F64
M7HNB^@)D/O:5T;_X7BA:2IR#%7B,KXN-*JO G^(]3WSO"9-9>*)%XBM'=P\L
M'\?<X)QJH9HX:JI3OLP$X,X+3[H:8J6'T' ^%(^]XVMQSWA-Z'@B6Y@R +#G
MQGP<7Q18SJU \H\R.F0BCN<_F*Z8YB), 52]+.RE,;LI@T*&0K/5"-OX642:
M +<#>:TY+.]R7VWLL?)F$F32P8N$L@PU2 H+<*+@"6IBR #/AL*6)>AM&CF>
M263FBZH*O@D^2)1*6+DMG_X@*/0<F;E3"MNI)-X@D:8E6OGS]OF9<Z%B:U'C
MQB60U\*,>$%?Q'BXJOK@HR=#PHP[)N0IN?ML:#I#<7=$A_) 5 4P<P1$#"VU
M*77I9%MTK^3^PU*5>>9A\59P(GE1E*XD938ICUR2E_>V!%:>"K?&MB5N2T[\
MFS0^C=G>-YJ*1NDBV!A9A-5#>5GI[(68::DN O0'R?4YF0K&B$7A5,TN>*+L
M&\&SY#21PG1*3%8ZR(V,1AS2)Z[N ^4@!>6#$]&,SYPY*O=Z)&8X$@=%PCP<
M6)S4K6L"_85C3_B6X\!2TNDO63GNU<=YEO"ID>^)(,3])0MVJXH.*INGSTNQ
M<:H1%PVG$ZH7FSG2[.7QV0#DR2$7%YX1,T@<[MY22L'B?+&4XW/.K94P).D:
MXUZ1>/FYG+1X8>E2Q!W/.))R?C-VP:''B/HFBC1%2IY0\P*(HRK)C6+4B;R2
M6<X6IO2W"68TK@-E',7 F[7P>.M.8)$-?ZV@Z\T"M;X.J+7<H'Y3G+V9IRJP
ML6U9X I3).$:\EYY\KVAR6!"YGR0%!M_8KQEL\ GCCRS.@*M@?KI#(%@(AQ.
M_I-J6:IQ"6@1\X5A\[5Y8$:(^EGS093R">]]7$\8)RYP)Z;XHB@TL)-J.8&Z
M L&Q+:R, *3<ACP;3JD;%$VQ52$H4\TO@"(\RS9%+NU"B.M+(:X"5XM!KMY#
M01#/*,5;!'&M5(B+&M+%D#8QCN5;FC M$S!_HYC/G!"G4L^0.!YZ=^%D7-ZE
M2O,6\"**2JQB:)J4'<"KR#>?JAQ<L'*JU!",=R'.HP53:RFZI/[LSJIE0OQC
M$IC!@\UTB116%@I]QKGCKZ62>.+M+*IXS/C^J5314)O79EP!B0Y%Z!*W\J%&
MV/)V4M%2U82@K+ A;2PH+L6[(N(@3]%8L\2BL5GC"S\(ETUSO;R(?K9D"SC2
M"0+>-V!D1@Z8RMR<Y:?F?S8HF=0U75&:I'9CBL,Y(>BR#[P4 -F-\$+(]7UA
M\]$W4$^0#^#7D@JQF,2'8MB;XST+$Y^KYV)OF 2L$G"60LYW"B8$(*0]'C.+
M6EX)I0@8A[8@&P[Y>A+A\YZ5;!;:1L:W$ *V+'P9FA$E*<O $O>->6HW$+"S
MX8+5-+ X@$H19E5$&>D7U5,+TRG)LDR)-F+T[+O:SW!1>R_IW=&0,;K1>, '
M2B0+JWU6O93/,F3#1]=&*+\Q*LY3M-$LIF@C%Q5O5/B9KS!SI@[^G9 CPB\E
MM)VTM,..5LN+,A4<B7>0KL],""DM>-30*1])2 _=G/^1TJC4LDUM9=GFK%=^
M8=%FH"^LVLQPCJ62@K299+!8S@F'8S(,0F9E9.97X*8\?ZSV(!C0'(JY3/!T
M8:U,8M&XUV+&6S&O1<UD.RD,FEK'F.YW/YJ$0U%Y,O.VRFKB= ORK@@#VIEJ
M"N.:!3_Y6^B.^&"-!\<;8"N<.%U2B0X( <,C_)1F8<OD%$(&649KHR3AU2F!
M(C2T+/U1#'-(>KZ)#JCI,9N(@8@_4G(FS([,>U$'EZI633STC)(A%&E*V?Q"
M_ABP+@_C9/!NZK--V0BR*D2Q-:Q(I*P@KP:F83_95D05E0KOQR^IW1/1)\$;
M&,D6(@))1+=L 80YTRB6D-0U\L4>P\M809[(2X"V*B+%)-;;*"2?/SD',M01
MT<0)<"21Z*(X"<,R-)*#BJ5$_E/\%"=LS N:@$*"N4*HFMN4!26.GM35@ &!
MY0K*%2BIO7:0%$EHHAHC\?'IBD,NIP8OM67A_*^@-"QI-^NE>'0.*1[EIG@T
M#RD>FY-34=ICKE$1)1:HQMD),[.E#"T1 2BZ9IGS8!K[:$1[/-EBCL2'XD2*
MX\R),XEZ;ECPH3")A"SHEJ4EY1 XUUCT=@[FFCN?4SD]<MZ!AVV(E1Y80G1E
MC':8B9ZGXMC ]A\!Q:2K2IMQ52UU#H*)*](?I/-*.#UBSR"I;SPK8'XYF67A
M>FY-FJ%<\&I";)*:DYR0-DIJ&G?U\7%]R_J*7<]FL,<:78:$3X0ASP:F#O@$
M0<LWGTTG[LBL;"FNX\OPY)DBX99/-(R3+\FW9L=5@Q3DQ:8N5#T[Z^OD#EKY
M.3@0+WI6H,@K-X-8/XT+H9^Q(G%DVHZJ1,\Y5U%]PGZ<L:(9IQV3UA5#1)M-
M'5:2-2PP%:8\4640BAQUU#G0W48A;4(<58&6M=H^4[,C$(EY;0J- TAG%/&E
M-5*4X\Q4^0&AF_)G, 58_33Y:5,YKU541K9@KGD*+9LE%EHF%\5K%&2YB<9S
MK&);( .YE9#85!AL<ZWUTI; 3'J2G%@(#P?HL@FY)1*2(HM/!$P8PPL8(W)\
MXO-9]D%<(SYCE2*W5%KGR3P=9,$I[I#V_ZM%'\9\W2C%*XQ<=L9SQKZF:'@$
MR@?BHA\O9CYDHD5C,,SA&JCD/8M'SIJZ:29)Y)28MP1ZGGU'C6^#.+*K ")=
M@CK'>-7VBK$5;U&FN,W3L B*\;:PM)J[%4/9A<DD0PG?H>H8QWS0U6*!5,A)
M>D%'E(.4-)$4N3UJ)@[G'0H#OO=4#P]RN9E'>#ED$"$7M<FR34L545Y#U7LT
M['"V6909:+Q-^R 1\S/MU>4LR(3Q"GY'G%=4 %*^)!^&B2=1+C5ALF^-$^:I
MI&V66$E[/X/9[SC[XS4:(]F+"[L3+U;'$EIP@*!]GIR)[Z;5.-E(3"&=[)S#
M6$-(<F=YQ@@QL!3^D4<]8XM)VPZ7>OWKC KP#/TA,JGA@^ [@CW* +'0.5#D
M*L[-9+& -ZA3OBWZC7G>]R"5@I1],,HD5KZ!K:YB/491<G@FBR6[T<X?4$O=
M@52!B5?Q(#)R:/@\6'JU)$-4R2TQQ,_"4A!%S8+;@IDPL4/B@G&&JFJ#\"([
M],I@3 8'<;\QJLQ3'MLLL#QVQDW!QQ"8ML\=+8@FR8 S31EP)H3/'9N B88Q
MGU;=T)OU9K/H:H&L#;Y**ZYFGC*,9O=HO;FPTGR]'25P5L!\[<9&\.THMH"_
MB! C7A3=T]HS90O^+!PZ)/(<,L>9(/MP'WXYPL/"S\'$',J?I8.(^]U($Y@$
M[+TN_X4YG5;XB.A2_POW:N5!G2-T!OT<^G)]$._4'U]B#W<R'0F746C)Y^8Q
MK/P1**'U<>D.0!9P ":N,71([F1C^P$?6NB9H1, K]:Q*@$R0&'\[2]'G:,U
M-Y_#"UWH $O,FZ%M)[0?O-4K6 7;S*.4CO:?;1'%77D-[T)_0]ZV^N3/CW;(
M:LB>86^N]^R;D_39'38*,P!4,#"4X],9;KQ0%T-6F?7SP'_WD6<2!_K?F/7
MFQ=G#UK=5[RM-+M <_P Y;*AG,0Z:+^@6A/F:QE-H#A)?/:&I,&^B:N)&7>S
MXK+S6QS/Y]=SK@3UB]#RRN>V;TXC?4U274FFFB13G1_O+>J[^T:SG]@;H=F\
MNB%Z39;1$5?S9M\-O4F1Q_CC^I]QVW^EN_A*T.]D<S-#X5;PG5?:4K5V\^H
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M[I</7Y9M9^TDJV<_,VY;><;XM+8=XS.K&)^2DG+T,9FM:@?JY)BQ&>#04E<
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M@497NV.-K7_FX6JCH=!+OR"MOIUATDW#GGY AN]WP /=,M#I]2<NU!/;+4"
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MRKQFN>M%T0MNU/TLF69@P)!>G9=C\'62XQ?"*/8U167R,I&6O<0D5[HF%J#
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M4M=+F2O5#=QJ5#*6"V(KI,[R$K ZC./!XO//.=2<AXK7L>0<SA@F7V+Z8%C
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MHD*U">E(TO%J\( :&3 &92.0?+S40%[%:B4M%_"W!K-.WDX;;)R>(-];V[^
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M"DYN?4-!:NE %)CBRQS!"*C0"U0N-.)9R 'D)L]0(S#P+\DG%[ "R]XT5_(
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ME4[$,ZA'PL<3L8CRQLIW=/J?@KJL5&D34T,W$4%#@]N'@@Q^M:4(2;F@6L3
MA)8FLVA!:" TL)_M4GS'1, 4GC2V4**U\3!]H0(::@$!Z!0QS1X5F"(,C.B(
MI\Z8HR L?.F0PC23)#?,L-9Y0.H<*E426(/3:OHY!]\]Z1MG-WO3/T!D+XG
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M-036NJA>B#W54YS)%V?:E]SV3DR7+SL-#%HY9;ITEVYW73N'%7 (2LL=1FA
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MYJ0L)ZR[0#RZ,66=0TY(D2K!ASDF57 HP/B[FK3\45@$D(-H #? R X([ E
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M,>R*1U,YJE=NE08BT$!X-7F&><++!2??O@8G-QB<W'\-3C[6,?@?J#NQ5(>
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MXN_I+9Q_MN,B;,JE?H"GA'_/_@\-(X@]J8UB2?)4NV9L8PY^.81\@U@G_V,
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M-W8(5UZF%0.:$HLD&VA'ZQ.NXZJ26=6\J?164-QQH;5%MKBA8HNU=3(W[+(
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MO$$5PQEF8) \D11<^Q4(L45.>:^7 GQT-+"C*E9>)TH../L[1;K#,@"5W2;
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MJ6P^AXZVKN#?WKR)5?D#4$L#!!0    ( !:(:%5[D7,%6 <  *XJ   :
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M#B_ST7Y%[YO&%U#I/=7_ U!+ P04    "  6B&A5_D<\4EH'  "]*@  &@
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M^W#9G1_YII/_B#C\UM'.5F>;*BS8?:FA<S;@(\&L&$DQ%AD0(!W[L^065%!
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MPC8C!'/-M]?,MW15?#L;<54&)2 HBCRGK=\1,.0@< MYS#0"?8:VQ9_+4YM
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MG>G2\A7N]M'R1==/XWU4NK;Z+U!+ P04    "  6B&A5+&HC4KL#  ")#@
M&@   &8Q,'$P.3(R97@S,BTQ7W9S=')U<W0N:'1M[9?=;N(X%(#OD7B'HTA;
MM5*  -O1#F0B0:$[73&4*>E*O32) ]Y)[-1VVK)//\<)R4"IRK9J9_=BN2&Q
MS[\_'SON9__+Q*O7W,_CP0C_P?Q<_\*?C#VW5?SC;&LS[0XO1S<P]V\FXT]6
M)+CN0=M)-?@LH0JF]!ZN1$*X70S8,*>2118JHNKLI7I]2(A<,MX#(^KT0=,'
MW2 Q6^*09,N5MCQWZ(T?5FS!-'0[S;;;&F+8L_=P&%"NJ<P]'O&%2OL_Q]<9
ME9I%+"":"0XB@IED/& IB6'\0(-,LSL*EQ%*4/ES(IIE4F6$:] "%0,35U&0
MC\X'$Z!>49@3N2"<JL;E0TS7]=H@T&:JXSB=-PW2JM;B]0:WTXQII/=<7' (
M!.=%JG#/] IS9 J^9D1B4>(U7-%42,R0UVOG0B9%3&VG\;5XBH3,JW);* #E
M(0W1?:IILL#WKF-C:3H=.#921W%XFXE^8?-(YB\GIGI_SL&7F=*/Q)9,:8GK
M48D2'M9KE 0KH\2T@O.,AY@O41"Q&#UO4J!PW9PWS1IFDFF&-4)-I"I8$;ZD
M<":2A"F58\=S\9!H"BLJJ8ALN+#A#PR&<;@1&5_:N40%9[VV1V?)QH^([=S8
M8HUT&<C7MD'*B"RHRGE)UO"-BWN,>4F- Z)[[[K2CV#R!\/)&,[&D\EL,!I=
M3'__9#E6_CZ?#<[*]U<2W- BS1U7 PNAM4@V8_<LU"MCS_D%=YU_5;JY,Z4*
M2%SF@59V$_O++$JT-DW7]4>EVG[J&P<.XY;I]"-O2[J<:W9.&=^O&RJ<7T[]
M[<P;BOU-B_0M[[A]XK:,Q)[AEUKR<U[RS15E,>ZT0"1I;% U#-=K!A9);S,F
M:8(=2AEH=GI2NWM,</-(:)\>AR=5>_J!?(7[ID6U/W9_S;<*2?)MVM\P<>WA
MYG!;U]YV9N9D]*_,LR'%^Y_*_S25G;>DDG'LZDEQ*N/IH GCV%D9+Y@LF27,
M' ^II,K0:>,\D#C&TN(QP/ (QXD4<55%]XP8)]@^<1PMABRW;5HR2F5Q ;=(
MJ<R=JOUVVGQS-/\IB-O@/0;SQ4ZW&.O#0LB0RD8@XIBD"E>@?++RR^KS"%J;
M"^T^0Q]R?I]=Y!&N40^FXJXXHW\KCNC=$C]M_/2@[>&Z]ZRA3=;EUAO&)/@&
M[>8I%D^)F(55D;J'?;54:^>@WMD#!I$7U;%B8#OL Q%,L97V2KTGLCZ@_N\&
M[S,=TZ=7ZX#FLQ?UMT_C%;F5%\JGPZDZQSOT#M.=S*=D\6UI/D&_ U!+ P04
M    "  6B&A5DNO1O\$#  "N#@  &@   &8Q,'$P.3(R97@S,BTR7W9S=')U
M<W0N:'1M[9=?;]HZ%,#?D?@.1Y%6M5*  .MT!UDD*'3K%:.LI)/Z:!('?)?8
MJ>VLY7[Z'2<D@U*UMU6[[>'R@A.?__[YV'$_^9\G7KWF?AH/1O@/YN?Z9_YD
M[+FMXA]G6YMI=W@^NH*Y?S49?[ BP74/VDZJP6<)53"E-W A$L+MXH4-<RI9
M9*$BJLZ>JM>'A,@EXSTPHDX?-+W5#1*S);Z2;+G2EN<.O?'MBBV8AFZGV7%;
M0PQ[]AH. \HUE;G' [Y0:?_7^#JA4K.(!40SP4%$,).,!RPE,9PR3G"(H_,(
M):C\-1'-,JDRPC5H@8J!B:LHR'OGG0E0KRC,B5P03E7C_#:FZWIM$&@SU7&<
MEUTBJUJ+YQO<3C.FD=YS<<8A$)P7J<(-TRO,D2GXDA&)18G7<$%3(3%#7J^=
M"ID4,;6=QI=B% F95^6Z4 #*0QJB^U339('/7<?&TG0Z<&BD#N+P.A/]PN:!
MS!^.3/6^SL&7F=)WQ)9,:8GK48D2'M9KE 0KH\2T@M.,AY@O41"Q&#UO4J!P
MV9PWS1IFDFF&-4)-&-\&*\*7%$Y$DC"E<NQX+AX236%%)161#6<V_(W!, Y7
M(N-+.Y>HX,1"5'0:JX,@0"F47I:PEJC\3,#.;2_6")MA?FT;PHS(@JH<GV0-
MW[BXP126U/@CNO>J"W^'+7\PG(SA9#R9S :CT=GTXP?+L?+G^6QP4CX_$^B&
M%FGNN'JQ$%J+9//NAH5Z9>PY;W 3^A>EF^^F5 &)RSS0RFYB_Y@UBM:F![O^
MJ%3;3WWCP&'<,HU_Y&U)EW/-SC'C^W5#A=/SJ;^=>4.Q?VF1ON4==H_<EI'8
M,_Q42W[.2[[7HBS&C1>()(T-N0;I>LW (NEUQB1-L&$I \U.BVIW#PGN)0GM
MX\/PJ.I6/W= 1?^F8[7?=]_F.X<D^:[M;YBX])!JMW7I;6=F#DK_PHP-*=[_
M5/[15+Y]22H9QR:?%(<T'A::,(Z-EO&"R9)9PLQID4JJ#)TVS@.)8RPMG@JF
M4^)$BKBJHIE&50=%BR'+;9M>BE)97, M4BISIVJ_G39?',W_"N(V>'?!?++3
M+<;ZL! RI+(1B#@FJ<(5*$=6?G=]&$%K<[_=9^A=SN^#BSS"->K!5'POCNR_
MBA-[M\3W&S]^U/9PW8.RF _8VR1?[L!A3()OT&X>8PV5B%E8U:K[N,N6:NT<
MWSM;P9#RI')6*&R'_4@$4^RHO0>R?D3]]P;O,QW3WG/BON_Z?O\%Z36R>D:J
MY:WS_G"J?O(*'<7T+/.]67R FN_4'U!+ 0(4 Q0    ( !:(:%5IG5.""A(
M  W/   :              "  0    !C:6LP,# Q-SDS-#DW+3(P,C(P.3,P
M+GAS9%!+ 0(4 Q0    ( !:(:%5Q JG_5@H  &1L   >              "
M 4(2  !C:6LP,# Q-SDS-#DW+3(P,C(P.3,P7V-A;"YX;6Q02P$"% ,4
M"  6B&A5GH"T%,LF  #=A@( '@              @ '4'   8VEK,# P,3<Y
M,S0Y-RTR,#(R,#DS,%]D968N>&UL4$L! A0#%     @ %HAH55=7X>OE7P
M?I\$ !X              ( !VT,  &-I:S P,#$W.3,T.3<M,C R,C Y,S!?
M;&%B+GAM;%!+ 0(4 Q0    ( !:(:%43(7#.JR<  #N- @ >
M  "  ?RC  !C:6LP,# Q-SDS-#DW+3(P,C(P.3,P7W!R92YX;6Q02P$"% ,4
M    "  6B&A5)S4AX$3H  #O5@< %               @ 'CRP  9C$P<3 Y
M,C)?=G-T<G5S="YH=&U02P$"% ,4    "  6B&A5>Y%S!5@'  "N*@  &@
M            @ %9M $ 9C$P<3 Y,C)E>#,Q+3%?=G-T<G5S="YH=&U02P$"
M% ,4    "  6B&A5_D<\4EH'  "]*@  &@              @ 'INP$ 9C$P
M<3 Y,C)E>#,Q+3)?=G-T<G5S="YH=&U02P$"% ,4    "  6B&A5+&HC4KL#
M  ")#@  &@              @ %[PP$ 9C$P<3 Y,C)E>#,R+3%?=G-T<G5S
M="YH=&U02P$"% ,4    "  6B&A5DNO1O\$#  "N#@  &@
M@ %NQP$ 9C$P<3 Y,C)E>#,R+3)?=G-T<G5S="YH=&U02P4&      H "@#:
) @  9\L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
